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THE WILLINGNESS TO PAY FOR  
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VULNERABLE PLAQUE RELATED TO HEART ATTACKS 
 
 
   
 Recent medical studies have led cardiologists to revise theories regarding the 
cause of heart attacks.  Rather than a gradual clogging of the arteries, eruption of a 
“vulnerable plaque” is thought to be the cause of approximately 75% of all heart attacks.  
As a result, traditional risk factors are no longer sufficient indicators of who is at risk for 
a heart attack.  Therefore, this research investigates the willingness to pay (WTP) for a 
new, hypothetical detection (screening) and treatment method for vulnerable plaque.  For 
this study, two survey instruments were developed that take advantage of the visual and 
interactive aspects of the Internet.  Individuals report their perception of heart attack risk 
both prior to and after receiving new information on who cardiologists currently believe 
to be at risk for a heart attack.  In addition, respondents are provided with information 
about the effectiveness and risks associated with screening and treatment.  Using web-
based surveys, which follow a contingent valuation format, an iterative bidding process is 
used to elicit the respondent’s WTP for either the screening or treatment method.  
Internet, on-line surveys are often prone to coverage bias; however, the survey valuing 
screening (a simple blood test) used a Knowledge Networks panel and resulted in a 
sample of 268 adults that is essentially representative of the general population.  The 
survey valuing treatment (a more invasive heart catheterization procedure) was 
administered only to individuals with doctor-diagnosed heart problems, who are 
presumably more familiar with these types of medical decisions, and resulted in a sample 
of 295 adults.  The mean for screening is $69 and the mean WTP for treatment that is 
85% effective is $5,816.  A two-part model is used to identify the factors that influence 
WTP, as well as the decision to receive the screening/treatment.  The data suggests that 
these factors vary across genders.  The data obtained for this study demonstrate construct 
validity; therefore, the results may provide useful information for policy analysis 
regarding the screening and treatment of heart attack.  
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Chapter I: Introduction  
 
1.1 Motivation 
This research was motivated by a recent development in the medical literature 
regarding the primary cause of heart attack.  Many of us are familiar with the idea that 
“clogging of the arteries” typically associated with high cholesterol levels can lead to a 
heart attack.  However, new medical evidence has shown that gradual plaque build up is 
not always the cause of heart attack – in fact, cardiologists now believe that 75% of all 
heart attacks are caused by pools of “vulnerable plaque” that lie hidden within the arterial 
walls.  Stress or other extrinsic triggers cause these plaques to erupt, creating a blood clot 
to form almost instantaneously within the coronary arteries, resulting in a heart attack.  
The reason this new information is so important is because it implies that prior to a heart 
attack, the individual’s vessels may be relatively free of plaque build-up, such that the 
individual never experiences chest pain or any other warning sign of a heart problem 
prior to the attack.  In fact, evidence from the Framingham Heart Study1 indicates that 
over half of those who die from a heart attack do so without ever experiencing any 
symptoms of heart disease (American Heart Association 2003).  Therefore, this new 
theory of an erupting vulnerable plaque explains why individuals who appear in good 
health and have low cholesterol levels have been known to die suddenly from heart 
attacks.   
Unfortunately, the factors that contribute to vulnerable plaque are not well 
understood; therefore, physicians still base heart attack risk on traditional factors that are 
associated with plaque build up, such as high cholesterol, smoking, and being 
overweight.  Although these factors may provide some information on who is at risk for a 
heart attack due to vulnerable plaque, an important piece of the equation is still missing, 
such that many individuals who are at risk for a heart attack are not being identified as 
needing treatment until they actually experience a heart attack.  Approximately 50% of 
the individuals who experience a heart attack die as a result.  For those who survive, 
outcomes can vary greatly – from essentially no effect, to the individual being left 
                                                 
1 The Framingham Heart Study is an ongoing study that is well-known and well-respected among 
cardiologists. 
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permanently disabled.  In response to the need for an inexpensive and non-invasive 
screening method that could be used on the general population, researchers have 
discovered some simple blood tests that may prove useful in identifying those who are at 
risk for vulnerable plaque.  With such a test available, treatment could be started on those 
identified as being at high risk to reduce the probability of a potentially fatal heart attack.  
Unfortunately, the only treatment currently available for treating vulnerable plaque is 
drug therapy, which is only about 30% effective.  In addition, drug therapy requires a 
considerable amount of time to become effective, so the currently available method of 
treatment offers little immediate benefit in terms of risk reduction for heart attack.  
Therefore, in addition to a new screening method for identifying those who are at high 
risk for a heart attack due to vulnerable plaque, a more effective treatment method is also 
needed.  Medical research is currently underway to develop both of these goods.  In fact, 
early forerunners offering limited potential as screening methods are already becoming 
available.  Therefore, it is expected that both screening and treatment for vulnerable 
plaque will be available in the near future.  
 
1.2 Why is Screening and Treatment of Vulnerable Plaque an Economic Issue?  
Although a growing number of heart attacks are occurring in younger individuals, 
heart attack risk is primarily an issue for those individuals 65 years of age or older, who 
are covered by Medicare.  As such, a large percentage of the expenditures associated with 
treating these individuals is borne by the government and financed with tax revenues.  
Therefore, decisions regarding who receives this screening and treatment (when it 
becomes available) will largely be at the discretion of public policy decision makers.2  
However, little is currently known about the underlying consumer preferences for these 
goods, which should be directing public policy decisions.  Even for those individuals not 
covered by Medicare, heart attacks and the symptoms associated with coronary heart 
disease (i.e. chest pain) are the “leading cause of premature, permanent disability in the 
U.S. labor force, accounting for 19 percent of disability allowances by the Social Security 
Administration” (American Heart Association 2003 p. 12)  Therefore, understanding the 
                                                 
2 In January 2002, Medicare started covering the cost of C - reactive protein (CRP), a simple blood test that 
indicates high levels of inflation (Comarow 2002), which may be associated with vulnerable plaque.  
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value individuals place on screening for preventing a heart attack and its associated 
treatment is necessary to ensure the efficient allocation of available health care resources.   
 
1.3 Measuring Health Benefits 
Benefit cost analysis (BCA) is often used as a means to measure the gain to 
society for various programs in order to determine which programs are potentially pareto-
improving.  BCA offers many advantages over other methods of valuation (i.e. cost-
effectiveness analysis) because net benefit is measured in dollars, which allows for a 
direct comparison of programs.  In addition, BCA is consistent with the assumption of 
consumer sovereignty, that is, that the individual is the best judge of his/her own utility 
(Mitchell and Carson 1989).  As a result, BCA analysis has become the accepted standard 
for evaluating the societal gains of a program and is now required by Federal agencies 
and many state agencies as an integral part of the implementation process (List et al. 
2004).   
The requirement for a formal measure of benefits in public policy decision 
making has created a particular challenge for environmental and health policy because 
environmental goods are not typically exchanged in consumer markets, and many 
markets for health-related goods and services are influenced by the presence of insurance 
companies as third-party payers.  Therefore, in valuing environmental and health-related 
goods, economists often utilize stated preferences obtained through a contingent 
valuation (CV) survey.  CV is a stated preference method that uses a survey to elicit 
individual preferences by asking respondents directly about their willingness to pay for a 
particular good or service contingent upon a market for that good existing.  A distinct 
advantage of stated preference is that this method has the potential to measure both direct 
values (those that are obtained through revealed preference methods), as well as passive 
use values.  Therefore, stated preference methods have the potential to measure the total 
value of the good, and as a result, are important to BCA in estimating the total benefit 
associated with a good or program (Carson et al. 2001).   
 There has been some debate regarding the ability of CV to provide accurate 
measures of valuation for non-market goods (Hanemann 1994; Diamond and Hausman 
1994).  One of the current concerns regarding values obtained using CV is that several 
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studies have indicated a tendency for stated preferences elicited through hypothetical 
markets to overestimate revealed preferences observed in actual markets (Cummings et 
al. 1995, List and Gallet 2001).  However, many studies have demonstrated that 
hypothetical bias can successfully be eliminated ex ante using a cheap talk script or ex 
post using a certainty follow-up question, such that stated preferences obtained in 
contingent markets coincide with actual purchase decisions (Cummings and Taylor 1999, 
Blumenschein et al. forthcoming 2007) 
Valuing health is important because, from a benefit-cost standpoint, it is 
necessary in order to ensure the combination of health services being offered is the one 
that will maximize the wellbeing of its citizenry.  Therefore, valuing health-related goods 
and services is necessary in order to make efficient decisions regarding the number and 
types of health programs to offer, and CV offers a meaningful method to accomplish this 
objective.  A review article by Diener et al. (1998) indicates that CV surveys have been 
utilized in valuing several health-related conditions and treatments, including (but not 
limited to) hypertension (Johannesson et al. 1993, Johannesson et al. 1991), screening for 
cystic fibrosis (Donaldson et al. 1995), anti-depression medication (O’Brien et al. 1995), 
and in-vitro fertilization (Neumann and Johannesson 1994).   
Although some studies have looked at the macroeconomic benefits and costs 
associated with heart disease, as measured by the number of cases avoided (Long et al. 
2006) or reduced medical expenditures (Cutler et al. 1998); few studies have asked 
individuals directly about their valuation for potential improvements in heart-related care.  
A Swedish study conducted by Johannesson et al. (1993) uses a CV survey to estimate 
the WTP of those with high cholesterol for participation in a program that would promote 
normal cholesterol levels.  In addition, two studies (Kartman et al. 1996 and Chestnut et 
al. 1996) estimate the WTP to reduce chest pain, a potentially debilitating symptom 
associated with CHD.  However, it does not appear from a review of the economic 
literature that any published studies have asked respondents to value a screening test that 
would better identify those at risk for a heart attack or treatment that would directly 
reduce the risk of heart attack by a specifically stated amount.  Therefore, this study 
utilizes two CV surveys to value these two health-related goods (screening and treatment) 
related to the prevention of heart attacks. 
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1.4 Method 
As part of the survey development process, decision trees (typically used in 
clinical decision analysis) were created to better understand the decision(s) that an 
individual would face both in the current state of the world (when screening and a more 
effective treatment are not available) and in the desired state of the world (when 
screening and a more effective treatment are available).  Using the decision trees as 
guides, two surveys were developed - one to elicit the WTP for screening and the other to 
elicit the WTP for a more effective treatment.  Both surveys were administered via the 
Internet.  The survey for screening was administered to adults in the general population 
using a nationally representative panel.  The survey on treatment was administered to 
adults who have a past medical history of heart-related problems, who are therefore more 
familiar with heart-related treatment options and, as a result, are expected to provide 
more reliable estimates of valuation.  As part of the surveys, individuals were provided 
with information on vulnerable plaque (similar to the information presented in the 
opening section of this chapter).  Respondents were asked to assess their perceived risk of 
having a heart attack both prior to and after receiving the new information.  Respondents 
were then asked about their WTP using an iterative bidding process.   
According to Alberini et al. (2003), “single-bounded dichotomous choice 
questions are notoriously imprecise as the only information revealed as whether WTP 
resides above or below the threshold provided by a single bid” (p. 42). Therefore, both 
surveys used for this study utilize an iterative bidding process to increase the efficiency 
of obtaining welfare estimates.  The iterative bidding process used for this study was 
inspired by the interactive computer program used by Viscusi, Magat and Huber (VMH) 
(1991).3  Respondents are assumed to have an underlying WTP that remains constant, 
such that the iterative bidding process (in conjunction with a series of follow-up 
questions) will elicit the maximum WTP (for either screening or treatment) for each 
respondent.  
Valuations obtained using iterative bidding have been known to be subject to 
starting point bias (Whitehead 2002, Watson and Ryan 2007); therefore, some 
                                                 
3 VMH (1991) use an interactive computer program to generate a series of pair-wise comparisons (based on 
the respondent’s pervious answers) to elicit risk-risk and risk-dollar tradeoffs related to chronic bronchitis. 
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economists advocate using a payment card as an alternative to iterative bidding as a 
means of obtaining stated WTP (Mitchell and Carson 1989, Alberini et al. 2003).  In the 
economics literature, many bidding games that are referred to as “iterative” do not 
actually allow the bids to both increase and decrease to converge upon the respondent’s 
WTP.  Rather pre-set bids are offered starting with a randomly chosen initial bid that 
increases (decreases) monotonically until the respondent changes from a “yes” to “no” 
response (or vice-versa).4   
The iterative bidding process used for this study is truly “iterative,” offering bids 
that become both higher and lower depending on the individual’s responses to each bid.  
In addition, subsequent bids are not pre-set, but rather created by a computer algorithm, 
that allows each survey to be tailored to the individual respondent.  The computer 
program also allows the bids to cover a much wider range than would be feasible to offer 
on a payment card.  For example, the algorithm used for the screening survey elicits WTP 
for screening to within a $5 margin and covers a range of $0 to $1600, which creates a 
number of possible bid options that would be impractical to include on a single payment 
card.  Therefore, the iterative bidding used in this study allows the potential bids to 
increase (decrease) quickly when several sequential “yes” (“no”) bids are indicated, while 
at the same time narrowing the range of WTP if the respondent changes their response 
frequently.      
Results from this study are analyzed using a two-part model, which is often used 
for analyzing health care data.  The hurdle model treats the decision to have the 
screening/treatment as one decision, and the WTP for screening/treatment as another, 
completely separate, decision. A probit was used to model the decision to have the 
screening/treatment, and an OLS regression on WTP for those who chose to have the 
screening/treatment was used to determine the factors that influence the WTP.  The 
results suggest that the factors that influence the decision to have screening/treatment are 
not necessarily the same as those that determine the individual’s WTP. 
                                                 
4  Bids are either increased or decreased according to a pre-set group of bids.  For example, if the pre-set 
bids are $5, $10, $15, $20, $25 and $30, and the respondent answered “yes” to the initial bid of $15, the 
interviewer would ask if the respondent was willing to pay $20.  The interviewer will continue to the next 
highest pre-set bid until the respondent answers “no”; thus, determining a narrow range in which the 
respondent’s WTP lies.  A similar process would occur if the respondent answered “no” to the initial bid.  
In that case, the interviewer would then proceed to go down to the next pre-set bid until the respondent 
switched their answer to “yes.”   
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1.5 Contribution to the Literature 
This study contributes to the literature in several ways.  Primarily, this study 
provides a consumer-derived valuation for two health-related goods that are likely to 
become available in the near future, offering insights into specific demographics and risk 
factors that affect those valuations and provides potentially useful information in 
determining public policy.  This study also provides additional information regarding the 
feasibility and accuracy of obtaining WTP valuations using a contingent valuation survey 
administered via the Internet.  And finally, this study provides insights into how 
information influences medical decisions made by the consumer patient, and whether 
individuals place a value on information even when it does not affect medical outcomes.    
   
1.5.1 Valuing Heart-Related Health 
As discussed above, only a few studies have used contingent valuation to estimate 
consumer benefits associated with improvements in heart-related health.  Kartman et al. 
(1996) and Chestnut et al. (1996) estimate the WTP to reduce chest pain.  Although chest 
pain is a symptom of heart disease, which may be related to heart attack,5 these studies 
only focus on the value of reducing this symptom, not a reduction in the risk of heart 
attack.  A CV study by Johannesson et al. (1993) estimates the WTP for a cholesterol 
lowering program for individuals in Sweden with high cholesterol.  In a self-administered 
survey, respondents are asked to value a program that reduces their cholesterol to a 
normal level.  This study does include information which states: “the risk of heart attack 
is influenced by, for instance, high blood pressure, high cholesterol levels, and smoking” 
indicating that high cholesterol levels increase the risk of heart attack; however, as this is 
one of several factors listed, the specific reduction in heart attack risk offered by the 
program is not included as part of the survey.  However, given the strong connection 
between cholesterol and heart attack risk at the time the Johannesson et al. (1993) survey 
was administered, it is likely that the results from this earlier study would be comparable 
to those obtained in this study; although it is certainly possible that cultural differences 
                                                 
5 As Chapter 3: Medical Background will explain, an individual may experience chest pain from calcified 
(stable) plaques and not necessarily be at risk for a heart attack.  However, due to the fact that chest pain 
can be debilitating, causing extreme discomfort which can cause the individual to limit work and other 
activities, it is not surprising that individuals express a significant WTP for the reduction of these 
symptoms. 
 8
between individuals in Sweden and the United States may account for some degree of 
variation in WTP.      
 
1.5.2 Iterative Bidding with Cheap Talk and Follow-up Certainty Question 
In the economics literature, the term “iterative bidding game” refers to the use of 
a multiple-bounded dichotomous choice (DC) question in which respondents are asked 
repeatedly if they are willing to pay $X for a good.  Although this process is termed 
“iterative” in some ways it is misnomer because the process does not go back and forth to 
converge on a single value.  Instead, the initial bid is monotonically raised or lowered 
(depending on the respondent’s answer to the first bid) until the respondent’s answer 
changes from “yes” to “no” (or “no” to yes”).6  Although bidding games increase the 
efficiency with which WTP values can be obtained, they are often prone to starting point 
bias (Whitehead 2002, Watson and Ryan 2007).   
Typically bidding games are administered using trained interviewers using a set 
of pre-determined bids.  Based on the initial bid, each subsequent bid is increased 
(decreased) in small increments until the respondent switches their initial response 
(Kartman et al. 1996, Desvousges et al. 1987, Randall et al. 1974).  For example, in the 
study by Randall et al. which estimates the WTP for aesthetic environmental 
improvements, respondents who answer “yes” to the starting bid receive higher bids until 
the respondent answers “no.”  Those that answer “no” to the starting bid receive 
incrementally smaller bids until the respondent answers “yes.”  In this form of bidding 
game, the same objective could clearly be accomplished using a payment card, 
eliminating the potential for starting point bias.  In fact, this is the reason several 
economists advocate the use of a payment card in place of this form of bidding game 
(Mitchell and Carson 1989, Alberini et al. 2003).   
Instead of a single range of preset bids from which the starting bid is randomly 
chosen, some bidding games use multiple “sets” of preset bids, in which respondents are 
randomly assigned.  Asgary et al. (2004) use three sets of four possible bids to estimate 
the WTP for health insurance in developing countries.  Each respondent is randomly 
                                                 
6 Examples of studies employing some form of this type of monotonic bidding game include Whitehead 
2002, Langford et al. 1996, Kartman et al. 1996, Desvouges et al. 1987, Randall et al. 1974, and Asgary et 
al. 2004. 
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assigned to one of the three possible “bidding games.”  As long as the respondent 
answers “yes,” the next pre-selected bid for that game is offered.  In this form of iterative 
bidding game, no option was available to reduce the bids; therefore, a “no” response to 
the first bid was simply recorded as a WTP=0 (Asgary et al. 2004).   
Langford et al. (1996) employ a more sophisticated model in which 8 randomly 
assigned starting bids are either doubled or halved (for up to 3 subsequent bids).  Again, 
the bids only increase or decrease based on the response to the first bid, and the bidding 
terminates when the respondent’s answer is reversed.  Therefore, the range of potential 
WTP values remains fairly wide if the respondent switches answers in the first follow-up 
question.  If additional iterations are known to increase the efficiency of WTP estimates 
and up to 4 bids were potentially planned for each respondent, then why not take 
advantage of asking all 4 questions to narrow down the WTP even further?  Most likely 
the reason is that performing the mathematical operations necessary to accomplish this 
task (quickly and accurately enough) does not lend itself well to surveys utilizing 
telephone or in-person interviewers.  Therefore, in order to ensure consistency and 
accuracy in the interviewing process, the iterative process terminates once the 
respondent’s answer changes.   
However, as VMH’s (1991) study demonstrated, a computer program can quickly 
and accurately use the respondent’s previous answers to determine the next question.  
Although VMH applied this to a series of risk-risk trade-offs, the same idea can be 
applied to a multiple-bounded DC question on risk-dollar tradeoffs that is truly “iterative” 
in nature – in which bids increase and decrease to converge on the respondent’s true 
WTP.  Given the fact that many multiple-bounded processes only move monotonically 
and often cover only a small range of bids, it is not surprising that economists have found 
iterative bidding to be subject to starting point bias.  Therefore, this study will take 
advantage of the quick and accurate mathematical capabilities of the computer to explore 
whether using a truly iterative bidding process administered via the Internet can be used 
to efficiently elicit values of consumer WTP that are free from starting point bias.   
Blumenschein et al. (forthcoming 2007) found that a cheap talk script was not as 
effective in removing hypothetical bias as a follow-up certainty question.  In an effort to 
ensure that hypothetical bias did not enter consumer valuations, both a cheap talk script 
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and certainty follow-up question were included in the surveys used for this study.  
Although actual WTP is unknown, collecting data on WTP both after the cheap talk 
script and after the certainty follow-up question does offer some potential for comparing 
these two methods.  Many focus group participants indicated that they were “definitely 
sure” of their stated WTP values by the end of the elicitation process.  Therefore, this 
study offers some potential to determine if an elicitation format that utilizes an iterative 
bidding process with a cheap talk and follow-up certainty question is a potential method 
for eliciting consumer WTP that are free from hypothetical bias.  
  
1.5.3 The Role of Information on Consumer Demand for Health-related Goods 
This study offers insight into the relationship between prior and new information 
regarding individual risk assessments and subsequent health decisions.  Hoehn and 
Randall (2002) state that new information may have different affects on respondents’ 
perception of risk, depending on the individual’s priors, and thus affect WTP 
accordingly.  Therefore, the surveys used for this study allow for this potential 
heterogeneity by collecting data on risk perceptions both prior to and after new 
information is presented to the respondent.  In addition, a qualitative question regarding 
the change in the respondent’s risk from the new information provides information on the 
strength of the individual’s priors and is used in the data analysis.  The empirical results 
suggest that the strength of priors plays an important role both on who chooses the 
treatment and on the individual’s WTP.   
 
1.5.4 Does Information have Value for its own Merit? 
Finally, this study investigates the question of whether individuals are WTP for 
information, even when it offers no value in terms of medical decision making.  A CV 
study by Berwick and Weinstein (1985) find that women with normal pregnancies place a 
value on information received from an ultrasound even when it offers no value in terms 
of medical decision making.  Based on these finding Berwick and Weinstein conclude 
that information obtained from screening may have value simply “for its own sake.”  
They explain that the decision to pay for information that has no relevance to medical 
decision making is analogous to people valuing being informed about world/local events, 
 11
which is evidenced by individuals purchasing newspapers and taking the time to read 
them or watch the evening news.  Clearly these behaviors reveal that people value being 
informed; therefore, Berwick and Weinstein surmise that individuals would be no less 
willing to expend some of their financial resources to have more information about their 
own health (Berwick and Weinstein 1985), especially if it has the potential to improve 
their expected level of utility. 
In order to test whether information has value for its own sake, a small arm of the 
screening sample received a version of the survey in which respondents were asked to 
value the screening when no treatment was available.  Although the sub-sample was 
relatively small in size, the results suggest that information does in fact have value to the 
patient consumer.  Berwick and Weinstein’s (1985) results indicated that 25% of the 
valuation for an ultrasound by women with normal pregnancies stemmed from 
information that had no bearing on medical decision making.  The results from this study 
suggest that the informational value (not related to medical decisions of treatment) for 
heart attack screening is potentially even larger.    
 
1.6 Study Objectives 
 Valuation of health-related goods and services is necessary in order to make 
public policy decisions that maximize social welfare.  In the area of health, a large 
proportion of individual expenditures occur in the last few years of life, when many 
Americans are covered by Medicare.  In particular, one of the main health concerns for 
those over 65 is heart disease and heart attack.  In addition, a significant percentage of 
disability allowances paid by the Social Security Administration (and financed with tax 
revenues) are related to CHD and heart attacks.  Therefore, a better understanding of the 
valuation individuals place on heart-related screening and treatment is necessary for 
sound public policy.   
Thus, the primary objective of this research is to estimate the demand for (1) a 
new screening method that would better identify those at risk for a heart attack and (2) a 
new minimally-invasive procedure for the detection and treatment of vulnerable plaque.  
Willingness to pay (WTP) estimates for each of these “goods” will provide insight into 
the value individuals place on health, specifically the value they place on avoiding a heart 
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attack.  In addition, a better understanding of the marginal effects of factors that influence 
demand for these services can assist policy makers in determining who should receive 
these services to help ensure the efficient allocation of our scarce health care resources. 
Copyright © Patricia L. Ryan 2007 
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Chapter II:  Review of the Literature 
 
The purpose of this chapter is to provide a review of the literature relevant to the 
dissertation.  As such, this chapter presents support for using benefit-cost analysis (BCA) 
as a tool to efficiently allocate scarce economic resources.  In addition, the chapter 
includes a discussion of the possible methods for valuing changes in health, including 
willingness to pay (WTP) in contingent markets, which is used for this study.  Due to the 
fact that there has been some debate regarding the validity of obtaining reliable 
valuations for non-market goods using stated preferences (Hanemann 1994; Diamond and 
Hausman 1994), a large section of this chapter is devoted to exploring this issue.  As part 
of the basic understanding of what drives the demand for health, this chapter also 
includes an explanation of Grossman’s (1972) household production model of health and 
the implications it has on the demand for health-related goods and services.  Finally, this 
chapter concludes with an overview of how risk and uncertainty and the availability of 
information in markets for health-related goods and services may influence consumer 
decisions in regard to the health choices they make. 
 
2.1  Welfare Economics and the Concept of Value  
In his book entitled The Measurement of Environmental and Resource Values, 
Freeman (1993) states “The basic premises of welfare economics are that the purpose of 
economic activity is to increase the well-being of the individuals who make up society, 
and that each individual is the best judge of how well off he or she is in a given situation” 
(Freeman 1993 p. 6).  If individuals are assumed to have well-defined preferences and 
can substitute between goods, the trade-offs that are made will reveal information about 
the value the individual places on that good (Freeman 1993).  If individuals are further 
assumed to be rational economic agents, they will choose the bundle of goods that will 
maximize their utility given their budget constraint (Mitchell and Carson 1989).  It 
therefore follows that as each individual maximizes his/her own utility, that society’s 
welfare will also be maximized in the absence of a market failure.   
The problem is that for many environmental goods, the non-rivalry and non-
excludability of these public goods means that private markets would tend to under 
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produce them as some individuals choose to be free-riders.  In an attempt to correct this 
market failure, the government often chooses the amount7 of these goods that will be 
provided and pays for them with tax revenues.  In addition, the quantity of some health-
related goods, especially those consumed by the elderly who are covered by Medicare, 
are also determined by the government.  In these cases, it is still important for the 
government to choose the amount of the good that will maximize overall societal utility; 
however, a problem arises in identifying this optimal amount because individual 
preferences are unknown.  As a result, several methods have emerged to assist policy 
makers in efficiently allocating scarce economic resources among competing public 
programs. 
 
2.2  Methods for Evaluating Public Policy Programs 
Methods that have been used to evaluate public programs include: Internal Rate of 
Return (IRR)8, Benefit/Cost Ratio9, Social Net Benefit, Cost Effectiveness Analysis 
(CEA)10, and Payback Period11; however, many of these methods have significant 
shortcomings.  For instance, IRR does not take into consideration the size of the project 
under consideration, nor the increase in consumer utility that will result from the project.  
CEA has an advantage over IRR in that it does take into account the size of the effect of 
the program; however, it is designed to find the least cost method of achieving a specific 
goal.  As a result, CEA will not provide decision makers with information on how to 
efficiently allocated resources among programs with different goals.  Therefore, using the 
Benefit/Cost Ratio is superior to CEA because it allows comparisons across programs 
and time; however, like the IRR, it does not indicate the size of the gain.  In addition, the 
Benefit/Cost Ratio can be unduly influenced by whether an improvement is classified as 
                                                 
7 Through direct provision of the goods or indirectly through regulation 
8 IRR compares the rate of return from the investment to the market interest rate.  The decision rule 
suggests that those projects for which the IRR is higher than the market interest rate should be approved. 
9 The Benefit/Cost Ratio is calculated by dividing the benefits associated with a program by the costs 
associated with a program.  The resulting ratio is then used as a measure to compare programs. 
10 Cost Effectiveness Analysis (CEA) allows decision makers to compare the costs of various programs in 
achieving a specific program goal.   Therefore, this method will theoretically identify the least costly 
method of achieving a unit of effectiveness (such as a one point increase in test scores or incremental 
increase in health status). 
11 Payback period indicates how long it will take the benefits derived from a program to pay back the costs 
associated with the program. 
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a decrease in costs or an increase in benefits, creating some ambiguity in decisions made 
using this method.  Finally, using Payback Period has the distinct disadvantage in that it 
does not allow decision makers to distinguish between programs for which most of the 
benefit occurs early versus programs in which the majority of the benefits accrue later; in 
particular, it does not consider the value of benefits accrued beyond the payback period 
(Zerbe and Dively 1994).     
Unlike these other methods, Social Net Benefit does not suffer from any of these 
shortcomings and is clearly the preferred method for evaluating public programs and 
making policy decisions.  Social Net Benefit is calculated by taking the total marginal 
benefits that accrue from a program and subtracting the total marginal costs associated 
with the program.  Therefore, unlike the Benefit/Cost Ratio methodology, calculating the 
Social Net Benefit through benefit-cost analysis (BCA) will yield a consistent value 
regardless of whether improvements resulting from the program are classified as a 
decrease in costs (savings) or increase in benefits.  In addition, Social Net Benefit allows 
programs to be compared across regions and time (using present value) and also allows 
for the comparison of programs with different goals.  Another advantage of using Social 
Net Benefit is that this method naturally produces a measurement of the social gain 
derived from the program in monetary terms.  This value can then be used to rank 
programs according to those offering the highest net benefit to society.  The level of 
financial resources available will then allow decision makers to select the bundle of 
programs offering the highest collective social net benefit (Zerbe and Dively 1994).   
From the above discussion, it is clear to see that BCA can be used to maximize 
utility for society because it will identify the programs that are potentially pareto-
improving.  The pareto-criterion suggests that if one person can be made better off 
without making another worse off, then it will increase society’s welfare.  Of course, 
improvements may accrue to certain members of society at the cost of others, but from 
the perspective of society as a whole, a positive social net benefit indicates an 
improvement to society.  To account for the possibility that some individuals within 
society may have gained at the expense of others, the assumption can be made that the 
benefits accrued to the “winners” are more than enough to compensate the “losers” such 
that overall everyone will be at least as well off as they were before the change (Mitchell 
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and Carson 1989).  In fact, one of Harberger’s (1971) three postulates for applied welfare 
economics states that for a given action “the costs and benefits…be added without regard 
to the individual(s) to whom they accrue” (Harberger 1971, p. 785).   
Clearly, BCA offers many advantages over other options as a tool for assisting 
decision makers in making efficient allocations of our scarce economic resources.  In 
addition, BCA is consistent with the assumption of consumer sovereignty, that is, that the 
individual is the best judge of his/her own utility (Mitchell and Carson 1989).  Therefore, 
it is not surprising that BCA is the preferred method for valuing programs.  In fact, 
Executive Order 12866 made during the Clinton Administration12 “explicitly requires 
federal agencies to consider costs, benefits, and economic impacts of regulations prior to 
their implementation” (List et al. 2004 p. 742) and state agencies are increasingly 
employing BCA as a prerequisite for policy implementation (List et al. 2004).   
 
2.3 Valuing Non-Market Goods through Revealed and Stated Preference 
 Unfortunately, determining the benefits of some environmental and health-related 
goods can prove challenging.  Environmental goods pose a problem in that as public 
goods, individuals have an incentive to act as free riders and understate their true 
preferences.  Although goods in the health care sector tend to be more private in nature, 
the presence of insurance companies as third-party payers distort the true preferences of 
consumers within the market.  In fact, the extensive use of co-payments (where 
consumers only pay a portion of the actual cost) suggests that individuals will consume 
more than they would if they were bearing the full cost of these goods out of pocket 
(Phelps 1992). 
In addition, many environmental and some health care goods simply do not have a 
market.  For example, better air quality and increased safety can not be purchased directly 
in a consumer market; however, related purchase decisions may provide insight into the 
value individuals place on these “goods.”  When actual purchases (in either an explicit or 
implicit market) reveal how much an individual values a good, this method is referred to 
as revealed preference.  When questions are asked such that the individual states how 
much they value a good or service, this is referred to as a stated preference method.      
                                                 
12 This reaffirmed an earlier executive order made during the Reagan Administration (List et al. 2004) 
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 2.3.1 Revealed Preference – Explicit Markets 
Valuation can be made directly by observing preferences revealed explicitly in 
consumer markets.  One of the three postulates made by Harberger (1971) in regards to 
applied welfare economics suggests that the market price of a good can be used as a 
measure of the value the consumer places on that good.  This stems from the fact that if 
the individual does not buy the good, then the price is an upper bound on the individual’s 
WTP; however, if the purchase is made, the price is clearly a lower bound on the 
individual’s maximum WTP.  Therefore, when a good can be purchased in an explicit 
market, the market price will provide information regarding the valuation of the good.  
As a result, for policies that involve marginal changes in the quantity of the good 
provided, market price can serve as a good starting point for valuation; however, for 
policies that involve larger changes in the provision of the good, a better measure of 
valuation is the area under the demand curve since this allows consumer WTP to vary 
with the quantity of the good provided (Blomquist and Whitehead 1995).  Although 
preferences revealed through actual market transactions are an effective way of valuing 
goods and services, a problem arises when estimating the value of a good that is not 
traded explicitly, or what is referred to as a non-market good.      
 
2.3.2 Revealed Preference – Implicit Markets 
Implicit values for many non-market goods have been estimated by observing 
purchases made in markets for related goods (Blomquist and Whitehead 1995).  For 
example, information on the value individuals place on their health and safety can be 
obtained by studying other markets in which these health-related goods are implicitly 
purchased, such as the market for housing or automobiles.  Following Rosen’s (1974) 
hedonic pricing model, the value of air quality has been derived by looking at median 
home values as a function of neighborhood characteristics, including air quality (Harrison 
and Rubinfeld 1978).  A meta-analysis performed by Smith and Huang (1993) indicated 
that using hedonic equations to estimate implicit prices is effective; however, further 
research by Smith and Huang (1995) suggests that the equation specification (including 
the functional form and number of characteristics included) could affect the marginal 
WTP values (Zabel and Kiel 2000).   
 18
Likewise, hedonic models can be applied to labor market data to obtain 
information on the value individuals place on their health and safety.  Compensating 
wage differentials are paid to induce workers into riskier positions.  Therefore, since 
labor markets are well-defined, observed wages and known levels of occupational risk 
can be used to determine the dollar tradeoff that an individual requires to accept a job 
with additional risk to personal health and safety.13  
Analyzing travel costs is another method that has been used to value public goods 
such as national parks.   Calculating the “travel costs” associated with visiting the 
destination, including the opportunity cost of time traveled, provides an estimate of the 
value individuals place on the natural resource.  However, this valuation method will 
only provide a lower bound on WTP because it does not include non-use or existence 
values14 for individuals who do not travel to the park.  
 
2.3.3 Stated Preference- Hypothetical Markets  
 Although revealed preference methodologies such as those described above have 
allowed economists to place a monetary value on some non-market goods, what happens 
when a good has no close market from which to collect data?  In this case, economists 
have used surveys to create a hypothetical market in which the good is offered and asks 
individuals directly about the value they place on that good.  This technique is referred to 
as contingent valuation and is a considered a stated preference technique because it relies 
on preferences stated by those surveyed rather than preferences that are revealed through 
actual observed behavior (Blomquist and Whitehead 1995).  A distinct advantage of 
stated preference methods is that they have the potential to measure both direct values 
(those that are obtained through revealed preference methods), as well as passive use 
values.15  In theory, stated preference methods have the ability to measure the total value 
of the good being valued, as either a willingness to pay (WTP) or willingness to accept 
                                                 
13 See Viscusi (1986, 1993) and Viscusi and Aldy (2003) for a review of the literature including risk-dollar 
trade-offs in consumer markets and risk-wage trade-offs in labor markets.  
14 Valuation associated with non-use or existence values may derive from the intrinsic value of the 
environmental resource, altruism, or a bequest motive (Blomquist and Whitehead 1995) 
15 Although the term “passive-use” was not coined until later, Krutilla (1967) introduce the concept in his 
article entitled “Conservation Reconsidered” in which he suggests that individuals may place value on the 
existence of a natural resource (such as the Grand Canyon), and thus, may be willing to pay to preserve it 
even if they never plan to utilize it themselves.  
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(WTA) amount.16  Since revealed preference techniques may exclude important 
components of an individual’s true WTP or WTA, stated preference methods have 
become increasingly important to BCA as a means of estimating the total valuation of a 
good (Carson et al . 2001).   
 
2.4 Valuing Health 
Just as individuals reveal their preferences for consumer goods and services 
through the purchases they make, the same basic approach can be applied to valuing 
health; however, instead of making financial outlays to purchase goods, “expenditures” 
for health and wellbeing are often revealed through the choices individuals make 
regarding their time and lifestyle choices (Tolley et al. 1994).   
 
2.4.1 Grossman’s Household Production Model of Health 
 Grossman’s (1972) household production model of health demonstrates how 
individuals, as rational economic agents, make choices on a daily basis that affect their 
health and overall utility.  According to the model, utility is defined as a function of the 
goods and services consumed, as well as the individual’s level of health or “health stock.”  
Individuals are endowed with a certain level of health stock, which gradually depreciates 
with age.  In addition, an illness or accident can cause a decrease in the health stock.  The 
model assumes no uncertainty, so when an individual’s health stock falls below some 
minimum level, death will occur (Grossman 1972).   
 To counter decreases in the health stock caused by aging and illness, individuals 
can make investments in their health.  Specifically, an individual can purchase market 
goods and services (i.e. doctor visits, prescription medication, tennis shoes, healthy 
foods, etc.) and combine them with their own time (i.e. time spend exercising, preparing 
healthy meals, etc.) as a means of “producing” health and adding to their health stock.  
Furthermore, market goods and own time are translated into a higher health stock 
according to the individual’s own production process; thus, allowing for the possibility 
that some individuals may be more efficient than others at producing health.  In 
                                                 
16 WTP measures how much the individual is willing to pay to receive an improvement or increase in a 
good.  WTA measures how much the individual requires to accept damages or a decreased level of the 
good.  The decision to use WTP versus WTA depends on how property rights are assigned.  
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particular, Grossman suggests that those with more education may be better at combining 
market goods with own time to produce health, such that they will tend to be more 
efficient producers of health (Grossman 1972).   
Because utility depends on the individual’s level of health,17 an illness can change 
the marginal rate of substitution between medical care and all other goods by increasing 
the marginal value of medical care.  As a result, individuals will increase their 
consumption of medical care relative to other goods.  However, if an illness reduces the 
individual’s ability to earn income, then both medical services and other consumption 
may fall in response to a lower budget constraint.  Acting as rational economic agents, 
individuals will continue to invest in their health as long as the present value of the 
marginal cost of gross investment is less than or equal to the present value of the 
marginal benefit (Grossman 1972).  
 
2.4.2. The Demand for Health 
Following Grossman’s model, several conclusions can be made as to the demand 
for health.  First, if the rate of depreciation in the health stock increases with age, then the 
demand for health will also increase with age because larger and larger amounts of 
investment will be required to maintain the individual’s prior health stock.  In addition, 
an increase in the individual’s wage rate will have the effect of increasing the value of 
healthy time, thereby increasing the marginal product of health capital.  This suggests 
that individuals with higher wages will choose a higher level of health stock and have a 
higher demand for health.  Finally, those who have more education may be able to 
combine market goods and own time to produce health more efficiently (Grossman, 
1972).  Therefore, it is expected that education will increase the marginal efficiency of 
health, and thus result in more educated individuals choosing a higher optimal level of 
health (Grossman 1972).   
 Grossman’s empirical findings support his theoretical predictions.  Using data 
from the 1963 Health Interview Survey conducted by the National Opinion Research 
                                                 
17 Empirical work by Viscusi and Evans (1990) supports Grossman’s assumption that utility is dependent 
on the health state.  Using data on chemical workers, Viscusi and Evans (1990) find that the marginal 
utility of income is higher when an individual is healthy (higher state of health) as compared to when the 
individual is injured (lower state of health). 
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Center (NORC) and the University of Chicago’s Center for Health Administration 
Studies, data showed a positive correlation between medical care with restricted activity 
days and work-loss days, suggesting a positive relationship between medical care and the 
depreciation rate.  Using health stock measures obtained through self-reported health 
status, depreciation rates were found to increase with age.  Grossman estimated 
depreciation to be approximately 2.1%, implying that 70% of the initial health stock 
would have depreciated by age 58, 80% by age 77, and 90% by age 96.  Education was 
found to have a positive and significant effect.  In addition, the wage rate was found to be 
positively related to the stock of health and the number of healthy days, which supports 
the hypothesis that an increase in an individual’s wages raises the return on an investment 
in health, thus resulting in the individual choosing a higher stock of health (Grossman 
1972). 
 
2.4.3 Tradeoffs Involving Health 
Household production models of health, such as that developed by Grossman, 
imply that “individuals will make expenditures of money and time to improve their health 
and reduce risks to their health” (Berger et al. 1994 p. 25).  For example, the decision to 
purchase a smoke detector is an averting behavior in consumption that requires an 
expenditure of income in order to reduce the risk of fatality by a marginal amount.  
Therefore, even though health is not explicitly traded in a well-defined market, the value 
that an individual places on their health, and ultimately their life, can be derived from 
observing the choices they make in markets for other goods and services that affect their 
health (Berger et al. 1994).   
 
2.4.4 Risk and Uncertainty 
 Risk is an inherent part of our everyday lives.  We face risks when we drive/ride 
in a car, fly on a plane, or take a bus.  In addition, we face possible risks of injury at our 
place of employment from the use of heavy equipment or coming into contact with 
hazardous materials.  In our recreation, whether it is downhill skiing or simply jogging, 
the risk of injury or death exists.  We even face significant risks in our homes, where a 
surprisingly large number of individuals are injured/die every day.  And finally, we are at 
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risk from disease and other medical conditions, such as cancer and heart attack.  
Although the average risk of injury or death from any single cause may be relatively 
small, the consequences from an unfortunate event have the potential to be life altering.  
Therefore, it is not surprising that individuals acting as rational economic agents will 
chose to expend some of their limited resources to reduce the probability of one or more 
of these risks (Viscusi  1992).   
 Because risk can not be eliminated completely, some risk of injury and/or death 
will always exist for each of us; however, it is possible to reduce those risks.  Individuals 
can purchase cars with added safety features, choose a job that is less risky (although it 
may pay less), use safety equipment (such as a helmet, goggles, etc.) while participating 
in recreational activities, invest in carbon monoxide detectors for the home, and choose to 
have medical screening, to name just a few examples.  These purchases which represent 
averting behavior in consumption will help reduce the probability of injury, illness, 
and/or death; however these risk minimizing efforts often involve a cost, either in 
monetary terms, utility, or both.  For example, choosing to wear a helmet while downhill 
skiing involves both the monetary cost required to purchase the helmet, as well as a 
potential utility cost in that the individual may not enjoy the experience of skiing as much 
due to wearing the helmet.   
Because individuals make decisions every day regarding how much risk to accept, 
these tradeoffs have the power to implicitly tell us how much a person would pay to 
avoid a certain amount of risk (either monetarily or in terms of lost utility).  Therefore, 
“these tradeoffs in effect set the price that people are willing to pay for greater 
safety”(Viscusi 1992, p. 4).  Thus, by observing these tradeoffs, estimates can be made as 
to the value society places on saving a life, as well as the value individuals place on their 
own health and wellbeing.   
 
2.4.5. Value of Life 
Thaler and Rosen introduced a methodology for estimating the value of a 
statistical life by addressing the question “How much will a person pay to reduce the 
probability of his own death by a ‘small’ amount?” (Thaler and Rosen 1976, p. 265).   
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In calculating the value of a statistical life, the identity of the person at risk is 
unknown.  This is appropriate since decisions regarding risks to health and safety are 
often made by society in this manner.  In fact, people often behave much differently in 
situations where the person at risk is known (Blomquist 2001).  For example, it is not 
uncommon to hear in the news a story of a small town that expended many of its 
available resources for a short time in order to save a child who became trapped in a well.  
In cases such as this, “society will often spend whatever is available or do whatever is 
possible to save the life” because “the situation involves a potentially large change in 
survival for a known individual” (Blomquist 2001).  Therefore, it is important to note that 
behavior under these circumstances is much different than when the risk is significantly 
smaller and exists for an unidentified group of individuals within society.    
Risk in our daily lives is unavoidable (Viscusi 1992).  As discussed above, 
individuals make risk tradeoffs everyday, including the choice to accept a riskier job in 
return for a higher wage – what Adam Smith (1776, 1994) referred to as compensating 
wage differentials.18  What is interesting to note is that these observed tradeoffs provide 
an implicit value of avoiding additional risk, which is illustrated by the following 
statement: 
Suppose a person is observed taking a known incremental 
risk that could be removed by spending one dollar.  Then the 
implicit value of avoiding the additional risk must be 
something less than one dollar or else it would not have been 
observed (Thaler and Rosen 1976, p. 266). 
  
                                                 
18 The theory of equalizing or compensating wage differentials was first described by Adam Smith in The 
Wealth of Nations.  Smith explained how some workers could expect to earn higher wages than others 
because of differences in key job characteristics.  For example, those individuals who worked in jobs that 
were generally considered harder, more dangerous or required special training would typically earn higher 
wages than those individuals with otherwise identical characteristics who were employed doing jobs that 
offered more favorable working conditions.  The higher wages paid to these workers was considered a 
means of compensating them for withstanding the unpleasant aspects of their job.  The amount of the wage 
differential paid for each type of job and its associated unpleasantness would be determined by the market.  
The wage would have to be high enough in order to induce the marginal worker to accept the unpleasant 
job rather than taking a more pleasant job offering a lower wage. 
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Using data from the 1967 Survey of Economic Opportunity (SEO)19 and the 1967 
Occupation Study of the Society of Actuaries,20 Thaler and Rosen (1976) test Adam 
Smith’s theory of compensating wage differentials.  They do this by incorporating risk 
into a standard wage equation to estimate the dollar amount required to induce an 
individual worker to accept a job with a slightly higher degree of risk (fatality).  This 
estimate is based on the assumption that if each worker is willing to pay $50 to avoid, 
say, a .001 chance of dying, it logically follows that 1,000 workers together would pay 
$50,000 to eliminate the probability of death and statistical save a life.   
Using this methodology, Thaler and Rosen (1976) estimate the value of life to lie 
in the range of $140,000 to $260,000 (in 1976 dollars), which would amount to 
approximately $500,000 to $940,000 in today’s dollars.21  Although this range is lower22 
than many of the more recent studies, Thaler and Rosen’s 1976 study contributed 
something incredibly significant - a meaningful way of “valuing” a human life in 
monetary terms.  The meta analysis by Viscusi and Aldy (2003) find the most reliable 
estimates for prime-age workers to be in the range from 5 to 9 million in current dollars. 
Tradeoffs involving risk are not unique to the labor market.  In fact, there are 
countless such tradeoffs that occur each day in consumer markets.  Consider for a 
moment the automobile and housing markets.  Individuals purchase used cars offering 
fewer safety features than newer models, and families buy homes in areas abutting 
                                                 
19 This data set provided demographic information, as well as the individual’s occupation and industry in 
which they work. 
20 This study used insurance company records between 1955 and 1964 to measure additional risks 
associated with extremely hazardous occupations.  Because the data reported information using a 
combination of both industry and occupation, it could be directly matched to individuals in the SEO 
sample.  In this regard, it provided a better measure of risk than data from the Bureau of Labor Statistics 
(BLS), which was the traditionally source for industry hazards data.  The BLS only reported the average 
hazard for each industry, regardless of occupation.   Since occupations within an industry could vary 
widely with regard to risk, use of this data could cause a large degree of measurement error.  Therefore, 
Thaler and Rosen used the 1967 Occupational Study on Society of Actuaries to avoid the aggregation 
problem inherent in the BLS data.   
21 (CPI March 2007 – Ave. CPI 1976)/ Ave. CPI 1976 = (205.352-56.9)/56.9 = 2.608998     
$140,000 * 3.608998 = $505,260 & $260,000 * 3.608998  = $938,340 
22 This is most likely a result of Thaler and Rosen’s chosen data set.  The Society of Actuaries data includes 
individuals in very high-risk occupations, and therefore would be expected to yield a lower value of life 
because of “the self-selection of individuals with low risk-dollar tradeoffs into the most hazardous pursuits” 
(Viscusi 1993).  For a detailed discussion of this and other data and econometric issues, see Mrozek and 
Taylor (2002) and Viscusi and Aldy (2003).  As Shogren and Stamland (2002) argue and Kniesner et al. 
(2005) find, self selection on unobserved productivity in dealing with risk in the labor market can produce 
estimates of value of life that are biased upward.  The net effect depends upon the relative strength of the 
effects of the unobservable factors. 
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Superfund sites.  Despite the fact that these purchases may pose a potentially higher 
health hazard, these goods are still consumed because they tend to be more affordable. 
Therefore, value of life estimates can be derived by observing purchasing behavior in 
certain private consumer goods markets that entail some amount of risk.  In particular, the 
demand for automobile safety features, cigarettes, and housing locations all provide 
information on the underlying safety preferences of individuals; and hence, can be used 
to estimate society’s willingness to pay to avoid higher levels of risk (Tolley et al. 1994, 
Blomquist 2004).      
 For example, Atkinson and Halvorsen (1990) estimate the value of a life based on 
the premise that individuals pay more for an automobile that offers a higher level of 
safety (or a lower probability of fatality risk).  Using the risk-dollar trade-off framework 
initially proposed by Thaler and Rosen (1976), Atkinson and Halvorsen use data obtained 
in the automobile market to estimate the value of a statistical life.  Since accident rates 
may be affected by the personal characteristics of the individuals who tend to buy that 
type of automobile, they use a hedonic equation to control for this possible effect.  After 
adjusting for the average number of occupant fatalities per accident (dividing by 1.15), 
they estimate the value of a statistical life to be $3.4 million (in 1986 dollars), which is 
approximately $6.3 million in today’s dollars.23  This amount is consistent with the 
findings in Viscusi and Aldy’s (2003) review article and therefore lends credibility to this 
method as a means of valuing a human life.    
 
2.4.6 Methods for Valuing Health 
 Although placing a value on something as intangible as one’s health may at first 
seem implausible, just as economists have found reliable means of valuing a life, they 
have used similar methods to value improvements in health.  Valuing health is important 
because, from a benefit-cost standpoint, it is necessary in order to ensure that the 
combination of health services being offered is the one that will maximize the wellbeing 
of its citizenry.  Therefore, finding a meaningful way to value health is necessary in order 
to make efficient decisions regarding the number and types of health programs to offer.  
                                                 
23 (CPI March 2007 – Ave. CPI 1986)/ Ave. CPI 1986 = (205.352-109.6)/109.6 = .873650 
     $3.357 million * 1.873650 = $6.29 million 
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As a result, economists have strived to improve the methodology employed to value 
health.  The following describes several methods that economists have utilized in 
estimating the value of health. 
 
Cost of Illness 
 One method that has been used to value health is the cost of illness (COI), or 
human capital, approach.24  The theoretical basis for this method relies on the assumption 
that individuals within our society represent human resources that produce goods and 
services (Berger et al. 1994). Therefore, when individuals within our society become sick 
and are not able to work, there is a cost involved – specifically, the cost of medical 
services utilized, as well as the loss of productivity during the illness.  These costs can be 
classified as either direct or indirect costs of illness.  Costs such as health expenditures 
and the value of resources used for treatment (doctor’s time, medical supplies, 
medications, etc.) are all considered direct costs; whereas the value of lost productivity 
and lost wages resulting from being sick (or dying prematurely) are considered indirect 
costs.  Therefore, using this approach, the value of a health improvement is equal to the 
sum of the direct and indirect costs associated with the illness (Berger et al. 1994).   
 When an individual works in a clearly defined market and/or has a specified 
wage, the COI approach can be used to estimate a lower bound for the value of 
improvements to health.  This method can only provide a lower bound for health 
valuations because it does not take into consideration the value an individual places on 
avoiding the pain and suffering associated with an illness (lost utility).  In addition, 
significant problems arise when this approach is used in an attempt to estimate the value 
the general population places on a health improvement.  This is because it completely 
disregards the value placed on health by those who are retired or who work in non-
defined markets (i.e. full-time homemakers).  Because these individuals do not have a 
market wage, their loss of productivity due to sick time is simply recorded as a zero in the 
calculation.  Therefore, this method clearly has limitations in estimating reliable values 
on health improvements and at best can only yield a lower bound (Berger et al. 1994).        
 
                                                 
24 For examples, see Weisbrod (1971) and Cooper and Rice (1976) 
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Cost-Effectiveness Analysis 
 The inherent shortcomings of the COI approach for valuing health - its lack of a 
theoretical foundation in utility theory, the fact that it does not account for the intrinsic 
value and quality of life, and that it discriminates against those not in the labor force - 
lead to the development of cost-effectiveness analysis (CEA).  Cost-effectiveness 
analysis measures the effectiveness of an intervention in terms of health outcomes (such 
as life years gained) for each dollar spent and is most often used in the field of public 
policy (Johannesson 1996).  In determining how to allocate financial resources between 
competing health programs, the decision rule is to maximize the effectiveness for a given 
budget.  This methodology works best when comparing alternate treatments that have the 
same goal; however, as discussed earlier in this chapter, CEA falls short when comparing 
programs with different outcomes.  The problem with this method is that it does not 
provide a basis for comparison between outcomes measured in different units.  Therefore, 
although this method is useful in finding the least costly way to achieve a specific health-
related outcome, it provides no systematic way to choose between programs designed to 
pursue unrelated health goals.   
 
Cost-Utility Analysis 
 One of the concerns with cost-effectiveness analysis was that the utility associated 
with a single outcome measure of life years gained could vary considerably depending on 
the quality of life associated with those years.  For example, consider two programs, both 
of which have an outcome of 5 additional life years gained.  One program will grant 
individuals 5 additional years with relatively no side effects, whereas the other will grant 
an additional 5 years with significant side effects.  Clearly, the outcome without side 
affects is preferable; however, cost-effectiveness analysis would rate these two programs 
equally. Therefore, cost-utility analysis was developed as a special form of cost-
effectiveness analysis in which life years gained are adjusted for the quality of life 
obtained in those years.  As a result, this method uses quality adjusted life years (or 
QALYs) as the measure of effectiveness.  QALYs are often obtained by taking the gain 
in life years and multiplying by a utility index based on the quality of life achieved in 
those years.  For example, if an individual has a quality of life equal to 80%, then 5 life 
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years gained would equal 4 QALYs  (5 life years *.8).  Because cost-utility analysis is 
essentially an extension of cost-effectiveness analysis, the same problems that are 
prevalent in cost-effectiveness analysis also exist for cost-utility analysis.  In addition, 
cost utility analysis faces the added challenge of measuring quality of life and 
transferring it into a valid utility index25 (Johannesson 1996). 
 
Household Production and Preventative Expenditures 
Whereas the COI approach looks at the expenditures made after the onset of an 
illness, the household production and preventative expenditures approach looks at 
expenditures intended to prevent illness (Berger et al. 1994).  From the earlier discussion 
of Grossman’s (1972) model on health production, it is clear that individuals can make 
purchases that contribute to their overall health.  Therefore, one way to value health is to 
calculate the sum of the additional income that can be earned plus the monetary value 
resulting from a higher level of utility associated with good health (Berger et al. 1994).  
Thus, the household production and preventative expenditures method not only includes 
the indirect cost of illness (lost wages), but unlike the COI approach, also includes a 
preference-based measure that stems from the individual’s own consumption and 
resulting utility26 
 
Willingness to pay – Implicit markets 
Household production models can also utilize observations of self-protection to 
estimate the WTP for small changes in fatality risks (Blomquist 2004).  Self protection 
refers to individual actions which avert risk, such as wearing a seatbelt, choosing not to 
smoke, or as discussed above, making purchases that improve the individual’s level of 
safety (buying smoke detectors for the home, purchasing a car with added safety features) 
(Blomquist 2004).  A study by Smith and Desvousges (1985) showed that households in 
the suburbs of Boston took varying preventative measures (including purchasing bottled 
                                                 
25 methods used to measure utility include the standard gamble and time-trade off 
26 For examples, see Cropper (1981),  Gerking and Stanley (1986), and  Dickie and Gerking (1991) 
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water, installing water filters, and attending public meetings) as a means of reducing the 
health risks associated with toxins in the drinking water (Berger et al. 1994).27     
 Because people invest time and money in producing their own health, it is 
possible to observe the consumption of goods that are indirectly related to health (and 
purchased in well-defined markets) to derive the value people place on health 
improvements.  As discussed earlier in this chapter, individuals chose jobs that reveal 
their preferences regarding risk (averting behavior in the labor market) and purchases in 
consumer markets (averting behavior in consumer markets) that involve dollar-risk trade-
offs that can be used to estimate valuations for health in terms of the individual’s WTP.  
WTP provides a more complete measure of valuation compared to COI and is preferable 
measure over cost-utility and cost-effectiveness measures because it is compatible with 
BCA.  Therefore, WTP28 is the preferred measure in valuing improvements in health. 
 
Willingness to pay – Contingent markets 
In valuing goods for which no market exists (i.e. lower health risk, reduced side 
effects), economists have used surveys to get respondents to reveal their willingness to 
pay (WTP) for a specific health commodity contingent on the existence of a market for 
that good.  This is known as the contingent valuation method (CVM).  The CVM is a 
stated preference method that uses surveys to elicit individual preferences by asking 
respondents directly about their willingness to pay for a particular good or service.  As 
discussed earlier in this chapter, stated preference methods have an advantage over 
revealed preference methods in that they have the potential to determine the total 
valuation of a good, including passive-use values.  Therefore, this method is incredibly 
useful for BCA.  As a result, contingent valuation (CV) is widely used to estimate values 
of environmental resources and is growing in popularity as a means for valuing health-
related goods and services. 
 
 
                                                 
27 See Blomquist (2004) for a review of the literature on self-protection and averting behavior 
28 WTP is the maximum amount an individual is willing to pay for a given quantity of a good.  Therefore, 
the benefit associated with a health improvement can be found by measuring the area under the aggregate 
demand curve (WTP plotted against quantity). 
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2.5 Contingent Valuation Methodology (CVM) 
Contingent valuation (CV) is a stated preference methodology that utilizes a 
survey to elicit information regarding an individual’s valuation for an improvement in a 
health, environmental, or other good for which a well-defined market does not exist.  CV 
surveys have been conducted face-to-face using an interviewer, over the phone, and 
through self-administered surveys delivered through the mail and via the Internet.   
 
2.5.1 Description of the Contingent Valuation Survey 
Although no formal standard exists, most CV surveys contain a detailed 
description of the good to be valued, including the manner in which it would 
hypothetically be made available to the respondent; a mechanism by which the 
respondent reveals his/her willingness to pay for the good; demographic questions; and 
questions regarding the individual’s attitudes that may influence his/her valuation of the 
good (Mitchell and Carson 1989).   
Since the CVM has a variety of applications, the “good” described in the survey 
can take many forms.  It can be a public good such as electric wind power (Champ and 
Bishop 2001), preserving rain forests acreage (Cummings and Taylor 1999), or 
reclaiming wilderness areas at the Grand Canyon (Champ et al. 1997); a semi-private 
good, such as a diabetes management program that may have positive externalities 
(Blumenschein et al . forthcoming 2007); or a private good, such as an electric juice 
maker (Cummings et al. 1995), sportscards (List 2001), sunglasses (Blumenschein et al. 
1998), or a box of chocolates (Cummings et al. 1995). Regardless of the good being 
valued, it is important to fully and accurately describe the good, to help ensure the 
respondent has a clear understanding of the good they are being asked to value. This will 
help prevent unwanted scope effects or embedding problems.  
 
2.5.2. Payment Mechanism for Eliciting WTP  
 Once the respondent has been provided with a description of the good, they are 
asked to value it in some way.  For public goods, a common method of eliciting estimates 
of WTP is through the use a dichotomous choice (DC) referendum question.  
Respondents are asked to vote either in favor or against everyone contributing a certain 
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dollar amount to a good (Brown et al. 2003, List et al. 2004, Cummings and Taylor 
1999).  Due to concerns that the referendum essentially “forces” everyone to contribute, 
information on individual WTP has been obtained by asking for voluntary donations for a 
public good, such that an individual’s decision to contribute does not affect others.  
Voluntary contribution mechanisms (VCM), in which respondents are asked to make 
voluntary donations may also include a provisional point mechanism (PPM) (Murphy et 
al. 2005).  In the context of the survey, respondents are informed of a minimum amount 
that is needed in order for the good to be provided (the provisional point).  It is thought 
that inclusion of a PPM with a “one-shot” voluntary donation reduces the occurrence of 
free-riding, and therefore provides more accurate measures of WTP (Poe et al. 2002).  It 
is not uncommon for CV studies that include a PPM to also tell respondents that if the 
total contributions do not reach the dollar amount needed to provide the good, individuals 
donations will be refunded (Murphy et al. 2005). 
In valuing private goods, WTP can be elicited using a DC question in which 
respondents are asked if they would be willing to pay a certain amount for the good.   
Because this method will only yield a yes/no response from each individual, providing 
either an upper or lower bound on the respondent’s WTP, econometric techniques are 
needed to estimate the mean WTP.  Therefore, in an effort to obtain additional data from 
each respondent, DC choice questions are sometimes repeated with different price 
offerings.  Depending on the number of times the question is asked, this is referred to as a 
single bounded, double bounded, or multiple bounded DC question (“bidding game”).   
In the economics literature, the term “iterative bidding game” refers to the use of 
a multiple bounded DC question in which respondents are asked repeatedly if they are 
willing to pay $X for a good.  Bids are either increased or decreased according to a pre-
set group of bids.  For example, if the pre-set bids are $5, $10, $15, $20, $25 and $30, 
and the respondent answered “yes” to the initial bid of $15, the interviewer would ask if 
the respondent was willing to pay $20.  The interviewer will continue to the next highest 
pre-set bid until the respondent answers “no”; thus, determining a narrow range in which 
the respondent’s WTP lies.  A similar process would occur if the respondent answered 
“no” to the initial bid.  In that case, the interviewer would then proceed to go down to the 
next pre-set bid until the respondent switched their answer to “yes.”  Although this 
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process is termed “iterative” in some ways it is misnomer because the process does not 
go back and forth to converge on a single value.  Instead, bids are simply move in a 
single direction until the respondent’s answer changes.   
Bidding games are often subject to starting point bias (Mitchell and Carson 1989); 
therefore, Mitchell and Carson (1989) suggest the use of a payment card in which 
respondents are provided with all the bids and asked to circle the highest amount they 
would be willing to pay.  Finally, another approach to eliciting respondent WTP is to 
simply let respondents state the maximum they would be willing to pay in an open-ended 
question.   
Through the use of one of these elicitation methods, CV surveys can determine 
WTP for a good contingent upon a market for that good existing.  This information can 
then be used to estimate the benefit of the good/program and subsequently be used to 
make recommendations regarding the efficient allocation of available resources.   
 
2.5.3 The Growing Use of CVM 
The use of contingent valuation (CV) first appeared in the environmental 
literature, see Carson (2001). Valuing environmental goods posed a somewhat unique 
difficulty in that market transactions reflecting consumer preferences are seldom 
observed since many environmental goods are public goods provided with tax revenues 
by the government.  However, the development of the CV approach allowed economists 
to collect data on the demand for environmental goods by asking individuals “to give 
their willingness to pay for some outcome contingent on the assumed existence of a 
market in which it [could] be purchased” (Magat, Viscusi, and Huber 1988, p. 395). 
Although a market for health care does exist, economists face similar problems in valuing 
health-related goods because of the presence of insurance companies as third party 
payers, which tend to obscure the true preferences of consumers in these markets.  
Therefore, the CVM gradually started appearing in the health literature as a means of 
evaluating the value of health-related goods and services.   
According to Portney (1994), the first mention of CVM occurred in 1947 in an 
article by Ciriacy-Wantrup about the benefits of preventing soil erosion; however, early 
applications of the method did not occur until years later.  Perhaps the first to employ the 
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CVM was Davis (1963), who as part of his dissertation research, used a survey to 
estimate the demand hunters and wilderness lovers placed on a particular recreational 
area.  In an effort to validate his results, Davis compared his estimates to those obtained 
using the “travel cost” approach, in which the quantity of visits is plotted against a range 
of “prices.”  In this case, the “price” is determined by the inferred cost required to travel 
the distance.  Davis discovered that the estimates derived using the CVM were 
comparable to those estimated using the travel cost method (Portney 1994); thus lending 
credibility to the use of CV as a method for valuation.  
In the early 1970’s, economists began to recognize the importance of CVM as a 
valuation method for environmental and resource economics.  In fact, Mishan (1971) 
encouraged economists to use this direct questioning approach to elicit willingness to pay 
values as opposed to methods that employed cost of illness measures (Berger et al. 1994).  
During the 1970’s the CVM became increasingly important for its potential to fully value 
environmental resources, including existence values (Blomquist and Whitehead 1995).  
In addition, the use of the method was not limited to environmental goods.  
Coincidentally enough, one of the first applications of the CVM in health economics was 
a study by Acton (1973) who used a CV survey to value reductions in the risk of death 
from heart attack (Portney 1994). 
  One of the unique features of the CVM is that it has the potential to capture 
passive use values29 that may not be obtained using other valuation methods (Carson et 
al. 2001).  Therefore, CVM is highly useful for benefit-cost analysis.  As a result, this 
method gained popularity as a means of valuing environmental goods and resources that 
were thought to have high passive use values.30  However, the use of this method to value 
environmental resource damages in Alaska following the Exxon Valdez oil spill, which 
resulting in a highly public court case and large monetary award for damages (resulting 
primarily from high existence and non-use values) has brought a lot of attention to the 
CVM and fostered a debate as to whether CV can provide accurate measures of valuation 
                                                 
29 “passive use value” was a term adopted by the courts intended to be a broad descriptor which included 
the following: non-use value, existence value, preservation value, bequest value, stewardship value, 
intrinsic value, and option value (Carson et al. 2001).   
30 In valuing environmental resources it is often the case that individuals place a value on a good even if 
they never plan to use it.  These existence values are utility based and may arise from purely intrinsic 
values, altruism, or the fact that individuals would like to see the resource preserved for future generations 
(Blomquist and Whitehead 1995). 
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(Portney 1994).  Unfortunately, opposition to the CVM may not be coming solely from 
individuals within the economic profession who are attempting to shed light on this issue 
for the sake of academic integrity.  Industry groups outwardly opposed to the use of 
CVM have sponsored research investigating the reliability of the CVM (Carson et al. 
2001).  This means that sources of financing for CV validation studies may need to be 
considered when making broad assessments as to the reliability of the CVM in valuing 
non-market goods. 
In response to the criticism over the validity of the CVM, a panel of well-
respected economists was convened by the National Oceanic and Atmospheric 
Administration (NOAA).  The purpose of the panel was to answer the question “Is 
contingent valuation capable of eliciting reliable estimates?” (Portney 1994, p 8).  The 
panel concluded that “CV studies can produce estimates reliable enough to be the starting 
point for a judicial or administrative determination of natural resource damages including 
lost passive use values” (Arrow et al. 1993 p. 4610).  In addition, the panel including a 
set of guidelines intended to help ensure the reliability of estimates obtained using this 
stated preference method (Arrow et al. 1993).  The NOAA panel has periodically updated 
these rules in accordance with general findings derived from the growing contingent 
valuation literature to help ensure the credibility of CV as a valuation method (List and 
Gallet 2001, Little and Berrens 2004, NOAA 1994, 1996).   
Although there are still some unanswered questions as to whether CV can 
accurately reflect consumer preferences in all cases, the CVM continues to be widely 
used in the environmental literature and a growing number of studies are using CV as a 
method to value health-related goods and services.31  It is expected that this trend will 
continue due to the important role stated preference methodology (including the use of 
CV surveys) plays in providing valuations for benefit-cost analysis which is required by 
federal agencies and more and more by state and local government for the 
implementation of public policy programs (List et al. 2004).   
 
 
 
                                                 
31 See Diener et al. (1998) for a review of the health care studies utilizing the CVM. 
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2.6 Potential Concerns with CVM 
 Some economists have expressed concerns regarding the validity and reliability of 
estimates obtained using CV (Diamond and Hausman 1994, Kahneman and Knetsch 
1992).  Therefore, the following section includes a discussion of each of these possible 
issues:  Hypothetical bias and other potential biases, embedding, insensitivity to scope, 
familiarity, and warm glow. 
 
2.6.1 Bias 
 There are several types of bias, or systematic error, that can occur when 
conducting a CV study including: hypothetical bias, strategic bias, starting point bias, 
vehicle bias, and information bias.  Hypothetical and strategic bias are an inherent part of 
any CV study, whereas the other biases stem primarily from the design of the survey 
instrument (Kenkel et al. 1994).  The bias that currently appears most often in the 
literature, and potentially poses the greatest concern for obtaining accurate valuations 
using CVM, is hypothetical bias.  The following provides a more detailed explanation of 
each of these potential biases. 
 
Hypothetical Bias 
The term “hypothetical bias” is commonly used in the empirical literature to refer 
to the tendency of stated values in hypothetical markets to overestimate preferences 
revealed through actual behavior.  Hypothetical bias has serious implications regarding 
the validity of utilizing CV valuations for policy decisions.  According to Kenkel et al. 
(1994)  hypothetical bias can occur when the respondent does not believe the credibility 
of the question being asked.  If the respondent puts little or no faith in the validity of the 
question, then their response will also tend to be less than credible (Kenkel et al. 1994).  
Because decisions being made in contingent markets do not require a financial outlay, 
one of the challenges in designed a CV survey is to select a payment mechanism that is 
incentive-compatible; that is, one that will provide an incentive for respondents to reveal 
their true WTP.  
One of the current concerns regarding values obtained using the CVM is that 
several studies have shown that stated preferences elicited through hypothetical markets 
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tend to overestimate revealed preferences observed in actual markets (Cummings et al. 
1995, List and Gallet 2001).  Cummings et al. (1995) compared decisions to purchase 
three goods: an electric juicer, a box of chocolates, and a thin solar calculator, and found 
that respondents were more likely to say they would purchase the good when the decision 
was hypothetical versus when the decision was real.  List and Gallet (2001) perform a 
review of the literature and find that for several studies, hypothetical values exceed actual 
values for both public and private goods.  This finding indicates that hypothetical bias is a 
real concern for CV surveys that needs to be addressed in order to obtain valid benefit 
measures using this method.      
 
Strategic Bias 
Even if the respondent believes the question to be credible (to help address 
hypothetical bias), the potential for strategic bias still exists.  According to Mitchell and 
Carson (1989), “strategic bias occurs when respondents deliberately shape their answers 
to influence the study’s outcome in a way that serves their personal interest” (Mitchell 
and Carson 1989, p. 238).  Therefore, the more credible the question is perceived to be by 
the respondent, the more likely he/she is to misrepresent a response in a strategic manner.  
In this case, the respondent’s valuation for a good would not necessarily be a statement of 
their true preferences, but rather would reflect their strategy to accomplish another, 
possibly completely unrelated, pursuit (Kenkel et al. 1994).   
Strategic bias is much more likely to occur in the valuation of a public good, 
because of the tendency for individuals to try and become “free-riders.” When 
respondents believe that the valuation they give in a survey could ultimately affect how 
much they would have to pay for the good (perhaps through an increase in taxes), there is 
an incentive to act strategically and give a valuation that is below their true valuation.  
Or, if the individual expects that because of their limited income, there may be a 
maximum amount that would be required of them to receive the good, there could be an 
incentive for these individuals to overstate their preferences in an attempt to ensure that 
the good becomes available.  In general, the overall expectation is that if strategic bias 
does exist in the sample, then a slight overestimation is likely to occur.  (Mitchell and 
Carson 1989).  However, even in this case, there is little evidence to support the theory 
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that people act strategically in completing CV surveys and because this is much less 
likely to occur in valuing a private good, strategic bias does not appear to be a significant 
issue for this particular study.    
 
Starting Point Bias 
 Starting point bias arises from the tendency of respondents to perceive the initial 
bid as reasonable, thus causing valuations to cluster around the starting point.  This can 
potentially be avoiding in several ways.  One way is to vary the starting points among the 
surveys.  Another method is to use a dichotomous choice framework in which the 
respondent is simply asked to accept or reject a single, random bid.  Based on the series 
of yes and no responses, the mean WTP can be calculated (Kenkel et al. 1994) using 
econometric techniques such as Kriström’s (1990) non-parametric approach. 
 
Vehicle Bias 
Vehicle bias occurs when a response is influenced by the payment vehicle.  For 
example, the questionnaire may state that the good will be financed by an increase in 
taxes.  In this case, the respondent may state their maximum WTP is zero as a protest to 
any increase in taxes, even though they may actually place a significantly higher value on  
the good (Kenkel et al. 1994).  Vehicle bias can potentially be avoided by wording the 
question in such a way that the payment method is vague; however, this could 
inadvertently increase the potential for hypothetical bias as it may reduce the credibility 
of the proposal as perceived by the respondent (Kenkel et al. 1994).   
 
Information Bias 
Finally, information bias can occur as a result of the information provided in the 
questionnaire.  It is necessary for contingent valuation surveys to provide some 
information, as asking an individual to value a good with no understanding of that good 
would not provide accurate assessments of valuation (Fabian and Tolley 1994).  
However, it is not always the case that more information is better.  As Mitchell and 
Carson (1989) point out, sometimes adding information to make the survey scenario 
more realistic can cause respondents to focus on unimportant details while losing sight of 
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the good being valued.  Therefore it is necessary to find a balance in which enough 
information is conveyed so the respondent understands and can credibly value the good, 
while avoiding too much detail that can will take excessive time and potentially lead to 
boredom on the part of the respondent (Fabian and Tolley 1994).    
Mitchell and Carson (1989) caution that information bias can have a significant 
effect on WTP values if respondents misunderstand the good being valued.  For example, 
if the researcher asks respondents to value a low-probability risk, but it is misperceived 
by respondents to be a high-probability risk, then it is likely to have an effect on stated 
WTP (Mitchell and Carson 1989).  Therefore, care should be taken to clearly define the 
good and test respondents’ understanding of the good, perhaps through the use of focus 
groups.  In addition, the potential for information bias can be diminished by ensuring the 
CV survey focuses on two types of information – elements that are valuation relevant 
(which are intended to be taken into account in the valuation process) and elements that 
are valuation neutral (those that provide a credible market for the good, and are not 
intended to influence the valuation) (Mitchell and Carson 1989).     
 
2.6.2 Embedding 
Some economists, including Diamond and Hausman (1994), have argued that 
stated WTP obtained through the CVM can be subject to an embedding effect.  
Embedding occurs when respondents to a CV study value more than what the researcher 
intends (Schulze et al. 1998).  For example, in an air quality study by Tolley at al. (1985), 
respondents were asked to provide a WTP amount for improved visibility.  In stating their 
WTP for improved visibility, it is possible that respondents also included a dollar value 
associated with the improved health that would additionally result from better air quality 
(Schulze et al. 1998).32   
                                                 
32 Schulze et al. (1998) offer three possible reasons why embedding might occur: (1) Individuals gain 
“moral satisfaction” from giving to a good cause; however, marginal utility derived from increased giving 
diminishes rapidly.  Therefore, giving to more than one cause or increasing the amount of the good has 
little effect on the individual’s WTP; (2) If goods have high substitutability, then respondents may view 
giving to one program as having high value, but giving to a second program would have little value; (3) 
Individuals consider “joint products” when making their valuations.  This occurs when respondents value 
more than they are asked to value.  For example, a respondent may be asked how much they would be 
willing to pay to save an endangered species of butterfly in the Amazon.  If the respondent feels that the 
only way to save the butterfly is to preserve its habitat, then the respondent may state their valuation for 
saving the forest, as opposed to just saving the butterfly (Schulze et al. 1998).     
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Hoehn and Randall (2002), two of the economists who worked on the Tolley et al. 
(1985) study, later utilize a procedure for valuing multi-dimensional goods that 
eliminates the embedding problem.  Hoehn and Randall (2002) use a CV survey to value 
improvements to the Coeur d’Alene River Basin that had sustained environmental 
damages due to years of coal mining.  Using an information booklet,33 respondents are 
asked to assess the severity of individual environmental injuries (i.e. toxicity to the area, 
fish mortality, swan mortality) associated with the resource damage.  After all of the 
information regarding resource injuries was made, respondents were then asked to state 
their preferences for improving the area by voting in favor or against a one-time tax (tax 
amounts ranged from $60 to $220).  Marginal WTP for each individual benefit stemming 
from the overall treatment can then be obtained using a linear model (in a manner similar 
to hedonic regression) in order to decomposes WTP into the implicit prices associated 
with each specific improvement (Hoehn and Randall 2002).  Although the authors agree 
that this method may still be susceptible to question order effects (Hoehn and Randall 
2002) which could affect marginal WTP values, this method does address the issue of 
embedding, and as such, should result in reliable valuations for the overall improvement 
being valued.   
 
2.6.3 Insensitivity to Scope 
Problems associated with scope occur when economic theory dictates that people 
should be willing to pay more (for an increase in quality or quantity of the good) and yet 
WTP remains relatively constant.  In an attempt to discredit the CVM, Diamond and 
Hausman (1991) cite a study by Desvousges et al. (1993) in which, according to 
Diamond and Hausman, the WTP valuations obtained were essentially the same for 
saving (a) 2,000, (b) 20,000, or (c) 200,000 birds.  Although this seems like strong 
evidence to suggest a problem with scope, Carson et al. (2001) point out that this 
statement is misleading because in fact, the Desvousges et al. (1993) survey was worded 
such that respondents were valuing “saving (a) much less than 1%, (b) less than 1%, or 
(c) about 2% of a population of 8.5 million migratory waterfowl” (Carson et al. 2001).  
                                                 
33 According to the authors, the booklet was organized following the hierarchical format suggested by 
Bettman et al. (1987) and Magat et al. (1988).   
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This is not to say that problems with scope are not possible; however, it does suggest that 
clearly defined goods (in terms that are easy for the respondent to understand), can help 
prevent scope from being an issue.  One area in which scope is known to be a valid issue 
is “valuing small changes in small probabilities in health risk” (Carson et al. 2001).  
Beattie et al. (1998) find that individuals have difficulty understanding low-level changes 
in risk which can result in valuations that are insensitive to scope. 
 
2.6.4 Level of Familiarity 
When people choose to make a purchase in an actual market, they generally know 
something about the good they are planning to purchase.  However, in asking about a 
good in a contingent market, respondents may not be familiar with the good they are 
being asked to value.  This can lead to problems associated with embedding or scope, as 
mentioned above, and can also bring into question the accuracy of using stated 
preferences as a method of valuation.  Regarding the degree of familiarity that is 
necessary to make valid estimations of value, some economists (Carson et al. 2001, 
Hanemann 1994) argue that numerous new products are introduced in consumer markets 
each year, such that individuals routinely make “purchase decisions involving goods for 
which they have no prior experience” (Carson et al. 2001 p. 178).  Therefore, the 
information provided in contingent valuation surveys may actually provide more 
information about the good than consumers have in making purchases for “unfamiliar or 
infrequent commodities” (Hanemann 1994 p. 20). 
Although this theoretical argument may appear to have merit, the empirical 
evidence suggests otherwise.  Whitehead et al. (1995) find that in valuing improvements 
in the water quality and wildlife habitat for an environmental resource in North Carolina, 
on-site and off-site users provide estimates of WTP that meet tests of construct validity; 
whereas those provided by non-users did not (Whitehead et al. 1995).  In addition, Boyle 
et al. (1993) find that experienced boaters provide more valid WTP responses than 
inexperienced boaters in valuing flow levels that can affect the quality of a white water 
rafting trip through the Grand Canyon.  These findings suggest that those who are more 
familiar with the good may give more valid estimates of WTP.  In addition, sampling 
respondents who are more familiar with the good being valued may also prevent other 
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related CV issues.   In a review of the CV literature, findings by Schulze et al. (1998) 
suggest that embedding may be less of an issue for respondents who are familiar with the 
good versus those who are unfamiliar.  These studies provide evidence that sampling  
respondents who have some degree of familiarity with the good may improve the 
accuracy of WTP estimates; however, it does not preclude the possibility that individuals 
with lower degrees of familiarity can still provide accurate valuations for certain types of 
goods, provided the CV survey provides relevant information and precautions are taken 
to mitigate the effect of hypothetical bias.  
 
 
2.6.5 Question Order and Context Effects 
 Question order effects arise when the valuation of multiple goods presented in a 
single CV survey is influenced by the order in which the goods are presented.  The 
following example illustrates a common occurrence for CV studies in which two or more 
goods are valued as part of the same survey.  If respondents are asked about their WTP to 
save whales in a certain natural resource area, and then asked about their WTP to save 
dolphins in the same area, respondents’ WTP for saving whales tends to be higher; 
however, when the order of the questions is reversed, respondents’ WTP for dolphins is 
higher.  Another related problem is when two different surveys are used to value whales 
and dolphins separately.  In this case, the sum of the WTP valuations when the two goods 
are valued independently tends to be larger compared to the sum of the WTP valuations 
for the two goods when they are valued together as part of the same survey.  Carson et al. 
(2001) asserts that these outcomes can largely be explained by income and substitution 
effects. When two goods are valued together, the household income available to spend 
for the second is diminished by the respondent’s stated WTP for the first.  In addition, if 
these goods are viewed as substitutes, then it is not surprising that WTP for the first 
would diminish WTP for the second.  However, income and substitution effects would 
not be observed when the goods are valued independently.  Therefore, Carson et al. 
(2001) caution that summing up CV estimates obtained independently does not take into 
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account substitution and income effects, and this is necessary in order to derive 
valuations that do not overstate true WTP.34 
  Evidence regarding question order effects in CV studies includes a study by Boyle 
et al (1993).  In this study related to the quality of a white water rafting trip along the 
Colorado River in the Grand Canyon, 8 different levels of river flow were valued in the 
same CV survey (Half the sample received a survey in which the flows ranged from low 
to high, and the other half received surveys in which the flows ranged from high to low).  
Since the goods being valued were completely independent of each other, resulting 
valuations should also have been unaffected by question order.  Boyle et al. (2003) found 
that those with more familiarity of the good (i.e. experienced boaters) did not 
demonstrate question order effects; however, those with less experience did have 
variances in their valuations that could be attributed to question order.  This finding 
suggests that those with a higher level of familiarity may be less susceptible to question 
order in valuing goods through CV.       
 
2.6.6 Warm Glow  
Warm glow35 is a concept that suggests that individuals can be motivated because 
they “derive utility from the act of giving through the associated social approbation, 
prestige, or moral satisfaction” (Carson et al. 2001  p. 177).  Empirical evidence from the 
CV literature suggests that the warm glow effect may be an issue when respondents make 
their preferences known in such a way that the information may be made public. 
A CV study by Leggett et al. (2003) in which visitors to Fort Sumter National 
Monument in South Carolina were asked about their WTP for a fort visit, suggested that 
conducting the survey using an interviewer resulted in “social-desirability bias” as 
compared to WTP estimates obtained using a self-administered mail survey.  However, a 
study by Carson et al. (1994) found that using a standard CV format with an interviewer 
versus a secret ballot box resulted in no statistically significant difference in WTP 
estimates.  In addition, in a comparison of mail versus telephone surveys, Ethier et al. 
                                                 
34 In as much as it does not take into account income and substitution effects, Carson et al. (2001) do not 
agree that the “adding-up test” proposed by Diamond and Hausman (1994) should be used to validate CV 
valuations. 
35 According to Carson et al. (2001), Becker (1974) used the term “warm glow” to describe the concept of 
impure altruism which was first introduced by Olsen (1965). 
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(2000) found that hypothetical decisions to participate in an environmentally-friendly 
energy program were not statistically different between survey modes, suggesting that 
social desirability bias did not occur when a respondent was interviewed over the 
telephone.    
Like Leggett et al. (2003), List et al. (2004) also found evidence of the warm glow 
or social-desirability bias when stated preferences were obtained using an in-person 
interviewer and, in addition, when there was a possibility that the respondent would have 
to make his/her preference known to a group.  List et al. use a referendum format to ask 
respondents whether or not they would support contributing $20 to the start-up of a new 
Center for Environmental Policy Analysis (CEPA) at the University of Florida.  
Respondents included a total of 268 undergraduate students recruited from the College of 
Business.  The students were divided into three groups representing different degrees of 
anonymity under which they would state their preferences for the good.  A split-sample 
format was used, such that half the students in each group received the hypothetical 
questions and the other half participated in the actual referendum.  Study results indicated 
that those in the peer group (in which 10 members of each group were required to share 
their response) were more likely to vote “yes” compared to those surveyed using the 
other two methods.  In addition, there was a statistically significant difference between 
those in the baseline group (for which only the surveyor would know the respondent’s 
stated preferences) as compared to the percentage of “yes” responses given by the group 
for which respondent answers were completely anonymous (List et al. 2004).   
The List et al. study suggests that when individuals are asked to state their WTP 
in a manner in which they feel their answers may be made public, there is a tendency for 
individuals to be influenced by an external source of utility -namely, that of “advertising 
one’s own goodwill” (List et al. 2001 p. 749) and including that as part of their stated 
WTP.  Since this value should not be included in assessing the WTP for the good itself, 
this study provides evidence that suggests confidentiality when stating preferences is 
important to elicit WTP values that are free from bias.36   
                                                 
36 This result also brings into question that assumption that is often made in validity tests – that “real” 
responses in laboratory and field experiments reflect true WTP.  If, in fact, these “real” values are inflated 
due to warm glow, then that implies the degree of hypothetical bias may not be as large as previous 
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2.7  Evaluating the Validity and Reliability of CVM 
 The validity of CVM refers to how well stated preferences match actual 
valuations, and the reliability of CVM refers the consistency of stated preferences over 
time or across different samples of the population (Carson et al. 2001).  Meeting one of 
these criteria does not necessarily imply that a contingent value measure will meet the 
other (Whitehead et al. 1995).      
 
2.7.1 Validity 
Ideally, validity would be confirmed by comparing results to a known standard 
(such as validating the weight of an object by comparing it to a known weight at the 
National Bureau of Standards); however, true underlying consumer preferences are 
unknown, such that no standard is available for comparing valuations obtained through 
CVM.  Therefore, researchers typically rely on two tests to determine validity: construct 
validity and convergent validity (Carson et al. 2001). 
 
Construct Validity   
Construct validity is determined by how well stated preferences are explained by 
factors that economic theory would predict.   For example, economic theory would 
predict that the percentage of individuals willing to pay for a good will decrease as the 
price increases (Carson et al. 2001).  According to a review of the literature by Carson et 
al. (2001), this result is widely confirmed.  In addition, construct validity implies that 
individual WTP can be explained by characteristics of the good and individual, in ways 
that economic theory would predict.37  In particular, one would expect WTP for a good to 
increase with higher levels of income (for a normal good), and for WTP to also rise for 
increases in the quantity (or quality) of the good being provided (Carson et al. 2001).  
The later is often referred to as a scope test.   
According to Carson et al. (2001), “a scope test looks at whether respondents are 
willing to pay more for a good that is larger in scope, whether in a quality or quantity 
sense” (Carson et al. 2001 p. 181).  Carson et al. further state that failure to pass a scope 
                                                                                                                                                 
thought.  However, the fact that hypothetical bias has been observed for private goods, suggests that even if 
this theory is true, it cannot account for the entire difference between revealed and stated preferences.      
37 Testing this assumption is referred to as a theoretical validity test (Blomquist and Whitehead 1998). 
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test may be due to (1) insufficient statistical power as described by Arrow and Leamer 
(1994); (2) poor survey design or administration as explained by Carson and Mitchell 
(1995); or (3) CV results that are inconsistent with economic theory as discussed by 
Hausman (1993).   
Two types of scope tests exist.  An internal scope test uses stated preferences 
from the same individuals at different levels of the good to see if the results are consistent 
with economic theory (i.e. a higher WTP is observed when larger amounts, or a higher 
quality, of the good is offered).  An external scope test examines the same assumption, 
but by comparing stated preferences from statistically equivalent subsamples, each of 
which value a different level of the good (Carson et al. 2001).  A study by Blomquist and 
Whitehead (1998) uses a CV survey to estimate the WTP to preserve wetlands offering 
various levels of quality.  Blomquist and Whitehead find that individual WTP does 
respond to differences in wetland quality as described in the CV survey; thereby 
suggesting that individuals do respond to variations in scope in CV surveys.   
Although some critics of the CVM, contend that scope is a serious problem, 
Carson et al. (2001) argue that these claims are based on a small subsample of the 
literature that is not representative.  In a review of the CV literature, Carson et al. (2001) 
find that 31 CV studies passed a scope test, while only 4 did not.  Based on these studies, 
Carson et al. conclude that “poorly executed survey design and administration procedures 
appear to be a primary cause of problems in studies not exhibiting sensitivity to scope” 
(Carson et al. 2001 p. 183).  Thus, suggesting that many issues related to scope 
insensitivity can be prevented with careful survey design and implementation.    
 
Convergent Validity  
Convergent validity is the degree to which stated preferences obtained through 
CVM match preferences revealed in implicit markets.  Therefore, convergent valuation 
can be tested by looking at either (1) the degree of correlation or (2) the ratio between 
valuations derived using CV surveys to estimates of value for the same good obtained 
using implicit market methods (namely, travel cost or hedonic pricing).38  Another 
potential way to test for convergent validity is to compare results of a CV survey 
                                                 
38 For examples, see Loomis et al. (1991) and Blomquist (1988). 
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involving an upcoming referendum and then comparing the results predicted by the CV 
method to the actual voting results (Carson et al. 2001).  According to Carson et al. 
(2001), CV studies using a referendum format that are conducted relatively close to the 
actual vote have been quite successful at predicting actual voting outcomes.39 
 
2.7.2 Reliability 
 Reliability is a measure of the consistency of CV results over time or across 
different samples.  Two tests of reliability include testing the consistency of CV 
responses by (1) surveying the same respondents at two different points in time, and (2) 
surveying two different samples at two different points in time (Carson et al. 2001).  
Carson et al. (2001) cite several studies40 that found valuations remained consistent over 
time,41 suggesting that the CVM has the potential to produce results that are reliable over 
time, both for across sample and same sample designs.   
 
2.8  Addressing Hypothetical Bias: Evidence Supporting the Validity of the CVM 
 As mentioned previously, hypothetical bias appears to currently pose the greatest 
problem for the CVM.  A meta-analysis conducted by List and Gallet (2001) compare 
hypothetical values to real values for 29 CV experiments and find the calibration factor42 
for many of these studies exceeds 1.2; thus, supporting the conclusion that valuations 
obtained through stated preferences (utilizing a CV survey) are, indeed, prone to 
hypothetical bias.  Hypothetical bias has been observed for both private (Blumenschein et 
al. 2007, Cummings et al. 1995, List 2001) and public goods (Champ and Bishop 2001, 
Champ et al. 1997, Cummings and Taylor 1999) and across a wide range of payment 
mechanisms; therefore it is unlikely that this phenomenon is dependent on these factors43   
                                                 
39 Carson et al.’s (2001) conclusion is drawn from studies by Carson, Hanemann, and Mitchell (1987) and 
Polasky, Gainutdinova, and Kerkvliet (1996)        
40 Studies include Carson and Mitchell (1993), Carson et al. (1997), Whitehead and Hoban (1999) 
(independent samples) and McConnell, Strand, and Valdes (1998) (same sample).  
41 For some studies, including Whitehead and Hoban (1997) and McConnell, Strand, and Valdes (1998), 
WTP changed (which could potentially be explained by changes in the household’s income or other 
relevant factors overtime), but the valuation function was unchanged (Carson et al. 2001).   
42 The calibration factor is found by dividing the mean hypothetical value by the mean real value and is 
used as a measure of the degree of hypothetical bias present in the valuation (List and Gallet 2001). 
43 Results from List and Gallet’s (2001) meta-analysis suggest that hypothetical bias will be less 
pronounced when private (versus public) goods are valued using WTP (versus other mechanisms); 
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As a result of the presence of hypothetical bias in stated preference valuations, 
several methods have been employed to remove hypothetical bias from the data ex post 
using various calibration methods.  Many of these methods involve assessing the degree 
of certainty with which the respondent states their preferences using a certainty scale or 
in answering a polychotomous choice question regarding how sure they are about their 
decision.  Another, completely different, approach focuses on encouraging respondents to 
address the potential for hypothetical bias before stating their preferences.  The idea 
being that if respondents are aware of the potential for hypothetical bias, they will then be 
able to correct for it before making a statement regarding their preferences for the good 
being valued.  This ex ante method was introduced by Cummings and Taylor (1999) and 
is often referred to as the “cheap talk”44 approach. 
 
2.8.1 Cheap Talk  
Cummings and Taylor (1999) introduce a potential method of eliminating 
hypothetical bias in which they use a “cheap talk” script to inform respondents directly 
about the possibility of hypothetical bias prior to stating their preferences for the good 
being valued.  Cummings and Taylor find that for decisions regarding donations toward 
several public goods, there is no statistically significant difference between actual 
referendum voting and hypothetical referendum voting when a cheap talk script is 
utilized.  Furthermore, additional testing on these public goods revealed that this result 
was robust for modifications of the cheap talk script and across variations in experimental 
design (Cummings and Taylor 1999).  The results of this study are supported by Ajzen et 
al. (2004) who found that hypothetical student donations toward a scholarship fund under 
a referendum model exceeded real donations; however, inclusion of a corrective entreaty, 
which followed the cheap talk script proposed by Cummings and Taylor, effectively 
removed the difference between real and stated preferences.   
Although the results of the Cummings and Taylor (1999) and Ajzen et al. (2004) 
studies suggest that utilizing a “cheap talk” script within a contingent valuation 
                                                                                                                                                 
however, these findings were not supported in a meta-analysis performed by Little and Berrens (2004), 
which expanded on the work done by List and Gallet (2001).    
44 The name “cheap talk” is a reference to the term used in bargaining for the costless transmission of 
information or signals (Cumming and Taylor 1999). 
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framework has the potential to effectively eliminate the difference between decisions 
made in real markets versus those made in contingent markets, other studies reveal that 
cheap talk may be limited in its effectiveness at removing hypothetical bias, at least in 
certain cases (Blumenschein et al. forthcoming 2007, Brown et al. 2003, Murphy et al. 
2005, List 2001).  
Brown et al. (2003) and Murphy et al. (2005) found that utilizing a cheap talk 
script reflective of the one used by Cummings and Taylor (1999) was effective at 
removing hypothetical bias for higher dollar amounts, but was not as effective at lower 
dollar amounts.  Brown et al. (2003) use a split-sample design to test whether the cheap 
talk script is effective at eliminating hypothetical bias for students making donations to a 
scholarship fund through a referendum mechanism.  The amount of the donation was 
varied between $1, $3, $5, and $8.  As economic theory would predict, the results 
indicate that the percentage of students voting “yes” decreased as the price increased 
when the referendum was real.  However, when the decision was hypothetical, the 
percentage of “yes” votes remained fairly constant across price levels.  This result implies 
that hypothetical bias may be larger for higher payment amounts; however, including a 
cheap talk script that mimicked the one used by Cummings and Taylor was very effective 
in eliminating the hypothetical bias for the higher bid amounts of $5 and $8.  The cheap 
talk method; however, did not sufficiently remove the hypothetical bias at the $3 level 
(Brown et al. 2003).   
A similar study conducted by Murphy et al. (2005) supports the finding that the 
cheap talk script may not be effective at lower price levels.  Murphy et al. investigated 
the use of a provisional point mechanism in making donations to a public good.  The 
purpose of the study was to use a wider range of values ($3 to $30) to further test the 
results of the Brown et al. study.  Murphy et al. found that the cheap talk script was not 
effective at lower amounts ($3 and $6), but for higher dollar amounts ($9 and greater) the 
percentage of hypothetical donations converged with real donations (Murphy et al. 2005).   
Interestingly enough, if you consider the prices used by Cummings and Taylor 
(1999) and Ajzen et al. (2004) in their referenda, then the conclusion drawn by Brown et 
al. (2003) and Murphy et al. (2005) - that the cheap talk script is only effective at higher 
dollar amounts - is not necessarily inconsistent across these four studies.  Cummings and 
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Taylor used a price of $10 for all of its public good referenda and Ajzen et al. used a 
price of $8.  The results of Brown et al. and Murphy et al. suggest that a price of $8 and 
$10 are high enough to fall within the range of prices for which the cheap talk was 
effective at eliminating hypothetical bias.  Therefore, Brown et al. and Murphy et al. 
seem to have discovered a limitation of the cheap talk method that was not observed by 
Cummings and Taylor and Ajzen et al. due to the fact that all the goods used in these 
experiments had relatively high prices for which the cheap talk method appears to work 
well.   
 Another possible limitation of the cheap talk method is suggested by List (2001) 
who found differences in effectiveness based on familiarity with the good being valued.  
Using a Vickery second-price auction to value sportscards, List found that the cheap talk 
script proposed by Cummings and Taylor (1999) was effective at eliminating 
hypothetical bias for non-dealers, but not for dealers.  Although this finding may suggest 
that a cheap talk script is more effective for those less familiar with a good due to the fact 
that those who are more familiar with the good may “rely on few, if any, external signals 
when formulating their value” (List 2001 p. 1498); it is also possible that a difference in 
recruiting methods between dealers and non-dealers may have contributed, at least in 
part, to this result.45 
 Although several laboratory experiments and field tests indicate that cheap talk is 
effective at eliminating hypothetical bias for higher dollar amounts, a recent field test by 
Blumenschein et al. (forthcoming 2007) and meta-analysis by Little and Berrens (2004) 
suggests that the cheap talk script is not effective in eliminating hypothetical bias in 
                                                 
45 The study includes both dealers and non-dealers of sportscards and was conducted at a sportscard show.  
Non-dealers were recruited for the study when interested parties stopped and inquired about the specific 
sportscard being valued (which was displayed on a table).  Dealers, on the other hand, were approached by 
the researchers at their own booths prior to the start of the show (between 7AM and 12 PM on Saturday 
and Sunday).  Therefore, there was a distinct difference in the recruitment method between these two 
groups that may account for the difference in effectiveness of the cheap talk script for this study.  The non-
dealers recruited for the study expressed a specific interest in the card being auctioned, and as such, had a 
vested interest in performing well in the auction (in order to win the card).  Dealers, on the other hand, may 
have been preoccupied with setting up their own booth when approached by the interviewer.  If the dealers 
included in the study were, in fact, pressed for time, they may not have taken the time and effort necessary 
to adequately read the lengthy cheap talk script and learn about the Vickery auction through the 
information sheet that was included as part of the study.  If dealers were less motivated to read the cheap 
talk script and auction procedure due to the circumstances in which they were recruited versus non-dealers, 
then the results of this study may be more a reflection of the study design as opposed to a true difference in 
the effectiveness of the cheap talk scheme across those with varying degrees of familiarity with the good.   
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stated preference studies that use the contingent valuation methodology.  Blumenschein 
et al. use face-to face interviews to value a pharmacy-provided diabetes management 
program.  The field test includes 260 diabetics recruited from nine pharmacies in the state 
of Kentucky.  Prices for the program varied between $15, $40, and $80.  Respondents at 
three of the pharmacies actually received the program, respondents at three different were 
given an opportunity to express their intentions of participating in the program by 
answering a dichotomous choice contingent valuation question, and respondents at the 
remaining three pharmacies were also asked whether they would participate in the 
program if it were offered, but prior to making their decision were read a cheap talk script 
similar to the one used by Cummings and Taylor (1999) in which hypothetical bias is 
described.  Blumenschein et al. find a significant difference between real and 
hypothetical stated preferences, indicating the presence of hypothetical bias in the data.  
Based on their study, the cheap talk script is ineffective at removing the hypothetical 
bias; however, when the follow-up certainty question is used to calibrate hypothetical 
responses there is no statistical difference between real and hypothetical responses for 
those who were “definitely sure” of their response (Blumenschein et al. forthcoming 
2007).   
 The results of the Blumenschein et al. (forthcoming 2007) study suggest that the 
cheap talk approach is not an effective tool at removing hypothetical bias in stated 
preference valuations.  Since the prices used in the Blumenschein et al. study were clearly 
in the range of “high prices” for which the cheap talk methodology worked in earlier 
studies (Brown et al. 2003, Murphy et al. 2005), these latest results certainly bring into 
question the reliability of stated preferences obtained using only a cheap talk script.  In 
addition, a meta-analysis by Little and Berrens (2004) also indicate that the cheap talk 
approach is not necessarily effective, but that using a certainty correction does effectively 
eliminate hypothetical bias.  
 
2.8.2 Using Certainty to Eliminate Hypothetical Bias 
 One possible explanation of the cause of hypothetical bias is based on the 
“discrepancy between intentions and behavior” (Ajzen et al. 2004 p. 1109).  This theory 
implies that individuals with strong dispositions in favor of (against) the provision of a 
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good, will vote in favor of (against) it regardless of whether the decision is real or 
hypothetical.  However, for individuals for whose disposition is not as strong, 
inconsistencies between real and hypothetical decisions will be more likely to occur 
(Ajzen et al 2004).  Although the results of the study by Ajzen et al., whose main purpose 
was to explore the formation of intentions and their relationship to actual behavior, 
suggest that those who vote consistently and those who vote inconsistently may express 
equally strong beliefs, they may do so with different degrees of confidence (Ajzen et al. 
2004).  This finding explains the difficulty economists have encountered in trying to 
develop a calibration function based on attitudes and beliefs, and lends support to 
pursuing the possibility of addressing hypothetical bias by looking at the certainty with 
which stated preferences are made.  In particular, this finding is not inconsistent with the 
hypothesis that individuals who have a lower degree of certainty in their stated 
preferences are more likely to be the source of hypothetical bias.  
 There are two basic approaches to using certainty to “calibrate” hypothetical 
choices: (1) the use of a certainty scale first used by Champ et al. (1997), and (2) the use 
of a follow-up certainty question.  Since the heart of the debate is the accuracy with 
which “hypothetical choices in the contingent valuation method correspond to real 
economic choices” (Johannesson et al. 1999), numerous studies have specifically tested 
this as a hypothesis by comparing stated preferences obtained in a hypothetical market 
with actual purchase decisions. 
 
Follow-up Certainty Scale 
Champ et al. (1997) included a certainty scale in their CV study that explored the 
difference between stated donations and actual donations to an environmental public 
good.  Using a mail survey, respondents were asked to make a donation to remove roads 
along the North rim of the Grand Canyon and return the area to wilderness.  The amount 
of the public good provided was continuous in that total donations would determine the 
amount of road that would be removed.  For some respondents, the decision was real and 
for others, the decision was hypothetical.  Following the voluntary donation question, 
respondents were asked to rate the level of certainty associated with their decision using a 
scale of 1 to 10 (where 1 was “very uncertain” and 10 was “very certain”).  Champ et al. 
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found that hypothetical donations exceeded actual donations; however, when a 
hypothetical “yes” was recoded to a “no” for all the respondents except those who were 
“very certain” (indicated a 10 on the certainty scale); hypothetical donations were not 
statistically different from actual donations.  Thus, these findings provide evidence to 
suggest that using a certainty scale to calibrate stated responses has the potential to 
effectively remove hypothetical bias, such that actual preferences can be obtained using a 
CV survey. 
Since the Champ et al. (1997) study, several other studies have successfully used 
certainty scales to calibrate hypothetical responses, such that they correspond with real 
decisions; however, the degree of certainty used to recalibrate the responses varied to 
some extent across studies.  For example, in a study by Ethier at al. (2000) on consumer 
participation in Green Choice (an environmentally-friendly electricity program), stated 
participation rates converged with actual participation rates at certainty level of 7 
(hypothetical participation rates at a certainty level of 8 were also not statistically 
different from actual participation rates).  Similarly, in a follow-up mail study that 
utilized a split-sample design, Champ and Bishop (2001) found that hypothetical 
donations toward the purchase of wind-generated energy corresponded to actual 
donations when a certainty level of 8 was used for calibration.  Like, Ethier et al. (2000), 
a study by Poe et al. (2002) also used the Green Choice program as their good to be 
valued, but in addition to evaluating participation rates, this study also used a voluntary 
contribution mechanism with a PPM.  Results were similar to those of Champ and Bishop 
and Ethier et al. in that hypothetical contributions most closely corresponded to actual 
donations when respondents indicated a certainty level of 7 or 8.   
Collectively these studies suggest that hypothetical bias can be eliminated such 
that stated preferences obtained using a CV will reflect revealed preferences for public 
goods.  However, the potential difficulty with the certainty scale method is that it is not 
entirely clear which level of certainty is the appropriate level to use for calibration.  
Although these studies suggest that a value of 7 or higher is appropriate, the exact value 
to be used for calibration may be dependent on the good being valued. 
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Follow-up Certainty Question (Definitely/ Probably) 
 Another approach that has proved very successful as a means of calibrating 
hypothetical responses, such that they correspond with real decisions, is the use of a 
follow-up certainty question in which respondents indicate if they are “definitely sure” or 
“probably sure” of their stated intensions.  Like the certainty scale, this question is 
presented immediately after the respondent indicates their hypothetical decision 
regarding the provision of the good.  To test the validity of using this type of certainty 
question as a means of calibration, several laboratory and field experiments have been 
conducted using private goods.  Overall, this method shows excellent potential as a 
means of eliminating hypothetical bias, such that hypothetical responses reflect actual 
behavior. The following provides details on several related studies that trace the 
development of this technique.  
 An experiment conducted by Johannesson et al. (1998) asked business and 
economics students at Lund University in Sweden about their WTP for a box of Belgian 
chocolates.  Following the hypothetical decision to purchase the box of chocolates, 
respondents were asked to assess how certain they were of their purchase decisions.  
Certainty could be expressed as “fairly sure” or “absolutely sure.” The results showed 
that hypothetical “yes” responses overestimated real “yes” responses, indicating 
hypothetical bias.  However, only counting those who were “absolutely sure” as a true 
“yes” response underestimated real “yes” responses, providing a conservative estimate of 
WTP.   
In another laboratory experiment by Blumenschein et al. (1998), the certainty 
categories were modified to “probably sure” and “definitely sure.”  In this experiment, 
133 college students were asked about their willingness to purchase a pair of sunglasses, 
either in a hypothetical or real context.  Students who responded “yes” to the hypothetical 
question to purchase the sunglasses were then asked to indicate if they were “definitely 
sure” or “probably sure” about their decision.  Using a nonparametric contingency table 
chi-squared test, the results revealed that simply using “yes” responses did tend to 
overestimate the true willingness to make the purchase; however, when only “definitely 
sure” responses were counted as a true “yes” there was no statistically significant 
difference between the two groups (Blumenschein et al. 1998).  Therefore, this study 
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suggested that hypothetical bias could be eliminated from CV estimates by simply adding 
a certainty follow-up question, and then calibrating the results using those who were 
“definitely sure” as a signal of a true intention to purchase the good.46    
Given the success of this laboratory experiment, Blumenschein et al. (2001, 
forthcoming 2007) then applied this methodology to in two field tests valuing health-
related goods.  In the Blumenschein et al. (2001) study, patients taking asthma 
medication were asked about their willingness to participate and pay for a pharmacist 
provided asthma management program.  Although 30% of the patients in the hypothetical 
group stated they would participate in the program at the stated price, compared to only 
12% who actually participated in the program, when hypothetical responses were 
adjusted to only include those who were “definitely sure” as true “yes” responses, there 
was no statistically significant difference in participation rates between the real and 
hypothetical groups. 
As discussed earlier, the Blumenschein et al. (forthcoming 2007) study which 
compared hypothetical and real decisions to participate in a pharmacy-provided diabetes 
management program, provides additional evidence to suggest that including only 
“definitely sure” respondents as a measure of true intentions to participate, can be an 
effective method to mitigate the effect of hypothetical bias often observed in CV studies. 
Clearly hypothetical bias is an issue for the CVM; therefore, several studies have 
focused on validating calibration methods such that preferences state in contingent 
markets correspond to actual behavior.  One of Diamond and Hausman’s arguments 
against CV is that calibrations in prior studies have been arbitrary, however, Mitchell and 
Carson (1989) correctly point out that quantifying the difference between actual behavior 
and that stated on CV surveys is the key to accurate calibration. 
                                                 
46 Johannesson et al. (1999) further explore the data collected in the experiments conducted by 
Johannesson et al. (1998) and Blumenschein et al. (1998), both of which included a certainty scale similar 
to the one used by Champ et al. (1997).  Using the respondent’s self-reported value on the certainty scale, a 
variable representing the price level, and socio-economic variables including age and gender as explanatory 
variables, Johannesson et al. estimate a probit function to determine the probability of a “yes” response 
being a “true yes” response.  After calibration, there was no statistically significant difference between the 
hypothetical “yes” responses and the actual “yes” responses in either study (Johannesson et al. 1999).         
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The results of several studies by Blumenschein et al. (forthcoming 2007, 2001, 
1998) suggest that using a simple follow-up certainty question in which respondents 
indicate whether they are “probably sure” or “definitely sure” of their stated preference 
holds vast potential for eliminating hypothetical bias in CV surveys.  Therefore, the 
results of these studies provide additional evidence to support that CV can accurately 
elicit individual WTP and provide valid valuations in deriving the benefits associated 
with health-related and other non-market goods.    
 
2.9 Information and Risk 
 When making decisions regarding risk and uncertainty, individuals often do not 
have perfect information.  However, According to Viscusi “if individuals were fully 
informed of the consequences of their decisions and made rational choices, then in a 
democratic society we should respect these choices” (Viscusi 1992, p. 4).  This could 
imply that if individuals chose to skydive or ride in a car without a seatbelt, then society 
should allow them to do so.  However, Viscusi (1992) goes on to state that it is often the 
case that consumers are not fully informed about risks, and therefore often make 
decisions with imperfect information.  Therefore, if individuals are not fully informed of 
the risks they face, then there is a potential for market failure which could potentially 
justify government intervention (Viscusi 1992). So this suggests the question, “Do 
individual risk perceptions tend to correspond with actual measures of statistical risk?” 
 
2.9.1 Perceived versus Actual Risk 
 If individuals do not fully understand the risks they face, then their perceived risk 
may be different from their actual risk.  Viscusi and O’Connor (1984) test whether 
chemical workers update their risk assessment when the current chemical they are 
working with is replaced.  Viscusi and O’Connor find that workers update their risk 
assessments in the correct direction, suggesting that individuals may, in fact, be good 
judges of actual risk.  A study by Lichtenstein et al. (1978); however, finds a general 
tendency for individuals to overestimate small risks, while underestimating larger ones; 
thereby suggesting that an individual’s perception of risk may not always correspond 
with actual risk.     
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2.9.2 The Effect of New Information on Risk Assessment  
Although Viscusi’s findings suggest that workers may be good judges of 
occupational risk, the result by Lichtenstein et al. (1978) demonstrate that individuals 
may not be good assessors of risk in all cases.  If this is true, then does providing 
additional information help?  What is the relationship between prior and new information 
regarding individual risk assessments?  Viscusi’s (1992) prospective reference theory 
(PRT) provides one explanation of how new information is incorporated into forming 
new risk assessments that are closer to the true value of statistical risk.  PRT is based on 
an expected utility model in which information is processed in a Bayesian manner, such 
that prior and new risk assessments carry a “weight” that is dependent on the perceived 
credibility of the new information being presented and the strength of the individual’s 
prior assessment of risk (Viscusi 1992).  This theory suggests that the higher the degree 
of credibility that is placed on prior information, the less “weight” will be given to the 
new information.  Findings by Tkac (1998) support this theory.  Tkac finds that although 
respondents with higher levels of prior information have a higher WTP for treatment, 
valuations by knowledgeable individuals were not influenced by the information 
presented (Hoehn and Randall 2002).  This finding supports the hypothesis that those 
with strong priors will place less weight on new information. 
Hoehn and Randall (2002) modify the Bayesian updating model used by Viscusi 
and O’Connor (1984) by making it more general.  In particular, Hoehn and Randall relax 
the “assumption that prior information is necessarily proportional to objectively true 
information” and “allow prior knowledge to differ across individuals” (Hoehn and 
Randall 2002 p 16).  Poe (1998) and Carson et al. (1996) suggest that heterogeneity exists 
in the prior information held by individuals; therefore, dropping these assumptions allows 
Hoehn and Randall to account for this difference across individuals in valuing the quality 
of an environmental resource.  Allowing for heterogeneity in prior knowledge implies 
that the new information may increase or decrease the individual’s perception of resource 
quality, depending on their prior perception.  In particular, if the new information 
suggests that the quality of the resource is higher (lower) than the individual previously 
thought, then they will have a positive (negative) change in their perception.  Therefore, 
Hoehn and Randall allow for the possibility that the same information can have different 
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effects for each individual.47  This, in turn, is expected to affect individual WTP (Hoehn 
and Randall 2002). 
Smith and Desvousges (1990) study the effect of various information 
presentations on the formation of risk perceptions of households relating to the presence 
of radon in their homes and discover that individuals systematically update risk 
perceptions when presented with new information regarding that risk.  They also find that 
providing only minimal information regarding risk can, in fact, cause individuals to 
overestimate the actual risk.  Therefore, from a public policy standpoint, the results of 
Smith and Desvousges (1990) suggest that providing more complete information 
regarding risk will lead to more accurate risk perceptions.  
In addition, a study conducted by Magat, Viscusi, and Huber (1988) also revealed 
the importance of information on the validity of respondents’ valuations.  This study 
focused on consumers’ willingness to pay for an increase in product safety for two 
common household items- bleach and drain cleaner.  Based on the responses, the value of 
avoiding a “statistical” injury from bleach gas poisoning was $1.38 million, child 
poisoning was $0.5 million, drain cleaner burn was $1.24 million, and $.82 million for 
drain cleaner poisoning.  These valuations are much higher than comparable morbidity 
valuations obtained through hedonic studies. One possible explanation posed by the 
authors is that the respondents looked primarily at the percentage decrease in risk posed 
in the question, without giving careful consideration to the base number of households 
subject to the risk.  If this were indeed the case, the responses would have essentially 
have been unaltered if the study had been based on 2 million, 200,000 or perhaps even 
20,000, which would have lowered the resulting valuations by a power of 10 to 100.  
Therefore, the authors caution that individuals must fully understand the risks if their 
responses are to be used to estimate benefits for the purpose of policy decisions (Magat et 
al. 1988). 
 
 
 
                                                 
47 This is different from past studies which assumed that the new information would have the same effect 
across individuals.  
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2.10 Applications to this Study 
2.10.1 Addressing the Potential for Hypothetical Bias 
This study utilizes two CV surveys to value two health goods related to the 
prevention of heart attacks.48  Because hypothetical bias was a concern, several measures 
were included as part of the survey to prevent the possibility of hypothetical bias from 
entering the data.  First, a modified version of the cheap talk script originally used by 
Cummings and Taylor (1999) was used.  Although recent literature (conducted after the 
fielding of this study) suggests that the cheap talk methodology may not be effective 
(Blumenschein et al. forthcoming 2007), some studies have shown that cheap talk is very 
effective at eliminating hypothetical bias for higher prices (when hypothetical bias is 
thought to be the greatest issue).  Therefore, the inclusion of the cheap talk script is still 
an important component of the CV surveys used for this study, especially since the goods 
being valued are expected to have relatively high valuations.  
 A second measure to prevent hypothetical bias was the inclusion of a certainty 
scale.  The meta-analysis by Little and Berrens (2004) indicates that use of certainty 
calibration within a CV survey is an effective method for eliminating hypothetical bias.  
In addition, Blumenschein et al. (forthcoming 2007) find that there is essentially no 
difference in hypothetical decisions to utilize a diabetes managements program once 
adjusting for individuals who are “definitely sure” as compared to real decisions.  
Therefore, these studies suggest that asking respondents to assess the certainty of their 
stated preferences is an important step in mitigating hypothetical bias.   
 
2.10.2 Information and Perceived Risk 
 The concepts proposed by Hoehn and Randall (2002) are particularly relevant to 
this study.  Presumably “new” information on who is at risk for a heart attack is presented 
and measures of individual risk perception are obtained both before and after respondents 
are made aware of this new information.  As Hoehn and Randall suggest, new 
information may have different affects on respondents’ perception of risk, depending on 
their priors.  The CV surveys used for this study allow for this heterogeneity.   In 
addition, data was collected in order to determine the direction and magnitude of the 
                                                 
48 See Chapter 5: Development of the Web-based Surveys for details related to the survey instruments. 
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change in each respondent’s perception of their own risk of heart attack.  Data was 
collected both as a quantitative variable in which each unit increase (decrease) of risk 
corresponded to a 1/100,000 increase (decrease) in fatality risk.   In addition, respondents 
were asked to qualify their change in risk by indicating whether they felt their risk of a 
heart attack after reading the new information was much higher (lower), somewhat higher 
(lower), or the same.  Although it was expected that the information presented was truly 
“new” and would increase individual’s perceived risk of a heart attack, both risk 
assessment methods allowed respondents to indicate that the new information did not 
change their risk perceptions.  In addition, risk perceptions were also allowed to decrease. 
Therefore, this data can be used to assess how risk perceptions changed in response to the 
new information, and how that in turn influenced individual WTP. 
 
2.10.3 Iterative Bidding  
Starting point bias has been known to be a problem in iterative bidding as a result 
of respondents “anchoring” their WTP on the first bid presented; however, Fabian and 
Tolley (1994) find evidence from focus groups to suggest this becomes less of a problem 
“as questionnaires are enriched in their information and preference review” (Fabian and 
Tolley 1994 p. 143).  Therefore, the CV surveys used in this study contain detailed 
information that is relevant to the formation of the individual’s valuation and several 
opportunities are given for the respondent to reflect on their true valuation before stated 
their WTP.  In doing so, this study utilizes a form of iterative bidding inspired by the 
interactive computer program used by Viscusi, Magat, and Huber (1990), which was used  
to elicit risk-risk and risk-dollar valuations of chronic bronchitis.  The interactive 
computer program in the Viscusi et al. (1990) study offers paired-comparisons for which 
the attributes differ (based on the respondent’s previous responses) until indifference 
between the two is reached (Viscusi et al. 1990).  The iterative bidding program used for 
this study is similar in that subsequent bids are determined by the respondent’s answers to 
previous bids, such that each survey is tailored to the individual respondent.  In addition, 
unlike other iterative bidding processes that simply increase or decrease using a pre-
determined set of bids, the computer program in this study follows a specially designed 
algorithm that allows the series of bids to vary considerably across respondents 
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dependent on their responses.  Through the use of this well-designed algorithm, 
respondent’s WTP is obtained by asking only a minimum number of questions. 
 
2.11 Summary 
Federal agencies, as well as an increasing number of state agencies, require a 
comparison of benefits and costs before implementing public policy.  Therefore, benefit-
cost analysis has become the “gold standard” for valuing improvements in economic 
goods, including those related to health.  For goods exchanged explicitly in well-defined 
markets, the market price offers a reasonable measure of value; however, for non-market 
goods such as environmental resources, market prices are not observed and therefore are 
not available for making valuations.  However, placing a monetary value on these goods 
is “essential for sound policy” (Hanemann 1994 p. 19).  This point became increasingly 
clear immediately following the Exxon Valdez accident, which spilled 11 million gallons 
of crude oil into Prince Edward Sound off the coast of Alaska.  In the wake of this 
unfortunate accident, the courts were left wondering how to assess damages.  Contingent 
valuation, a method that asks respondents to state what they would pay for a good 
contingent on the fact that it was available in a market, provided one possible answer.   
Contingent valuation not only offered a viable means in which to value goods that 
are not explicitly traded, but it also had the added advantage of including passive use 
values, which are often a significant component of the total benefit derived from 
environmental resources.  As a result, the use of CV grew rapidly in the environmental 
literature and its use is now growing in the health literature as well.   
Although markets for health-related goods and services exist, prices do not 
accurately reflect consumer preferences due to the large presence of insurance companies 
as third-party payers.  Therefore CV offers a method of eliciting underlying consumer 
WTP for health-related goods and services that would otherwise be unknown.  In 
addition, the CVM is utility-based and derives a measure of benefit in terms of monetary 
value (WTP), which is preferable to other measures (i.e. COI) that have been used to 
value improvements in health.      
There has been some debate as to the reliability and validity of the CVM method, 
in particular the tendency of stated preferences to be subject to hypothetical bias.  
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However, several studies suggest that calibration mechanisms, specifically those 
involving the degree of certainty with which the preference is stated, have the potential to 
correct for hypothetical bias and provide accurate reflections of observed consumer 
behavior.  Although refinements to the CVM are certainly likely to occur as the further 
studies suggest additional improvements, several existing studies have already 
demonstrated that CV surveys can produce reliable and valid results.  In addition, using 
stated preference offers a methodology for valuing non-market goods that could 
otherwise not be valued.  Therefore, due to its importance to BCA, especially for valuing 
environmental resources, it is likely that the CVM will continue to be used as it provides 
the potential to obtain valuable information that is necessary to make efficient use of our 
scarce economic resources, including those related to health. 
  
Copyright © Patricia L. Ryan 2007 
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Chapter III: Medical Background 
 
The purpose of this chapter is to provide the medical information necessary to 
understand a recent change in theory regarding the primary cause of heart attacks and to 
also explain why traditional risk factors currently used by physicians fail to identify a 
large percentage of the population who are at risk for a heart attack.  This chapter will 
also describe how medical technology is changing in response to this new information 
and will provide the basis for the hypothetical screening and treatment that respondents 
are asked to value in the two surveys used for this study.  In addition, this chapter will 
explain the current standard of care for a patient who presents with symptoms of heart 
disease, subsequent decisions that would typically be made regarding the course of 
treatment; and finally, how anticipated future developments in medical technology will 
affect these decisions.  Thus, the information in this chapter will explain the medical 
advances that motivated this study as well as provide the medical background necessary 
to fully understand the decisions trees that are presented as part of the theoretical model 
in the next chapter.  
 
3.1 Changing Theory Regarding the Primary Cause of Heart Attacks 
It has long been thought that the primary cause of heart attacks is coronary 
stenosis – the buildup of plaque within the small arteries of the heart (Gazelle 2000).  
Doctors diagnose this condition as atherosclerosis, but many of us have heard it 
commonly referred to as “hardening of the arteries.”   For decades, it was presumed that 
as the degree of stenosis progressed and decreased the size of the lumen (vessel opening 
through which blood passes), it would restrict the flow of oxygenated blood to the heart.  
Then, when the heart muscle did not receive a sufficient amount of oxygen (for example, 
during times of exertion), the individual would experience chest pain, or angina.  As the 
individual’s medical condition worsened, the symptoms would persist and become more 
frequent until eventually the build up of plaque within the vessel was severe enough to 
cause a heart attack (Gazelle 2000).   
Although this medical theory still correctly explains why individuals experience 
chest pain associated with heart disease, it does not explain why numerous heart attacks 
 63
occur in individuals who, prior to having the attack, never experienced chest pain or any 
other symptoms of heart disease (Ryan 2000).  In fact, according to the American Heart 
Association, at least 50% of the individuals who experience a heart attack have no 
symptoms prior to the attack (American Heart Association 2003).  In addition, autopsy 
data from several studies have revealed that heart attacks and stenosis are often NOT 
correlated (Shah 1996); thereby, directly contradicting the theory that plaque build-up is 
the primary cause of heart attacks.  Further evidence to refute this theory includes studies 
that have found lipid-lowering medication to significantly reduce the mortality and 
morbidity risk due to heart attack, while having little improvement on the size of the 
lumen (Gazelle 2000).  In other words, the risk of heart attack for individuals who take 
cholesterol lowering medication has been shown to decrease significantly, without 
diminishing the amount of plaque within the coronary arteries. 
Findings such as these led cardiologists to revisit an earlier study on plaque 
composition (Davies and Thomas 1984) published in the New England Journal of 
Medicine in the mid-1980’s.  In fact, the work by Davies and Thomas (1984) is now 
considered a landmark study in linking plaque composition to heart attacks (Ryan 2000).  
Looking at histology from patients who had experienced heart attacks, Davies and 
Thomas (1984) found that approximately 75% of the patients who had experienced a 
heart attack died from a blood clot (or thrombosis) in the vessel.  Interestingly enough, 
the clot that caused the heart attack was not necessarily located in an area of the coronary 
vessel that contained stenosis.  Instead, these clots were located at a point in the vessel 
where lipid-rich lesions (fatty plaques) were present (Davies and Thomas 1984).  
Therefore, this study strongly suggested that the cause of heart attacks was not due to the 
amount of plaque within the vessel, but rather to the composition of that plaque.   
Unfortunately, numerous other studies indicated that plaque burden was a more 
powerful predictor of a patient’s prognosis (Yock 2001); therefore, advances in medical 
technology continued to focus on opening the restricted vessels, specifically by placing 
coronary stents and performing angioplasty (Ryan 2000).  During the late 80’s and early 
90’s significant advancements in cardiac inpatient care took place and the number of 
procedures performed increased dramatically.  These procedures clearly reduced the 
occurrence of chest pain and improved the quality of life for these patients (Ryan 2000); 
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however, what continued to puzzle cardiologists was that despite these great advances in 
the type and number of procedures performed to treat patients, national heart attack 
mortality rates remained high (Muller 1999).   
This prompted cardiologists to return to the idea that plaque composition rather 
than plaque burden was the primary cause of heart attacks.  After further investigation, it 
is now the general consensus among cardiologists that it is not the volume of plaque in 
the coronary arteries, but rather the composition of that plaque that presents the greatest 
risk for a potentially fatal heart attack (Falk et al. 1995, Ravn and Falk 1999).  Therefore, 
cardiologists and medical researchers in this field now believe that correctly determining 
the type of plaque is an important key in accurately identifying those at risk for a heart 
attack, or what physicians commonly refer to as myocardial infarction.  
 
3.2 What is a Myocardial Infarction? 
Myocardial Infarction, or “MI” as it is often called, is the medical term used to 
describe a heart attack.  A MI occurs when cells within the heart muscle do not receive a 
sufficient supply of oxygenated blood, resulting in cell death and permanent damage to 
the heart muscle.  If the depletion of oxygen to the heart is great enough, it can cause the 
heart to stop (cardiac arrest) and result in death.  Even if a heart attack is not fatal, it 
causes irreversible damage which weakens the heart muscle; therefore, individuals who 
experience a MI are at much greater risk for a future heart attack (American Heart 
Association 2003). 
 
3.3 Social Costs Associated with Heart Attack   
An individual who experiences a heart attack is typically diagnosed with coronary 
heart disease (CHD).  CHD includes both MI and angina pectoris49 (a medical term for 
chest pain).  According to the Heart and Stroke Statistical Update published by the 
American Heart Association, “CHD is the single largest single killer of American males 
                                                 
49  CHD includes International Classification of Disease (ICD/9) codes 410-414, and 429.2  Note: Every 
10-20 years the ICD codes are revised.  These revisions reflect changes in medical technology, diagnosis 
and terminology.  Starting in 1999, the tenth revision of these codes was used.  Therefore, according to 
ICD/10 the codes for CHD include I20-I25.  
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and females” (p. 12) and is responsible for more than 1 out of every 5 deaths in the U.S. 
(American Heart Association 2003).  In the year 2000, an estimated 681,000 individuals 
died from CHD, of which 239,000 were due to MI (American Heart Association 2003).  
Each year, more than 500,000 Americans experience a heart attack, and approximately 
47% of those individuals die as a result (American Heart Association 2003).  Of those 
who do survive, only about one-third will make a complete recovery.  In fact, “CHD is 
the leading cause of premature, permanent disability in the U.S. labor force, accounting 
for 19 percent of disability allowances by the Social Security Administration” (American 
Heart Association  2003, p. 12).   
 Since the risk of heart attack increases with age, the elderly population is typically 
thought to be at greatest risk for a heart attack.  Although it is true that 84% of the people 
who die of CHD are over the age of 65, there has recently been an increase in the number 
of heart attack related deaths in young people, especially women.  In addition, almost 
50% of the men and women under age 65 who experience a MI die within 8 years of the 
attack (American Heart Association 2003).  Furthermore, what is possibly even more 
concerning is that evidence from the Framingham Heart Study indicates that over half of 
those who died suddenly of CHD had no previous symptoms of this disease (American 
Heart Association 2003).  Therefore, thousands of people who are at risk for a heart 
attack are not even identified as needing treatment until it is too late.    
 
3.4 Plaque Rupture: The Primary Cause of Heart Attacks 
 So, how could current medical technology fail to identify so many individuals 
who are at risk for a heart attack?  The answer lies in the fact that for years, physicians 
have been looking at only part of the problem.  As discussed in the opening section of 
this chapter, physicians thought that the long-term build up of plaque was the primary 
cause of heart attacks; however, medical research now suggests that most heart attacks 
(as many as 75%) are actually caused by plaque rupture (Falk et al. 1995, Davies and 
Thomas 1984).  This rupture can almost instantaneously create a blood clot (thrombosis) 
that can completely or partially block the vessel, thereby preventing oxygenated blood 
from traveling to the heart and causing a heart attack (Falk et al. 1995).  Prior to the 
plaque rupture, the blood vessel may be relatively clear and the individual may not 
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experience any symptoms (such as chest pain) typically associated with heart disease 
(Shah 1996).  Therefore, because plaque rupture is not necessarily correlated with a 
substantial build-up of plaque within the vessel, the individual may be completely 
symptom free and unaware that they are at risk for a sudden and possibly fatal heart 
attack. 
 
3.4.1 Plaque Composition 
 There are different types of plaque that exist within the coronary vessels and 
medical research has shown that not all plaques are equally dangerous (Falk et al. 1995).  
In fact, some plaques are more prone to rupture than others; therefore, correctly 
identifying the composition of a plaque has become an important key in determining who 
is at risk for a heart attack. 
Plaques are generally comprised of different types of materials.  In fact, the term 
“atherosclerosis” is derived from the two main components of a mature plaque: (1) the 
soft, lipid-rich atheromatous gruel and (2) the hard, collagen-rich sclerotic tissue.  
Although the sclerotic component makes up about 70% of the plaque, it is the smaller 
atheromatous component that is by far more concerning (Ravn and Falk 1999).  This is 
because the soft atheromatous gruel tends to “destabilize” the plaque, making it more 
prone to rupture (Falk et al. 1995).  Plaques that are primarily composed of the hard, 
collagen-rich sclerotic tissue tend to be mature plaques that are considered more stable – 
that is, less prone to rupture.   There are different types of stable plaques, including 
calcified plaques, which are so named because they contain calcium that forms deposits 
when present in large amounts.  These are the plaques typically associated with long-term 
plaque build-up that results in chest pain (Ryan 2000).  Fatty plaques, on the other hand, 
are plaques that are comprised primarily of the soft, lipid rich atheromatous gruel.  These 
plaques are more prone to rupture (Falk et al. 1995).  In fact, it is a specific type of fatty 
plaque that researchers believe is most vulnerable to rupture; hence it has been given the 
name “vulnerable plaque” (Ryan 2000). 
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3.4.2 What is Vulnerable Plaque? 
Vulnerable plaque is so named because its soft atheromatous component tends to 
“destabilize” the plaque, making it vulnerable, or prone, to rupture (Schroeder and Falk 
1996).  A vulnerable plaque is comprised of a lipid pool that lies hidden beneath the wall 
of the artery, much like lava within a volcano.  The only thing that separates the lipid 
pool from the blood flow in the vessel is a very thin cap (Ryan 2000).  This cap is 
extremely important because the gruel of the vulnerable plaque is highly thrombogenic, 
meaning that when it comes into contact with blood, it will cause the blood to clot almost 
instantaneously (Schroeder and Falk 1996).  As long as the vulnerable plaque stays 
within the arterial wall, there is no problem; however, once it ruptures and enters the 
bloodstream, the resulting clot (thrombosis) can restrict the flow of blood to the heart, 
resulting in an almost instantaneous and possibly fatal heart attack.  Therefore, plaques 
that are comprised primarily of the lipid-rich (fatty) atheromatous gruel pose a greater 
risk because they are more likely to rupture and cause a clot that will lead to a heart 
attack.  Although some heart attacks are the result of arrhythmias (irregular beating of the 
heart) and stenosis (narrowing of the arteries), cardiologists now believe that 75% of all 
heart attacks are caused by the eruption of a “vulnerable” plaque (Falk et al. 1995). 
 
3.4.3 Vulnerable vs. Stable Plaques 
In addition to being more prone to rupture, vulnerable plaques also differ from 
stable plaques in that they tend to be smaller in size and appear in much greater frequency 
within the vessel, which can make detection and treatment difficult.  Since the likelihood 
of having vulnerable plaque increases with plaque burden, it is not coincidental that 
patients with atherosclerosis often suffer heart attacks – it is just that the cause of the 
heart attack is different than previously thought (Ryan 2005).  What is interesting to note 
is that it is not simply the presence of plaque or even the size of the plaque, but rather the 
likelihood of plaque rupture that places an individual at risk (Falk et al. 1995).  In fact, 
someone who has been diagnosed with atherosclerosis, and has a significantly large 
amount of plaque which is predominantly stable could actually be at lower risk for a heart 
attack than an individual with a small amount of vulnerable plaque.  This means that 
individuals with large deposits of calcified (stable) plaques who periodically experience 
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chest pain and shortness of breath could actually be at lower risk for a heart attack than 
an individual with vulnerable plaque who is completely asymptomatic.  In addition, 
traditional risk factors only give us one piece of information in determining an 
individual’s actual risk.  Therefore, the key to early detection is finding a screening 
method that can distinguish between those individuals who have stable, calcified plaques 
versus those who have fatty, vulnerable plaques.       
 
3.5 Who is at Risk for a Heart Attack? 
According to Falk et al. (1995) “age, male sex, hypercholesterolemia, 
hypertension, smoking, and diabetes correlate with the coronary plaque burden” meaning 
that the degree of atherosclerosis is associated with these risk factors; however “apart 
from…age and possibly male sex, a relation of specific risk factors to composition of 
plaque burden remains to be identified” (Falk et al. 1995).  This suggests that traditional 
risk factors (age, sex, cholesterol level, etc.) may be good indicators of stenosis and 
identifying those individuals who are likely to experience chest pain and other symptoms 
of heart disease, but these risk factors provide very little information regarding who has 
vulnerable plaque and is actually at risk for a heart attack.  Therefore, simply using 
traditional risk factors for heart disease (as is often done today) will fail to identify many 
individuals at risk for a heart attack (Gazelle 2000).  This is why apparently “healthy” 
individuals who are asymptomatic suddenly die from heart attacks (Falk et al. 1995).  
Currently, a definitive set of risk factors is not known – that is why it is so important to 
find a way to determine who has vulnerable plaque in order to correctly identify those at 
risk so treatment can be started. 
 
3.6 Limitations in Detecting Vulnerable Plaque 
There are several potential treatments for vulnerable plaque once it is detected.  
The main problem lies in consistently and correctly detecting its presence within the 
coronary vessel.  Unfortunately, the medical community does not currently have a 
method for doing so, although numerous research efforts are pursuing this goal (Muller 
2001).  In light of the potential risks posed by the presence of vulnerable plaque, a 
growing number of people, especially male physicians over the age of 50, have opted to 
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take lipid-lowering medications, even though they have no other indication that they are 
at risk for vulnerable plaque (Ryan 2000).  Although statin (cholesterol lowering) drugs, 
such as Lipitor, Pravachol, and Zocor, have been somewhat successful in lowering 
cholesterol levels, at best, they lower the individual’s risk of heart attack by only about 
30% (Waters 2000).  Not to mention that prolonged usage of these drugs can have serious 
side effects, including liver failure (Ryan 2000).  Therefore, medical researchers are 
working on developing a more effective way to detect and treat vulnerable plaque.   
Many companies are funding these research efforts, including Pfizer, a Fortune 
500 company, and other well-known medical device firms including Guidant and Boston 
Scientific (Muller 2001).  Current research in this area involves a wide range of imaging 
technologies including ultrasound, MRI, laser, and spectroscopy (Ryan 2000).  Although 
it is not entirely clear which technology will ultimately prove successful, it is highly 
likely that a method for detecting and treating vulnerable plaque will be developed in the 
near future.   
 
3.6.1 Screening for Vulnerable Plaque 
However, simply detecting vulnerable plaque is not enough.  In order to be used 
as a screening method, it must also be inexpensive and non-invasive enough to use 
routinely on the general population (Muller 2001).  In addition, the test should be very 
sensitive – that is give few to no “false-negatives.”  Sensitivity refers to how well a test 
finds everyone within the population that has a disease.  Typically, highly sensitive tests 
have a tendency to pick up individuals who do not have the disease as well; thereby 
resulting in false-positives.  On the other hand, a highly specific test is more specific to 
what the test is looking for, but it is also more likely to miss someone – resulting in a 
false-negative (Ryan 2000).  Ideally, you would want a test that has both a high 
sensitivity and a high specificity; however, due to the nature of laboratory tests, there is 
often a tradeoff between the two.  In practice, the goal for many health care professionals 
is for the screening method not to miss anyone who is at risk.50  Therefore, tests with a 
                                                 
50 Economists would recognize that false positives (stemming from higher sensitivity) will result in 
disutility for the patient/consumer.  Therefore, from an economic standpoint, the goal of a screening 
method would be to balance the value derived from high sensitivity against the social costs associated with 
false positives.     
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high sensitivity are generally used for screening.  This reduces the chances of missing 
someone who has the disease, but as discussed above, will result in false-negatives.  
Therefore, for those testing positive to the screening, a follow-up test or procedure that is 
more specific (and typically more invasive) would be necessary to identify those 
individuals who are actually at risk.    
 
3.6.2 Using Technology to Detect Vulnerable Plaque 
There are several technologies that are currently being explored as methods for 
detecting vulnerable plaque and identify those at risk for a heart attack.  However, as 
described below, each technology still has limitations in either its ability to correctly and 
consistently identify those individuals with vulnerable plaque or to do it in a timely and 
cost effective manner. 
 
CT scan  
Coronary CT (computed tomography) scanning, specifically electron beam 
(EBCT) and multi-detector CT, which cost about $500 to $700, has proven to be an 
effective way of identifying plaque build up (Yorke 2005).  This non-invasive method 
takes only about 10 minutes and clearly shows calcium in the arteries.  Because calcium 
is drawn to inflammation in the plaque, calcium is known to be correlated with plaque 
burden. Therefore, CT scans can provide physicians with good information on the 
amount of calcified plaques in the arteries; however, the technology can not (as of yet) 
detect the fatty vulnerable plaques (Yorke 2005) that are now thought to be the most 
dangerous (Falk et al. 1995).  Although this test is non-invasive, it is too expensive to be 
used as a screening method.  In addition, with false negatives in the 5-10% range (Yorke 
2005), the results of CT scans are not yet reliable enough to use this method, even as a 
secondary test that would follow the initial general screening. 
 
Ultrasound 
Unlike CT scans, high-resolution ultrasound uses no radiation, costs much less, 
and can be performed by a physician after receiving only minimal training.  Like the CT 
scan, ultrasound is non-invasive and is relatively fast, taking only about 12 minutes to 
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perform (Yorke 2005).  Ultrasound allows the physician to see plaque in the six major 
arteries in the body.  This is done by placing a high-frequency probe on the neck and 
groin, which allows the physician to see the arteries from the outside in.  Performing this 
procedure on a routine basis allows the physician to track plaque build up over time and 
treat the patient accordingly.  However, the primary drawback of high-resolution 
ultrasound is that it can not be used to see the arteries within the heart (Yorke 2005).  
Since the coronary arteries are where the vulnerable plaque that causes heart attacks is 
located, this technology is currently not useful as a screening method for vulnerable 
plaque.   
 
MRI 
MRI can provide limited images of the arteries as well as plaque; however, it does 
not yet have sufficient resolution to distinguish between different types of plaques (Ryan 
2005).  Therefore, the inability of this technology in being able to identify those who 
have vulnerable plaque and well as the fact that this is very costly procedure, preclude 
MRI as an means of screening.  Although this technology may prove useful as a 
secondary, confirming method as the resolution produced by this technology improves, 
more studies will still be needed to determine the efficacy of using this as a definitive 
means of identifying those at risk for a heart attack. 
From these descriptors, it is clear to see that none of these technologies currently 
meet the criteria needed for an effective, cost-efficient, and relatively non-invasive 
screening technique.  Yet, another completely different approach which utilizes the  
correlation between inflammation and plaque, may allow researchers to develop a simple 
blood test that may prove useful as a screening method (Comarow 2002, Falk et al. 
1995).  In order to understand the correlation between inflammation and plaque rupture, 
it is necessary to understand in more detail the process by which a plaque ruptures. 
 
3.7 Factors that Lead to Plaque Rupture and MI 
There are two factors that increase the risk of plaque disruption, or rupture.  As 
discussed above, the first is the composition of the plaque.  A plaque that contains more 
of the soft atheromatous gruel is more unstable and therefore considered “vulnerable” to 
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rupture.  Plaques that are comprised almost entirely of the harder collagen-like sclerotic 
material are considered more “stable” (Falk et al. 1995).  This is why some studies 
utilizing autopsy data have revealed individuals with substantial stenosis who never 
experienced a MI, and who are now believed to have been at lower risk for a heart attack 
than someone with a much smaller amount of vulnerable plaque (Ryan 2000).   
The second factor that increases the likelihood of plaque rupture is the presence of 
an extrinsic force or “trigger” acting on the plaque (Falk et al. 1995).  This can be caused 
by strenuous exercise, emotional stress, or in some cases, simply getting out of bed in the 
morning (Schroeder and Falk 1996, Muller 1999).  In short, the presence of vulnerable 
plaque predisposes the individual to an acute coronary event, whereas the trigger or acute 
risk factors can precipitate the rupture (Falk et al. 1995).  Although it is beyond the scope 
of this dissertation, it is interesting to note that a similar process occurring in the carotid 
arteries of the neck is now believed to be a major cause of stroke (Ryan 2000). 
 
3.7.1 How does Plaque Rupture Occur? 
The lipid-rich soft atheromatous gruel typically makes up the “core” of the plaque 
and is surrounded by the collagen-rich sclerotic tissue.  For the most part, this is located 
within the vessel wall, with the exception of a “cap” which is created where the sclerotic 
tissue is exposed to the lumen (or vessel opening).  Therefore, the only thing separating 
the highly thrombogenic lipid pool from the blood stream is this very thin cap.  Triggers 
that increase blood pressure and tensile forces can then cause the cap to rupture at a weak 
point.  This typically occurs at the shoulder region of the plaque, where the cap is thinnest 
(Falk et al. 1995). 
From this discussion, it is clear to see that the risk of plaque rupture is dependent 
on (1) the size and consistency of the atheromatous core, (2) the thickness and collagen 
content of the fibrous cap covering the core, and (3) the amount of cap “fatigue” (Falk et 
al. 1995).  In addition, researchers now typically list “inflammation within the cap” as a 
fourth risk factor (Falk et al. 1995).  The following provides an explanation of the role 
inflammatory cells are thought to play in vulnerable plaque rupture.  
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3.7.2 Inflammation 
Autopsy data has revealed that a higher number of inflammatory cells (such as 
macrophages that are associated with fighting infection) are often present at cites of 
plaque rupture (Falk et al. 1995).  Researchers theorize that the inflammatory cells help 
create the lipid pool and eat away at the surface of the vessel, leaving only a “thin cap” 
(Ryan 2002, Falk et al. 1995).  Because of the high correlation between inflammatory 
cells and the occurrence of plaque rupture, it is thought that inflammation itself may 
provide the key to finding a screening test for those potentially at risk for a heart attack 
due to vulnerable plaque (Falk et al. 1995, Comarow 2002).   
One possible method of screening is a blood test that detects inflammatory cells 
that form the lipid pool of the vulnerable plaque (Comarow 2002).  This potential 
screening method would consist of a simple blood test similar to existing tests that detect 
high density lipoprotein (HDL) and low density lipoprotein (LDL), commonly referred to 
as “good” and “bad” cholesterol.   
 
3.8 Potential Screening and Treatment Methods 
3.8.1 CRP: A Possible Screening Test for Vulnerable Plaque 
The November 25, 2002 issue of U.S. News and World Report describes a test 
that measures levels of C - reactive protein (CRP), an indicator for inflammation, which 
could potentially be used in the near future to screen for those at risk for a heart attack.  
This article describes the results of an eight-year study of nearly 28,000 individuals in 
which it was found that CRP was a better indicator of MI and stroke than high levels of 
LDL (“bad” cholesterol) (Comarow 2002).  The CRP test is similar in nature to any 
simple blood test, such as cholesterol, HDL, or LDL, and is conducted by many 
laboratories across the country.  The test generally costs between $10 and $25 but is not 
yet covered by most insurance companies; however, Medicare did start covering the cost 
of this test starting in January 2002 (Comarow 2002).   
Since “half of all heart attacks strike people who don’t have a cholesterol 
problem…and at least 25 percent of heart attacks happen to individuals with no major 
risk factors” (Comarow 2002), at the very least CRP could provide an additional piece of 
information in assessing a patient’s risk of having a heart attack.  However, as of yet, 
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there is no standard regarding the use of CRP testing.  In fact, several different CRP tests 
exist, each with varying degrees of sensitivity.  Therefore, according to a top researcher 
in the field, the first step is to establish a uniform test, with agreed upon guidelines 
regarding the interpretation of the results (i.e. high, moderate, and low levels of risk) 
(Comarow 2002).   
After establishing a uniform test, studies would then need to be done to verify that 
there is a statistical correlation between high levels of CRP and a higher risk of heart 
attack (Comarow 2002).  Unfortunately, the current CRP test can not distinguish between 
inflammation associated with lipid pools versus inflammation due to injury or infection 
Ryan 2002).  This means that someone who has a common cold virus (and has a large 
number of macrophages present in their blood stream) would likely have an abnormally 
high CRP test result, yet it would be a result of the infection and not necessarily an 
indicator of the presence of lipid pools and possible risk of heart attack.  Therefore, the 
CRP test may not be specific enough to serve as an effective screening method for 
identifying those at risk for heart attack.  For now, physicians may choose to use this test 
on a limited basis – specifically, as a source of additional information to help assess the 
risk of marginal patients (Comarow 2002).  Although it is still unclear whether the CRP 
test will ultimately prove effective as a general screening method to detect those at risk 
for heart attack, it is clear that the potential of a simple blood test being used in this 
fashion is certainly feasible.   
 
3.8.2 Inflammation as an Indicator for Treatment  
If inflammation is an indicator for lipid pools and could potentially be used as a 
screening method, then could it not also be used as an indicator in developing a 
detection/treatment method for vulnerable plaque as well?  Unfortunately, the answer to 
this question is “probably not.”  Although the presence of a large number of 
inflammatory cells may be an indicator of a higher risk of heart attack and offer a 
potential method for screening, it is unlikely that locating inflammatory cells could be 
used in the detection/treatment of the lipid pools.  This is because the inflammatory cells 
can be located in many places within the coronary vessels, including many places where 
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lipid pools are not present. Therefore, using inflammation as an indicator would lead to 
treating numerous areas unnecessarily (Ryan 2002).   
 
3.8.3 Potential Treatments for Vulnerable Plaque 
     Currently, drug therapy (taking a cholesterol-lowering drug such as Lipitor, 
Pravachol, or Zocor) is the only treatment for vulnerable plaque. Unfortunately, as 
mentioned previously, this treatment method is only about 30% effective (Waters 2000).  
In addition, these drugs work slowly and therefore require a considerable length of time 
to reduce the individual’s risk of having a heart attack (Ryan 2000).  Therefore, this is not 
a very effective treatment for the immediate threat posed by the presence of vulnerable 
plaque within the coronary vessels.  This has led medical researchers to explore several 
potential treatment techniques in an attempt to develop a more effective detection and 
treatment method for vulnerable plaque.  Several of these methods utilize a heart catheter, 
a device that can be threaded through the coronary arteries so that the physician may 
either “see” or treat a specific area of the vessel.  The following describes drug therapy, 
as well as some other potential methods that may ultimately prove successful in the 
development of a detection and treatment method for vulnerable plaque.  
 
Systemic drug therapy  
“Systemic” means to put in the blood stream, typically by mouth or intravenously 
(IV).  Drug therapy is the current “standard of care” and requires the patient to take a 
statin (cholesterol lowering) drug like Lipitor, Pravachol, or Zocor on a daily basis, often 
for the remainder of the patient’s life.   Although these drugs have been shown to lower 
cholesterol (and CRP), they are only about 30% effective at reducing the individual’s risk 
of heart attack.  In addition, individuals taking these drugs have a higher risk of liver 
failure.  However, to reduce this risk, patients taking statin drugs typically have liver 
function tests periodically (about every three months for the first year) to monitor for 
potential liver damage (Ryan 2000).  
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Localized drug treatment  
This is a catheter directed treatment, meaning that a heart catheter is used to apply 
a drug at the point of interest.  One possible procedure for treating vulnerable plaque 
would be similar to catheter-directed TPA (tissue plasminogen activator), a procedure in 
which a clot dissolving drug is given at the site of an acute thrombosis (clot).  However, 
the treatment of vulnerable plaque would require a catheter that could deliver the drug 
into the coronary wall.  Such a device does not currently exist (Ryan 2000). 
 
Photo-activated drug therapies   
For this therapy a patient is given a systemic “inactive” drug treatment.  A fiber 
optic heart catheter is then used to emit a certain frequency of light at the point of 
interest.  The light causes the systemic drug to become active, but only at the point of 
interest.  This allows the drug to take effect only at designated points within the body, as 
opposed to the entire body.  Therefore there is less risk of an adverse side effect from the 
drug being administered.  Although some photoactive drugs currently exist, none are 
commercially available at this time for the treatment of vulnerable plaque (Ryan 2000). 
 
Angioplasty  
Balloon angioplasty is traditionally performed to expand a vessel; however, the 
same treatment could potentially be used for treating vulnerable plaque.  For this 
treatment, a patient is given a dose of heparin through an IV.  This drug acts 
instantaneously to prevent the patient’s blood from clotting; however, this is only a short 
term effect.  A heart catheter is then used to expand a balloon within the coronary vessel 
at the point of interest.  The balloon will cause the plaque to rupture; however, due to the 
effect of the heparin, a clot will not result.  Therefore, this method reduces the risk of 
heart attack by allowing for a controlled rupture.  This is analogous to how controlled 
fires are used to reduce the risk of forest fires (Ryan 2000). 
 
Stent  
This is similar to angioplasty, except that the balloon has a wire mesh around it, 
resembling a Chinese finger puzzle.  As the balloon inflates the wire mesh expands and 
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once in place remains in the coronary vessel to help stabilize the point of interest.  This 
method is designed to force the cap up and prevent it from rupturing.  In fact, the use of a 
stent will often cause the cap to thicken, making it more stable.  It is possible for the 
placement of the stent to rupture the plaque; however, just as in angioplasty, the use of 
heparin prior to the procedure will allow for a controlled rupture with little to no resulting 
clot.  Therefore, this procedure will have one of two outcomes: stabilization or a 
controlled rupture (Ryan 2000).    
As indicated by these descriptions, a method tailored to the detection and 
treatment of vulnerable plaque does not yet exist; however, almost all of the potential 
therapies do have one thing in common – localized treatment.  This is a strong indication 
that the detection/treatment method that is ultimately developed will utilize a heart 
catheterization procedure, such as those described above (Yock 2001, Ryan 2000).  
Therefore, for the purpose of this dissertation, a heart catheterization procedure will be 
utilized as the hypothetical detection/treatment method that is more effective than drug 
therapy. 
 
3.9 Standard of Care 
3.9.1 Current Standard of Care for Symptomatic Individuals 
 When a patient presents with symptoms of heart disease, such as chest pain or 
shortness of breath, the physician will typically order a stress test.  If the results of the 
stress test indicate a possible blockage of the coronary vessels, then the patient will 
undergo an angiogram in the catheterization lab (Ryan 2000).  This procedure cost 
around $4,000 (Yorke 2005) and requires making a small incision in the upper thigh and 
placing a “guide” wire.  A heart catheter is then threaded through the artery up to the 
coronary vessels.  This procedure allows the physician to determine if a blockage exists 
and identify its location (Ryan 2000). 
Depending on the degree of stenosis found, the physician may choose to place a 
stent in specific locations where the stenosis could potentially create a blockage.  Placing 
a stent typically reduces angina (chest pain) because it expands the lumen, thereby 
increasing the flow of oxygenated blood to the heart.  In the past, it was also believed that 
this procedure would reduce the patient’s risk of a heart attack; however, in light of new 
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evidence involving vulnerable plaque as the primary cause of heart attacks, this is no 
longer believed to be the case.  Although placing a stent may allow a controlled rupture 
or stabilize a single lipid pool located directly beneath the stent as described above, 
vulnerable plaques tend to be small and appear in multiple locations within the coronary 
arteries.  Since a stent only treats an area up to 30 mm in length, this procedure does 
little, if anything, to prevent the occurrence of a heart attack if vulnerable plaque is 
present in the individual’s vessel walls.  Following the stent procedure, patients are 
placed on a statin drug, which is typically taken for the remainder of the patient’s life.  
Although placing a stent may alleviate the patient’s chest pain, any reduction in the 
occurrence of heart attacks for these patients can most likely be attributed to the drug 
therapy, and not from the placement of the stent (Ryan 2000).    
 
3.9.2 Current Standard of Care for Asymptomatic Individuals 
For asymptomatic individuals, a stress test may be ordered if the patient has a 
family history of heart problems or a large number of risk factors.  However, an 
estimated 25 million Americans who do not have traditional risk factors or exhibit 
symptoms of heart disease are also at risk for a heart attack, and are not receiving 
treatment (Yorke 2005).  Since it is not feasible (or affordable) to perform a heart catheter 
procedure on everyone to determine who is at risk (Yock 2001), there is a need for an 
inexpensive, non-invasive screening method to begin the process of better identifying 
those at risk.  This will get potential “at risk” individuals “into the system” such that 
additional (and often more invasive) procedures can be performed to determine if they 
are truly at risk (Muller 2001).   
However, even if the individual is found to be at high risk for a heart attack, the 
current treatment of drug therapy is only about 30% effective, and because it takes time 
for the drugs to become effective, it offers very little in terms of immediate risk reduction 
(Ryan 2000).  Therefore, a new treatment method that is more effective at reducing the 
occurrence of a heart attack is also needed. 
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3.9.3 What change is needed? 
To effectively identify and treat those at risk for a heart attack due to vulnerable 
plaque, there are two things that would need to occur.  First, an inexpensive and relatively 
non-invasive screening method would need to be developed that could be administered to 
the general public.  Second, a more effective detection and treatment method would need 
to exist (Muller 2001). 
In this particular case, detection and treatment go hand-in hand.  Since potential 
treatment methods already exist, the key is being able to accurately locate the pockets of 
vulnerable plaque within the coronary vessels so they can be treated.  According to 
doctors conducting research in this field, the most likely candidate for a 
detection/treatment method is one that is localized, meaning that it utilizes a heart 
catheter (Yock 2001, Ryan 2000).  Although such a device would look similar to a heart 
catheter used to place a stent, it would need to be specifically designed for the sole 
purpose of detecting and treating vulnerable plaque (Ryan 2000).  Because this device 
would be able to discern between stable and vulnerable plaque, it would allow the 
physician to assess with greater accuracy the patient’s risk of a future heart attack.  If the 
physician detects a significant amount of vulnerable plaque, he/she would also be able to 
treat the patient as part of the same procedure; thereby eliminating the risks (primarily 
resulting from anesthesia and the possibility of infection) associated with an entirely 
separate surgical procedure51.   
Since stress tests, angiograms, and stents are primarily used to treat blockages and 
chest pain, these procedures would most likely no longer be part of the treatment regimen 
for the detection and treatment of vulnerable plaque.  Therefore, for the patient found to 
be at high risk for vulnerable plaque, the only real alternatives would either be drug 
therapy or a new detection/treatment procedure. 
 
 
 
                                                 
51 It is important to note that when the patient agrees to undergo the catheterization procedure to detect 
vulnerable plaque, he/she will be sedated during the procedure such that the individual would not be able to 
give informed consent for subsequent treatment.  Therefore, by consenting to the procedure, he/she is also 
giving consent for treatment should the physician determine that it is warranted. 
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3.10 Summary 
Although there are many factors that may play into who is at risk for a heart 
attack (age, gender, stress), and several tests (CRP, LDL) can provide some additional 
information, the bottom line is: there is currently no method to correctly and consistently 
identify who is at risk for a heart attack.  In fact, current risk factors and tests miss a large 
percentage of the “at risk” population, such that 50% of those individuals who currently 
die from a heart attack do so without ever having been diagnosed with CHD or 
experiencing a warning sign prior to the attack (American Heart Association  2003). 
Recently the idea of plaque burden as the primary cause of heart attacks has been 
replaced by a newer theory that indicates that it is not the amount of plaque, but rather the 
type of plaque that places an individual at risk for a heart attack.  Specifically, the 
existence of vulnerable plaques, which are prone to rupture, are now thought to be the 
primary cause of heart attacks.  Therefore, efforts are underway to develop a new 
screening method, such as the CRP blood test, which is inexpensive and non-invasive 
enough to use routinely on the general population that will better identify those at risk for 
a heart attack due to vulnerable plaque.  Since this is clearly the direction medical 
technology is taking, it was logical to choose a simple blood test as the hypothetical 
screening method that respondents would be asked to value in Survey 1: Screening. 
As discussed in this chapter, highly sensitive screening methods have a tendency 
to result in false-positives.  Therefore, it is often necessary to further test those who have 
positive screenings using a more specific procedure in order to gain additional 
information and more accurately assess the individual’s true risk.  A more specific 
procedure for identifying those at risk for a heart attack currently does not exist, but in 
the near future it may involve having a MRI or heart catheterization procedure.   
Once a patient is correctly identified as being at risk for a heart attack, the only 
treatment that currently exists is drug therapy.  However, because drug therapy requires a 
significant time to take effect, and even then is only about 30% effective at reducing the 
occurrence of a heart attack, this treatment method does not really address the immediate 
threat of a vulnerable plaque rupture.  Therefore, a new, more effective treatment method 
is also needed.  Since the potential treatments currently being explored all involve 
localized procedures in which a heart catheter is utilized, it followed that the detection 
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and treatment procedures would most likely be combined to reduce the risks associated 
with anesthesia and infection stemming from having an additional procedure.  
Furthermore, because a slight modification to the heart catheter procedure that is 
commonly used today was a likely candidate for eventually being able to detect and treat 
vulnerable plaque, this was the logical choice for the hypothetical treatment that 
respondents were asked to value in Survey 2: Treatment.   
 
 
 
 
Copyright © Patricia L. Ryan 2007 
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Chapter IV: Theory 
 
The purpose of this chapter is to develop a theoretical framework to identify the 
factors that will influence willingness to pay (WTP) for both a screening and 
detection/treatment method for vulnerable plaque.  This is accomplished by using a set of 
decision trees that represent decisions faced by individuals in the current state of the 
world, as well as potential decisions that are likely to occur if a new screening and 
detection/treatment method for vulnerable plaque were made available.  Using the 
decision trees, equations representing expected utility are derived for various treatment 
alternatives in both the current and desired states of the world.  Then, using a model 
which closely resembles that of Michael Jones-Lee (1974), expected utility is held 
constant under different conditions in order to define the consumer’s maximum WTP for 
a change in his/her risk of having a heart attack, or for additional information regarding 
that risk.  In addition, the factors affecting the marginal WTP for treatment are also 
identified since payment for a new treatment method reduces the individual’s risk of a 
heart attack.  Finally, this chapter concludes with a discussion of how these models 
influenced the development of the surveys, such that the theoretical expectations 
regarding WTP for screening and treatment could be tested empirically.  
 
4.1 Fundamentals of Clinical Decision Analysis using Decision Trees  
In treating patients, physicians are continually faced with having to make 
decisions involving risk and uncertainty.  Since decision analysis provides a “systematic 
approach to decision making under conditions of uncertainty” (Weinstein and Fineberg 
1980 p. 3) it is appropriate to utilize this method when making clinical decisions.  In fact, 
because decision analysis allows the physician to determine the treatment option that 
would maximize a desired outcome (such as the highest probability of survival), decision 
analysis provides a valuable tool in determining the best treatment for an individual 
patient as well as for an entire population.  Therefore, decision analysis can be used to 
identify what physicians often refer to as the “best practice” or “standard of care”52 and 
can also be applied in decisions regarding social policy (Weinstein and Fineberg 1980).   
                                                 
52 The usual course of treatment when a patient presents with a certain set of symptoms. 
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Decision analysis often utilizes decision trees as a means of visualizing the 
problem being addressed.  The decision trees presented in the figures at the end of this 
chapter were developed in accordance with the information presented in Weinstein and 
Fineberg’s (1980) book Clinical Decision Analysis.  Each branch of the decision tree 
represents actions or consequences that occur over time.  A square represents a decision 
node, or a point at which a decision is made (it should be noted that for this type of 
analysis, doing “nothing” is considered a decision).  Branching points that do not involve 
a decision (but are merely a function of chance) are referred to as chance nodes and are 
indicated by a circle.   
When the decision tree is completed, it visually illustrates all of the possible 
courses of action (paths) and their resulting outcomes.  For example, consider the 
decision tree presented in Figure 4-4.  This tree illustrates the treatment decision that is 
made when a physician is presented with a patient who has already been identified as 
being at high risk for a heart attack (or MI)53.  The physician54 has two options: he/she 
may either choose to (1) simply monitor the patient (do nothing) or (2) place the patient 
on a cholesterol lowering medication (drug therapy).  Since this branch represents a 
decision, it is considered a decision node and is indicated by a square.     
For illustrative purposes only, assume that the physician decides not to put the 
patient on drug therapy.  Once the decision to simply monitor the patient has been made 
(i.e. do nothing), the subsequent outcome is based solely on chance.  The patient may or 
may not experience an MI (the probability of each possibility is indicated on the 
respective branch).  Because the occurrence of a MI is beyond the control of the patient 
or physician, it represents a chance node and is illustrated with a circle.  If the patient 
does experience an MI, he/she will either live or die as a result.  The final outcomes are 
represented by boxes at the end of each path.  In this case, there are three possible 
outcomes: (1) the patient lives without experiencing an MI (denoted as L); (2) the patient 
experiences a MI, but survives (M); or (3) the patient experiences a MI and dies (D).   
                                                 
53 “Heart attack” and “MI” (the abbreviation for myocardial infarction, which is the medical term for heart 
attack) are used interchangeably throughout this chapter.  
54 When clinical decision analysis was first developed, the physician was often viewed as the primary 
decision maker; however, as will be discussed in the following section, more recent applications of clinical 
decision analysis are more oriented toward the consumer-patient as the primary decision maker, instead of 
being expert-based. 
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The expected utility of an entire branch can be determined by assigning a utility to 
each outcome and then using a process that Weinstein and Fineberg refer to as “folding 
back.”  Basically, this is nothing more than using the probabilities assigned to each 
branch as “weights.”  For a simple example, refer to Figure 4-1.  Suppose that the 
probability of having an MI for an individual who demonstrated no symptoms of heart 
disease was 2 percent (r = .02).55  Therefore, the probability of not having an MI would 
be 98 percent (1-r = .98).  According to the Heart and Stroke Statistical Update 
published by the American Heart Association (2003), the probability of dying as a result 
of an MI is approximately 0.5, and is already indicated in the figure.  Therefore, the 
probability of surviving the MI is also 0.5.  If the utility associated with L, M, and D were 
10, 7, and 0 respectively, then the expected utility could be calculated as: 
 
E(U) =  .98 (10) + .02 (.5) 7  + .02 (.5) 0 = 9.8 + .07 + 0 = 9.87 
 
When this branch is part of a larger tree (such as when it appears as the upper 
branch in the decision tree presented in Figure 4-3), this process can be used to estimate 
the expected utility of each branch stemming from a decision node; thereby allowing the 
physician to choose the treatment option corresponding to the path offering the highest 
expected utility.  
 
4.2 Utilizing Decision Trees to Identify Risk-Dollar Tradeoffs 
 As described above, decision trees are used in clinical decision analysis to 
identify the treatment option (path) that offers the highest level of utility, best chance of 
survival, or some other desired outcome.  The application of the decision trees in this 
study; however, is slightly different.  Instead of identifying the branch that maximizes the 
individual’s utility, the expected utility from different branches is equated in order to hold 
expected utility constant and identify risk-dollar tradeoffs associated with lower levels of 
heart attack risk.  Each decision tree identifies a different state of the world - the current 
state in which no screening and limited treatment exists, and the desired state in which 
                                                 
55 According to the American Heart Association, the 10-year risk of an individual with no risk factors is 2% 
(Wilson et al. 1998). 
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screening and a better treatment method exist - for both high risk and asymptomatic 
individuals.  By identifying the individual’s expected utility in the current state and 
holding that level of utility constant, the decision trees can be used to set up equations 
similar to those used by Jones-Lee (1974), such that the WTP for a change in heart attack 
risk can be determined.  
 
4.2.1 Risk-Dollar Tradeoffs 
Michael Jones-Lee (1974) developed an expected utility model that can be used to 
determine how much an individual would be willing to pay in order to lower the 
probability of death by a marginal amount.  The model assumes two possible states: life 
and death.  If the probability of death is p (0 < p < 1); then, the probability of not dying is 
1-p.  The model also includes the individual’s utility as a function of wealth, W, in each 
state of the world.56  Therefore, the individual’s initial expected utility is given by: 
 
         E(U) = (1-p) L(W) + p D(W),  
 
where L(W) is the individual’s indirect utility associated with the good state “life” and 
D(W) is the individual’s utility in the bad state “death.”  The model assumes that L(W) 
and D(W) are continuous and twice-differentiable, such that L'(W)  > 0 and L''(W) < 0.  
These conditions imply that in the good state utility increases with increased wealth, but 
at a decreasing rate.  In addition, the individual derives more utility in the good state than 
in the bad state for a given level of wealth, such that L(W) > D(W).  The marginal utility 
of wealth is also assumed to be greater in the good state than in the bad, such that L'(W) 
>D'(W).  And finally, L''(W) >D''(W), which implies that the individual is more sensitive 
to changes in wealth in the good state as compared to the bad state. 
The individual can make an expenditure, X, to reduce the probability of death to 
p*, such that expected utility becomes: 
 
E(U) = (1-p*) L(W-X) + p* D(W-X) 
 
                                                 
56 The utility associated with death is derived from wealth being passed on to the individual’s heirs.   
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The expenditure occurs regardless of whether the individual lives or dies, and although 
the expenditure reduces the probability of death from p to p*, there is no guarantee that 
the expenditure will prevent death from occurring (Jones-Lee 1974).57  According to 
Jones-Lee, the maximum amount an individual would be willing to pay to reduce their 
probability of death to p* is defined as the expenditure that will still provide the 
individual with their initial expected level of utility.  Mathematically, the individual’s 
willingness to pay, or Hicksian compensating variation58, can be found by setting the  
expected utilities equal and then solving for X using the following equation: 
 
(1-p*) L(W-X) + p* D(W-X) = (1-p) L(W) +p D(W)  (4.1) 
 
The marginal willingness to pay for a change in risk can also be found by differentiating 
the entire expression by p and then rearranging terms to solve for ∂X/∂p (Jones-Lee 
1974).  Assuming that wealth (W) and the risk of death without the expenditure (p) are 
constant, differentiating equation 4.1 with respect to p will cause the entire right hand 
side of the equation to go to zero and result in the following expression: 
 
    - L + (1-p*) L' ∂X/ ∂p  + D + p* D' ∂X/ ∂p = 0  (4.2) 
 
where L = L(W-X), D = D(W–X), L' = ∂L(W-X)/ ∂X, and D' = ∂D(W-X)/ ∂X.  
Rearranging terms in equation 4.2 and solving for ∂X/∂p, Jones-Lee (1974) provides the 
following equation which defines the risk-dollar tradeoff: 
 
                                                 
57 This expenditure is made prior to the individual knowing which state of the world they will experience, 
and is therefore considered an option price.  According to Freeman (1999), option price is defined as the 
maximum amount an individual would be willing to pay in order to reduce a given risk and return to a state 
in which the risk does not exist, thereby maintaining the individual’s initial level of utility. 
58 The Hicksian compensating variation refers to the maximum amount that the individual is willing to pay 
(WTP) to avoid a loss, such that the individual’s utility is equal in both states.  When a loss has been 
imposed on an individual (or group of individuals), then the Hicksian equivalent variation refers to the 
amount that the individual is willing to accept (WTA) in order to return them to their prior level of utility.  
As discussed in Chapter 2, the appropriateness of WTA versus WTP is based on the assignment of property 
rights.  The Hicksian compensating variation assumes that the individual will move to a lower level of 
utility, whereas the Hicksian equivalent variation assumes that the individual will be returned to their prior 
level of utility before the loss was imposed on them.  WTA was used in assessing damages for the Exxon 
Valdez Oil Spill and illustrated that WTA and WTP measures may, in fact, be considerably different.     
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        ∂X/ ∂p = [L – D] / [(1-p*) L' + p* D'] 
 
Since L > D, the numerator will always be positive.  The denominator will be negative, 
indicating that a reduction in risk, p, requires an increase in expenditures, X. 
 Many decisions regarding risk do not involve life and death, but rather varying 
degrees of quality of life.  Diseases such as multiple sclerosis and chronic conditions like 
asthma can greatly influence the utility an individual derives from wealth.  In fact, 
Viscusi and Evans (1990) find empirical evidence to indicate that the utility derived from 
income is higher in the healthy state compared to utility in an ill state.  Therefore, it is 
useful to modify the model developed by Jones-Lee (1974) such that the “good” and 
“bad” state are not “life” and “death”, but rather different states of health. 
 
4.2.2. Developing the Decision Trees 
Although the final decision trees presented in Figures 4-1 through 4-5 appear 
relatively simple, their development required considerable research regarding the various 
types of treatment used for patients presenting with symptoms of heart disease.  In 
addition, it was necessary to understand how new developments regarding the screening 
and treatment of vulnerable plaque would alter the current standard of care.59  Thus, the 
decision trees were developed after attending vulnerable plaque seminars sponsored by 
CIMIT (Center for Innovative Minimally Invasive Therapies) at the Massachusetts 
General Hospital (MGH) and after numerous conversations with several M.D.s familiar 
with vulnerable plaque research.  Once the underlying medical issues were clearly 
understood, the decisions that would be faced by the patient/physician60 were simplified 
                                                 
59 Information related to this can be found in section 3.9 of Chapter 3 under the heading “Standard of 
Care.”   
60 This analysis is done from the patient’s point of view.  Although the physician may recommend a 
particular course of action, most decisions are ultimately that of the patient.  Therefore, all decisions that 
are made by the patient (with or without his/her doctor’s advice) will be represented as decision nodes.  For 
the few exceptions where the physician must make a decision without conferring with the patient (for 
example, when the doctor must decide whether or not to treat the patient while performing the detection 
procedure described in scenario 5), it is assumed that the physician will follow the “standard of care.”  
Meaning that if the detection procedure reveals a certain level of plaque, treatment will be performed, 
otherwise, it will not.  Since this decision is out of the hands of the patient, and is in essence contingent 
only on the level of plaque discovered during the detection procedure, it will be represented as a chance 
node.   Throughout this paper, the term “patient/physician” will generally be used when describing a course 
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into five scenarios.  The following provides a description of these scenarios that are used 
to develop the theoretical framework for this project.  Some scenarios represent the 
current state of the world, while others represent hypothetical situations modeling the 
decisions that would most likely exist if a screening and detection/treatment method did 
exist.61  Each scenario is accompanied by a list of relevant assumptions/conditions and by 
a decision tree that visually illustrates the scenario.   
The first three scenarios are related to the benefits associated with a screening 
method that could be used to identify individuals within the general population who are at 
risk for a MI due to vulnerable plaque (including those who are asymptomatic).  The first 
scenario illustrates the current situation in which no such screening exists.  The third 
scenario illustrates the hypothetical state in which both screening and treatment exist.  
Since drug therapy is currently available for those individuals who are identified as being 
“at high risk” for a heart attack, the second scenario (in which screening is available, but 
no treatment exists) would never occur.  However, it is included as a stepping stone, and 
will be utilized later in this chapter to isolate the individual’s WTP for information 
obtained from the screening in the absence of possible treatment.    
The last two scenarios are used to illustrate the benefits associated with 
developing a more effective treatment for those who have already been identified as 
being at high risk for a MI due to vulnerable plaque.  The fourth scenario describes the 
current state of the world in which only drug therapy is available, and the fifth scenario 
describes the hypothetical state of the world in which a more effective 
detection/treatment is available.   
 
4.3 Theoretical Framework for a New Screening Method 
4.3.1  Current State for an Asymptomatic Individual 
The first scenario (See Figure 4-1) represents the current state in which no 
screening is available. Therefore, individuals who do not exhibit symptoms of heart 
problems are currently “left out of the system” even though they may be at risk for a 
                                                                                                                                                 
of treatment involving several decisions, which could be made by the patient, physician, or a combination 
of the two.  This term also reflects the collaborative nature with which most medical decisions are made.    
61 It was necessary to simplify the medical process that actually occurs to some degree in order to make the 
decision trees manageable.  However, care was taken not to simplify any element that was thought to be 
meaningful, given the scope of the analysis. 
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heart attack.  Since screening and treatment are currently not available to these 
individuals, the following conditions apply: 
 
• Individual has NO symptoms of coronary heart disease (CHD)  
• Screening for vulnerable plaque is NOT available 
 
If the individual’s probability of having a heart attack (or MI) is r (0 < r < 1), then 
with probability (1 - r) the individual will NOT experience an MI.  It should be noted that 
r is specific to the individual and is largely unknown.  The individual may have some 
information (N0) regarding r based on family history, past cholesterol tests, and other 
traditional risk factors; however, as explained in Chapter 3: Medical Background, these 
factors are not always good indicators of who is at risk for a heart attack.  Therefore, the 
current information held by the individual (N0) provides very little information as to 
his/her actual risk of having a heart attack.   
The medical literature indicates that an individual who experiences an MI has 
about a 50 percent chance of survival (American Heart Association 2003).  Surviving a 
heart attack may leave the individual in a state of significant disability, or at the very 
least, with a weaker heart muscle that puts them at greater risk for a future heart attack 
and may place limits on their activity.  Therefore, it is reasonable to consider the utility 
associated with three possible health outcomes: the individual lives without experiencing 
an MI, the individual experiences an MI and lives, or the individual experiences an MI 
and dies as a result.  The indirect utility62 associated with each health state will be 
denoted as L, M, and D respectively.   
Following the model developed by Michael Jones-Lee (1974) for the willingness 
to pay for reductions in the risk of death, utility in each state is dependent on the 
individual’s wealth (W); however, this model is modified such that instead of paying to 
reduce the risk of death, the individual can pay to reduce his/her risk of a heart attack, r.  
                                                 
62 Consumers will choose the quantities of available goods and services that maximize his/her utility 
subject to a budget constraint.  Therefore, it follows that an individual’s optimal utility level will be 
indirectly determined by his/her income and the prices of the goods being purchased (Nicholson 1992 p. 
116).  The indirect utility function is useful because it is expressed in terms of income and prices, which are 
measured in dollars. Therefore, by using indirect utility it is possible to examine the effect changes in prices 
and income will have on consumer utility (Nicholson 1992 p. 117). 
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In addition, the bad state of the world - having a heart attack – has two consequences: 
survival and death.  Viscusi and Evans (1990) find empirical evidence to suggest that the 
utility derived from income is higher when the individual is in the healthy state compared 
to an unhealthy state.  Therefore it would follow that L(W) > M(W) > D(W).  In addition, 
the marginal utility of wealth diminishes in each of the health states, such that L'(W), 
M'(W), and D'(W) are all negative.  Applying these indirect utilities to the decision tree in 
Figure 4-1, expected utility can be written as: 
  
    E(U)1 = (1-r) L(W | N0) + r (.5) M(W | N0) +  r (.5) D(W | N0),          
 
where the utility derived from each health state is a function of the consumer’s wealth 
(W), given the current amount of information (N) that the individual possesses on their 
risk of heart attack.  If the individual’s utility from death is assumed to be zero, then the 
individual’s expected utility becomes:    
  
   E(U)1 = (1-r) L(W | N0) + .5 r M(W | N0)     (4.3) 
 
The simple decision tree illustrated in Figure 4-1 will appear as a branch in several other 
trees and is indicated by chance nodes labeled α.  In addition, other branches that appear 
in more than one decision tree will similarly be labeled to facilitate comparisons across 
figures.   
 
4.3.2 Intermediate State for an Asymptomatic Individual 
The second scenario (See Figure 4-2) represents an intermediate state of the world 
in which screening exists, but treatment does not.  Drug therapy currently exists for those 
identified as being at high risk for a heart attack, therefore, the following scenario is not 
realistic; however, it is possible that individuals would be willing to give up some of their 
wealth in order to find out more about their risk of having a heart attack, even if a 
treatment is not available.  Therefore, this scenario is included as a stepping stone to 
isolate the factors affecting the WTP for information provided by the screening in the 
absence of a treatment.  Therefore, in the second scenario the following conditions apply: 
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• Individual has NO symptoms of coronary heart disease (CHD) 
• Non-invasive screening for vulnerable plaque IS available to the general 
public (i.e. routine blood test similar to a cholesterol test) 
• BUT a treatment does NOT exist    
 
The individual now has the option to find out more about their risk of having a 
heart attack by paying some dollar amount for a screening test.  Interestingly enough, 
regardless of whether the individual has the screening or not, they will still face the same 
gamble illustrated in Figure 4-1.  As illustrated in Figure 4-2, the only difference between 
the upper (α) and lower (γ) branches is the amount of information (N) the individual 
possesses regarding his/her risk of heart attack.  Since there is no treatment, the 
individual’s risk of heart attack, r, will remain unchanged.  Although screening will not 
lower r, it will provide the individual with more information regarding the actual value of 
r.  Therefore, by offering individuals more information as to their actual risk of having a 
heart attack, screening has the potential to enable the individual to make decisions that 
would enhance his/her utility.   
Even though this scenario assumes no treatment is available, there are possible 
benefits derived from being screened.  Namely, individuals found to be “at low risk” 
receive peace of mind.  In addition, this new information regarding the true value of r 
may allow some individuals to alter their behavior in ways that increases their utility.  For 
example, an individual who discovers herself to be “at low risk” after believing that she 
was “at high risk” may no longer feel compelled to adhere to as strict a routine of diet and 
exercise, which could potentially increase utility.  For an individual found to be “at high 
risk” this new information can also be beneficial in that it allows him to better prepare for 
the future.  For example, the individual now has the opportunity to obtain more life or 
disability insurance to provide financial security for his family in the event of a heart 
attack.  Additionally, this new information may lead the individual to spend their time 
differently or alter their consumption patterns, thereby reducing feelings of regret in the 
event that death or disability does occur. 
 Although there are many possible benefits, it is also possible that the information 
provided from the screening could lower utility for some individuals.  An individual who 
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is found to be “at high risk” may experience stress and anxiety from knowing they have a 
medical condition for which no treatment is available.  Therefore, it is not clear that more 
information will increase the utility in each health state for all individuals.   
Again, following the model by Jones-Lee (1974), a payment (Ps) is required to 
receive the screening.  The payment will reduce the individual’s wealth, but will increase 
their level of knowledge regarding their risk of heart attack from N0 to N1.  Therefore, 
expected utility derived from the screening (lower branch in Figure 4-2) can be expressed 
as:       
E(U)2 = (1-r) L(W - Ps | N1) + .5 r M(W - Ps | N1)   (4.4)   
   
Assuming utility is held constant at the initial level of E(U)1, the individual’s 
maximum WTP for information (WTPi) from the screening (when no treatment is 
available) is defined by setting E(U)1 = E(U)2.  Because this decision is made ex ante 
(prior to the individual knowing whether he/she is at risk), this expenditure is an option 
price that is paid regardless of whether the individual experiences a heart attack or not.  
Substituting in for the expected utility using equations 4.3 and 4.4 and changing Ps to 
WTPi yields the following expression:  
 
 (1-r)L(W | N0) + .5rM(W | N0)  = (1-r)L(W –WTPi | N1) + .5rM(W –WTPi | N1)   (4.5)   
 
As this equation implies, there is clearly a tradeoff between information and 
wealth.  Choosing to have the screening will not change the individual’s probability of 
having a heart attack (because no treatment is available); however, if the individual 
chooses to pay for screening, then he/she will obtain information (N1) regarding his/her 
risk of having a heart attack.  Therefore, the maximum WTP for screening when no 
treatment is available (WTPi) will be dependent on the dollar equivalent of the marginal 
utility derived from the additional information (which could be either positive or negative 
as the previous discussion illustrates).  Therefore, it is expected that those who 
experience a gain in utility from the information will be willing to pay some dollar 
amount for it, but those individuals for which the information causes disutility will not 
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elect to have the screening, and may even require compensation in order to accept the 
screening. 
 
4.3.3 Desired State for an Asymptomatic Individual 
The third scenario (See Figure 4-3) represents the desired state of the world in 
which an asymptomatic individual can be screened for vulnerable plaque, and if found to 
be at high risk, can receive treatment.  Figure 4-3 is very similar to Figure 4-2.  However, 
since the possibility of treatment now exists, a bottom branch is included in Figure 4-3 
and the chance node γ becomes a decision node.  Drug therapy which is 30% effective 
currently exists, and it is anticipated that a new treatment which is even more effective 
will be available in the near future.  Therefore, in the third scenario, the following 
conditions apply: 
 
• Individual has NO symptoms of coronary heart disease (CHD) 
• Non-invasive screening for vulnerable plaque IS available to the general 
public (i.e. routine blood test similar to checking your cholesterol) 
• A treatment DOES exist in the form of drug therapy which is 30% effective, 
and a new treatment which is 85% effective also exists.    
 
The treatment received will reduce the individual’s risk of a heart attack r, such 
that the individual’s new level of risk with treatment is r*.  The new lower level of risk 
will be determined by the effectiveness of the treatment.  Therefore, having the new 
treatment will lower r more than if the individual chooses drug therapy.  The expected 
utility derived from screening is illustrated in the lower branch of Figure 4-3.  In this case 
screening offers information as well as the opportunity for treatment.  Treatment is not 
actually delivered; however, an individual who pays for the screening has the opportunity 
to receive treatment if the results indicate that the individual is at high risk, which occurs 
if the individual’s risk of heart attack, r, is found to be above some threshold amount, z.   
Therefore, using the lower branch of Figure 4-3, expected utility from screening can be 
written as: 
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E(U)3 =  (1-p(r>z))[(1-r) L(W - Ps | N1) + .5 r M(W - Ps | N1)] 
+  (p(r>z))[ [(1-r*) L(W - Ps | N1) + .5 r* M(W - Ps | N1)]  (4.6) 
 
Since screening involves an expenditure, utility will be reduced if the screening 
indicates the respondent is not at high risk.  However, as the last scenario illustrated, only 
those who have a positive marginal utility associated with the information will elect to 
have the screening.63  Plus, the other potential gain from the screening is the benefit from 
the treatment if the individual is found to be at high risk.64  Holding the individual’s 
utility constant at the level defined by E(U)1 , the WTP for screening will be determined 
by:  
     E(U)1  =  E(U)3   
 
Substituting in equations 4.3 and 4.6, the WTP for screening (WTPs) is defined by the 
equation: 
 
(1-r) L(W| N0) + r (.5) M(W| N0) = (1-p(r>z))[(1-r)L(W-WTPs| N1) + .5rM(W-WTPs |N1)] 
 + p(r>z) [ [(1-r*) L(W - WTPs | N1) + .5 r* M(W - WTPs | N1)]65  
                                                 
63 This lends support to the two-part model included in Chapter 7: Data Analysis 
64 In estimating the total benefits derived from the screening and/or treatment, it would be necessary to 
consider potential effects on markets for substitute goods.  For example, if the screening test identifies 
individuals who do not currently know they are at risk for a heart attack, the demand for statin (cholesterol-
lowering) drugs is likely to increase.  Likewise, development of a localized treatment (such as that 
described in Survey 2: Treatment) would most likely reduce the demand for stent procedures, but have little 
effect on the demand for statins since those having either procedure would still receive drug therapy 
regardless of the procedure.  In addition, another consideration in conducting a benefit-cost analysis would 
be to consider the potential for offsetting behavior, or the Peltzman effect (Peltzman 1975).  Studies 
(Peltzman 1975, Chirinko and Harper 1993) have shown that auto safety regulations have had little (if any) 
net effect on the reduction of highway traffic fatalities.  One potential explanation is that consumers have a 
constant demand for health/safety and will therefore engage in offsetting behavior (such as driving faster) 
in response to additional auto safety features that reduce the probability of a auto fatality (Peltzman 1975).  
Therefore, given this evidence of the Peltzman effect in the demand for highway safety, it is reasonable to 
expect that consumers may also engage in some degree of offsetting behavior if an improved treatment 
which reduces the risk of heart attack is developed.  
65 This equation does not include a cost for treatment, which is consistent with the design of the survey 
instrument.  For those respondents who received a version of the survey in which treatment was available, 
they were informed that treatment was either 30% or 85% effective (corresponding to the two treatment 
options); however, no mention of the cost of the treatment was includes. However, this is not necessarily an 
unrealistic specification.  Typically, insurance companies will cover the cost of treatment that is determined 
necessary.  Therefore, if the screening indicates that the individual is at high risk for a heart attack, then the 
insurance company is likely to cover the cost of drug therapy.  
 
 95
From this equation, it is clear that WTP for screening is a combination of the 
informational value it provides as well as the expected decrease in risk that treatment 
offers if the individual is found to be at high risk.  Therefore, it is expected that those who 
are offered a greater effectiveness for treatment will be willing to pay more; however, 
this may be influenced by their perceived level of risk.  If the individual does not 
perceive their risk to be very high, then they may anticipate that the screening will 
indicate that they do not need treatment.  For example, consider the extreme case of 
p(r>z)=0 in which the individual believes there is zero probability that the screening will 
indicate that they are at high risk, such that their individual risk of a heart attack, r, is 
above the threshold level z.  In this extreme case, the effectiveness of the potential 
treatment will have no impact on the individual’s WTP for screening.  In fact, if p(r>z) =0 
then the last two terms on the right side of the equation become zero.  Thus, the 
expression simplifies to equation 4.5 and is no different from the second scenario in 
which the screening only offers informational value. 
 
4.4 Theoretical Framework for a More Effective Treatment 
The last two decision trees apply to individuals who are already known to be at 
high risk for a heart attack.  The decision tree in Figure 4-4 represents the current options 
(drug therapy) available to the patient/physician, while the added branch in Figure 4-5 
represents the options available if a new detection/treatment method were made available.  
In scenario 4, the individual has already been identified as being at high risk for MI, 
therefore, he/she has some additional information (N1) regarding his/her actual risk of 
heart attack.  However, in scenario 5, the patient now has the opportunity to choose a new 
detection method that would provide more precise information (N2) about his/her risk of 
MI.  Notice that if the patient chooses drug therapy, no additional information is gained, 
which is indicated by the level of information N1 in the indirect utility function.    
 
4.4.1 Current State for an Individual at High Risk for a MI 
Individuals who experience symptoms of coronary heart disease (or who have in 
the past) are considered “at high risk” for an MI.  Therefore, the decisions facing these 
individuals would be the same as those who are identified as being “at high risk” for MI 
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through screening.  Currently, the only treatment available is drug therapy, which is 
considered to be 30% effective at reducing the risk of heart attack.  Therefore, the fourth 
scenario (See Figure 4-4) represents the current state of the world for those individuals 
who have been identified as being “at high risk” for a heart attack, given the following 
conditions: 
    
• Individual has been identified “at high risk” for MI either through screening 
or because the individual has symptoms and/or a medical history of coronary 
heart disease (CHD).  
• A treatment does exist in the form of drug therapy; however, at best, it is 
only 30% effective    
 
Once a patient is identified as being “at high risk” for a MI, he/she has two 
possible options.  The first option is to do nothing.  Although this would not be 
recommended by a physician, a patient does have the right to refuse medical treatment.66  
If the patient elects not to have treatment, he/she will still possess information N1 
regarding his/her risk of heart attack; therefore, selecting this option would simply lead to 
a branch (γ), which is identical to the branch in Figure 4-2 in which no treatment is 
available.   
The patient’s second option is drug therapy, which would involve the patient 
taking a statin (cholesterol lowering) medication on a daily basis.  A very small 
percentage of patients (<1/10,000)67 who take statins die from medical complications 
(such as liver failure).  However, because this risk is so small and because the focus of 
the study is the WTP for a new treatment, this negligible risk associated with drug 
therapy was not mentioned in the survey, and therefore is not included in the decision 
trees.   
Studies have shown that for patients taking statin drugs there is a statistically 
significant difference in the probability of having a MI, and that drug therapy reduces the 
                                                 
66 Although the patient does not choose medical treatment, it does not preclude the possibility that the 
individual may respond to the information that he/she is “at high risk” of a heart attack by adjusting his/her 
behavior in ways that could potentially improve health (e.g. increased exercise, improved diet). 
67 Any medical risk that is lower than 1/10,000 is simply reported as “< 1/10,000” 
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risk of heart attack by an average of 30% (Ryan 2007).  This means that a statin drug 
may have a larger effect for an individual at very high risk of a heart attack, while having 
a much smaller effect for an individual who is just over the threshold of being “at high 
risk.”  Thus, just as the risk of heart attack, r, is dependent on the individual, so will the 
magnitude of the risk reduction resulting from drug therapy.  Therefore, the individual’s 
risk of a heart attack while on drug therapy, rd, is unique to the individual and, like r, is 
largely unknown.  However, it is clear that rd < r due to the fact that the individual’s risk 
of heart attack is lower from drug therapy compared to when the individual receives no 
treatment.   
The decision tree illustrated in Figure 4-4 is essentially the same as the entire 
bottom branch in Figure 4-3 except, in this case, treatment is defined.  The top branch of 
Figure 4-4 illustrates the expected utility for the individual if he/she refuses treatment, 
and is given by: 
   
E(U)4  = (1-r) L(W | N1) + .5 r M(W | N1)  (4.7) 
 
Clearly the expected utility for someone who knows they are at higher risk for a 
heart attack will be different than the utility, E(U)1, for an individual who does not have 
this information; therefore, E(U)4 will become the baseline level of utility for those 
known to be at high risk for a heart attack.  Since the focus of this study was the WTP for 
the new procedure, the out-of-pocket cost for drug therapy was assumed to be zero.  
Therefore, the expected utility from drug therapy is defined by the bottom branch (λ) in 
Figure 4-4 such that: 
 
E(U)5  = (1-rd) L(W | N1) + .5 rd M(W | N1)  (4.8) 
 
As stated earlier, rd < r; therefore expected utility68 from the drug therapy is 
clearly higher when compared to the expected utility derived from doing nothing.  This is 
why drug therapy is currently the standard of care for those who are identified as being 
“at high risk” for a heart attack.  Although not formally modeled, it is possible that an 
                                                 
68 As defined by equations 4.7 and 4.8 
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individual would elect not to have drug therapy if the losses in utility from possible side 
effects or having to take the medicine on a daily basis outweighed the benefits associated 
with the reduction in heart attack risk.69 
 
4.4.2 Desired State for an Individual at High Risk for an MI     
 Currently, the only available treatment for those known to be “at high risk” for a 
heart attack is drug therapy, which is only 30% effective. Therefore, this final scenario 
(See Figure 4-5) describes the desired state of the world in which a detection/treatment 
method for vulnerable plaque does exist, such that patients at high risk for a heart attack 
have a treatment option available to them that is more effective than drug therapy. 
 
• Individual has been identified “at high risk” for MI either through screening 
or because the individual has symptoms and/or a medical history of coronary 
heart disease (CHD).  
• A NEW method for detecting and treating vulnerable plaque exists that is 
MORE effective than drug therapy  
 
Although screening and/or symptoms of coronary heart disease (i.e. chest pain) 
may place an individual “at high risk” for MI, these are only indicators.  As explained in 
Chapter 3: Medical Background, these “indicators” only provide limited information as to 
the individual’s true risk of having a heart attack.  Therefore, the development of a  
procedure that could locate pockets of vulnerable plaque within the coronary arteries 
would allow the physician to better assess the patient’s actual risk and determine the best 
course of treatment (either drug therapy or the new treatment procedure utilizing a heart 
catheter).  Regardless of the final treatment option selected, having this procedure would 
increase the patient’s information regarding his/her actual risk of a heart attack (from N1 
to N2). 
                                                 
69 The decision trees are modeled using the individual’s actual probability of having a heart attack, r; 
however, individuals will make their decisions based on their perception of this risk.  Therefore, if the 
individual has poor information regarding their actual risk of having a heart attack, they may make 
decisions that are non-optimizing.    
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As the lower branch in Figure 4-5 illustrates, the new procedure does involve an 
additional risk of death.  As explained in the previous chapter, this risk of death stems 
from the possibility of medical complications from the surgical procedure.  In the survey, 
respondents were told that the added risk of death from the procedure was equal to 
1/10,000; therefore, the probability of survival (ps) for this study was 0.9999.  However, 
in writing the equations it will be left as a variable, so that it is clear how changes in the 
risk of death from the procedure will affect WTP.   
In looking at the bottom branch of Figure 4-5, it is interesting to note that once the 
patient chooses the catheter procedure, all remaining decisions are beyond his/her 
control; therefore, all the branches stemming from this decision appear as chance nodes.  
Assuming the patient survives the detection procedure, the physician will then be able to 
determine if vulnerable plaque is present, such that the new catheter treatment is 
warranted.  Because there is a significant added risk from performing the procedure more 
than once (due to the anesthesia involved) and because additional procedures are an 
inefficient utilization of medical resources, the procedure includes both detection and 
treatment (if it is warranted).  However, because the patient is medicated and cannot 
provide his/her informed consent, the decision to treat the vulnerable plaque will be 
determined by the physician, who is assumed to follow the accepted standard of care.   
Therefore, once the patient chooses to have the procedure, the resulting outcome (path) is 
dependent solely on the existing probabilities associated with this treatment option. 
 If the detection procedure reveals that vulnerable plaque is not present, then the 
patient will be treated using drug therapy which, as discussed earlier, lowers the 
individual’s risk of heart attack to rd.  However, if vulnerable plaque is detected, then the 
new treatment will be performed.  The new treatment will lower the individual’s risk to rt 
and because the treatment is more effective than drug therapy, rt < rd for each individual.   
Earlier it was determined that if the individual did not receive treatment at all, expected 
utility would be equal to: 
 
E(U)4  = (1-r) L(W | N1) + .5 r M(W | N1)       (4.7) 
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Since E(U)4 defines expected utility if the individual does not receive any form of 
treatment, this will be used as the individual’s baseline utility level.  Following the lower 
branch of Figure 4-5, the individual’s expected utility from the new treatment procedure 
is given by:     
  
E(U)6  = (ps){ pv (1-rt) L(W - Pt | N2) + .5pv rt M(W - Pt | N2)  +  
(1-pv)(1- rd) L(W - Pt | N2) + .5(1-pv) rd M(W - Pt | N2) }    (4.9)    
 
where ps is the probability of surviving the procedure,70 pv is the probability that 
vulnerable plaque is detected during the procedure,71 Pt is the price of the treatment, and 
N2 is the higher level of information on heart attack risk that is gained from having the 
procedure.  Therefore, the WTP for the reduction in heart attack risk due to the treatment 
can be found by holding expected utility constant, such that E(U)4 = E(U)6 .  Substituting 
in equations (4.7) and (4.9) gives: 
 
(1-r)L(W| N1)+.5rM(W| N1)=(ps)[pv(1- rt)L(W-WTPt | N2)+.5pv rtM(W-WTPt | N2) ]  
 + (ps)[(1-pv)(1- rd)L(W-WTPt | N2) + .5(1-pv) rd M(W-WTPt | N2) ] (4.10) 
 
Assuming that the information effect from the procedure is negligible, WTP for 
the change in risk associated with the procedure can be found by differentiating 4.10 with 
respect to r.  Since risk remains constant without the treatment, the left side will become 
zero, such that: 
 
0 =   -pspvL + pspv(1-rt)L' ∂WTPt/∂r + ps(1-rt)L ∂Pv/∂r + .5pspvM  + .5pspvrtM' ∂WTPt/∂r 
+ .5psrtM ∂Pv/∂r – ps(1-pv)L +  ps(1-pv)(1-rd)L' ∂WTPt/∂r - ps(1-rd)L ∂Pv/∂r +.5ps(1- pv)M 
+ .5ps(1-pv)rdM' ∂WTPt/∂r  - .5psrdM ∂Pv/∂r 
 
Solving for ∂WTPt/∂r gives an expression for the marginal change in WTP for treatment 
for a change in heart attack risk, and is defined by: 
                                                 
70 For this study ps is equal to 1 minus the probability of death from the new treatment procedure;  
ps =1 -.0001 = .9999 
71 pv is dependent on the individual’s risk of heart attack, r 
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∂WTPt/∂r = [pspvL  - ps(1-rt)L ∂Pv/∂r - .5pspvM  - .5psrtM ∂Pv/∂r + ps(1-pv)L  
+ ps(1-rd)L ∂Pv/∂r -.5ps(1- pv)M  + .5psrdM ∂Pv/∂r]  /   [ pspv(1-rt)L' + .5pspvrtM'   
+  ps(1-pv)(1-rd)L' + .5ps(1-pv)rdM']       (4.11) 
 
Some simple algebra results in some terms cancelling out, such that equation 4.11 
simplifies to: 
 
∂WTPt/∂r = L  -.5M  + rtL ∂Pv/∂r -.5rtM ∂Pv/∂r + .5rdM ∂Pv/∂r - rdL ∂Pv/∂r]  /    
[pv(rd-rt)L' + (1-rd)L' +.5pvrtM'  + .5(1-pv)rdM']   (4.12) 
 
where L = L(W-WTPt |N2), D = D(W-WTPt |N2), L' = ∂L(W-WTPt |N2)/ ∂WTPt, and D' = 
∂D(W-WTPt |N2)/ ∂ WTPt .     
From equation 4.12, it follows that higher the effectiveness of the treatment, the 
higher the WTP for treatment; however, the higher the effectiveness of drug therapy, the 
lower the WTP for treatment.  Therefore, this implies that the greater the difference 
between the effectiveness of the two treatments, the larger the WTP for treatment.  In 
addition, the higher the likelihood of having vulnerable plaque, the greater the expected 
WTP.72   
 
4.5 Application to Survey Instruments  
The theoretical framework presented in this chapter is used to develop the two 
surveys utilized for this study: Survey 1: Screening and Survey 2: Treatment.  Survey 1: 
Screening was developed based on scenarios 1-3 and was administered to a sample 
representative of the general population.  Through this survey, information on the 
individual’s perceived risk of a heart attack, health characteristics, financial resources, 
and other demographics was obtained.  In addition, the survey elicited the individual’s 
WTP for screening.  In order to better understand how treatment effectiveness might 
                                                 
72 The probability of the individual having vulnerable plaque is unknown; however, it may be possible to 
use the individual’s perceived risk of a heart attack as a proxy for this variable in the empirical analysis in 
Chapter 7.    
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influence the WTP for screening (as suggested by the third scenario), respondents 
received versions of the survey in which treatment effectiveness was 30% (corresponding 
to drug therapy) or 85% (corresponding to the new treatment).  In addition, in order to 
explore the question of whether screening has value if it offers purely informational value 
(scenario 2), a small arm of the sample received a slightly modified survey in which no 
treatment was available. 
Scenarios 4 and 5 are addressed by Survey 2: Treatment.  Since these scenarios 
involve patients who are already known to be at high risk for a heart attack, the sample 
for this survey only included individuals with doctor-diagnosed heart problems.  Like 
Survey 1: Screening, Survey 2: Treatment collects information on the individual’s 
perceived risk of a heart attack, health characteristics, financial resources, and other 
demographics.  In addition, respondents for this survey were presented with the treatment 
options discussed in the final scenario and were asked about their WTP for a more 
effective detection/treatment method for reducing their probability of experiencing a 
heart attack. 
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Chapter V:  Development of the Web Surveys 
 
 The purpose of this chapter is to describe the development of the two web-based 
survey instruments used in this study.  Survey 1: Screening was designed to elicit the 
maximum willingness to pay (WTP) for a screening method that would better identify 
individuals in the general population who are at risk for a heart attack.  The goal of 
Survey 2: Treatment was to determine the value an individual, who is known to be at high 
risk for a heart attack, places on a procedure that could provide more precise information 
regarding his/her risk of a heart attack, in addition to providing treatment that could 
substantially reduce the individual’s risk of a future heart attack.  Both surveys elicited 
the respondent’s maximum WTP through the use of an iterative bidding process, which 
utilized the real-time interaction capabilities of a web-based survey. 
Web-based surveys are relatively new and provide researchers with several 
advantages over other survey modes; however, research on web-based survey 
methodology indicates that there are several issues related to this survey mode that have 
the potential to affect the quality of the data (Solomon 2001).  Therefore, the first half of 
this chapter explores what is known about web-based surveys - the advantages and 
potential drawbacks – as well as identifies a set of guidelines for developing an effective 
and reliable web-based survey.  The second half of this chapter explains the development 
of the individual survey questions included in Survey 1: Screening and Survey 2: 
Treatment.  In particular, this section focuses on the rationale for including each question, 
as well as its contribution to the overall purpose of the survey.  In addition, explanations 
as to how the web-based guidelines presented in the first half of this chapter were 
integrated into the creation of the individual questions (as well as the overall survey 
format) are included throughout the second half of this chapter in the form of footnotes.    
 
5.1  Emergence of Electronic Surveys 
Electronic surveys, which include e-mail and web-based surveys, emerged with 
the development of e-mail and the Internet.  Although the initial use of e-mail surveys 
dates back to the late 1980’s, it was the rapid growth of the Internet during the 1990’s 
that resulted in electronic surveys becoming prevalent (Schonlau et al. 2001).  The 
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increased use of e-mail as a means of communication made e-mail surveys attractive to 
researchers as a way to reach a lot of people in a short amount of time.  In addition, 
electronic surveys (specifically e-mail surveys) can be less expensive to conduct than 
paper surveys because they eliminate the need for printing, postage, and data entry 
(Dillman 2000).  As a result, the use of e-mail surveys over paper surveys has increased 
significantly in the past decade. 
 
5.1.1  E-mail Surveys   
E-mail surveys are essentially paper surveys delivered via e-mail.  The e-mail 
received by a respondent typically includes a brief introduction to the survey, followed by 
the actual survey.  The respondent may then be instructed to print the survey and mail it 
back, or if the design allows, fill out the survey electronically and submit it via e-mail 
(Dillman 2000).  Although e-mail surveys have the potentially to reduce the time and cost 
associated with conducting a survey, e-mail surveys are still limited in much the same 
way as self-administered paper surveys (Schonlau et al. 2001).  In particular, e-mail 
surveys do not allow for extensive skip patterns (Dillman 2000).  As a result, researchers 
have gravitated toward the use of a more intricate form of electronic survey: web-based 
surveys (Schonlau et al. 2001). 
 
5.1.2  Web-based Surveys 
Web-based surveys are surveys that are administered using the Internet, or world-
wide web.  Web-based surveys are typically programmed using HTML (Hypertext 
Markup Language), Java or other web-design computer language, and are accessed by a 
computer with Internet access using a specific URL (universal resource locator), or “web 
address” (Dillman 2000, Solomon 2001).  Programming a web-based survey in HTML 
has several advantages including the ability to tailor the survey to each individual based 
on responses given throughout the survey (Solomon 2001).  Web-based surveys also 
allow answers keyed in by the respondent to be automatically transferred into a database 
(Solomon 2001), thereby preventing the need for data entry and eliminating the potential 
for transcription error (Schonlau et al. 2001).  In addition, the ability of the Internet to 
deliver video and audio gives web-based surveys far more versatility than electronic 
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surveys delivered via e-mail (Schonlau et al. 2001).  In fact, in Don Dillman’s book 
entitled, Mail and Internet Surveys, Dillman asserts that Internet surveys have the 
potential to revolutionize surveying in much the same way as random sampling 
techniques did in the 1940’s and telephone interviewing did in the 1970’s (Dillman 
2000).  Therefore, due to several distinct advantages, including their greater versatility, 
web-based surveys have replaced e-mail surveys as the electronic survey of choice 
(Solomon 2001). 
 
5.2  Potential Drawbacks of Web-based Surveys 
5.2.1  Coverage and Self-Selection Bias 
By far, the greatest challenge facing the administration of web-based surveys is 
coverage bias (Solomon 2001, Schonlau et al. 2001).  The primary cause of this coverage 
bias is the lack of computer ownership and access to the Internet among U.S. households 
(Schonlau et al. 2001).  According to a U.S. Census Bureau report, less than 62% of U.S. 
households owned a computer in 200373 (Day, Janus, and Davis 2005).  Although this is 
significantly higher than the 8.2% reported in 1984 (Day, Janus, and Davis 2005), this is 
far lower than the percentage necessary to generate a reliable random sample of the 
general population.   
 It has been argued that although individuals may not own computers, they may 
have Internet access (and e-mail address) at their place of work.  However, the difficulty 
associated with using e-mail accounts to invite survey participants is that unlike 10-digit 
telephone numbers, e-mail addresses are not standardized, and it is possible for a single 
individual to have more than one e-mail address.74  Therefore, random sampling methods, 
such as those that have been used for telephone surveys, can not be applied directly to e-
mail addresses (Dillman 2000).  As a result, web-based surveying often relies on 
                                                 
73 This is the relevant time period because it is when the web-based surveys used for this study were 
administered. 
74 It is interesting to note that in the future, phone interviewing will most likely face similar issues.   With 
the emergence of cell phones, some households have chosen to no longer carry (and pay for) a land line, 
but rather use their cell phone as their “home” number.  In addition, it is not uncommon for a single 
household to include several members who each have their own cell phone.  Therefore, 10-digit telephone 
numbers no longer have a one-to-one correspondence with individual households.  In addition, as the use of 
cell phones increases, generating a sample using only land lines will become less reliable as a means of 
generating a random sample because it will exclude households who no longer carry land lines, but rather 
rely solely on a cell phone for their phone service.   
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recruiting respondents by advertising the survey or posting it where respondents who are 
interested in the topic may naturally come across it while surfing the web.  Because this 
approach to sampling involves individuals self-selecting into surveys that interest them, 
these convenience samples do not provide valid data for drawing conclusions regarding 
the entire population (Pineau and Slotwiner 2003).  Although part of this problem could 
potentially be overcome by mailing the survey invitation (which would then direct the 
individual to the survey’s web address), limited access to the Internet would then become 
the critical issue.  Data analyzed from the Current Population Survey (CPS) indicates that 
there is a large disparity in computer ownership and Internet access by income, race, and 
level of education (McConnaughey and Lader 2007).  Therefore, this clearly suggests that 
data obtained using a standard web-based survey approach would not be representative of 
the general population, but instead would be prone to systematic bias and unreliable 
results. 
One strategy Dillman (2000) suggests for overcoming the coverage bias 
associated with web-based surveys is to administer the survey using mixed modes.  This 
method acknowledges the existence of coverage bias and attempts to overcome it by 
collecting additional data from underrepresented groups using an alternative mode of the 
survey – for example, through a paper or telephone survey.  The problem with this 
strategy is that it introduces the potential for mode effects – that is, inconsistencies in the 
data arising from obtaining the data using different “modes” or formats of the survey 
(Dillman 2000).   
  
5.2.2  Minimum Hardware and Software Requirements 
Another challenge presented by web-based surveys is that they often require a 
minimum hardware capacity.  In addition, updates in hardware and software occur so 
rapidly, there is no equipment “standard” on which to base the design of an Internet 
survey.  Thus, web-based surveys may appear differently across respondents due to 
variations in the size of the monitor being used, the horizontal and vertical configuration 
of the viewing “window”, variations in the operating system (PC versus Macintosh), web 
browser version, capacity of the hardware, or formatting specifications of the software.  
These variations (if not caught through extensive pre-testing) can result in the respondent 
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having to scroll to see the entire question, text wrapping to the next line, misalignment of 
items in tables, or other visual disparities that could inadvertently influence respondents 
in unknown ways (Dillman 2000).   
In addition, Internet connection speeds can vary significantly across users, 
creating vast differences in the time (from a few seconds to several minutes) it takes an 
item to appear on the respondent’s screen.  This is especially true when transmitting 
larger files such as those that contain audio or video (Schonlau et al. 2001, Dillman 2000)  
Because there is a tendency for businesses and higher income areas to have better Internet 
service providers (offering faster Internet connection speeds); variations due to Internet 
speed can create a systematic disparity across socioeconomic groups (Dillman 2000).  As 
a result, survey designers are encouraged to minimize the size of files and extensively test 
the entire survey on systems with varying Internet connection speeds (especially those 
that are slower) to help ensure consistent survey appearance and delivery (Schonlau et al. 
2001, Dillman 2000). 
 
5.2.3  Lack of Computer Experience Among Respondents 
Another issue for web-based surveys is that it is not uncommon for individuals 
(especially those who are older) to have limited experience using computers.  Even those 
individuals who have mastered using a word processor or other specific computer 
application may have difficulty transferring those skills and applying them to the 
relatively “new” format of an online survey (Dillman 2000).  As a result, individuals with 
limited computer knowledge may have difficulty completing a web-based survey, as 
compared to the same survey offered in a more familiar paper or telephone format.   
To help prevent the introduction of survey error due to lack of computer 
knowledge, web-based surveys should be designed at a level at which those with limited 
computer experience would feel comfortable.  In addition, the survey should also include 
any instructions regarding relevant computer functions that are necessary to move 
through the survey (Dillman 2000).  For example, it may be important to inform 
respondents to click on the button marked “next” when they are ready to move on to the 
next screen.  These basic computer logic functions can be easily overlooked by 
programmers familiar with computers; however, they are important in keeping response 
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rates high since respondents may abandon a survey if they become confused or unsure of 
how to continue (Dillman 2000). 
 
5.2.4  Security and Confidentiality 
Finally, web-based surveys are prone to security issues because information 
transferred over the Internet could potentially be viewed by unauthorized individuals.  
Therefore, administering a web-based survey necessitates utilizing additional security 
measures, such as encryption, in order to safeguard the confidentiality of the data.  In 
addition, the survey should establish a perceived level of confidentiality for the 
respondent, such that he/she will feel confident answering the questions honestly 
(Schonlau et al. 2001, Dillman 2000). 
 
 5.3  Advantages of Web-based Surveys 
5.3.1 Real Time Interaction 
One of the foremost advantages of web-based surveys is that this format allows 
interaction between the survey and the respondent.  Real time interaction allows the 
computer program generating the survey to tailor the survey questions to the respondent 
based on his/her prior answers.  Therefore, web-based surveys have the advantage of a 
telephone survey in that they can provide seamless skips based on the respondent’s 
responses, but without the need for extensive human resources to administer the survey 
(Dillman 2000) and without introducing the possibility of interviewer bias. 
 
5.3.2   Use of Color, Video, and Audio 
In addition, web-based surveys can utilize color, audio, and video, which greatly 
increases the type of information that can be presented.  Web-based surveys also have the 
option of allowing respondents to access pop-up help screens whenever needed.  In 
addition, drop-down boxes for long lists (such as “state of residence”) reduce the need for 
typing and help eliminate data entry error (Dillman 2000).  
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5.3.3  Shorter Fielding Time & Fewer Human Resources 
  The nature of the Internet also allows surveys to be administered to 
geographically diverse populations quickly and easily (Dillman 2000).  Therefore, web-
based surveys can often be conducted faster than comparable mail surveys (Schonlau et 
al. 2001) and without the extensive training or manpower required to administer a 
telephone survey. 
 
5.3.4  Less Expensive “on the Margin” 
Finally, the cost of a web-based survey does not increase proportionally with 
sample size (as is the case with paper and telephone surveys).  As a result, “lower costs 
are often touted as one of the benefits of Internet surveys” (Schonlau et al. 2001, p. 24).  
Although some e-mail surveys may be administered with a lower overall cost in relation 
to a comparable paper survey, this is far less likely to be the case with a well-designed 
web-based survey.  Web-based surveys typically have a high initial cost associated with 
the time required to program and extensively test the survey (Schonlau et al. 2001). 
However, after the survey is developed and tested, the marginal cost of administering the 
survey to an additional person is relatively low, if not negligible.  This is not to imply that 
web-based surveys are less expensive overall when compared to a comparable paper 
survey – in fact, the expense associated with the time and computer resources required to 
create and extensively test a well-designed web-based survey can far exceed that of a 
paper survey (Dillman 2000).  Therefore, the decision to utilize a web-based survey 
should stem from the nature of the survey itself, which dictates certain functions that only 
a web-based survey can provide. 
 
5.4 Decision to Use a Web-based Survey 
 For this study, the decision to use a web-based survey was driven primarily by the 
desire to achieve a nationally representative sample utilizing a survey mode that allowed 
extensive skip patterns and offered real-time interface.  The interactive capabilities of the 
web-based survey meant that an iterative bidding process could be used to obtain each 
individual’s maximum willingness to pay (WTP) for the screening and treatment of 
vulnerable plaque as a means of better understanding the value individuals place on their 
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health by avoiding a heart attack.  Typically, paper surveys have been used to obtain 
WTP estimates for various goods and services using a dichotomous choice question in 
which respondents either accept or reject a single bid.  Subsequently, econometric 
techniques such as Cameron’s (1988) or Johansson’s (1995) parametric approaches or 
Kriström’s (1990) non-parametric approach are then required to derive the mean WTP.  
This study does not rely on econometric techniques to derive the mean WTP, but rather 
uses an iterative bidding process to elicit an exact WTP value from each respondent. 
However, in order for this value to be meaningful from a policy perspective, it was 
imperative that the sample represent the U.S. population.  Therefore, a web-based survey 
which could be used to administer the iterative bidding process to a national sample was 
the desired format.  As such, an understanding of web survey design was needed in order 
to create the survey and ensure the reliability of the data collected. 
 
5.5 Guiding Principles for Web Survey Design 
The virtually endless possibilities of web-based technology for creating surveys 
also poses a problem in that it carries with it the vast potential for introducing survey 
error.  Therefore, basic principles have evolved to help govern the design and 
implementation of web-based surveys.  In the chapter entitled “Internet and Interactive 
Voice Response Surveys” of the book Mail and Internet Surveys, Dillman (2000) 
identifies a comprehensive list of principles intended to guide the design and delivery of 
web-based surveys.  Likewise, Schonlau et al. (2001) includes many of the same ideas in 
the chapter entitled “Guidelines for Designing and Implementing Internet Surveys” of 
their online book, Conducting Research Surveys via E-mail and the Web.  Therefore, the 
following includes specific guidelines from each of these sources to establish a set of 
guiding principles that were used to develop the web-based surveys for this study: 
   
 Introduce the survey with a welcome screen that provides motivation for completing 
the survey and also include instructions that will direct the respondent to the 
appropriate web address and to the first question of the survey.  Respondents may be 
contacted and directed to the web survey either through a mailed invitation or an e-
mailed hyperlink; therefore, it is important to make it clear to the respondent that they 
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have arrived at the correct location (Dillman 2000).  A simple way to do this is to use 
a logo that is on both the invitation as well as the welcome screen.  The welcome 
screen will set the tone for the entire survey; therefore, it should motivate the 
respondent to complete the survey as well as convey that completing the survey will 
not require extensive or specialized computer knowledge.  The final goal of the 
welcome screen is to move the respondent to the first question of the survey with ease 
so he/she can begin the survey (Dillman 2000). 
 
 Utilize a password, personal identification number (pin), or some other means to 
limit access to the survey to only those invited to respond.  Because web surveys are 
located on the Internet which can be accessed by anyone who types in the correct web 
address, it is necessary to limit access to the survey in some manner.  Utilizing a 
password or pin will prevent access to individuals who were not invited to take the 
survey, as well as prevent invited respondents from completing the survey more than 
once (Dillman 2000, Schonlau et al. 2001).  The password or pin can be included with 
the survey invitation along with a simple set of instructions informing the respondent 
on how to use it to access the survey (Dillman 2000).  When choosing a password for 
the survey, it is important to select one that can not easily be guessed.  In addition, in 
typed form, it is very difficult to distinguish the letter “l” from the number “1” or the 
letter “O” from the number “0”; therefore, it is recommended that these be avoided 
when creating passwords or pins (Schonlau et al. 2001).          
 
 Make the first question one that applies to everyone, is easily answered, and is of 
interest to respondents. This will convey to the respondent that the survey is on a 
topic that is of interest to them and that completing it does not require extensive 
computer knowledge.  Therefore, drop-down boxes, scrolling, and other higher level 
computer functions should be avoided on the first question.  In addition, numerous 
demographic questions should not appear first (Dillman 2000) as they often do in 
paper surveys – instead, these can be included at the end of the web-based survey.   
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 Avoid unconventional formats, instead present questions in a familiar manner (such 
as those often used on paper surveys).  Web-based surveys should strive to look as 
much like paper surveys as possible, therefore, it is not advisable to use an unfamiliar 
format that is likely to confuse the respondent.  On a computer screen, individuals 
tend to start at the upper left hand corner, so this is an ideal location to start a new 
question (Dillman 2000).  This can easily be achieved if each screen only includes 
one question. 
 
 Use radio buttons for questions with a relatively small number of answer choices.  
Radio buttons are named for the round knobs found on older radios that were used to 
“tune-in” to a station (Schonlau et al. 2001).  Radio buttons appear as circles before 
each answer choice in a web-based survey and look similar to the “bubbles” that often 
appear in front of each answer choice on paper surveys.  Therefore, radio buttons can 
give questions on a web-based survey an appearance similar to that of a paper survey, 
as Dillman (2000) suggests.  To select an answer choice using a radio button, all the 
respondent needs to do is point the cursor at the radio button and “click” the mouse.  
As such, radio buttons are easy to use and require very little computer knowledge on 
the part of the respondent.  In addition, radio buttons have the added benefit of 
automatically “deselecting” the respondent’s first answer choice if a second answer 
choice is selected (Schonlau et al. 2001).  Therefore, in a self-directed web-based 
survey (in which an interviewer is not available to answer questions) radio buttons 
will convey to the respondent that only one answer choice may be selected (Schonlau 
et al. 2001). 
 
 Minimize the use of colors.  Color is very easy to add to a survey; therefore, there is a 
natural tendency to overuse it, and this can lead to potential interference with the 
survey itself (Dillman 2000).  The exact color shown on a monitor is determined by 
the color palette, which can vary greatly across computers (Schonlau et al. 2001, 
Dillman 2000).  Therefore, web survey programmers should be careful to restrict 
themselves to a smaller palette to help insure consistency in viewing and also reduce 
the necessary time it takes to transmit the survey (Dillman 2000).  In addition, some 
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combinations of background colors with font colors can make the text difficult to 
read; therefore, if color is used, it is important to choose colors that have a sufficient 
amount of contrast (black font on a neutral background, blue font on a bright yellow 
background).  Even red and green, which is a high contrast combination, can cause 
problems if any of the respondents are color-blind and cannot distinguish red from 
green.  Mistakenly choosing colors that make it difficult for the respondent to read the 
survey questions can lead to an increased likelihood of non-response or potential 
survey error.  In addition, the use of large blocks of color may inadvertently attract 
the eye away from what the survey designer intended the respondent to focus on.  
Similarly, when color is used around word choices of different length, some color 
bars will appear longer than others, which could possibly influence the respondent’s 
choice.  Finally, colors often have meanings associated with them, such as red means 
“stop” and green means “go.”  As a result, including color may inadvertently 
introduce meanings that have no relevance to the survey question being asked, and 
thereby influence the respondent in unintended ways (Dillman 2000).  Appropriate 
uses of color include intentional “highlighting” to draw the respondent’s attention to 
special elements or directions.  Color can also be used (cautiously) to direct 
respondents to navigational elements that will help them proceed with the survey, 
assuming that it does not distract the respondent from the survey question (Schonlau 
et al. 2001, Dillman 2000).  Since there is no evidence to support that the use of color 
enhances response rates, Dillman recommends using color sparingly in web-based 
surveys in order to help avoid the numerous potential risks associated with it 
(Dillman 2000). 
 
 Limit the use of graphics.  Although the web allows a designer to incorporate 
graphics and video clips with ease, these applications should be used sparingly.  
Graphics and video require a large amount of information to be transferred and can 
lead to large variances in the time required to display the survey and result in 
frustration (and lower response rates), particularly for those using modems or other 
slower Internet connections (Schonlau et al. 2001). Another potential problem with 
graphics is that they may unintentionally alter the meaning of a question.  Schonlau et 
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al. (2001) present an example from an actual marketing survey in which individuals 
are asked how many times they have gone shopping within a certain time period.  
Although the question was intended to inquire about all shopping, the picture 
adjacent to the question shows people shopping in a grocery store.  As a result, it is 
unclear whether respondents are indicating the number of times they have gone 
shopping at any store or have limited their response to include only visits to the 
grocery store (Schonlau et al. 2001).  Therefore, the use of graphics and videos within 
a web-based survey should be limited and done in such a manner as to not alter the 
intended meaning of the question. 
      
 Program the questions as to avoid differences in appearance across different 
machines.  The display resolution configuration determines the number of pixels that 
appear horizontally and vertically on the computer monitor.  Although there are some 
configurations that tend to be more common, such as 640 X 800, 800 X 600, and 
1024 X 748, there is no definitive standard.  Therefore, different settings of the 
resolution configuration can certainly influence the appearance of a web-based 
survey.  In addition, the actual physical size of the monitor can also affect how the 
survey is displayed.  A survey that appears in its entirety using a larger screen and 
configuration may require scrolling (either horizontally or vertically) on a smaller 
screen in order for the respondent to view the entire question with answer choices. 
Although the proportionality of the survey will tend to stay the same, smaller 
configurations may also result in wrapping of the text, which can lead to 
misalignment.  This is particularly problematic if it makes the question unclear, or if 
it leads to the misalignment of headings and their associated choice buttons.  To help 
prevent this from occurring, it is recommended that web survey programmer limit the 
horizontal width to 600 pixels – this allows even the smallest configurations to 
present the entire line of text without wrapping, and helps ensure that the survey will 
be presented consistently regardless of the size or configuration of the monitor. 
Finally, testing should be done using different types of computers with various 
configurations in order to ensure the consistency of survey viewing across machines 
(Dillman 2000). 
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 Provide detailed instructions on necessary computer functions required to complete 
the survey; however, do not provide extensive instructions at the beginning of the 
survey as several pages of detailed instruction may make the survey look complicated 
and deter individuals from proceeding.  Instead, Dillman suggests providing specific 
instructions on necessary computer functions at the time they are needed.  For 
example, instructions on operating a drop-down box may appear in a floating window 
on the screen in which this type of question first appears.  This will provide 
information on an “as needed” basis, as opposed to testing the respondent’s ability to 
learn and remember several computer functions throughout the survey.  Another 
possible way to accomplish this is include a “help” button on each screen or to 
provide instructions following the stem of each question using a different font that 
will easily be recognized by the respondent as instructions rather than an integral part 
of the survey.  Again, these instructions should be clear and limited only to the 
information needed to perform the necessary computer functions required to answer 
the specific question being addressed (Dillman 2000). 
 
 Refrain from overusing drop-down boxes, and always include the direction “click 
here” in the visual line item of a drop-down box.  This will not only help the 
respondent identify the presence of a drop-down box, but will also provide clear 
instructions on how to make the answer choices visible.  Drop-down boxes are 
appealing to web survey programmers because they can hide a lot of information until 
it is needed.  For example, when asking a respondent which state he/she lives in, a 
drop-down box can be accessed that lists all 50 states (Dillman 2000).  Although the 
advantage of this is clear from a programming perspective, drop-down boxes do have 
some potential drawbacks that should be addressed.  First, if data is collected using 
both web and paper surveys, the use of drop-down boxes only on the web-based 
version of the survey can present issues related to mixed modes.  If the survey is not 
being administered using additional modes, then drop-down boxes should still be 
reserved for questions which have several possible answer choices. Clearly, using 
radio buttons for yes/no questions is more efficient (and a more logical) choice than 
using a drop-down box.  In addition, Dillman suggests that when using a drop-down 
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box, the visual line item (the one item that is visible even when the drop-down box is 
not activated) should simply read “click here” and that the first answer choice should 
then be included on the next line (which is hidden).  This suggestion has two positive 
effects.  First, it prevents unnecessary bias because it does not allow the default 
answer choice to be visible while the other possible choices are hidden; and second, it 
helps prevent the respondent from unintentionally skipping a question.  When a 
default choice is displayed, respondents are more likely to think they have already 
responded to that question and because closing a drop-down box may move the 
cursor unexpectedly on the screen, it can make it easy for the respondent to lose their 
place in the survey.  Therefore, including the words “click here” in the visible line 
item will clearly indicate which questions still remain to be answered and help the 
respondent avoid unintentional skips in completing the survey (Dillman 2000).  
 
 Include a mechanism in the survey design that allows respondents to skip questions.  
Although it may seem advantageous that the format of web-based surveys could 
essentially be used to “force” respondents to answer each question in order to proceed 
with the survey, this is certainly not advisable.  First, designing a web-based survey in 
this manner could potentially cause problems from a human subject protection 
prospective if permission for the survey was granted under the proviso of voluntary 
participation in the survey and on each question.  In addition, the respondent may not 
feel that any of the possible answer choices adequately match their intended response 
(Dillman 2000).  Therefore, from a human subject protection standpoint, it is 
necessary to program the survey such that the respondent is allowed to skip any 
question item.  In addition, from a research perspective, it may also be advisable to 
include a choice of “prefer not to answer” or “I don’t know” as a possible answer 
choice, such that unintentional skips can be distinguished from other causes of item 
non-response. 
 
 Let the questions dictate the design of the web-based survey.  Web surveys can either 
be constructed such that each screen includes a single question with a “next” button 
that will make the next screen (and question) appear, or it can be designed such that 
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the web-based survey looks similar to a paper survey with respondents scrolling to 
view all the questions.  Dillman (2000) recommends following the paper survey 
format with scrolling, which permits respondents to move back and forth between 
questions.  As such, this format enables respondents to view previous questions when 
making decisions about subsequent questions, and because this format requires less 
interaction with the host computer, it minimizes transmission time (Dillman 2000).  
However, Schonlau et al. (2001) disagree and recommend including only one (or a 
few) questions per screen in order to prevent excessive scrolling that may give the 
respondent the impression that the survey is too long; thereby increasing 
abandonment and lowering response rates.  However, both are in agreement that 
questions which are intended to be considered together, should be grouped; and that 
when questions are meant to be completed in a specific order, they should appear on 
their own screen (Dillman 2000, Schonlau et al. 2001).  In the latter case, respondents 
may be reminded of previous information when it is likely to be needed, or the survey 
can allow the respondent to move back and forth only within a certain section of the 
survey.  
 
 Give respondents a sense of where they are in the survey to avoid abandonment close 
to the end.  In a paper survey, it is easy for respondents to judge how much of the 
survey remains at any given point; however, the same is not true with web-based 
surveys.  Therefore, it is recommended that the survey include a graphical progress 
indicator or other mechanism that gives respondents a sense of how much of the 
survey remains to be completed.  The rationale is that by keeping the respondent 
informed of his/her progress, they are less likely to abandon the survey because they 
have a sense of how much remains (Schonlau et al. 2001, Dillman 2000).  For 
example, even a simple transitional phrase such as “Finally, please answer a few 
questions about yourself” will indicate that the survey is near completion and 
encourage respondents to answer the last few remaining questions (Dillman 2000).   
 
 Avoid ‘check-all-that-apply and other question formats that have not traditionally 
worked well on paper formats.  Questions that ask the respondent to “check all that 
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apply” have not traditionally worked well in paper surveys; therefore, these types of 
questions should be avoided in web-based surveys as well.  The problem with “check 
all that apply” questions is that respondents have a tendency to satisfice – that is, 
simply check boxes until they feel satisfied that they have checked enough boxes to 
adequately answer the question.  Therefore, an alternate to this is often used in 
telephone surveys in which the respondent is asked a series of yes/no questions.  This 
same approach is recommended for web-based surveys.  Each question can be 
presented separately with answer choices of “yes” and “no” which the respondent can 
select by clicking on the appropriate radio button.  Another question type that can 
create issues on paper surveys, as well as web-based surveys, is open-ended 
questions.  On paper surveys, open-end questions are typically not well received, with 
respondents often providing little information or information for which the meaning 
is unclear.  The good news regarding the potential use of open-ended question on 
web-based surveys is that there is preliminary evidence that respondents may provide 
more specific responses when using an electronic format when compared to a paper 
survey (Dillman 2000). Regardless, open-ended questions should still be used 
sparingly due to the difficulty they pose in reporting and making comparisons across 
respondents. 
 
 Overall, keep it simple.  Utilizing a relatively simple web-based survey will increase 
the probability of a uniform survey being viewed across varying systems (Dillman 
2000) and avoid many of the other issues discussed above.  As a result, the best 
programmers of web-based surveys are likely to be those who can create a relatively 
simple survey that is efficient in size and can be transferred quickly and with a low 
likelihood of crashing the receiving system (Dillman 2000).  Furthermore, simple 
web-based surveys that load faster have been found to have higher response rates 
compared to “fancier” versions that require more time to load (Solomon 2001). 
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5.6 Development of the Survey Instruments 
In addition to adhering to the guiding principles on web survey design presenting 
in the first half of this chapter, developing the survey instruments also required an 
understanding of the medical process and types of decisions a patient would be asked to 
make regarding his/her heart-related health.  Therefore, information was collected by 
attending seminars on vulnerable plaque at the Massachusetts General Hospital in Boston 
as well as having several discussions with researchers and physicians in the field (See 
Chapter 3: Medical Background).  As the medical background suggests, there are two 
economic questions of interest.  First, what are individuals willing to pay for a screening 
method that will better identify those at risk for a heart attack; and second, how much 
will those individuals found to be at high risk for a heart attack be willing to pay for a 
more effective treatment method?  To address these questions, two survey instruments 
were developed: Survey 1: Screening and Survey 2: Treatment (See Appendix A).   
Survey 1: Screening would be administered to adults in the general population.  
After providing respondents with some new information on the cause and potential risk 
factors associated with heart attacks, each individual would be asked about his/her 
maximum WTP for a screening test that would indicate if they were at high or low risk 
for a heart attack.  Survey 2: Treatment would be administered to adults with doctor-
diagnosed heart problems.  These individuals (who are already at high risk of having a 
heart attack) would be asked to value a procedure that would more precisely determine 
their risk of a heart attack, as well as provide treatment which could significantly reduce 
their risk of a future heart attack.   
Since the medical decisions respondents would be asked to consider are 
preventative in nature, both surveys were designed from an ex ante perspective. When 
making the decision to have a blood test designed to identify those at risk for a heart 
attack or to undergo a procedure to obtain more exact information on that risk, the patient 
does not know if he/she will eventually experience a heart attack.  Therefore, medical 
decisions involving uncertainty lend themselves to an ex ante approach in which the 
respondent is asked about his/her willingness to pay before the actual risk is known.  
Even though the sample for the second survey is comprised of those who have doctor 
diagnosed heart problems (including individuals who have experienced one or more heart 
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attacks), the relevant question is still prevention – prevention of a future heart attack that 
could result in permanent disability or even death. 
 The following includes a detailed description of the thought process that went into 
the creation of the questions included in the survey instruments, including how each 
question (or set of questions) contributed to the overall purpose of the survey (See 
Appendix A for survey instruments).  Once the initial surveys were created, focus groups 
were conducted to refine them, and then the completed surveys were submitted to 
Knowledge Networks (KN) for programming (Background information on Knowledge 
Networks and the reasons why this company was chosen to administer the web-based 
surveys is presented in Chapter 6: Data Collection).   
 
5.6.1 Initial Question 
  Following Dillman’s advice, both Survey 1: Screening and Survey 2: Treatment 
begin with a question that is easy to answer and applicable to everyone taking the survey.  
The purpose of this question was to generate interest in the survey as well as convey the 
ease of completing the survey in an online format.  With this in mind, the first question 
(which was the same for both surveys) asked the respondent how important it was for 
their doctor to include them in decisions regarding their own health.  The question 
included three answer choices: “very important”, “somewhat important”, “not very 
important” and respondents indicated their answer by simply clicking on a radio button75 
next to the desired answer choice.  Given that 99.8% of the respondents who saw this 
question completed the entire survey, it appears that this opening question was quite 
effective in achieving its intended purpose. 
     
5.6.2 Warm Up Questions 
A contingent valuation survey typically begins with a series of “warm-up” 
questions in which the respondent is familiarized with the good or service he/she will be 
asked to value later in the survey.  In Survey 1: Screening, the warm-up section includes a 
                                                 
75 Radio buttons were used almost exclusively throughout the two online surveys.  The use of radio buttons 
allows the web-based survey to closely reflect the format of a paper survey, as Dillman (2000) suggests.  In 
addition, radio buttons do not require the higher level of computer experience needed to correctly use drop-
down boxes.  
 125
series of questions related to the respondent’s experience with heart conditions and 
treatments, as well as a risk assessment quiz published by the American Heart 
Association (AHA).  This quiz lists several risk factors typically used by physicians to 
assess a patient’s risk of having a heart attack and is designed to remind/inform the 
respondent of factors that could influence his/her own risk of having a heart attack.  In 
Survey 2: Treatment the warm-up section consists of the same “experience” questions 
used in Survey 1: Screening.  In addition, it includes a set of questions designed to get the 
respondent thinking about how having a heart attack could affect his/her ability to work 
and overall quality of life.   
In both Survey 1: Screening and Survey 2: Treatment, the questions used to obtain 
information about the individual’s experience and/or familiarity with heart disease are 
questions 2-7.  These questions are worded exactly the same in both surveys and include 
items such as: “Have you ever experienced a heart attack?”; “Have you ever taken 
medication to reduce your cholesterol?”; “Do you have a relative in your immediate 
family who has experienced a heart attack?; and if so, “Were you involved in making the 
decisions regarding the treatment of this family member’s heart condition?”76  The 
original intent of this series of questions was to identify individuals who were familiar 
with heart related conditions and possible treatments such that the sample could be split – 
with more familiar respondents being directed to Survey 2: Treatment.  However, during 
a conversation with Dr. Bill McCready, Vice President of Client Development at 
Knowledge Networks, it was discovered that health data obtained when individuals 
joined the panel was available and could be used to create two distinct samples – one for 
each survey.  Therefore, it was decided that Survey 1: Screening would be administered 
to a sample representing the general population, and Survey 2: Treatment would be 
administered to individuals with doctor-diagnosed heart conditions.  From a survey 
design standpoint, this method was clearly superior and therefore, was the method chosen 
for this study.  However, even with this change, the familiarity questions still provided 
                                                 
76 For multi-part questions such as this one, the web-based survey was an excellent survey format in that it 
allowed skip patterns that were completely unobserved by the respondent.  Those who answered “yes” to 
the first part of the question received the follow-up question; whereas those who answered “no” would 
simply receive the next question. 
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information that could provide valuable information in explaining the individual’s WTP.  
Therefore, these questions remained in the opening section of both surveys. 
The final question in this series (question #8) asked respondents if they have ever 
experienced a life threatening condition or illness.  Discussion from focus group 
participants indicated that those who had experienced life threatening conditions or 
illnesses in the past (not necessarily related to the heart) tended to be willing to pay more 
for screening and subsequent treatment; therefore, this question was included so it could 
be used as a possible explanatory variable of an individual’s WTP for 
screening/treatment.   
Following this initial set of questions,77 the two surveys diverged slightly.  Survey 
1: Screening included a risk assessment quiz published by the American Heart 
Association (AHA).  The purpose of this quiz was to provide information to respondents 
regarding their risk of having a heart attack based on the criteria typically used by a 
physician to assess a patient’s risk of a heart attack.  The risk assessment quiz asked 
respondents to answer “yes”, “no” or “don’t know”78 to a series of traditionally accepted 
risk factors, including: “Are you a man over 45 years old”; “Are you a woman over 55 
years old”; “Do you smoke, or live or work with people who smoke every day”; and “Are 
you 20 pounds or more overweight for your height and build.”79  Because respondents 
completing Survey 2: Treatment had already experienced a heart attack or been diagnosed 
with a heart problem (and therefore were already aware that they were at high risk of a 
heart attack), this quiz did not seem pertinent.  However, information regarding the effect 
a heart attack could have on an individual’s quality of life was relevant, especially since 
heart attack outcomes can vary substantially.  Therefore, the final segment of the warm-
up section for Survey 2: Treatment focused on an individual’s quality of life following a 
heart attack.    
                                                 
77 In the online version of the surveys, each of the first eight questions appeared one at a time on its own 
screen.  This allowed the font size to stay large and prevented the respondent from having to scroll.  
Possible answer choices (including “I don’t know” for some questions) appeared immediately below the 
question stem and the answer choices were selected simply by clicking the corresponding radio button.     
78 This is the format recommended by Dillman (2000) because it more closely reflects the method used in 
telephone surveying and is preferable to the “check-all-that-apply” format which is subject to satisficing.  
79 These questions could certainly be viewed together; however, keeping the font size sufficiently large 
prevented all the items from appearing on a single screen.  Therefore, the questions were grouped with 3-4 
items appearing together on a series of three screens.  
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The quality of life section included two parts – the first section provided 
information on heart attack outcomes, including the fact that “about half of the people 
who experience a heart attack die as a result.”  The text further stated that “for those who 
do survive, the results can vary substantially – from ‘no difference’ for some, to others 
who are left permanently disabled…”  Information on chronic symptoms experienced by 
those who have had a heart attack was presented in a table, such that individuals could 
assess how having a heart attack may affect their lives.  Before moving on, respondents 
were asked to review the table carefully and told that in a moment they would be asked 
how having a heart attack could affect their life.80   
The second part of the quality of life section asked respondents to indicate how a 
heart attack would affect or has affected different aspects of their life.  The exact wording 
of the question was tailored to the individual based on his/her response to an earlier 
question “Have you ever experienced a heart attack?”  If the respondent answered “yes” 
to this question, they were asked to assess the degree to which the heart attack has 
affected their life including their “ability to perform daily functions”; “ability to 
effectively complete work duties”; “ability to provide for family”; and “overall quality of 
life.”  The question was set up as a matrix with radio buttons corresponding to each of the 
five possible answer choices ranging from “not at all” to “extremely.”81  For the 
respondents who had not experienced a heart attack, the wording to this question was 
slightly altered to read “Imagine that you experience a heart attack and survive…”  
Respondents were asked to reflect on the amount of physical exertion required by their 
daily lives and work, as well as their ability to handle stress during a typical day.  They 
were then asked to “indicate to what extent each area of your life would be affected by 
these symptoms” using the same matrix question described above. 
Both the risk assessment quiz in Survey 1: Screening and the quality of life 
questions in Survey 2: Treatment provided a natural transition into the next section of the 
survey – the individual’s perceived risk of having a heart attack.                         
 
                                                 
80 Respondents in the focus group for Survey 2: Treatment indicated that this was a very effective question 
that really got them thinking about the impact a heart attack could have on their quality of life.  
81 Following Dillman’s advice on basic survey design (for paper or web-based surveys), all answer choices 
for questions such as this contained a neutral response and an equal number of positive and negative 
options, presented in either ascending or descending order (Dillman 2000).   
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5.6.3 Perceived Risk 
It is expected that an individual’s WTP for screening and/or treatment of heart 
attacks would be related to his/her perceived risk of having a heart attack.  Therefore, in 
conducting this study, it was necessary to obtain both an estimate of the individual’s 
perception of risk as well as their change in perceived risk upon receiving the new 
information on the cause of heart attacks.  For paper surveys this has been accomplished 
using a visual analog scale in which the respondent is asked to place an “X” (or other 
mark) on a horizontal line that measures 10 cm in length and ranges from “no risk” at one 
endpoint to “certain risk” at the other.  A reference point somewhere in between is often 
provided to give the respondent an “anchor” on which to base his/her assessment of risk 
for the proposed situation.  Then, the respondent’s perceived risk is obtained by 
measuring the distance from 0 to his/her mark.  As such, this method will result in a 
measure of perceived risk that is continuous between 0 and 10.82  The advantage of using 
this method is that once new information is provided, respondents can be asked to assess 
their risk a second time, such that the change in perceived risk can be calculated and will 
represent a meaningful quantitative variable.   
To emulate this method using the computer, respondents were asked to assess 
their risk using a computerized version of the visual analog scale.  The figure was labeled 
“Annual Risk of Fatality (Deaths per 100,000 Persons).”  The horizontal line started at 0 
“no risk” and continued to 100,000 and beyond (as indicated by an arrow).  Two anchors 
were included – 19 (corresponding to the risk of fatality from an auto accident) and 50 
(which was labeled “high risk”).  Respondents were asked to use the scale as a guide and 
enter the number that they felt best reflected their risk of having a heart attack within the 
next year.   
The risk of fatality from an auto accident was selected as a reference point for 
several reasons.  First, it was felt that since most respondents would be familiar with 
driving (and riding in a car), they could relate fairly easily to this level of risk.  Also, 
from a theoretical standpoint, this reference works well because it is a risk that remains 
fairly constant over time and throughout a person’s life (See Table 5-1), unlike the risk of 
                                                 
82 Measuring out to 1 or 2 decimal places and then multiplying by 10 will result in a continuous measure of 
perceived risk ranging from 0 to 100, where 0 is “no risk” and 100 is “certain risk” 
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cancer that tends to increase with age.  Table 5-2 includes statistics for actual death rates 
from a sudden heart attack (acute myocardial infarction) by age group.  Table 5-2 clearly 
shows that the risk of death from a heart attack increases substantially for each age group, 
particularly for individuals 55 years of age and above.83  A comparison of Tables 5-1 and 
5-2 indicates that for individuals below the age of 45, the risk of dying from a heart attack 
is lower than the risk of dying in a car accident; however, this relationship is reversed for 
individuals over the age of 45, such that the risk of dying from a heart attack becomes 
greater than the risk of dying in a auto accident.  Therefore, it is expected that younger 
people would place their perceived risk of a heart attack below that of a car accident, 
while an older individual (particularly one who is over 55 and has other risk factors) 
would be more likely to place their perceived risk of a heart attack above that of a car 
accident.  In fact, discussion from the focus groups indicated that many of the participants 
followed this logic when selecting their level of perceived risk.   
The value of 19 which corresponds to an annual risk of fatality from an auto 
accident of 19/100,000 was based on the number of fatalities per 100,000 registered 
vehicles as reported in national fatality statistics published by the U.S. Department of 
Transportation and the National Highway Traffic Safety Administration for the year 
2000.84  Two other statistics were considered - including the number of fatalities per 
100,000 population (15.23) and the number of fatalities per licensed driver (21.94) (U.S. 
Department of Transportation 2002).  The fatality rate for the entire population of 15.23 
was significantly lower than the fatality rate of 21.94 for licensed drivers, presumably 
because a significant portion of the population is comprised of minors.  Since this survey 
was only being administered to adults, it seemed that using the fatality risk per 100,000 
population would underestimate the auto fatality risk faced by an adult.85  In addition, 
                                                 
83 The significant decrease in death rates between 1979 and 1995 for acute myocardial infarction is most 
likely due to the substantial improvements in the treatment of heart disease that occurred during that time 
period; however, death rates from heart attack have remained fairly constant in the last decade, therefore, 
the 1996 values (the year for which data was available) are most likely good estimates of current death 
rates from heart attack.    
84 This was the most current data available at the time the survey instruments were developed. 
85 Table 5-2 also supports the use of the higher value.  As the table indicates, death rates from car accidents 
are higher for individuals who are elderly - ranging from 18.3 per 100,000 (for individuals 65 -74 years of 
age) to 30.1 per 100,000 (for individuals 85 years of age and over).  Since the samples, particularly the 
sample for Survey 2: Treatment includes a large percentage of elderly individuals, the use of the higher 
value as the mean fatality risk from auto accidents seems appropriate. 
 130
restricting this statistic to licensed drivers seemed too narrow in that many individuals 
(including the elderly) may be unlicensed but are still placed at risk (and are well aware 
of that risk) as passengers in a vehicle.  Therefore, it seemed most appropriate to use 
19.27 (fatalities per 100,000 registered vehicles), which was rounded to 19.  An added 
feature of using the number 19 (as opposed to 15) was that respondents would not feel 
constrained to selecting numbers rounded to the nearest 5, thereby helping to ensure a 
continuous variable for perceived risk. 
After indicating their level of perceived risk of having a heart attack within the 
next year, respondents were given new information on vulnerable plaque as a cause of 
heart attacks.  The information provided was based on a news segment that aired on the 
television program 20/20 in January 2001.  The purpose of the new information was to 
make the respondent aware of a potential misconception regarding who is at risk for a 
heart attack, and to make them aware that those who show no signs or symptoms of heart 
problems may still be at risk for a fatal heart attack.  Focus group participants indicated 
that the new information section of the survey was clear, concise, and easy to understand.   
After reading the new information, respondents were asked again about their level 
of perceived risk.  First, they were asked a qualitative question about the degree to which 
the new information had changed their level of perceived risk.  Then they were asked to 
quantify their new level of risk a second time using the computerized visual analog scale 
described earlier.  As a result, information could be obtained on the individual’s 
perceived risk before and after receiving the new information, as well as a qualitative and 
quantitative measure of their change in perceived risk resulting from the new 
information. 
 
5.6.4 Willingness to Pay   
The goal of Survey 1: Screening was to estimate the WTP for a simple blood test 
that would screen for those at risk for a heart attack and the goal of Survey 2: Treatment 
was to estimate the WTP for a treatment method that is more effective than medication, 
the current standard of care.  Therefore, the WTP section of the survey was a key element 
of the surveys in that it would elicit the individual’s maximum WTP for either the 
screening or the treatment.  This was accomplished using an iterative bidding process in 
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which the respondent would receive up to five bids, each of which could be accepted or 
rejected.  The first bid was selected at random, then, subsequent bids were based on the 
accept/reject pattern of the respondent, utilizing the web’s capacity for real-time 
interaction.  Prior to the bidding process, respondents were provided with a framework in 
which the hypothetical good they were being asked to value was presented.  In addition, 
they were asked questions intended to remind them of their budget constraint.  And 
finally, several steps were taken throughout the WTP section of the survey to help 
prevent the possibility of hypothetical bias. 
In Survey 1: Screening, respondents were given a scenario in which their regular 
physician recommends an additional blood test as part of their routine exam.  The 
physician explains that studies have shown that people with low cholesterol and no other 
risk factors can still be at risk for a heart attack, and that this additional test would 
provide better information on the patient’s risk of having a heart attack.  If the test comes 
back negative, it will give the patient peace of mind, but if it comes back positive, then 
further testing could be done to see if treatment is necessary.86  The respondent is then 
asked to take a moment to think about what information from this screening would be 
worth to them.   
While the respondent reflects on how much they would value this test, they are 
presented with information on hypothetical bias.  The rationale for including this section 
is consistent with Cummings and Taylor’s (1999) finding that using a “cheap talk” script, 
in which hypothetical bias is explained directly to respondents being asked to value a 
good as part of a contingent valuation survey, can reduce the occurrence of hypothetical 
bias in the data.  Therefore, using a script modeled after the original “cheap talk” script 
used by Cummings and Taylor (1999), respondents were told about hypothetical bias and 
how it often leads to respondents saying they would pay more for a good or service than 
they actual would if the purchase decision were real.  Following the explanation of 
hypothetical bias (which included two full screens), respondents were asked if they 
                                                 
86 This is similar to the type of information that would typically be presented by a doctor at a routine visit 
(if such a test existed).  It is interesting to note that many decisions regarding our health are made “on the 
spot” and without perfect information.  Therefore, it was thought that the information on risk factors and 
the brief description of the risk due to vulnerable plaque presented in the first part of the survey would be 
comparable to information that would be provided by a physician in a clinic/hospital setting prior to an 
individual being asked to make a decision regarding the screening. 
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understood hypothetical bias, to which they could select either “yes” or “no, I would like 
further clarification.”  If the respondent requested further clarification, they were directed 
to an additional screen that provided more detailed information on hypothetical bias, 
including an example.87  After being presented with the additional information, those 
respondents were once again asked if they understood hypothetical bias.88 
Following the discussion on hypothetical bias, respondents were asked how much 
they typically spent each month on medical care.  The purpose of this question was to 
remind respondents of their actual purchase decisions regarding health care.  In addition, 
the wording following this question, which read: “Based on what I am already spending 
for medical care, how much do I have available to spend on this test” was also designed 
to remind respondents of their budget constraint before proceeding to the WTP section of 
the survey.   
As stated earlier, an iterative bidding process was used to elicit the respondent’s 
maximum WTP for the screening (treatment).  Each respondent received up to five 
possible bids using the following question format: “If this blood test (procedure) costs 
$____, would you choose to have it done?”  The question was framed in this manner to 
reflect an actual purchase decision in which the consumer is offered a good or service at a 
given price, which he/she can choose to accept or not.  To avoid starting point bias, one 
of five possible starting bids was selected at random by the computer.89  If the respondent 
answered “yes” to the question, the bid was doubled.  If the respondent answered “no” 
then the bid was reduced by half.  Once the respondent’s answers established a relevant 
range of possible WTP values, subsequent bids were derived by dividing the remaining 
range in half.  For example, if the first bid is $40 to which the respondent answers “no” 
the bid will decrease to $20.  If the respondent answers “yes” to $20, then the computer 
will split the difference between the upper and lower values, and generate $30 as the next 
bid.   
                                                 
87 Only 12 out of 268 respondents (4.5%) for Survey 1: Screening and 28 out of 295 respondents (9.5%) for 
Survey 2: Treatment requested additional information and viewed the more detailed explanation of 
hypothetical bias. 
88 A total of 5 out of 268 respondents (1.9%) for Survey 1: Screening and 6 out of 295 respondents (2.0%) 
for Survey 2: Treatment answered “no” to both hypothetical bias questions – more specific information on 
how these observations influence the overall results of this study is included in Chapter 6: Data Collection. 
89 The starting bids for Survey 1: Screening were $10, $40, $50, $60, and $100.  The starting bids for 
Survey 2: Treatment were $1,000, $2,000, $5,000, $8,000, and $10,000. 
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The iterative bidding process continues until either (1) the respondent’s answers 
converge and result in a maximum WTP (to within a specified margin of error)90 or (2) 
the respondent receives a maximum of five bids.91  For example, if the bidding sequence 
described above continues such that the respondent answers “no” to $30, then a fourth 
bid of $25 would be generated.  If the respondent answers “yes” to $25, then the bidding 
process would end and the individual’s maximum WTP would be recorded as $25 (after 4 
bids).  The use of this algorithm allowed the bids to cover a large range of values if 
necessary,92 while at the same time enabling the program to quickly narrow the range to 
converge on the respondent’s maximum WTP. 
If, after a series of five bids, the respondent’s WTP could not be determined, then 
the respondent was reminded of the range of WTP values obtained through the bidding 
process and then asked to state the maximum amount they would be willing to spend to 
have the test.93  For example, if the respondent was given an initial bid of $40 and they 
chose “yes” the following bid would be $80.  If the respondent answered “yes” again, the 
third bid would be $160.  A “no” response to $160 would then yield a fourth bid of $120.  
Another “no” response would result in a fifth (and final) bid of $100.  During the bidding 
process, the computer was programmed to keep track of the respondent’s highest “yes” 
bid and lowest “no” bid.  Therefore, if the respondent said “no” to $100, the computer 
would recognize that the respondent was willing to pay at least $80, but not $100 or 
more.  The bidding process would conclude (since the maximum of five bids had been 
reached) and the respondent would receive the following reminder and question: 
 
You indicated that you would pay at least $80 {computer will insert highest “yes” bid}, 
but less than $100 {computer will insert lowest “no” bid}. 
 
What is the most you would be willing to spend out of pocket for this test to find out if 
you are at increased risk for a heart attack? 
                                                 
90 The margin of error was $5 for Survey 1: Screening and $100 for Survey 2: Treatment. 
91 The iterative bidding process terminated after a maximum of five bids in order to prevent the survey from 
appearing too redundant and prevent respondents from abandoning the survey.   
92 If the respondent received a starting bid of $40 for Survey 1: Screening and continued to answer “yes” to 
each subsequent bid, their fifth (and final) bid would be $640.  The lowest start bid was $10 and the highest 
was $100, which yields a possible bid range of $0 to $1600 across respondents. 
93 A similar version of this question was used for individuals who answered “yes” to every bid.    
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 Enter dollar amount here [ _________] 
 
Immediately following the bidding process, the respondent is asked to state how 
certain they are that they would actually pay this amount.  Respondents use a scale of 0 
(“not sure at all”) to 10 (“definitely sure”) to indicate how certain they are that they 
would really pay this amount out of pocket for the test.  After stating their degree of 
certainty, the respondent is reminded of their previously stated WTP amount and given 
the opportunity to revise it if they so chose.94  The survey reads: “Earlier you said that 
you would pay $____{computer will insert previously stated WTP amount} for this test.  
Now that you have had a chance to consider how sure you are about this decision, please 
enter the amount you would definitely (beyond any doubt) pay for this test.”    
During a focus group, one participant remarked that the number of times an 
individual expected to get the test may affect how much they were willing to pay for it.  
If the respondent expected this was an annual test (as suggested in the survey), he/she 
may be willing to pay less for it than if they felt it was something they would only need 
to purchase once in their lifetime.  Therefore, the final question in this section asked 
respondents how many times they expected to get this test over the course of their 
lifetime. 
For Survey 2: Treatment, the WTP section followed a format very similar to that 
of Survey 1: Screening; however, there were a few differences.  In Survey 2: Treatment, 
the wording of the initial scenario was modified to support a more immediate need for 
potential treatment. Again, respondents for this survey are individuals with doctor-
diagnosed heart problems.  Therefore, in Survey 2: Treatment, the section describing the 
good began with: “Suppose you begin to experience chest pain.  You immediately go see 
your regular doctor...”  The respondent is then informed by the doctor that his/her tests 
indicate that he/she is at high risk for a heart attack and two possible treatment options 
are presented.  The physician explains that the standard treatment for patients with this 
                                                 
94 Respondents did not feel compelled to revise their WTP due to the inclusion of the certainty question.  In 
fact, 131 out of 268 individuals (48.9%) sampled for Survey 1: Screening did not choose to revise their 
maximum WTP amount following the certainty question.  A relatively large percentage (32.8%) of these 
individuals reported a 10 on the certainty scale, indicating that they were “definitely sure” of their initial 
WTP value.  For Survey 2: Treatment, 109 out of 295 individuals (36.9%) sampled did not choose to revise 
their maximum WTP following the certainty question, and 33 of those 109 respondents (11.2%) reported a 
10 on the certainty scale, indicating that they were “definitely sure” of their initially stated WTP.   
 135
condition is to prescribe a cholesterol-lowering medication; however this treatment is 
only 30% effective.  Therefore, the physician recommends a new treatment option that 
involves a minimally invasive procedure.  The physician explains that the procedure in 
addition to medication will reduce the risk of heart attack by 85%.  The physician further 
explains that the procedure does have a small risk of death associated it – about 10 out of 
100,000 people who have the procedure die from complications.  To make this risk level 
less abstract for the respondent and to relate it back to the perceived risk scale presented 
earlier in the survey, the doctor qualifies this risk by stating the following: “To put this in 
perspective, your risk of dying in a car accident each year is about twice this high or 19 
out of 100,000.”  The respondent is then told that another trusted physician was consulted 
for a second opinion and both doctors agree that the new procedure (with medication) is 
the recommended treatment.  The respondent is shown a table clearly illustrating the two 
treatment options, including the effectiveness of each treatment as well as the additional 
risk of death associated with the procedure.  Respondents are then asked to indicate 
which treatment option they would choose based on the risk and effectiveness of each 
option.  Their choices include: “Procedure and Medication”, “Medication Only”, “Not 
sure, I would like more information before deciding.” 
The option for additional information was included in response to comments 
made by focus group participants who completed Survey 2: Treatment.  It is expected that 
individuals will spend more time considering the implications of undergoing a more 
invasive procedure before consenting (compared to time and consideration given before 
consenting to a simple blood test such as the one presented in Survey 1: Screening).  
Therefore, it was very encouraging when focus group participants made comments 
clearly indicating that prior to making their decision to undergo the procedure they had 
considered things such as: the opportunity cost associated with recovery time, if they 
could afford to take time away from work, and possible arrangements for childcare while 
they are hospitalized.  These comments demonstrated that the focus group participants 
were taking the hypothetical situation presented in the survey seriously and basing their 
decision on actual limiting factors (and resources) for their household.    
Because these factors were clearly important considerations for many individuals 
when faced with this treatment decision, respondents were given an option of requesting 
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additional information before making a treatment choice.  By selecting “Not sure, I 
would like more information before deciding” the respondent was directed to an 
additional screen in which the doctor who would be performing the procedure provides 
more specific information on what the procedure entails, including the use of a sedative; 
a description of how the procedure is performed; the expected level of discomfort that 
can be expected during the procedure; the projected length of stay in the hospital; 
expected recovery time; and anticipated time away from work.95   
Following this additional information regarding the procedure, respondents were 
once again asked to make a treatment choice.  Those who selected “Medication Only” 
received an open-ended question asking why they chose not to have the procedure.96  
Respondents who chose “Procedure and Medication” were presented with information on 
hypothetical bias described earlier and reminded of their budget constraint by asking the 
same question regarding monthly medical expenditures used in Survey 1: Screening.  
However, because the treatment method described in Survey 2: Treatment could 
significantly reduce the individual’s risk of having a heart attack (whereas the screening 
test described in Survey 1: Screening only provides information on that risk), it is 
expected that the individual would place a much more substantial value on the treatment.  
Therefore, respondents for Survey 2: Treatment were also asked about the amount of 
money they currently had available in savings.  Although the answer choices to the 
savings question included broad ranges in order to minimize refusals, it was anticipated 
that some respondents would chose not to provide an answer to this relatively personal 
question.97  However, regardless of whether the respondent answers the question or not, 
the mere presence of the savings question immediately prior to the bidding still serves the 
purpose of reminding respondents of their available financial resources when making 
decisions regarding their WTP for the treatment.98   
                                                 
95 The content of the information provided was based on questions asked by focus group participants.  
However, it was presented to respondents in a manner designed to closely reflect the way it would be 
presented to a patient prior to making this type of decision in an actual clinic/hospital setting. 
96 Additionally, respondents who answered “no” to a zero bid (during the iterative bidding process) were 
also directed to an open-ended question which asked the respondent to please explain why they chose not to 
have the procedure even when it was offered for free.  
97 27 out of 295 respondents (9.2%) refused the question asking about the amount they currently have in 
savings. 
98 After completing the extensive willingness to pay section of the survey, it would be natural for 
respondents to want to stop taking the survey.  Therefore, in order to prevent respondents from abandoning 
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5.6.5 Demographic Questions/ End of the Survey 
The final section of the survey consisted of demographic questions.  Since 
Knowledge Networks already had a great deal of demographic information on each of its 
panel members (including age, race, marital status, education, etc.) it was not necessary 
to ask those questions again.  Therefore, this section included only four questions related 
to: general health status, life insurance, existence of dependents (such as a child or elderly 
parent) that did not reside at the same address, and level of financial security of the 
respondent’s family if he/she were to die suddenly.    
Survey 1: Screening concluded by thanking the individuals and making them 
aware that the November 22, 2002 issue of U.S. News and World Report describes a 
blood test that some researchers now believe could provide additional information on 
who is at risk for a heart attack.  In Survey 2: Treatment respondents were also thanked 
and reminded that the proposed treatment they were asked about was hypothetical, but 
that clinical research is currently being done such that this type of procedure could 
become available in the near future.    
 
5.7 Addressing Hypothetical Bias 
As discussed in Chapter 2 (Literature Review), one of the main criticisms of 
contingent valuation studies is the occurrence of hypothetical bias.  Therefore, because 
the goods being valued in Survey 1: Screening and Survey 2: Treatment do not represent 
actual purchase decisions, several methods were employed in the survey to help prevent 
the possibility of hypothetical bias from occurring.  
The first method was the use of an abbreviated “cheap talk” script modeled after 
the one used by Cummings and Taylor (1999).  Focus group participants reported that 
they understood the concept of hypothetical bias from the information provided in the 
survey.  In addition, specific comments made by focus group participants while 
discussing how each individual had arrived at their WTP revealed that several 
                                                                                                                                                 
the survey so close to the end, the following verbal cue (consistent with Dillman’s advice) was given to 
indicate that the survey was near the end: “To complete this survey, please answer a few questions about 
your background…”   
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participants had taken hypothetical bias into account either directly or indirectly when 
determining their maximum WTP for the screening/procedure.   
 A second means of preventing the existence of hypothetical bias was to remind 
respondents of their budget constraint.  This was achieved in Survey 1: Screening by 
asking respondents how much they spend on medical care each month.  In addition, 
respondents for Survey 2: Treatment were asked about the amount they had available in 
savings.  After answering these questions, respondents were then asked to consider how 
much they have available to spend and if they would really choose to spend their money 
in this way (a reminder of the tendency for hypothetical bias to enter into the response).  
Individuals participating in the focus groups seemed to take these prompts seriously and 
again, based on their comments during the discussion, took several moments during the 
course of the survey to reflect on their decisions and really evaluate the benefits and costs 
associated with them. 
Another method used to eliminate hypothetical bias included the use of a certainty 
scale.  Following the iterative bidding process and determination of the individual’s 
initial WTP, each respondent was asked to assess their degree of certainty using a scale of 
0 to 10 (with 0 being “not sure at all” and 10 being “definitely sure”) that they would 
really be willing to pay this amount out of pocket.  This type of certainty scale was first 
used by Champ et al. (1997) in comparing hypothetical dichotomous choice questions 
about donations to a public good with actual donations to the public good.  After 
indicating their degree of certainty, respondents were given an opportunity to enter a 
revised amount of what they “would definitely pay” for this test/procedure.   
 In the original survey given to focus group participants, a second certainty 
question was included after the respondent stated their final WTP.  However, this 
certainty question was formatted as a fixed-choice which more closely reflected an actual 
purchase decision.  Respondents were asked “Would you have the screening (procedure) 
if it were offered to you at a price of $_____ {computer would insert respondent’s stated 
WTP amount}?” Answer choices included the following: definitely yes, probably yes, not 
sure, probably no, definitely no.  The motivation for including this question was that 
Blumenschein et al. (forthcoming 2007) conducted a field experiment offering a diabetes 
management program delivered by a pharmacist, and found that individuals who were 
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“definitely sure” of their response in a contingent valuation exhibited no hypothetical bias 
compared to similar individuals who made real purchase decisions about the program 
(For a detailed discussion of the effect these methods had on the data collected for this 
study, see Chapter 6: Data Collection). 
  
5.8 Conclusions 
 This chapter highlights several guidelines that were instrumental in developing 
the two web-based surveys used for this study: Survey 1: Screening and Survey 2: 
Treatment.  In addition, this chapter provides a detailed explanation on how each survey 
question was developed and discusses the motivation for including each question in the 
survey instrument.  By giving careful attention to the recommendations governing web-
survey design, the surveys created for this study served as a valuable and reliable tool in 
the data collection process.  
In addition to providing a set of guidelines for developing a web-based survey and 
explaining the process by which the two surveys used for this study were developed, this 
chapter also offers a practical understanding of the extensive computer resources and 
expertise that is required to program and administer a reliable web-based survey.  As 
Dillman (2000) points out, it is not necessary (or even desirable) to have a programmer 
who creates a survey that utilizes the most cutting edge technology, but rather it is far 
more important that the programmer understand how differences in hardware and 
software capabilities can affect the consistency of viewing, such that the web-based 
survey can be designed with this in mind.  This type of understanding requires expertise 
as well as extensive computer resources in order to adequately test the survey and feel 
confident that visual aspects of viewing the survey will not affect the data collection 
process.  As such, this chapter provides support for the decision to outsource the 
programming and fielding of the survey instruments used for this study.   
Knowledge Networks, the organization chosen to program, test, and administer 
the surveys for this study, specializes in the design and administration of web-based 
surveys.  As such, they clearly demonstrated their extensive knowledge of web-based 
programming and understanding of the principles presented in this chapter throughout the 
programming process.   In addition, outsourcing the fielding of the surveys addressed the 
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remaining issue of coverage bias.  Utilizing their nationally representative panel, 
Knowledge Networks offers a unique (and highly marketable) sampling method designed 
to overcome the coverage bias typically associated with web-based surveys.  Background 
information on Knowledge Networks as well as detailed description of their recruiting 
and survey administration process is included in the following chapter. 
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Chapter VI: Data Collection 
 
 The purpose of this chapter is to describe the data collection process used for this 
study, as well as provide an overview of the type and source of data collected.  In 
addition, this chapter includes a discussion of the study design; sampling methodology; 
the three versions for Survey 1: Screening; pre-testing of the survey instruments; and 
background information on Knowledge Networks, the company that was chosen to 
administer the web-based surveys.  Response rates and the effects of the methods 
incorporated into the surveys to prevent hypothetical bias are also discussed.   
As stated in Chapter 1, the objective of this research is to estimate demand curves 
for (1) a new screening method that would better identify those at risk for a heart attack 
and (2) a new minimally-invasive procedure for the detection and treatment of vulnerable 
plaque.  Willingness to pay (WTP) estimates for each of these “goods” will provide 
insight into the value individuals place on health, specifically the value they place on 
avoiding a heart attack.  In addition, a better understanding of the marginal effects of 
factors that influence demand for these services will allow society to make more efficient 
decisions in the delivery of our scarce health care resources.  
 
6.1 Study Design and Sampling Methodology 
This cross-sectional study utilized two contingent valuation surveys in order to 
better understand the WTP for information on heart attack risk and the WTP to reduce 
that risk.  Survey 1: Screening was given to a national random sample of adults in the 
general population.  These respondents were asked to value a blood test that would 
provide them with additional information on their risk of having a future heart attack.  
Survey 2: Treatment was administered to adults with previously diagnosed heart 
problems.  These respondents, who are more familiar with heart related issues, were 
asked to value a procedure that would provide more precise information on their risk of 
heart attack than could be obtained from the screening alone.  In addition, the procedure 
they were being asked to value would also allow for the treatment of vulnerable plaque if 
it was detected, thus reducing their potential risk of a future heart attack.   
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In both Survey 1: Screening and Survey 2: Treatment, the respondent’s WTP was 
elicited through an online survey utilizing an iterative bidding process.  The iterative 
bidding process, which allowed subsequent bids to be based on past responses, was 
similar to that generated by an interactive computer program used by Viscusi, Magat, and 
Huber (1991).  In the Viscusi, Magat, and Huber study, they obtained a nationally 
representative sample by recruiting volunteers in a mall whose visitors were known to 
have demographics that closely reflected those of the U.S. population.  Like their study, 
one of the goals of this study was to also achieve a nationally representative sample, but 
through the use on an online survey.  Online surveys, however, have the inherent problem 
of being prone to bias due to the uneven access of computers and the Internet across 
socioeconomic groups.  Therefore, to overcome the potential for coverage bias and 
achieve a nationally representative sample, Knowledge Networks was selected to 
administer the online surveys. 
   
6.2 Knowledge Networks 
6.2.1  Background on Knowledge Networks and its Founders 
Knowledge Networks (KN) was founded as a private company in 1998 by two 
Stanford University professors and has established itself as a reputable and reliable 
resource for researchers conducting online surveys.  Knowledge Networks and the 
company’s co-founders, Norman Nie and Douglas Rivers, have received recognition 
from national organizations, including the American Association of Public Opinion 
Research (AAPOR) who awarded them the 2001 Innovators Award for “their 
development of a probability sampling method for Internet based surveys in the United 
States” (McPhee 2001).  In addition, the founders of Knowledge Networks have each 
served for several years in well respected positions in academia, and prior to establishing 
KN, “had already made significant contributions in the development of quantitative tools 
to facilitate social science research” (McPhee 2001).   
Norman Nie, the current Chairman of Knowledge Networks, received his Ph.D. 
from Stanford University.  Prior to that position, he was a professor of Political Science 
at the University of Chicago and a Senior Study Director at the National Opinion 
Research Center for more than 25 years.  He founded SPSS, which has become 
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prominent among statistical software used in research and business applications.  In 
addition, Nie has served as chairman of SPSS and as Director of the Stanford Institute for 
Quantitative Studies in the Social Sciences.  His co-founder, Douglas Rivers, has equally 
impressive credentials.  Rivers received his Ph.D. from Harvard University and holds the 
position of Professor at Stanford University and Senior Fellow at the Hoover Institute.  
Rivers currently serves as the CEO of Knowledge Networks and is considered “a leading 
authority on the application of statistical methods to social science” (McPhee 2001). 
 
6.2.2. Why Knowledge Networks? 
Knowledge Networks and its founders have established well respected reputations 
in statistically based research methods.  Although this was certainly an important  
consideration, the main determinant in selecting KN to administer the web-based surveys 
was the fact that KN has established a panel of randomly selected households; thereby 
allowing researchers to obtain a national random sample through an online survey.  
Previously, data collected through web based surveys were prone to selection bias, which 
made data collected in this manner subject to credibility issues.  However, Knowledge 
Networks has overcome this potential shortfall by offering Internet access to all of the 
households that participate on its panel. 
 
6.2.3. How is KN’s Panel Selected?   
In creating its panel, Knowledge Networks uses random digit dialing to obtain a 
sample of phone numbers.  Addresses corresponding to those phone numbers are then 
located using a reverse directory, and a letter is mailed to those households.  These letters 
of introduction are followed a few days later by a phone call inviting members of the 
household to participate on the panel.  In return for completing no more than one survey 
per week, panel members receive free Internet access.  If a household does not have a 
computer, KN provides WebTV equipment at no charge.  Therefore, this reduces the 
possibility of selection bias as any U.S. household with a telephone has the potential to be 
invited and to participate in Knowledge Network’s panel. 
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6.2.4 How are KN’s Surveys Administered? 
 Once a household chooses to participate, each panel member receives a password 
protected e-mail account and is asked to respond to no more than one survey per week 
(household members between the ages of 13 and 18 can become members of the panel 
with the written permission of their parents; however, no panel member under the age of 
18 was contacted for this study).  Surveys for which that panel member has been chosen 
will appear in their mailbox.  Participation in the Knowledge Network panel and in any 
individual survey is completely voluntary; therefore, if a panel member chooses not to 
participate in a survey, they will simply receive another one.   
 Prior to viewing a survey, panel members are asked to provide their informed 
consent.  In return for their consent, KN agrees to uphold their previously agreed upon 
policy of privacy and terms of use for the information provided.  This includes protecting 
the panel member’s identity so that it cannot be linked to the information provided in the 
survey.  Since panel members can easily withdraw their participation from any survey or 
from the entire panel at any time, it is of interest as to whether there has been an effect as 
a result of individuals leaving the panel over time.  A study by Josh Clinton examined the 
effects of attrition on the KN panel.  According to his study, he found “no evidence of 
systematic panel attrition among any population subgroup” (McPhee 2001).   His results 
also suggest that individuals who participate on the panel for an extended period of time 
are not systematically different in terms of attitude and behavior from those who have 
just joined the panel (McPhee 2001). 
 
6.2.5 Commitment to Research Involving Human Subjects 
 Knowledge Networks has worked with researchers from leading universities across 
the United States, and is therefore familiar with the standards governing research 
involving human subjects.  In fact, over the years, KN’s has made modifications to their 
materials in response to requests from Internal Review Boards from certain universities.  
This compliance with past IRB requests, along with KN’s desire to maintain their 
reputation and profitability, provided assurance that Knowledge Networks would 
continue to demonstrate a high level of care in regards to protecting the rights of the 
individuals being asked to participate in this survey.  An application for this study was 
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submitted to the University of Kentucky Internal Review Board (IRB), and approval was 
granted in January, 2003.  Upon receiving approval, Knowledge Networks was 
contracted to begin programming the online surveys. 
 
6.3 Survey Instruments – Versions of Survey 1: Screening 
As stated earlier, both web-based surveys utilized an iterative bidding process to 
elicit the respondent’s WTP.99  In Survey 1: Screening, respondents were first given 
warm-up questions, including a heart attack risk assessment quiz published by the 
American Heart Association.  After reflected on these risk factors, respondents were 
asked to indicate their perceived risk of having a heart attack in the next year using a 
visual analog scale that started at 0 (no risk) and went to infinity (100,000 and beyond).  
Two benchmarks were included: 19, a measure of the annual risk of fatality from a car 
accident (19/100,000)100, and 50, which was labeled “high risk”.   
After indicating their initial perceived level of risk, respondents were provided 
with new information on who is at risk for a heart attack, including a description of 
vulnerable plaque and the role it plays in causing heart attacks.  Following the new 
information, respondents were asked to again assess their perceived risk, this time taking 
into account the new information.  Respondents were then told of the new blood test that 
could provide them with additional information regarding their risk of heart attack. 
In order to better understand how treatment effectiveness would affect the WTP 
for screening, there were three (3) versions of Survey 1: Screening.  The majority of the 
respondents who completed Survey 1: Screening received a survey in which the treatment 
effectiveness was either 30% (corresponding to the existing drug therapy) or 85% (the 
effectiveness assigned to the new procedure).  In addition, a small number of respondents 
received a version of the survey in which “no treatment” was available.  The purpose of 
this survey “arm” was to determine how much individuals would pay for the screening if 
it only offered informational value.  Even with no treatment available, the information 
                                                 
99 An advantage of iterative bidding is that more information about a respondent’s WTP is obtained 
compared to other elicitation formats such as dichotomous choice in which only an upper or lower bound 
on WTP is obtained.  The additional information may come at the cost of incentive incompatibility in any 
format that elicits WTP responses beyond the first dichotomous choice question.  For further discussion, 
see Alberini, Kanninen, and Carson (1997), Whitehead (2002), and Watson and Ryan (2007). 
100   From the 2000 Traffic Safety Facts published by the U.S. Department of Transportation and the 
National Highway Traffic Safety Administration. 
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received from the screening could potentially allow individuals to plan their consumption 
and savings activities better. 
The contract with Knowledge Networks included a total of 500 observations to be 
obtained from the two web-based surveys.  Although it is not possible for Knowledge 
Networks to determine in advance the exact number of individuals who will respond to 
each survey, past response rates give them a good indication of the number of individuals 
that need to be invited in order to achieve a specific number of respondents.  Therefore, 
in determining how the 500 observations would be divided between the two surveys, it 
was planned that 270 observations would be obtained from Survey 1: Screening, while 
the remaining 230 would come from Survey 2: Treatment.  An additional 40 observations 
were devoted to Survey 1: Screening in order to create the “no treatment” arm discussed 
above (See Figure 6-1: Planned Sampling Distribution).    
To elicit the WTP for screening, each respondent received an initial dollar amount 
to which they could respond “yes” or “no”.  To avoid starting point bias, the computer 
was programmed to select one of several starting points for each survey.101  Based on the 
respondent’s answers, the computer would provide up to four (4) additional bids.  If the 
bidding process did not sufficiently narrow the WTP value to within a specified margin 
of error ($5 for the screening and $100 for the treatment), respondents were reminded of 
the range they had selected through their bids and then asked to enter “the most you 
would be willing to spend out of pocket for this test.” 
  Survey 2: Treatment followed the same format as Survey 1: Screening with two 
main modifications.  Because the panel members invited to take Survey 2: Treatment 
were limited to individuals with doctor-diagnosed heart problems, it was reasonable to 
assume that these individuals were already familiar with the risk factors associated with 
coronary heart disease.  In fact, 110 individuals in the sample (37%) had already 
experienced a heart attack.  Therefore, the first difference between the surveys is that 
instead of using the risk assessment quiz included in Survey 1: Screening, the warm-up 
                                                 
101 Starting points for each survey were based on the median and range of WTP values obtained from the 
initial focus groups. Starting points for Survey 1: Screening were $10, $40, $50, $60, and $100.  Starting 
points for Survey 2: Treatment were $1,000, $2,000, $5,000, $8,000, $10,000. One of these 5 starting 
points, corresponding to the appropriate survey, was randomly selected by the computer program for each 
respondent.     
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questions for Survey 2: Treatment included questions regarding the impact a heart attack 
could have or has had on the respondent’s ability to work, perform daily functions, and 
on their overall quality of life.  
The second significant difference between the surveys is that in Survey 2: 
Treatment, respondents had the option to choose their preferred treatment method.  
Therefore, prior to eliciting their WTP for the procedure, respondents were given the 
opportunity to select whether the procedure was indeed their preferred method of 
treatment.  After being asked to consider a hypothetical situation in which they were told 
by their regular physician (and another trusted physician) that their initial tests indicated 
they were at high risk for a heart attack, respondents were asked to make a treatment 
choice.  They could either select “Medication only” which is 30% effective or the 
“Procedure and Medication” which was stated as being 85% effective.  Although the 
“Procedure and Medication” option did offer a higher level of effectiveness, the survey 
also stated that it had an additional risk of death equal to 10/100,000.102  Respondents 
who chose “Medication only” as their preferred treatment option were given an open-
ended question asking why they chose not to have the procedure, while those who 
selected the procedure completed the bidding process to determine their maximum WTP.     
  
6.4  Pre-Testing 
 A total of four focus groups were conducted prior to administering the online 
survey.  Two focus groups (one for Survey 1: Screening and one for Survey 2: Treatment) 
were conducted in November 2002 using paper versions of the surveys.  Two additional 
focus groups (one for each survey) were conducted in March 2003 using the online 
surveys programmed by Knowledge Networks.  All of the focus groups were conducted 
following the guiding principles set out in Richard Kruger’s book entitled Focus Groups.    
                                                 
102 Drug therapy does have a risk of death; however, patients who undergo the type of procedure described 
in this survey would have already been diagnosed as being at high risk for a heart attack and therefore 
would most likely already be taking a cholesterol lowering medication.  Since both treatment options 
included drug therapy (and the associated risks), the survey focused only on the marginal increase in risk of 
death associated with the procedure when presenting the treatment options.  The additional 10/100,000 
(1/10,000) risk of death associated with the procedure stems primarily from the risk of death due to 
infection resulting from the minimally invasive procedure and from other complications that could arise 
from the anesthesia used in performing this procedure. 
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Prior to conducting the focus groups, the survey was also given to four individuals 
(2 males and 2 females, ages 48-61) as an initial pre-test in November 2002.  The most 
significant finding from this pre-test was that the “cheap talk” dialog, which closely 
followed the original cheap talk script proposed by Cummings and Taylor (1999), was 
too lengthy for a web-based survey.  All of the pre-test participants indicated that they 
wanted to abandon the survey during this section.  Following a suggestion made by one 
of the participants, this section was significantly reduced in length.  However, due to a 
concern that shortening the cheap talk script would diminish its effectiveness, an optional 
screen that provided more detailed information on hypothetical bias was added to the 
online survey.   
In the final version of each survey, respondents were asked if they understood 
hypothetical bias after reading the shortened explanation.  Those who responded “no” 
were presented with the secondary screen that provided them with additional information 
on hypothetical bias, including an example.  Specific comments made by focus group 
participants, who clearly indicated that they considered hypothetical bias before stated 
their final WTP, confirmed that the abbreviated “cheap talk” script was indeed effective. 
 
6.4.1 Initial Focus Groups: Paper Survey 
Conducting a focus group for both Survey 1: Screening and Survey 2: Treatment 
using the online format was clearly an important step prior to administering these web-
based surveys nationwide.  However, realizing that making significant changes (that 
would require additional computer programming) would be costly, initial focus groups 
for each survey were conducted using a paper version of the surveys.  The purpose of the 
initial focus groups was to ensure the clarity of the survey questions (both in terms of 
intended meaning and interpretation by the respondent) in order to establish the basic 
format of the surveys prior to programming.  Participants for the first two focus groups 
were recruited from a local scrapbooking group and Newcomer’s Club in Hopkinton, 
Massachusetts.  Upon completing the focus group session, which lasted about an hour 
and a half, each participant received a small photo album (valued at about $15) as a thank 
you gift.   
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During the focus group session, participants completed the survey, and then as a 
group were led in a discussion by the facilitator using a series of predetermined 
questions.  Each group was asked about the length of the survey, clarity of the questions, 
and the process by which they arrived at their final WTP.  In these initial focus groups, 
participants were not given bids (as would be done later in the online versions), but rather 
were asked to respond to an open-ended WTP question.  The WTP values obtained in 
these initial focus groups were then used to establish the relevant range of starting bids 
that appeared in the online surveys.  Key statistics from these initial focus groups can be 
found in Appendix B. 
 
6.4.2 Follow-up Focus Groups: Online Survey 
After the programming for the online surveys was completed by KN, a second set 
of focus groups were conducted (one for each survey).  Again, participants included 
individuals in the community of Hopkinton, MA, including a group of seniors with 
doctor-diagnosed heart problems from the local Senior Center.  At the completion of the 
session, each respondent was given a $15 gift certificate to either a local restaurant or 
grocery store as a thank you gift for participating. 
During the focus group sessions, each participant was seated at his/her own 
computer and given an opportunity to complete the online survey.  The group then came 
together around a table to discuss the survey.  For the discussion, each participant was 
given a paper version of the survey so they could refer to specific questions or sections of 
the survey they completed online.  Other than a few minor wording changes, the only 
significant change that resulted from the online focus groups was the deletion of the 
second follow up question which asked how sure the respondent was of his/her final 
stated WTP amount.  It was determined that this question was redundant because a follow 
up certainty question was asked after the end of the iterative bidding.  Therefore the 
second certainty question was deleted from the final versions of the surveys.  
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6.5  Survey Data 
6.5.1 Survey Administration 
Survey 1: Screening was fielded from May 9, 2003 through June 1, 2003 and was 
given to a sample representing the general population.  Knowledge Networks invited 552 
panel members to participate.  Of those, 269 consented.  Respondents for Survey 1: 
Screening took an average103 of 16 minutes to complete the survey, which is consistent 
with the time it took for focus group participants to complete this survey.  Only one 
individual did not complete the survey, resulting in a final sample size of 268 and a 
response rate of nearly 49%.  Table 6-1 compares the sample for Survey 1: Screening to 
the U.S. population in regards to several key demographics, including gender, age, race, 
marital status, education, employment status, and household income.  The sample from 
this study is a bit more middle income and better educated, but overall, it is quite similar 
to the U.S. population.  
The fielding of Survey 2: Treatment also began on May 9, 2003 and lasted for 
approximately two (2) weeks, ending on May 26, 2003.  Because respondents who are 
more familiar with a good tend to provide more reliable estimates (Mitchell and Carson, 
Chapter 8, 1989), potential respondents for Survey 2: Treatment were limited to panel 
members with doctor diagnosed heart problems.  466 panel members were invited, of 
which 295 consented and completed the survey,104 resulting in a response rate of 63%. 
  
 
 
                                                 
103 KN allows respondents to leave the survey and return at a later time to complete the survey.  Data 
obtained from KN includes the “duration”; however, this variable measures the total amount of time that 
elapses starting when the survey is first accessed until is completed; therefore, a few of the duration times 
are extremely high (>10,000 minutes, which represents several days).  90% of the sample completed the 
survey in 35 minutes or less; therefore, the median time of 16 minutes is a better measure of central 
tendency (compared to the mean of 441 minutes – approximately 7 hours and 20 minutes).     
104 The median completion time for Survey 2: Treatment was 28 minutes.  A natural break appears in both 
surveys the duration variable between the 2-3 hour mark, which could suggest that some individuals leave 
the survey to conduct outside research prior to completing the WTP section.  Interestingly, a larger 
percentage of the sample appears to leave Survey 2: Treatment (12.5%) as compared to Survey 1: Screening 
(6.7%).  Focus group discussion indicated that individuals did take additional time to reflect on the decision 
to have the more invasive treatment procedure compared to the blood test for screening.  Unfortunately, no 
information is available regarding the reason panel members leave and return to the survey; therefore, is not 
clear whether respondents left the survey to reflect and/or possibly collect additional information, or if the 
higher rate was simply due to the fact that the Survey 2: Treatment sample was more elderly and therefore 
was more likely to take breaks while completing the survey.    
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6.5.2 Response Rates 
 Both surveys had good response rates; however, during the fielding process there 
was a noticeable difference in how quickly panel members chose to participate in the 
surveys.  In fact, due to a slightly slower rate of response than KN’s average, Survey 1: 
Screening was fielded for an additional week.  Interestingly enough, panel members 
responded very quickly to Survey 2: Treatment, such that during the two week fielding 
period, significantly more observations were obtained than were originally contracted 
(See Figure 6-2: Actual Sampling Distribution).   
 The difference in the response rates between the two surveys can most likely be 
attributed to the consent screen that panel members saw prior to beginning the survey.  In 
addition to requesting consent from the participant, the consent screen also indicated the 
topic of the survey.  Looking at the summary statistics of those who responded to Survey 
1: Screening, it appears that younger individuals in the general population saw the topic 
of heart attacks and felt the survey was not of interest to them, therefore, they did not 
consent to the survey.  Whereas Survey 2: Treatment, which was only offered to those 
with doctor-diagnosed heart problems, appears to have been of very high interest to the 
targeted panel members.  The consent screen for both surveys followed the example 
provided by KN (See Appendix C: Informed Consent Screens); however, in hindsight, it 
may have been better to omit the specific topic of the survey and perhaps include only a 
general statement about health or not include the topic at all.  However, this may have 
simply led to a high non-completion rate if those who were not interested in the topic 
chose to abandon the survey upon discovered the topic.  As is stands, only 1 out of the 
564 respondents (< 0.2%) who gave their consent did not sufficiently complete their 
survey to be included in the sample; thus, yielding a 99.8% completion rate for all the 
respondents who began the surveys. 
 
6.5.3 Hypothetical Bias 
 Hypothetical bias is the tendency of respondents in contingent valuation surveys 
to say “yes” they would be willing to pay a specified amount more often than they would 
actually pay that amount.  Therefore, several methods were integrated into this survey to 
avoid the potential for hypothetical bias.   These include the use of an abbreviated version 
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of the “cheap talk” script initially proposed by Cummins and Taylor (1999), inclusion of 
a series of questions to remind the respondent of their budget constraint, the use of a 
certainty scale in which respondents assess the certainty of their stated bid, and finally, 
the use of a follow-up certainly question utilized during the focus groups. 
Prior to respondents receiving a series of iterative bids, they were first asked to 
consider what this test/procedure would be worth to them.  While respondents reflected 
on how much they would value the good, they were presented with a shortened version of 
Cummings and Taylor’s (1999) “cheap talk” script in which the potential for hypothetical 
bias was discussed.  The motivation behind the “cheap talk” script is the idea that 
informing individuals about the tendency of respondents in contingent valuation surveys 
to say “yes” they would be willing to pay a specified amount more often than they would 
actually pay, will then cause them to take hypothetical bias into account in stating what 
they would do.  Therefore, before asking respondents to make decisions regarding their 
own WTP for the test/procedure, they were first given an abbreviated “cheap talk” script 
followed by a question asking if they understood hypothetical bias.  If they answered 
“no” or indicated “I would like additional information” they were provided with further 
explanation, including an example.   
For Survey 1: Screening, 263 of the 268 respondents (over 98%) indicated that 
they understood hypothetical bias.  The mean WTP for the remaining five observations105 
was $38, far below the sample mean of $94, suggesting that it is highly unlikely that 
these observations artificially inflated the final WTP value obtained in this study.  In 
Survey 2: Treatment, 289 of the 295 respondents (98%) indicated that they understood 
hypothetical bias.  Of those that indicated they did not understand hypothetical bias, four 
stated WTP values ($0, $100, $400, and $2,000) were far below the sample mean of 
$7,821.  The remaining two observations included stated WTP values of $30,000 and 
$80,000.  These two observations are in the top 5% of the values obtained, and therefore 
may suggest the presence of a small degree of hypothetical bias.  Excluding these two 
observations reduces the mean WTP for the procedure to $7,499, a difference of $322 
(4.1%).  Excluding all six observations (all those who indicated they did not understand 
                                                 
105 The stated WTP values for these 5 observations were $0, $0, $10, $40, and $140.  $140 is in the top 25th 
percentile, suggesting a possibility of hypothetical bias.  Excluding this observation from the sample yields 
a WTP value of $93.84 (which is not significantly different from the mean WTP using the entire sample). 
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hypothetical bias), reduces the mean WTP for the procedure to $7,594, a difference of 
$227 (2.9 %) from the mean WTP derived when using the entire sample.        
An additional measure to reduce the presence of hypothetical bias in the data set 
was the inclusion of questions designed to remind respondents of their budget constraint.  
While respondents reflected on what the test/procedure was worth to them, they were 
asked about the amount of money they currently spend out of pocket for medical care.  
They were also asked about the amount of money they currently have available in 
savings.  As expected, some respondents did not choose to answer the savings question, 
however, it served its purpose in reminding respondents of the amount of money they 
currently have available in savings (and perhaps other sources) to spend on this 
test/procedure.  In addition, by taking a few moments to consider their available funds 
and ask how they typically spend their money on medical care, respondents are more 
likely to consider their budget constraint when stating their WTP for the test/procedure. 
Another method used to reduce the occurrence of hypothetical bias was the 
inclusion of a certainty question.  Following the iterative bidding process and 
determination of the respondent’s initial WTP, respondents were asked to assess “how 
certain are you that you would pay this amount” using a scale of 0-10.  A certainty scale 
was first used by Champ et al. (1997) who compared hypothetical dichotomous choice 
questions about donations to a public good with actual donations to the public good. 
After indicating their degree of certainly, respondents were then given an opportunity to 
enter a revised amount of what they “would definitely pay” for the test/procedure.  
Discussion from the focus groups indicated that the use of a certainty question followed 
by a chance to revise their stated WTP amounts appeared to be an effective way of 
eliciting their true WTP.  Interestingly enough, the focus groups showed that respondents 
would sometimes (justifiably) revised their bids upward because evaluating their 
certainly and having time to reflect on their WTP gave them time to consider additional 
sources or available funds.  For example, in the focus group for the treatment, one 
participant increased her maximum WTP from $10,000 to $25,000.  When asked about 
this increase she explained that her life was important and that she would certainly pay as 
much as she would for a car.  Therefore, it would be worth it to her to sell her car, take 
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out a second mortgage, or ask family members for help in order to obtain the funds 
necessary to pay this amount for the procedure. 
The final and closely related method of preventing the admission of hypothetical 
bias into the data was the utilization of a follow-up certainty question in the focus groups.  
In the versions of the survey that were given to the focus group participants, a second 
certainly question was included after the final WTP value was given.  This question 
asked the respondent how certain they were that he/she would pay the stated amount.  
However, this time, instead of a certainty scale, participants were asked how sure they 
were that they would pay this amount by selecting one of the following: definitely yes, 
probably yes, not sure, probably no, definitely no.  This follow up question used in the 
focus group indicated that almost all participants were “definitely sure” of their response 
by the end of the survey.106   In a field experiment that offered a diabetes management 
program delivered by a pharmacist, Blumenschein et al. (forthcoming 2007) found that 
individuals who were “definitely sure” of their responses in contingent valuation were not 
statistically different from individuals who made real purchase decisions about the 
program.  Therefore, based on the responses to this question by the focus group 
participants, it was determined that the combined use of an abbreviated cheap talk script, 
and providing an opportunity for respondents to revise their stated WTP after assessing 
their certainty seemed to provide an effective method for reducing the occurrence of 
hypothetical bias in the data.  In fact, the results of a study by Whitehead and Cherry 
(forthcoming 2007) suggest that these two approaches to mitigating hypothetical bias 
(cheap talk and a certainty follow-up question) are complements rather than substitutes, 
and therefore, should be used together to help eliminate the possibility of hypothetical 
bias.   
      
6.6 Health Data 
In addition to the data collected through the online surveys, detailed health 
information on each respondent was also obtained from KN.  Upon joining the KN panel, 
extensive health data is collected on each individual.  This health data contains several 
variables of interest to this study, including frequency of exercise, amount of stress, body 
                                                 
106 This question was not included in the online survey because it was considered redundant. 
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mass index (BMI), and numerous chronic conditions and diseases, such as high 
cholesterol, hypertension, and diabetes.  Therefore, this health data, together with the 
survey data, provided a rich data set from which to conduct the data analysis presented in 
the following chapter.  
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Table 6-1: Comparison of U.S. Census Data to those who were Invited and Completed 
Survey 1: Screening  
Characteristics
U.S. Census (CPS, 
Feb. 2002)
Invited       
(n=552)
Completed      
(n=268)
Gender Male 48.0% 48.9% 53.4%
Female 52.0% 51.1% 46.6%
Age 18-29 21.7% 21.9% 16.0%
30-44 31.1% 30.8% 28.7%
45-59 25.8% 23.7% 24.6%
60+ 21.4% 23.6% 30.6%
Race/Ethnicity White 72.7% 70.1% 76.9%
Black 11.6% 12.3% 8.2%
Other 4.7% 6.0% 6.0%
Hispanic 11.0% 11.6% 9.0%
Employment Status In labor fource 64.0% 70.0% 64.6%
Not in labor force 36.0% 30.0% 35.5%
Marital Status Married 57.3% 59.8% 60.4%
Not married 42.7% 40.2% 39.6%
Household Income Under $10,000 7.5% 7.8% 7.1%
$10,000 - $24,999 18.5% 17.6% 19.0%
$25,000 - $49,999 29.2% 33.5% 35.8%
$50,000 - $74,999 19.9% 21.2% 20.5%
$75,000 or more 24.9% 19.9% 17.5%
Education Less than HS 16.4% 10.1% 9.0%
High School 32.0% 33.9% 36.6%
Some College 27.4% 30.4% 28.0%
College 24.3% 25.5% 26.4%
Region Northeast 19.1% 17.6% 18.3%
Midwest 22.8% 24.6% 25.7%
South 35.6% 35.3% 32.1%
West 22.6% 22.5% 23.9%
*CPS data are weighted.  K (Census data provided by KN)    
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Chapter VII: Data Analysis and Results 
 
The primary purpose of this chapter is to present the results of the study, including 
the mean value obtained for the willingness to pay (WTP) for (1) a new screening method 
that will better identify those at risk for a heart attack, and (2) the mean WTP for a more 
effective treatment method for those individuals who have been identified as being at 
high risk for a heart attack.  The chapter includes a brief discussion of the data 
preparation and how a single WTP value was defined for each respondent.  Summary 
statistics for the key variables used in the econometric analysis are presented.  In 
addition, the chapter includes models of general health and perceived risk for both data 
sets.  These models are included because WTP is greatly influenced by the respondent’s 
perceived risk of having a heart attack, which in turn, is affected by the individual’s 
general health.  Therefore, these models are reported to gain a better understanding of the 
individual factors affecting these variables and the role they play in influencing WTP.   
To further explore the factors that influence WTP for a new screening method and a 
more effective treatment, a censored regression model and a two-part model (probit with 
OLS) are used to isolate the marginal effects of individual factors on the respondent’s 
WTP.  Overall, the general health and perceived risk models provide evidence supporting 
the reliability of the data set, including the reported mean WTP for screening and 
treatment.  In addition, the results from the WTP regressions offer insights regarding the 
factors that may influence consumer WTP for the screening and treatment of vulnerable 
plaque.  Finally, the chapter concludes by making a connection between the WTP for 
treatment obtained in this study and the value of a statistical life (VSL).     
 
7.1 Data Preparation  
7.1.1 Item Non-response and Internal Consistency Checks 
 For observations in which there was item non-response, the sample mean was 
assigned, and then the models were run with and without those observations to check for 
potential differences in the results.  In addition, some internal consistency checks resulted 
in a few minor adjustments – for example, a few individuals checked that they were both 
“a male over 45” and “a female over 55.”  Using data obtained from Knowledge 
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Networks on the respondent’s actual age and gender allowed for the correction of this 
survey error.  Appendix D includes a detailed accounting of adjustments made to the data 
sets in preparation for analysis, as well as a complete list of the variables available in the 
two data sets used for this study.  
 
7.1.2 Defining WTP 
 As described in Chapter 5, the use of an iterative bidding process with follow-up 
questions elicits a single WTP value from each respondent.  If the bidding process itself 
does not establish an initial WTP amount, respondents are reminded of the range they 
were willing to pay based on the answers given for each bid and are then asked to enter 
the most they “would be willing to spend out of pocket” for the test/procedure.  After the 
initial WTP value is established, respondents are then asked to assess how sure they are 
on a scale of 0-10 (0=not sure and 10=definitely sure) that they would actually spend this 
amount.  Following the certainty question, respondents are reminded of their initial WTP 
and asked to enter the amount they “would definitely pay for this test/procedure.”   
For those who completed the process, a single WTP value was obtained.  
However, a few respondents did not complete the entire process.  In many of these cases, 
the respondent did not answer the final WTP question after indicating that he/she was 
very certain (10) of their earlier stated amount.  Thus, it is reasonable to assume that the 
individual was satisfied with their earlier amount, had expressed that they were definitely 
sure they would spend this amount, and did not feel it was necessary to enter the number 
again.  Therefore, for observations in which the respondent did not complete the final 
WTP question, the initial WTP value was used.  Initial WTP is a good measure of the 
respondent’s actual WTP because it was obtained either by the bidding process narrowing 
the respondent’s WTP down to within the pre-specified margin of error, or it was entered 
directly by the respondent.  The only disadvantage of using this value is that it may have 
a greater tendency to be subject to hypothetical bias because it was determined prior to 
the respondent considering the follow-up certainty question.  However, as stated 
previously, many of the individuals for whom this value was used indicated that they 
were very certain of their initial WTP, therefore, this is considered a very good measure 
of the respondent’s true WTP. 
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There were a few respondents in both surveys for which the respondent did not 
offer an initial WTP or final WTP value.  In these cases, the bidding process did not 
sufficiently narrow the range and the respondent did not complete the follow-up question 
asking for their WTP.  For these few observations, the highest “yes” bid was used as a 
measure of the respondent’s WTP.  Presumably the respondent may be willing to pay 
more than their highest “yes” bid, therefore, this serves as a lower bound.  Although 
using this value may understate the individual’s true preference, it is the best available 
measure because it will not artificially inflate the mean WTP for screening/treatment.   
There was only one observation for which the process described above could not 
be used to obtain the respondent’s WTP.  For one observation in Survey 1: Treatment, the 
respondent only spent a total of 8 minutes on the entire survey (significantly less than the 
average), skipped both the initial and final WTP questions, and all the bidding questions.  
With no available information on which to base the respondent’s WTP, the observation 
was dropped from the sample, resulting in a final sample size of 268 for Survey 1: 
Screening.  This process of defining WTP was also applied to data from the second 
survey (with no necessary exclusions); therefore, the full sample of 295 was utilized for 
analysis of the Survey 2: Treatment data. 
 
7.2 Summary Statistics for Survey 1: Screening Data 
 An overview of several key demographic and health variables for the sample data 
obtained from Survey 1: Screening can be found in Table 7-1.  These summary statistics 
are also included for the Survey 2: Treatment data for easy comparison of the two 
samples.  A complete list of the variables used in analyzing the Survey 1: Screening data 
can be found in Table 7-2.  Table 7-2 also includes descriptors of each of the variables 
and more detailed summary statistics, including minimum/maximum values and 
frequency distributions.  
 
7.2.1 Demographics 
 The sample for Survey 1: Screening includes 268 individuals (age 18 or older) 
from the general population who responded to the survey invitation and offered their 
informed consent.    The sample for the WTP for screening includes slightly more men 
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(53%) than women (47%).  The individuals comprising the sample range from 18 to 83 
years of age, with the mean just under 48 years old.  Over 90% of the sample competed 
high school, with approximately 55% attending at least some college.  Five percent of the 
individuals in the sample earned an associates degree, 17% earned a bachelor’s degree, 
and 9% completed a graduate or professional degree.  Slightly more than three-quarters 
(77%) of the sample is white, 8% is black, 9% is Hispanic, and 6% represent other ethnic 
groups.  Sixty percent of the individuals included in the sample are married, and the 
average household size is 2.6.  Approximately 65% of the sample is in the labor force, 
20% is retired, and 6% is disabled.  Mean household income for this sample is $48,223.  
A fairly large percentage of respondents (85%) indicated that they were heads of their 
household, and a majority of the respondents (83%) in this sample reside in a 
Metropolitan Statistical Area (MSA). 
 
7.2.2. Health Statistics 
   Of the 268 individuals in the general population sample, approximately 12% have 
self-reported heart disease and nearly 5% have experienced a heart attack.  Seventeen 
percent are currently taking or have taken medication in the past to reduce their 
cholesterol.  Mean self-reported health status is 3.4 on a 1-5 scale (1=poor and 
5=excellent).  Body Mass Index (BMI) for this sample ranges from 16 to 62, with a mean 
of 28.3.  The ideal range is 18.5 to 24.9; therefore, using published definitions based on 
BMI, nearly 30% of the sample is overweight, 17% is obese, and over 19% of the sample 
is comprised of individuals considered to be very obese.  Thirty-five percent indicated 
they have elevated cholesterol levels, 32% suffer from high blood pressure, and 8% are 
diabetic.  Thirty-four percent of the individuals in the sample indicate that they live or 
work with people who smoke everyday, and 40% have a family history of heart problems 
or have a member of their immediate family who has experienced a heart attack.  
 
7.3 Summary Statistics for Survey 2: Treatment Data 
 As mentioned above, an overview of several demographic and health variables for 
both data sets is presented in Table 7-1 for easy reference and comparison purposes.  A 
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complete list of the variables, descriptors, and more detailed summary statistics used in 
analyzing the Survey 2: Treatment data can be found in Table 7-3.  
 
7.2.1 Demographics  
 The sample for Survey 2: Treatment includes 295 individuals (age 18 or older) 
with doctor-diagnosed heart problems who responded to the survey invitation and offered 
their informed consent.  The sample for the WTP for treatment is evenly comprised of 
men (50.5%) and women (49.5%).  The sample includes individuals between the ages of 
18 and 91, with a mean of just under 64 years old.107  Since this sample is limited to 
individuals with doctor-diagnosed heart problems, which tends to be more common after 
age 55, it is not surprising that this sample has a much higher mean age compared to the 
general population sample obtained for the screening survey (See Table 7-1 for a 
comparison of the two samples).  Given the considerably older age of the sample, there is 
relatively little difference in the level of education for the two samples.  Over 86% 
graduated from high school, and 47% attended at least some college.  Seven percent 
earned an associates degree, 15% earned a bachelor’s degree, and over 6% completed a 
graduate or professional degree.  In terms of race, nearly 88% of the sample is white, 7% 
is black, 3% is Hispanic, and 2% is representative of other ethnic groups.  Approximately 
two-thirds (66%) of the sample is married, and the average household size is 2.3.  A large 
percentage of the sample (47%) is retired, and 10% are disabled.  Approximately 34% of 
the sample is in the labor force, and the mean income is $43,538.  A fairly large 
percentage of respondents (87%) indicated they were heads of household, and a majority 
of the respondents (87%) in this sample reside in a Metropolitan Statistical Area (MSA). 
 
7.3.2. Health Statistics 
   Of the 295 individuals with doctor-diagnosed heart problems included in this 
sample, 75% report they have heart disease and over 37% have experienced a heart 
                                                 
107 Survey 2: Treatment was only administered to individuals with doctor-diagnosed heart problems.  Since 
heart problems are more common in elderly individuals, this sample included a high percentage of 
individuals over the age of 65.  Therefore, an additional age category (Age 75 and above) was included for 
all the data analysis completed for Survey 2: Treatment to account for any differences in general health, 
perceived risk, or WTP for this age group 
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attack.  Nearly 63% are currently taking or have taken medication in the past to reduce 
their cholesterol.  Mean self-reported health status is 2.8 on a 1-5 scale (1=poor and 
5=excellent).  Body Mass Index (BMI) for this sample ranges from 16 to 77, with a mean 
of 29.2.  As stated above, the ideal range is 18.5 to 24.9; therefore, using published 
definitions based on BMI, nearly 38% of this sample is classified as overweight, 23% is 
obese, and 16% of the sample is comprised of individuals considered to be very obese.  
Approximately 40% of the individuals in the sample suffer from hypertension (high 
blood pressure), 22% are diabetic, and 58% have a family history of heart problems or 
have a member of their immediate family who has experienced a heart attack.  
 
7.4 General Health 
Respondents for both Survey 1: Screening and Survey 2: Treatment were asked to 
report their health status using a five category scale (1=poor health, and 5=excellent 
health).  Self-reported general health was found to play a significant role in perceived 
risk, which in turn, helped explain the WTP for screening.  Therefore, to better 
understand general health, a standard OLS (Ordinary Least Squares) regression was run 
on self-reported health status.  Following Grossman’s model of health production, the 
independent variables include age, education, significant decreases to the health stock (as 
measured by the respondent reporting having had a life threatening condition or illness), 
and several lifestyle variables, including amount of stress, frequency of exercise, and 
amount the individual exceeds his/her ideal body mass index (BMI).  The effects of 
household income and frequent visits to the doctor’s office have on health status are also 
explored.   
 
7.4.1 General Health Model for Survey 1: Screening 
In the general health model using data from Survey 1: Screening (See Table 7-4, 
Column 1), age is negative and significant, as expected, with coefficients becoming 
increasingly negative for each age category.  All of the coefficients on education are 
positive, with the coefficient on bachelor’s degree significant at the 5% level.  The 
positive effect of education on health is consistent with Grossman’s prediction that more 
educated individuals will tend to have higher levels of health, all else constant.  The 
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regression results also support the fact that individuals who have experienced a life 
threatening condition or illness have a significantly lower general health ceteris paribus, 
indicating a reduction in the health stock for these individuals.  In addition, individuals 
who report being under higher levels of stress or who are above their ideal body weight 
(as measured by the amount the individual exceeds his/her ideal BMI) also have a 
statistically (at the 1% level) lower self-reported general health status.  Finally, increased 
frequency of exercise, which represents an investment in health according to Grossman’s 
model, is highly significant and has the expected positive effect on the individual’s 
general health.   
Other specifications of the general health model include the addition of two 
variables, frequency of visits to a doctor and household income, which were included to 
measure investments in (or access to) health care (See Table 7-4, Columns 2, 3, and 4).  
Although it was anticipated that going to the doctor would improve health, the highly 
significant negative coefficient on frequency of doctor visits did not demonstrate that 
these “investments” in health were having a positive impact on the individual’s health 
status.  Instead, it appears that this variable is standing in for the effect of “chronic” 
conditions – that is, those that require a significant amount of care, yet treatment creates 
little improvement in overall health.108   This hypothesis is further supported by the fact 
that inclusion of frequency of doctor visits in the model (Table 7-4, Column 2) reduces 
the coefficients on the age variables, particularly for those who are 65 and over.   
 Including household income as an independent variable (See Table 7-4, Column 
3) yields a positive coefficient that is significant at the 1% level.  Including household 
income does increase the explanatory power of the model; however, not surprisingly, it 
reduces the coefficients of the education variables and makes them statistically 
insignificant.   
 It was thought that differences in attitudes toward health and the individual’s 
willingness to make investments in health may be reflected in their degree of being 
overweight.  Therefore, instead of using a continuous variable that captures the amount 
an individual is over their ideal BMI, many of the models analyzing data from Survey 1: 
                                                 
108 A simple regression conducted with frequency of doctor visits as the dependent variable and chronic 
back pain, arthritis, asthma, and diabetes as the independent variables strongly supports the hypothesis that 
frequency of doctor visits is capturing the effect of chronic conditions in the general health equation. 
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Screening include dummy variables for the following weight categories: overweight, 
obese, and very obese.109  Individuals are assigned to each category using their individual 
BMI and standardized ranges for each weight category that are defined as: overweight 
(24.9 < BMI < 30); obese (30 ≤ BMI < 35); and very obese (BMI ≥ 35) (Partnership 
2007).  Inclusion of these weight categories in the general health regression (See Table 7-
5) yields very similar results to those just discussed when amount over ideal BMI is used 
as the weight variable (Table 7-4).  When the weight dummies are used in place of 
amount over BMI, the coefficients on the other covariates remain essentially unchanged; 
however, the marginal effects on overweight, obese, and very obese do suggest that the 
relationship between increased weight and general health is not necessarily linear (See 
Table 7-5).  As expected, the coefficients on overweight, obese, and very obese are all 
negative; however, the t-values indicate that those individuals who are classified as 
overweight have no statistically significant difference in their self-reported general health 
status from those who are not overweight; while individuals who are classified as “obese” 
and “very obese” have statistically significant lower general health.  In addition, the 
coefficient on very obese is larger in magnitude than the coefficient on obese.  Therefore, 
the farther the individual is above their ideal weight, the larger the decrease that can be 
expected in that individual’s general health.  
 
7.4.2 General Health Model for Survey 2: Treatment  
Comparable regressions performed on data for Survey 2: Treatment indicate very 
similar results (See Table 7-6).  The coefficients on age become increasingly negative 
with higher age categories, with age having a statistically significant decrease on general 
health for those individuals who are 55 years of age or older.  In general, education has a 
positive effect on health status, with statistical significance for individuals who hold 
some type of college degree.  This finding is consistent with the efficiency of health 
production Grossman predicted for individuals with higher levels of education.  As 
before, an individual who has experienced a life threatening condition reports a lower 
level of general health ceteris paribus.  Higher levels of stress and being overweight 
lower the individual’s general health by a statistically significant amount, while increased 
                                                 
109 The excluded category is those individuals who are at (or slightly below) their ideal (normal) BMI. 
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time spent exercising has a statistically significant positive effect on general health.  
Again, those who visit the doctor more often (See Table 7-6, Column 3), tend to have 
lower general health, suggesting that, as discussed previously, this variable is acting as a 
proxy for chronic conditions.  In addition, the fact that inclusion of this variable in the 
model decreases the coefficients on the age variables (particularly for individuals 75 and 
over) offers further evidence to support that this variable is capturing the effect of chronic 
illnesses on health.  And finally, as observed in the data from Survey 1: Screening, 
income has a statistically positive effect on the individual’s self-report general health.  
Overall, factors explaining the variation of general health status for both samples are 
consistent with economic theory and provide confidence as to the reliability of the data 
sets.   
 
7.5 Perceived Risk   
As discussed in Chapter 5, respondents for both Survey 1: Screening and Survey 
2: Treatment were asked to enter the number that best represented their perceived risk of 
having a heart attack in the next year using a computerized version of a visual analog 
scale.  The visual analog scale went from 0 (labeled no risk) to 100,000 and included two 
anchors – 19, which corresponds to the annual fatality rate from a car accident 
(19/100,000), and 50 (which was labeled “high risk”).  Respondents were asked to assess 
their perceived risk twice  – once prior to receiving new information on vulnerable plaque 
as a cause of heart attack (Initial Perceived Risk) and once immediately after receiving 
the new information (Perceived Risk after New Information).   
For the general population sample completing Survey 1: Screening, mean 
perceived risk was 15.07 prior to the new information and 17.92 following the new 
information.  Since the visual analog scale indicated that risk was per 100,000 
individuals, these values indicate an average increase in perceived risk of about 
3/100,000 due to the new information.  For the Survey 2: Treatment sample, mean 
perceived risk is significantly higher (which is expected given the health history of these 
individuals), with a mean Initial Perceived Risk of 26.56, mean Perceived Risk after New 
Information of 30.22, and Change in Perceived Risk equal to 3.65.   
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Although the actual clinical risk associated with experiencing a heart attack is 
specific to the individual (and can depend on several factors), one of the primary 
determinants of heart attack risk is age.  Table 5-2 includes the annual risk of fatality 
from an acute myocardial infarction (heart attack) for twelve different age groups.  As 
Table 5-2 clearly indicates, the risk of fatality from heart attack increases substantially for 
those individuals 55 years of age and above.  The mean age-adjusted fatality rate for the 
population is reported as 42 / 100,000.  According to the American Heart Association, 
approximately 47% of heart attacks are fatal; therefore, this value implies that the mean 
annual probability of experiencing a heart attack is 89 / 100,000.  This value is higher 
than the annual perceived risk indicated by the individuals completing the survey; 
therefore, it appears that both individuals in the general population and those with doctor-
diagnosed heart problems tended to underestimate the probability of experiencing a heart 
attack.110  To gain a better understanding of the factors influencing perceived risk, an 
OLS regression was estimated using both measures of perceived risk (before and after the 
new information) as the dependent variable.  The perceived risk models include various 
risk factors for heart attack, while controlling for level of education, cholesterol 
medication (which would tend to lower the individual’s perceived risk), and, in some 
specifications, the individual’s general health.  These models account for approximately 
30% of the variation in Initial Perceived Risk and 25% of the variation in Perceived Risk 
after the New Information. 
 
7.5.1 Initial Perceived Risk with Risk Factors from AHA Quiz 
As part of the warm-up section in Survey 1: Screening, respondents were asked to 
complete a risk assessment quiz published by the American Heart Association (AHA).  
As discussed in Chapter 5, the quiz contains 11 risk factors that are traditionally used by 
physicians to assess a patient’s risk of having a heart attack.  The eleven risk factors 
(labeled r1 through r11) are all dummy variables, with 1 representing a “yes” response 
and 0 otherwise.  Regressions including these risk factors are presented in Table 7-7 
                                                 
110 For Survey 1:Screening, maximum values for Initial Perceived Risk and Perceived Risk after New 
Information were 80 and 100 respectively.  For Survey 2:Treatment, values were similar with a maximum 
value of 85 for Initial Perceived Risk and maximum value of 100 for Perceived Risk after New Information. 
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(using Initial Perceived Risk as the dependent variable) and Table 7-8 (using Perceived 
Risk after the New Information as the dependent variable).    
The first regression in Table 7-7 (See Column 1) includes the set of eleven AHA 
risk factors, and controls for cholesterol lowering medication, and education.  With Initial 
Perceived Risk as the dependent variable several of the AHA risk factors are highly 
significant, including (1) being a male over the age of 45, (2) being a female over the age 
of 55, (3) having high cholesterol, (4) being 20 pounds or more overweight, and (5) 
having coronary heart disease or having had a prior heart attack.  All of the other risk 
factors (with the exception of low HDL111) have the expected positive sign.  Taking 
medication to lower cholesterol lowers the individual’s probability of having a heart 
attack, therefore, the negative coefficient on medication is expected; however, it is not 
statistically significant.  Education was highly significant and negative at all levels, with 
coefficients larger in magnitude for college degrees, suggesting that those with more 
education have lower levels of perceived risk.   
Because some of the risk factors include more than one variable (i.e. male over 
the age of 45), another regression was performed on Initial Perceived Risk separating out 
these variables (See Table 7-7, Column 3).  Specifically, risk factors r1 (male over age 
45), r2 (female over age 55), and r11 (heart disease or heart attack) were replaced with 
variables for gender, age, and independent variables for heart disease and heart attack.  In 
separating out these risk factors, there are two things that become of interest.   
First, the two risk factors that include gender and age are highly significant (at the 
1% level) in the first specification; however, by separated these out, it appears that age is 
the driving factor.  The coefficient on male is positive, however, it is not statistically 
significant.  In contrast, the age categories are positive and significant above 45 years of 
age.  In fact, the “55 to 64” and “65 and above” age groups are consistently significant (at 
the 1% level and 5% level respectively) across all specifications (See Tables 7-7, 7-8, and 
7-9).  The second finding of interest results from separating out heart disease and heart 
attack in the last risk factor (r11).  Independently both variables are still significant; but in 
                                                 
111 Many respondents answered “I don’t know” for this risk factor.  This is not unexpected since this is the 
risk factor with which respondents would be the least familiar, therefore, making it the most difficult to 
recall while taking the survey.   “I don’t know” responses were coded as “no”; therefore, this is most likely 
causing the negative sign on this variable. 
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separating out these factors, the coefficient on heart attack is much larger than that of 
heart disease (See Table 7-7, Column 3).  This is not unexpected since those who have 
experienced a heart attack are at higher risk of having another attack.  Therefore, the 
larger coefficient on heart attack provides validity to the model, indicating that those who 
have experienced a heart attack in the past have a higher perceived risk compared to 
those individuals who have simply been diagnosed with heart disease.    
To explore whether those who have suffered an injury or illness in the past may 
feel more at risk for a heart attack, general health was included as a possible explanatory 
variable in the perceived risk model (See Table 7-7, Columns 2 and 4).  The coefficient 
on general health is negative and highly significant, indicating that those individuals with 
lower self-reported general health status will tend to have higher levels of perceived risk.  
As expected, including general health in the regression does affect the coefficients of 
some of the covariates, such as diabetes; therefore, the two specifications discussed above 
are presented both with and without general health included in the model.     
 
7.5.2 Perceived Risk after New Information with Risk Factors from AHA Quiz 
Table 7-8 includes the same regressions reported in Table 7-7, but uses Perceived 
Risk after the New Information as the dependent variable (instead of Initial Perceived 
Risk).  As described in Chapter 5, the new information presented to the respondent 
includes a description of vulnerable plaque and explains that individuals with no 
symptoms of heart disease can still be at risk of a potentially fatal heart attack.  Like the 
previous specifications, age is positive and significant for higher age categories (See 
Table 7-8, Column 3).  As expected, having high cholesterol increases perceived risk and 
is significant at the 5% level with a small decrease in the marginal effect from the Initial 
Perceived Risk model.  Smoking becomes significant at the 10% level and the coefficient 
on r9 (20 pounds or more overweight) becomes considerably larger.  Heart disease is no 
longer significant, although having experienced a heart attack is still positive and 
significant at the 5% level.  When general health is added to the model, it is still negative 
and highly significant across specifications (See Table 7-8, Columns 2 and 4).  The 
education variables are also still negative, although many lose some degree of 
significance in the various specifications.   
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In general, using the individual’s self-reported perceived risk obtained after the 
new information was presented results in a lower R-squared with less explanatory power 
compared to the same specifications using perceived risk prior to the new information.  
Given that the new information essentially states that traditional risk factors for heart 
attack are no longer thought to be good predictors of who is at risk for a heart attack, the 
loss of explanatory power provides evidence to suggest that respondents understood the 
new information and adjusted their perceived risk accordingly.  After the new 
information, it appears that in stating their perceived risk, respondents tended to place 
more emphasis on whether they live/worked in a smoking environment and on whether 
they were overweight, two factors that are commonly known to be associated with heart 
disease.  In general, it appears that the new information was effective in dislodging (at 
least to some extent) beliefs regarding the reliability of traditional risk factors in 
predicting heart attack risk.  This is evident by the lowered predictive ability of the 
models presented in Table 7-8 (compared to Table 7-7) and the larger amount of “noise” 
that entered respondent’s perceived risk assessment after the new information was 
presented; whereas their initial perceived risk relied more heavily on the traditional risk 
factors (r1 – r11) presented in the risk assessment quiz. 
  
7.5.3 Perceived Risk – General Risk Factors – Survey 1: Screening Data 
Substituting in for various factors in the risk assessment quiz was clearly useful in 
identifying that age, rather than gender, was the driving force behind risk factors r1 (male 
over 45) and r2 (female over 55) being significant.  Therefore, other substitutions are 
made and reported in Table 7-9.  Risk factor r9 “are you 20 pounds or more overweight” 
is fairly ambiguous, and as the general health model indicates, differences may exist 
depending on the degree to which the individual is above their ideal BMI.  Therefore, the 
variables overweight, obese, and very obese (as defined earlier) are substituted for r9.  
Risk factor r3 asks respondents whether their father or brother had a heart attack before 
age 55 or their mother of sister had a heart attack before age 65.  An additional survey 
question asks if the respondent has a relative in their immediate family (regardless of age) 
who has experienced a heart attack.  Therefore, a more broadly defined dummy variable 
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for Family History of a Heart Attack is included that is equal to 1 if the individual 
responded “yes” to either of these questions.   
The health panel data obtained from Knowledge Networks contains detailed 
information on respondents’ health behavior and medical history.  Therefore, this 
information was also incorporated into the model.  Instead of using risk factor r8, which 
asks the respondent if they typically get less than 30 minutes of physical activity per day, 
a variable for exercise that captures the frequency with which the individual exercises on 
a weekly basis was included.  In addition, medical information on diabetes and 
hypertension were available, such that these two variables were broaden to include any 
individuals who had a past medical history of these two conditions.  Several individuals 
were unsure of their HDL, and as a result this was coded as a “no” – and most likely 
accounts for the negative sign for r6 in the regressions presented in Table 7-7.  Since 
those with High Cholesterol often have a low HDL, risk factors r5 and r6 were combined 
into a single variable to indicate that the respondent has a medical problem related to 
cholesterol – either their total cholesterol is too high or their good cholesterol (HDL) is 
too low – both of which place the individual at higher risk for a heart attack.  Finally, race 
is added as a control variable.   
Although race was not included in the AHA risk assessment quiz, the AHA 
website includes race as a major risk factor for coronary heart disease (a contributing 
factor for heart attack); therefore, it was added to the regression.  Interestingly enough, 
many people typically think of “white males” as being at high risk of a heart attack, 
thereby suggesting that whites may be at higher risk.  However, according to the AHA, 
African Americans tend to have higher blood pressure than whites, and therefore, are at 
higher risk of heart disease.  In addition, Mexican Americans, American Indians, native 
Hawaiians, and some Asian Americans are also at higher risk of heart disease, partly as a 
result of higher rates of obesity and diabetes in these groups (American Heart Association 
2006).  Therefore, based on this information, whites would be expected to have a lower 
risk of heart attack compared to non-whites, all else constant.   
The model including the substitutions described above is presented in Table 7-9, 
Columns 1 and 2.  Initial Perceived Risk is used as the dependent variable in Column 1, 
whereas the dependent variable in Column 2 is Perceived Risk after the New Information.  
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A comparison of the Initial Perceived Risk model (See Table 7-9, Column 1) to the 
regression presented in Column 3 of Table 7-7 reveals very similar results.  Age 
categories 45 and above are still significant, with very little change in the marginal 
effects.  Being overweight is still negative and significant; however, as expected, the 
coefficients in the new model increase with each higher overweight category.  Heart 
disease and heart attack are still significant and positive, with only a small decrease in the 
coefficient on heart disease, which falls from 7.6 to 6.6.  Since obesity is likely to 
increase heart disease, this decrease is most likely due to the inclusion of the weight 
dummies.  In the new specification having a cholesterol problem is not significant; 
however, it is significant at the 10% level in the Perceived Risk after the New Information 
specification.  The education control variables are also still negative and significant with 
very little change in the marginal effects.  
Although the overall R-squared does not really change between the two 
specifications, it is thought that the models presented in Table 7-9 Columns 1 and 2 
(Compared to Table 7-7, Columns 3 and 4) include variables comprising better 
information, and therefore are likely to provide more precise estimates of the marginal 
effects.  In addition, this set of risk variables is included in the extended version of the 
WTP equations discussed later in this chapter; therefore, it is helpful to see their effect on 
perceived risk for comparison purposes.   
Since the individual’s self-reported general health is highly significant in the 
perceived risk equations (See Table 7-7 Columns 2 and 4); the two remaining factors112 
that were significant in the general health model - having experienced a life threatening 
condition and level of stress - are substituted in for general health (See Table 7-9, 
Columns 3 and 4).  Neither variable is significant in the model explaining Initial 
Perceived Risk; however, having experienced a life threatening condition or illness is 
significant at the 10% level when explaining Perceived Risk after the New Information 
(Table 7-9, Column 4) therefore, it is possible that this variable may play a role in 
explaining the WTP for screening.   
 
                                                 
112 Age, Education, Exercise, and Amount Overweight were also significant, but are already included in the 
model.  
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7.5.4 Perceived Risk – General Risk Factors – Survey 2: Treatment Data 
 The Survey 2: Treatment data also includes two measures of perceived risk – one 
before and one after receiving new information on who is at risk for a heart attack (See 
Table 7-10).  This model uses several of the same risk factors included in the perceived 
risk equations for analyzing the Survey 1: Screening data.  However, since respondents 
completing Survey 2: Treatment were not asked to complete a risk assessment quiz (they 
already know they are at high risk for a heart attack), there are a few variables, such as 
information about living/working in a smoking environment, that were not available.  
Health variables including high cholesterol, hypertension, exercise, BMI, and diabetes, 
were obtained from the health data provided by Knowledge Networks as discussed in 
Chapter 6.  The remaining health variables – family history of heart attack, heart attack, 
and expected/actual decrease in the quality of life following a heart attack – were 
collected as part of the survey.   
The regression results (See Table 7-10) indicate that perceived risk is higher (and 
significant) for the 55 to 65 age group across all specifications. This is not surprising 
given that physicians typically start treating heart disease more aggressively after age 55.  
In addition, having high cholesterol or having experienced a heart attack results in a 
statistically significant increase in an individual’s perceived risk.  Because the 
consequences of a heart attack can vary from virtually no effect to a severe permanent 
disability, a variable was included to capture the “severity” of the heart attack as 
measured by the reduction in quality of life that resulted from (or is expected to result 
from) a heart attack.  This variable was highly significant (at the 1% level) and positive 
across all specifications indicating that the  more severe the heart attack was (or was 
expected to be), the higher the perceived level of risk.  Like the perceived risk equations 
for the Survey 1: Screening data, general health is negative and significant at the 1% 
level.  The education variables are also negative and significant for individuals with a 
Bachelor’s or graduate degree.  This may be due, at least  in part, to those with higher 
levels of education having a better understanding of the visual analog scale; and 
therefore, stating smaller and more “precise” measures of risk.  Finally, including 
whether the individual has had a life threatening condition or illness in the past also 
significantly increases perceived risk (See Table 7-10 Columns 3 and 4), as well as 
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increases the explanatory power of the model.  Overall, the models presented in Table 7-
10 explain approximately 30% of the variation in perceived risk for the Survey 2: 
Treatment data. 
Interestingly, taking cholesterol lowering medication does not significantly reduce 
perceived risk in any of the specifications, for either the Survey 1: Screening data or the 
Survey 2: Treatment data.  Currently, statin (cholesterol lowering) medications are only 
about 30% effective and take a long time to work; therefore, the findings from the 
perceived risk models suggest that individuals recognize the shortcoming of the drug 
therapy treatment currently available, and lends support to the need for a new, more 
effective treatment method.    
 
7.6 Willingness to Pay 
The goals of this study were to (1) determine the WTP for a screening method 
that would better identify individuals in the general population who are at risk for heart 
attack, and (2) determine the WTP for a new treatment method that is more effective than 
the currently available standard of care.  One of the distinct advantages of using a 
multiple-bounded dichotomous choice question in comparison to a single-bounded 
dichotomous choice question is that significantly more information is obtained from each 
respondent.  In fact, in this study, using an iterative bidding process with follow-up open-
ended question elicited an exact WTP value from each respondent.  Therefore, the mean 
WTP obtained in this study did not rely on econometric techniques, but rather was simply 
the mean of the reported WTP values from each respondent. 
 
7.6.1 Mean WTP for Screening and Treatment  
The distribution of the maximum WTP amounts for screening is illustrated in 
Figure 7-1.  The mean WTP for screening is $94 with a median of $50, and standard 
deviation of $143.  This distribution includes 16 individuals who chose not to have the 
screening and were assigned a WTP=0.  In addition, some individuals indicated during 
the bidding process that they would have the test, but only if it were offered for free, and 
therefore also had a WTP=0.  However, most of the respondents indicated that the test is 
valuable to them and provided a positive WTP for the screening that ranged from $1 up 
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to $1,000.  These WTP values include positive amounts for some individuals who were 
told that no treatment existed, which provides evidence that individuals place a value on 
the information provided by the screening even when no treatment is available; thereby 
suggesting that having this information increases the individual’s utility because it allows 
for better planning and allocation of the individual’s time. 
The distribution of the maximum WTP amounts for treatment is illustrated in 
Figure 7-2.  The mean WTP for treatment is $7,821 with a median of $2,500 and standard 
deviation of $21,084.  This distribution includes 43 individuals who chose not to have the 
procedure.  Of those, 36 individuals chose medication as their treatment option, while 7 
individuals did not select either treatment.  Since none of these respondents were willing 
to have the procedure, they were all assigned a WTP=0.113  In addition, there were others 
who chose the procedure, but during the bidding process indicated that they would only 
be willing to pay $0 for it.  Therefore, these respondents also have a WTP=0.  However, 
many of the respondents reported positive values of WTP, ranging from $1 up to 
$300,000114, indicating that a new, more effective treatment would be of value to them.   
 
7.6.2 General Models for Analyzing Health Data  
 In addition to the mean WTP, it is also of interest to determine which factors 
influence WTP.  Understanding the factors that affect WTP can provide insight into 
which individuals have the highest demand (and benefit) for the screening/ treatment.  
Since the medical expenditures of many of these individuals are covered by Medicare, 
understanding the specific factors that drive demand could potentially assist policy 
makers in making determinations as to who should receive the treatment and who should 
not.  Typically this could be accomplished by simply regressing a set of explanatory 
variables on WTP.  However, health data often present difficulties in econometric 
analysis because the data is often characterized by (1) an outcome variable (in this case 
WTP) which is non-negative, (2) a substantial number of zeros, and (3) a positively 
skewed distribution for the non-zero observations (Manning et al. 2001).  Therefore, 
analyzing the data creates challenges in order to obtain estimates of the marginal effects 
                                                 
113 Before exiting the survey, all of the respondents who did not select the procedure were asked an open-
ended question asking them to explain why they did not want the procedure even if it were offered for free. 
114 The potential for outliers is addressed later in this chapter in the WTP models. 
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for the covariates that are both unbiased and precise, which is warranted for policy 
decisions.   
 For the Survey 1: Screening sample, a total of 31 (12%) of the 268 observations 
indicated a WTP=0.  Fifteen of these individuals indicated they would have the screening 
if it were offered at no out-of-pocket cost to them, however, the remaining 16 indicated 
that they would not have the screening even if it were offered for free.  These individuals 
were identified by their response to a zero bid.  Those that answered “yes” to a zero bid 
continued with the survey, while those who answered “no” to a zero bid were directed to 
an open-ended question asking why the respondent chose not to have the screening even 
when it was offered for $0 (free).  Almost half of the respondents who said they would 
not have the screening had received a version of the survey in which “no treatment” was 
available.  In fact, almost all of the respondents who chose not to have the screening and 
had a “no treatment” version of the survey, indicated in their response that having no 
treatment available was their reason for choosing to forego the screening.  Other 
respondents whose surveys included a treatment option indicated that they would prefer 
not to know so they did not worry.  Some indicated a distrust of doctors and/or medicine 
that would prevent them from having the treatment if the test came back positive, and one 
indicated that he/she had had two heart attacks already, implying that the screening would 
have little additional benefit (See Table 7-11 for all open-ended responses to Survey 1: 
Screening).        
 For the Survey 2: Treatment sample, a total of 62 (21%) of the 295 observations 
indicated a WTP=0.  Nineteen of these individuals indicated they would have the 
screening if it were offered at no out-of-pocket cost to them, however, the remaining 43 
indicated that they would not have the screening even if it were offered for free.  Thirty-
six of those individuals chose drug therapy as their treatment and 7 individuals “refused” 
treatment (by not selecting either treatment option).  During the survey, respondents were 
presented with the possible treatment options and then asked to select the treatment they 
would prefer.115  Respondents who chose the procedure continued with the iterative 
                                                 
115 This was prior to the iterative bidding, therefore, it is assumed that respondents were selecting their 
preferred treatment option based solely on the treatment without regard to the potential cost.  Comments 
from focus group participants indicate that at this point in the survey, respondents assumed that the cost of 
the  treatment selected would be covered by insurance.  
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bidding portion of the survey; however, as mentioned above, 19 of those respondents 
indicated a WTP=0.  Those respondents who selected drug therapy or refused treatment 
were directed to an open-ended question asking them why they chose not to have the 
procedure.  Several of the respondents indicated that they were already taking a 
cholesterol medication or that they had other medical conditions that made the procedure 
unsuitable for them.  Some respondents stated that they were concerned about the risk 
associated with the procedure, had a fear of surgery, felt they were too old, or would 
simply like more time to consult with their own doctor (who they trusted) or other outside 
resources (Internet) before making a decision. (See Table 7-12 for all open-ended 
responses to Survey 2: Treatment).        
One approach for handling the relatively large number of zeros observed in these 
data sets is to model WTP using a tobit116 equation.  The tobit model is also referred to as 
the censored regression model because it is based on the premise that some of the 
observations are censored, or unobserved.  When the dependent variable is censored, 
values in a certain range are all transformed or reported as a single value.  A classic 
example of this from labor economics is the number of hours worked by women.  A large 
percentage of married women choose not to work, therefore, their hours are simply 
recorded as a zero.  Another example discussed by Greene (1993) is the demand for 
tickets to an event held at an arena.  The capacity of the arena is limited, therefore, when 
a sellout occurs, demand for tickets above the seating capacity is unobserved, which 
results in a truncated distribution.   
A similar argument could be made for the data in these samples.  It is possible 
that some people would experience disutility from having the screening/treatment.  As 
the open-ended responses suggest, this may stem from any number of reasons, including 
the risk associated with the procedure, a distrust of physicians/medicine, or the anxiety 
caused by the knowledge that you are at risk for a potentially fatal condition for which 
treatment does not exist.  In cases such as these, it is not unreasonable to assume that 
some individuals may require payment in order to compensate them for their loss of 
utility in order to induce them to accept the screening/treatment.  However, since the 
potentially negative WTP for these individuals is unknown, their actual WTP is censored 
                                                 
116 Named in reference to Tobin (1958) who first proposed the model (Greene 1993). 
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and simply recorded as a zero.  Interestingly, those who choose to have the test/procedure 
when it is offered for free actually have a WTP=0, so these observations are not truly 
censored.  Therefore, these observations are distinguished from each other such that only 
those not having the test are treated as censored data in much of the econometric 
analysis.117 
Another method for handling the large number of zeros is to treat WTP for the 
screening/treatment as a two part decision using a hurdle model.  In this two-part model, 
the individual’s decision to participate is modeled using a probit or logit specification; 
then, the outcome variable is modeled using a separate regression but only includes those 
observations for which participation is observed.  The use of a two-part model has 
become a common practice in analyzing health data, in particular health expenditures.  In 
a study by Deb et al. (2006), which uses a two-part model to investigate the effect of 
health insurance on medical expenditures, they state “individuals…are more likely to 
choose [health] insurance based on personal characteristics such as overall health status, 
the existence and severity of chronic health conditions and physical limitations, 
preferences for risk, preferences over intensity of treatment, and so on” (Deb et al. 2006 
p. 1082).  Therefore, it could similarly be argued that an individual’s choice of treatment 
(in the absence of insurance) would also be based on similar factors.  Deb et al. (2006) 
further state that if all of these factors can be included as explanatory variables in the 
expenditure equation, then this “will adequately control for the influence of these factors” 
(Deb et al. 2006 p. 1082); however, since many of these factors are unobservable, 
inclusion of some factors will only control for a portion of this effect; and, as a result, 
lead to biased coefficients in the expenditure equation.  Thus, Deb et al. (2006) 
recommend modeling the selection of treatment separately from that of expenditures. 
 
7.7 Modeling WTP for Screening 
The two approaches discussed above are used to model the WTP for screening.  
First, a censored regression model is used and then a two-part model (comprised of a 
probit which models the decision to have the screening test, followed by an OLS 
                                                 
117 The cnreg function in STATA is a generalization of tobit that allows the user to designate the censored 
group.  Therefore, instead of all WTP=0 being censored (which occurs when the “tobit, ll” function is 
used), only those who chose not to have the test will be treated as censored data (TEST=0). 
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regression on WTP, which only includes those individuals who chose the screening test).  
For these models, two general specifications are reported -  a basic model that includes 
control variables for income, risk aversion, level of education, treatment effectiveness, 
and measures of perceived risk as the explanatory variables; and a more detailed model 
that includes specific risk factors substituted in for perceived risk. 
 
7.7.1 Basic Model: WTP for Screening 
The censored regression on WTP presented in Table 7-13 utilizes the STATA 
command cnreg, which is a generalized tobit function.  Using the tobit command would 
assume that all WTP=0 observations are censored, and would not distinguish between 
those who chose to have the test when it was offered for free, versus those individuals 
who chose not to have the screening at any price (those observations that are truly 
censored).  Therefore, using the cnreg function allows only those who chose not to have 
the screening to be treated as censored observations.  Explanatory variables in the 
censored regression on WTP include household income, whether the respondent lives in a 
MSA (to account for nominal differences in income), life insurance118 (as a measure of 
the individual’s degree of risk aversion), the amount of the individual’s average monthly 
spending on medical care (excluding insurance premiums), level of education, treatment 
effectiveness (30% or 85%)119 as indicated on the respondent’s survey, a measure of the 
individual’s perceived risk, and controls for the starting bid and the respondent’s level of 
certainty regarding their initially stated WTP.   Perceived risk can be measured by the 
respondent’s Perceived Risk (after the new information was presented to them), or as a 
combination of their Initial Perceived Risk and Change in Perceived Risk120 that resulted 
from the new information.   
In the first specification (See Table 7-13, Column 1), household income is 
positive and significant at the 1% level.  The coefficients on MSA, life insurance, and 
                                                 
118 The life insurance variable was also included to capture the individual’s willingness to spend financial 
resources to ensure the wellbeing of their family (spouse and children).  During the focus groups, several 
individuals indicated that they would expend financial resources on the screening for heart attacks to help 
ensure that they would be around for their spouse or to care for their children.  Because not all individuals 
share this trait, it was felt that whether or not the individual had life insurance would be a better proxy for 
this unobservable benevolence, as opposed to simply including children and/or married in the regression. 
119 “No Treatment” is the omitted category.  
120 Change in Perceived Risk = Perceived Risk (after new information) minus Initial Perceived Risk 
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medical spending are all positive, as expected, although not significant.  The marginal 
effect of education on WTP is negative, with significance at the 1% level for those with a 
graduate degree.  The negative coefficients on education were not the expected result;121 
however, this is a consistent finding across all specifications for the entire study, and 
appears reflective of a change in how consumers gather information before making 
decisions regarding their health care.   
In the past, patients would rely almost solely upon their physician as a source of 
information related to available treatment options, and when faced with medical decisions 
would often defer to the physician’s recommendation.  However, focus group comments, 
the open-ended responses to these surveys, and conversations with practicing MD’s 
indicate that with the emergence of the Internet, individuals now have another reliable 
source of information on potential medical care, and this has changed the role of the 
physician in consumer medical decision making.  A growing number of patients, 
particularly those who are more educated, now view their physician as one source of 
information, and are more likely to research information on their own using the Internet.    
The opening question for both surveys asked respondents how important it is for their 
physician to include them in medical decisions regarding their health.  Ninety-one 
percent of those completing Survey 1: Screening and 99% of those completing Survey 2: 
Treatment indicated that it was very important that they be included in decisions 
regarding their health.  Clearly, this indicates that individuals want to understand their 
health and be included in making decisions affecting their health.   
Although a physician may still have some patients who say “Whatever you think 
is best, Doc” and defer to their physicians opinion, there is evidence to suggest that this is 
becoming much less common.  Benbasset et al. (1998) discuss how updates in the 
medical code of ethics regarding the rights of patients to be informed about their medical 
care has changed the doctor-patient relationship over the last few decades.  They explain 
that the doctor-patient relationship can be viewed as a continuum.  At one extreme is the 
paternalistic model in which the physician is assumed to have the best interest of the 
patient in mind and therefore acts with authority and autonomy in making treatment 
                                                 
121 Grossman’s (1972) theory suggests that those with higher education would be more likely to make 
investments in health; therefore, a positive relationship between higher levels of education and WTP would 
be expected 
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decisions for the patient.  Benbasset et al. state that this type of doctor-patient relationship 
was not uncommon in the 1950’s.  At the other extreme is the informative model in 
which the doctor simply provides information, and the patient is primarily responsible for 
decisions regarding his/her care.  Along this continuum lie varying degrees of shared 
decision-making in which the doctor provides advice and the patient participates by 
asking questions and expressing preferences regarding treatment options.  From a review 
of the literature, Benbasset et al. found that individuals who have more severe illnesses, 
have lower levels of education, are of a minority ethnic group, are male, and/or are 
elderly have a tendency to prefer a passive role in clinical decision-making (Benbasset et 
al. 1998).  Therefore, it follows that these individuals would be more likely to rely on 
their physician in making decisions regarding their medical care.    
Based on these findings, it is not surprising that patients with higher levels of 
education may now view their physician’s recommendation as simply that “a 
recommendation.”  Therefore, the negative coefficient on education may suggest that 
individuals with higher levels of education are more familiar researching information on 
their own, and are therefore less likely to select a medical test on the spot simply because 
their physician recommends it.  Instead, it appears that highly educated individuals are 
more likely to conduct their own research and consider that information in conjunction 
with their physician’s recommendation122 prior to making a medical decision.   
In the WTP model, the coefficient on the individual’s level of perceived risk (after 
the new information) is positive and significant at the 10% level.  To test whether the 
individual’s WTP is dependent more on their prior perceived risk or perceived risk 
stemming from the new information, Initial Perceived Risk and Change in Perceived Risk 
are included in the model (See Table 7-13, Column 2).  The coefficients on the other 
covariates remain essentially unchanged; however, Initial Perceived Risk becomes 
significant at the 5% level and Change in Perceived Risk is not statistically different from 
zero.  This implies that the WTP for screening is not influenced by the new information, 
but rather by the individual’s prior (established) perception of risk.  
                                                 
122 Comments from the focus groups and the open-ended responses indicate that the level of trust the 
individual has with their doctor will affect how much weight is place on his/her recommendation.  
Although the survey indicated that the information presented was from their regular physician, some of 
those individuals who refused treatment clearly did not accept this statement.     
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To further test whether there is a difference between those who have strong priors 
on their Initial Perceived Risk compared to those with weak priors, dummy variables 
were created using the respondent’s Initial Perceived Risk and the strength of this prior.  
During the survey (immediately following the new information), respondents were asked 
the following question: “After reading this new information, I feel my risk of having a 
heart attack within the next year is now…”  Possible responses included: much higher, 
somewhat higher, the same, somewhat lower, or much lower.  For those who indicated 
that their risk remained “the same” after reading the new information, it is presumed that 
these individuals have strong priors regarding their risk of heart attack.  For those who 
indicated that their risk was either much higher/lower, the new information greatly 
affected their perception of risk, suggesting weak priors regarding their risk of heart 
attack.  When these variables are included in the regression (See Table 7-13, Column 3), 
there is a positive and significant (at the 5% level) effect on WTP for Initial Perceived 
Risk, but only for those with strong priors regarding their risk of heart attack.  This 
suggests that those who have a higher perceived risk and have more prior knowledge 
about their risk (or at least believe they do) will have a higher WTP for the screening, 
compared to those with a higher perceived risk who do not feel as confident about the 
accuracy of their prior knowledge, 
The starting bid was included as a control variable in all the WTP specifications.  
The coefficient on Starting Bid is positive and significant at the 5% level, indicating 
some degree of starting bias in the data.  As discussed in Chapter 2, the contingent 
valuation literature has shown that bidding games are often prone to starting point bias.  
Unfortunately, as the empirical results will continue to indicate, the iterative bidding 
process used for Survey 1: Screening and Survey 2: Treatment is also subject to some 
degree of starting point bias.  However, as will be shown later in this chapter (See Section 
7.9: Correcting for Starting Point Bias) the correction procedure suggested by Whitehead 
et al. (1995) is used to correct for the marginal effect of starting point bias such that 
unbiased estimates of WTP are obtained.  
The final specification (See Table 7-13, Column 4) includes dummy variables for 
treatment effectiveness (30% and 85%)123 as presented on the respondent’s survey.  In the 
                                                 
123 “No Treatment” was the omitted category. 
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censored regression on WTP, treatment effectiveness is not significantly different from 
zero.  This finding contradicts the expectation from the theoretical model developed in 
Chapter 4, and suggests that a two part model or Heckman model may be a more 
appropriate method of analyzing the decision to select and pay for screening.            
The basic two-part model includes a probit on whether the individual chooses to 
receive the screening test (TEST=1), and an OLS regression on WTP for those 
individuals who chose to have the screening.  Explanatory variables for the probit model 
are essentially the same as the censored model, with the exception of medical 
spending.124  In addition, the starting bid and certainty of the respondent’s WTP are not 
included as those are not relevant to the decision to have the screening.   
Table 7-14 includes a specification similar to the censored model, using various 
measures of perceived risk.  As before, using Change in Perceived Risk with dummies for 
strong and weak priors on perceived risk offers the best fit (See Table 7-14, Column 3).  
Household income and MSA are positive as expected, although neither is significant.  
Life insurance is positive and significant at the 5% level implying that those who are 
more risk averse are more likely to get the screening.  Education is positive for those with 
a high school education or less, but becomes negative for individuals who have attended 
at least some college.  Although none of the coefficients on education are significant, the 
signs are consistent with the earlier discussion that those with more education are more 
likely to conduct their own research when presented with new information before making 
a health-related consumer decision.   
In terms of perceived risk, Change in Perceived Risk is positive and significant at 
the 10% level.  This indicates that the new information increases the probability that the 
respondent will choose to have the screening test.  In particular, the coefficient on this 
variable indicates that the brief information presented in the survey increased the base 
likelihood of the respondent getting the screening by 3%, ceteris paribus.  The negative 
coefficient (significant at the 10% level) on perceived risk for those with weak priors 
suggests that those individuals with higher levels of perceived risk, who are less certain 
                                                 
124 Medical spending was asked immediately prior to respondents entering their final WTP as a means of 
reminding respondents of their budget constraint; therefore those who answered “no” to a zero bid 
(indicating that they did not want the screening at any price) did not complete the medical spending 
question.  See Table 7-15 for a comparison of the probits in Table 7-14 when the mean value of medical 
spending is assigned to the individuals who chose not to have the test.    
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of those risk assessments, are less likely to get the screening (at least when it is initially 
presented to them).125               
So far, the results of the probit model have been largely consistent with those of 
the censored regression.  However, in terms of treatment effectiveness, there is a 
noticeable difference between the two models.  The censored regression indicates the 
effectiveness of the treatment (for those whose screening indicates they are at high risk) 
has no statistical effect on WTP.  However, the probit model indicates that treatment 
effectiveness is positive and highly significant (at the 1% level) in the respondent’s 
decision to have the screening.  These inconsistent findings bring up an important point 
regarding the potential validity of using a censored regression in analyzing health data.  
As discussed earlier in section 7.6.2: General Models for Analyzing Health Data, 
different factors may be responsible for the decision to have treatment and other variables 
responsible for determining the WTP.  If all of these variables only affect one of these 
outcomes and all relevant factors are included in the model, then the tobit can produce 
reliable results.  However, if individual factors influence both the decision to get the 
screening and the WTP, or if unobservables driving each of these outcomes is omitted 
from the regression, the marginal effects may not be accurate.  The probit clearly 
indicates that the effectiveness of available treatment influences the decision to have the 
screening.  This is further supported by the open-ended responses of those who chose not 
to have the screening, many of whom indicated they did not want the screening if 
treatment was not available.  Therefore, it appears that the two-part model may offer 
more accurate results compared to the censored model. 
The second part of the model includes an OLS regression on WTP for those 
respondents who chose the screening.126  If the tobit is in fact, capturing the combined 
effects of the two-part decision, then we would expect household income to be positive 
and significant, a graduate level education to be negative and significant, and strong 
priors on Initial Perceived Risk to be positive and significant.  A comparison of the OLS 
regression in Table 7-16, Column 3 to the censored regression in Table 7-13, Column 3 
                                                 
125 It is possible that those individuals would choose to have the screening once they had an opportunity to 
research more about it on their own. 
126 This includes some respondents for which their WTP=0 (those who would have the screening, but only 
if it were offered at no out-of-pocket cost to them). 
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suggests that the tobit model is in fact picking up the effects of the OLS regression; 
however, the tobit model fails to indicate the significance of treatment effectiveness in 
the decision to have the screening.  Therefore, based on the basic models that include 
general measures of perceived risk, it appears that the two-part model is more appropriate 
than the censored regression; and as such, the two-part model is likely to provide more 
accurate estimates on marginal effects compared to the censored regression. 
Another possible way to analyze the data is using a Heckman selection model.  
The Heckman selection model is an appropriate choice if the correlation between the 
error terms of the selection equation and regression equation is not equal to zero (ρ ≠ 0); 
that is, if there is a relationship between the two equations.  A classic application of the 
Heckman selection model from labor economics is the estimation of a wage equation for 
women.  Applying the Heckman model to this example includes specifying a wage 
equation that follows the standard model in which the wage is determined by education, 
experience, and other relevant factors.  In addition, a separate selection equation is also 
defined which models the woman’s decision to participate in the labor force.  If the 
choice to participate in the labor force is made randomly, then the error terms between 
these two equations will not be correlated (ρ = 0), making it appropriate to analyze each 
decision (and treat the equations) separately.  However, if the error terms are correlated 
(ρ ≠ 0), then analyzing the equations separately (without taken the selection bias into 
account) could result in biased coefficients.  This is likely to occur if women who only 
have the ability to earn lower wages in the labor market tend to find a higher value for 
their productivity elsewhere (i.e. the home); thereby making these women less likely to 
participate in the labor force.  If this is indeed the case, then it follows that observed 
wages will be biased upward as observed wages will tend to be limited to those women 
who can earn higher wages.  However, using a Heckman selection model will adjust for 
the selection bias; thereby providing unbiased coefficients on the covariates for the wage 
equation (Maddala 1983) .    
To test whether the Heckman selection model is appropriate for this study, two 
specifications of a Heckman selection model are applied to the Survey 1: Screening data 
and reported in Table 7-17.  Model 1 (Table 7-17, Columns 1 and 2) includes Initial 
Perceived Risk and Change in Perceived Risk as dependent variables; while Model 2 
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(Table 7-17, Columns 3 and 4) includes the strength of the individual’s priors on 
perceived risk.  Model 1 includes the basic probit equation  from Table 7-14, Column 2 
as the selection equation, and the basic OLS on WTP from Table 7-16, Column 2 as the 
regression equation.  Model 2 includes the basic probit equation from Table 7-14, 
Column 3 as the selection equation, and the basic OLS for WTP from Table 7-16, 
Column 3.  Results of the Heckman models (See Table 7-17) are highly consistent with 
those from the two-part models.  In terms of the WTP for screening, the marginal effect 
of household income is positive and highly significant, as is the individual’s self-reported 
level of initial perceived risk.  Including the strength of the individual’s prior on 
perceived risk indicates that those who have strong priors have a statistically significant 
higher WTP, ceteris paribus.  Like the two-part model, education in the Heckman model 
has a negative effect on WTP and is statistically significant for those individuals with a 
graduate education.  In terms of the decision to have the screening test, the selection 
equation results indicate that higher levels of education decreases the probability of 
having the screening, and like the probit equation, this result is significant for those 
individuals with an associates or graduate degree.  The Heckman selection equation also 
indicates that treatment effectiveness is an important factor in the decision to have the 
screening; In fact, the second Heckman model (Table 7-17, Column 4) indicates that 
having a treatment available that is 85% effective increases the base probability of having 
the screening by 34%.       
Overall, the results of the Heckman selection model and two-part model are very 
similar, although the marginal effects differ to some degree.  Therefore, which is the best 
choice?  The Heckman selection model provides an estimate of λ = 139.11 and the results 
of the likelihood ratio test (χ2 =54.33 and p=0.000) which, according to the Stata 
reference manual, is equivalent to testing the null hypothesis that ρ = 0, indicate that the 
null hypothesis can be rejected in favor of the alternative hypothesis ρ ≠ 0.  Therefore, 
these results clearly support (econometrically) the use of the Heckman model in 
analyzing the data for Survey 1: Screening.  However, in choosing the most appropriate 
model, it is also important to understand what the coefficient results imply about WTP.  
The Heckman selection model reports coefficients that represent the marginal effects of 
the covariates on WTP assuming that all individuals will have the screening.  Following 
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the example used earlier for women’s wages, it is clear to see why it is important to take 
into account the wages that could be earned by women, including those who choose not 
to participate in the labor force.  However, in estimating the demand for screening, it is 
not clear that this is the information that is most relevant to the questions being addressed 
by this study.   
Clearly, the responses to the open-ended questions for both Survey 1: Screening 
and Survey 2: Treatment indicate that some individuals would rationally choose not to 
have the screening/treatment.  Therefore, if the goal of this study is to better understand 
the actual anticipated demand for screening/treatment and its associated marginal effects, 
then the Heckman model (although mathematically appropriate) may not provide the 
most useful information.  In fact, according to the Stata reference manual, the Heckman 
model is most appropriate “when the goal is to analyze an underlying regression model or 
to predict the value of the dependent variable that would be observed in the absence of 
selection”  However, “when the goal is to predict an actual response, the two-part model 
is usually the better choice” (p. 70).  In addition, Manning, Duan, and Rogers (1987) find 
that for data sets with a non-significant number of zeros, in which these zeros represent 
actual observations (rather than censored data), the two-part model can perform better 
than a selection model.  It is important to note that for this study the general results of the 
Heckman model are consistent with the basic findings of the two-part model.  However, 
because the goal of this project is to better understand actual anticipated demand for 
screening/treatment, the focus will be on the two-part model, and as such, will utilize 
those measures of marginal effects in analyzing the influence of various factors on WTP. 
 
7.7.2 Detailed Model: WTP for Screening 
To further explore which specific risk factors may be influencing the decision to 
have screening and also the determination of WTP for that screening, more detailed 
models are reported that include specific risk variables in place of a general measure of 
the respondent’s perceived risk.  The risk variables include the set of risk factors used 
earlier in the perceived risk equations (age, gender, race, family history, cholesterol 
problems, diabetes, hypertension, amount of exercise, amount overweight, smoking or 
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being exposed to second-hand smoke on a daily basis, and taking cholesterol lowering 
medication).   
Table 7-18 presents the results of the probit model including the individual risk 
factors.  In comparing the basic probit model (Table 7-14, Column 3) to the associated 
detailed probit model (7-18, Column 3),  the pseudo R-squared increases from 0.2205 to 
0.3929, indicating that the detailed model containing individual risk factors provides a 
better fit for the data, and explains approximately 39% of the variation in the decision to 
have the screening.  In the detailed model (Table 7-18, Column 3), household income 
becomes significant at the 5% level.  The coefficient does increase quite a bit from the 
basic model; however, the significance of the income variable in the detailed model 
(along with the higher R-squared) suggests that the marginal effect of income in Table 7-
18, Column 3 is the more precise estimate.  MSA remains positive and insignificant, 
although the coefficient increases in the detailed model.  Life insurance is positive and 
significant at the 1% level.  Like income, the coefficient for life insurance increases and 
becomes more significant in the detailed model.  The signs on the education variables 
remain the same as the basic model, with some relative changes in the coefficients.  In 
addition, the coefficients are significant for those individuals who have attended some 
college or received an associate’s degree.  The coefficients on the treatment effectiveness 
dummies are still positive and highly significant at the 1% level, although the marginal 
effects do increase to some extent in the more detailed model.  In terms of risk factors, 
those that are significant include: male, hypertension, exercise, and heart attack.  The 
coefficient on male is negative and significant at the 5% level, indicating that men are 
less likely to get the screening compared to women.  Those individuals who have (or who 
have had) high blood pressure are more likely to get the screening and those who exercise 
more frequently are less likely to get the screening.  Perhaps the most interesting finding 
is that those who have had a heart attack are far less likely to get screening.  However, 
this is consistent with the theory developed in Chapter 4 because these individuals know 
they are at high risk of having a heart attack; and therefore, would receive little benefit 
from the information provided by the screening.  
Table 7-19 presents the results of the OLS regression on WTP for those who 
chose the screening.  In the detailed model including the risk factors, household income is 
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positive and significant at the 1% level.  The marginal effect is .000933, resulting in an 
income elasticity of willingness to pay for screening equal to 0.48.127  This value should 
not be confused with the income elasticity of demand which, as Flores and Carson (1997) 
demonstrate, can vary substantially from this value and may even have a different sign.  
Therefore, the income elasticity of willingness to pay of 0.48, which is positive and less 
than one, does not indicate that screening is a necessity, nor does it provide evidence that 
screening is a normal good.  In fact, the income elasticity of demand can only be found 
using the income elasticity of willingness to pay if additional information on cross-price 
elasticities and the budget shares of other available goods is known, such that it can be 
included in the calculation (Flores and Carson 1997).   
The coefficient on life insurance is positive and significant at the 10% level.  
MSA and medical spending also indicate a positive effect on WTP, but it is not 
significant.  The coefficients on education are negative with Some College and 
Bachelor’s Degree significant at the 10% level and Graduate Degree significant at the 
1% level.  Having high cholesterol (or low HDL) is positive and significant at the 5% 
level and increases WTP for screening by approximately $46.  In addition, the negative 
and significant coefficient on race, indicates that whites are willing to pay approximately 
$43 less for the screening compared to non-whites.  To see if the new information has an 
effect on WTP in the detailed model, Change in Perceived Risk was added to the model, 
however, it was not significantly different from zero.  
A comment made by a discussant, when research from this paper was presented at 
the ASHE (American Society for Health Economists) conference, suggested that it may 
be valuable to estimate WTP for men and women separately, as factors that influence 
WTP may vary across gender.  Therefore, to test whether there is a statistically 
significant difference between the coefficients of the pooled model versus when the 
gender subgroups are treated separately, a likelihood ratio test was conducted comparing 
the restricted (pooled) model, to the unrestricted (coefficients are allowed to vary across 
gender) models.  The null hypothesis for the likelihood ratio test is that the coefficients 
are equal (indicating that the data can be pooled); therefore the resulting χ2 = 45.6 and p-
                                                 
127 (.000933 * 48,223 )/94 = 0.48, where 48,223 is mean household income and 94 is the mean WTP for 
screening.  
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value of 0.04 indicate that there is a statistically significant difference between the 
coefficients and that the subgroups should be treated separately.  Columns 3 and 4 of 
Table 7-19 include the detailed regression on WTP for the female sub-sample (Table 7-
19, Column 3) and male sub-sample (Table 7-19, Column 4).  Although the samples are 
significantly smaller, n=119 for females and n=133 for males, the results of the likelihood 
ratio test suggest that gender differences exist in regards to factors that influence WTP.  
For women, household income, education, frequency of exercise, weight, and diabetes 
are significant; whereas for men, the significant factors include the effectiveness of 
treatment, high cholesterol, and obesity.           
Since one of the issues regarding the analysis of health data is the accuracy of 
different models in estimating the marginal effects of the independent variables, Table 7-
20 provides a comparison of WTP models for OLS (for TEST=1), the censored 
regression (cens: TEST=1), the standard tobit (with all WTP=0 observations treated as 
censored data), and the associated OLS regression (for WTP>0).  Based on the above 
analysis, it appears that the two-part model is the most appropriate in explaining the 
decision to get screening and estimate the individual’s subsequent WTP for screening.  In 
addition, the detailed models for each of these provide information on specific risk 
factors that are likely to affect the individual’s decision to get screening as well as 
determine their WTP for the test. 
 
7.8 Modeling WTP for Treatment 
 As mentioned earlier the mean WTP for a new, more effective treatment 
procedure is $7,821.  To better understand the factors influencing the demand for 
treatment, a two-part model was used, which includes a probit to model the decision to 
have the procedure, and an OLS regression on WTP for those who chose the procedure as 
their preferred treatment option.  
Tables 7-21 and 7-22 present various specifications for the probit model on the 
decision to have the treatment procedure, and Table 7-23 reports the results of the OLS 
regression for WTP for those individuals who chose the procedure.  Table 7-21 includes 
two basic probit models.  The first (Table 7-21, Column 1) closely mirrors the 
specification used for the Survey 1: Screening data.  Explanatory variables include 
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household income, MSA, life insurance, education, and measures of perceived risk.  In 
addition, the decision to have the procedure may be influenced by the existence of an 
alternative treatment, drug therapy.  Those individuals who are already taking cholesterol 
lowering medication may feel that the expected benefit from the procedure is not as great 
because they are already receiving some form of treatment.  Therefore, a dummy variable 
is included to control for the possibility that the individual is already receiving treatment 
by taking a cholesterol lowering medication.   
  In the first basic probit model (Table 7-21, Column 1) household income is 
positive and significant at the 1% level, indicating that individuals with higher levels of 
income are more likely to get the procedure.  The sign on MSA is negative; however, it is 
not statistically different from zero.  Life insurance has a positive coefficient, although it 
is also not significant.  As before, the education variables are all negative, with those 
individuals who have earned a graduate degree having a significantly lower likelihood of 
having the procedure.  The Change in Perceived Risk variable is positive and significant 
at the 5% level.  It is interesting to note that in this specification, Change in Perceived 
Risk is significant, while Initial Perceived Risk is not statistically significant at all.  
Therefore, it appears that the decision to have the procedure is influenced far more by the 
change in risk resulting from receiving the new information than on past priors 
concerning the risk of heart attack.  As expected, the sign on cholesterol medication is 
negative, but it is not significant at the 10% level.        
As part of Survey 2: Treatment, the new treatment procedure was described to 
respondents before they were asked to select a treatment.  Those familiar with a heart 
catheterization procedure, which involves inserting a small tube into the upper thigh and 
“threading” it through the blood vessels up into the coronary arteries of the heart, would 
quickly recognize that the new procedure described in the survey is very similar in nature 
to a heart catheterization procedure they may have had performed in the past.  After the 
procedure was recommended by the physician, the respondent was asked to select their 
treatment option – the new procedure or drug therapy.  The respondent was also given the 
option of requesting additional information.  Those that requested additional information 
were provided with more detailed information provided by the specialist who would be 
performing the procedure.  The specialist explained the use of a sedative, the expected 
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length of time needed for recovery (and away from work), as well as provided a general 
description of what the procedure entailed.   
During the survey, it was expected that those individuals who have had a heart 
catheterization procedure in the past would recognize that they were already somewhat 
familiar with the new procedure being presented to them; and as a result, would be more 
willing to choose the new treatment.  Likewise, those who requested additional 
information may feel less comfortable with the procedure and wish to research it in more 
detail on their own prior to making a decision to have the new treatment.  Therefore, it is 
likely that those who requested additional information would be less likely to choose the 
procedure.   
The second basic specification of the probit model (See Table 7-21, Column 2) 
tests these assumptions by including the dummy variables Heart Catheterization (=1 if 
the respondent has had a heart catheterization procedure in the past) and Special 
Information (=1 if the respondent requested additional information before selecting a 
treatment option).  As expected, the marginal effect on Heart Catheterization is positive 
and significant at the 5% level, and remains significant across specifications.  The 
coefficient on Special Information has a negative sign and is significant at the 10% level; 
however, this result is not robust when additional explanatory variables are added to the 
model. 
In specifying the remainder of the factors that would influence the decision to 
have the procedure, comments from focus group participants, as well as the open-ended 
responses were incredibly useful.  Focus group participants for Survey 2: Treatment 
indicated that if they felt the new treatment procedure was valuable enough, they would 
utilize many different financial resources available to them in order to pay for it.  Some 
focus group participants indicated that they would be willing to take out a second 
mortgage to access equity in their homes or sell an asset, such as a car or boat.  
Therefore, in addition to household income, other measures of wealth are included as 
explanatory variables in the probit equation for who chose to have the procedure.  These 
additional wealth variables include a dummy variable for whether or not the individual 
owns their home, as well as a measure of how secure the respondent feels their family 
would be in the event that the respondent were to die suddenly.  Respondents had the 
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option of indicating that their families would be very secure, fairly secure, or not very 
secure, which were coded as a 3, 2, and 1 respectively.  Therefore a higher value for 
Secure indicates a higher level security (presumably wealth) that would be available to 
the respondent’s heirs.  Although some of this financial security may be the death benefit 
from a life insurance policy, the model controls for life insurance, such that the variable 
Secure should provide a fairly good proxy for the individual’s current level of wealth. 
In choosing to have the procedure, focus group participants indicated that time 
away from work and family obligations were important considerations.  The procedure 
described in Survey 2: Treatment is a surgical procedure.  Although the procedure is 
considered minimally invasive, it could require a short stay in the hospital if 
complications arise.  Therefore, individuals who work would need to plan for the 
possibility that he/she could miss several days of work in order to have the procedure.  To 
account for the fact that some individuals may have more difficulty requesting time off 
due to the demands of their job, the variable Stress was included.  In addition, individuals 
who do not work, but have dependent children to care for may be less likely to choose the 
procedure, unless a spouse is available.  Therefore, dummy variables for married and 
having a dependent child (Child under 18) were also included in the model.  In addition, 
the variable male was included to account for possible gender differences.      
Finally, the open-ended responses indicated that physical limitations may prevent 
some individuals from choosing the procedure as their treatment option.  Individuals who 
are disabled may have difficulty getting to the hospital; or as the open-ended responses 
suggest, other medical conditions may increase the risks associated with the procedure.  
Individuals who have a very high BMI may feel that the resulting benefit of the 
procedure will be less for them due to their weight, or they may be less likely to have the 
procedure because they may feel the risk to them of the procedure is actually higher than 
the stated risk for the average person.  Likewise, individuals who have other chronic 
health conditions (as measured by the frequency of MD visits) may feel they will obtain a 
lower overall benefit from the procedure.  Finally, those who are very old may feel that 
the benefit from the procedure is not worth the emotional, physical, and time cost 
involved for having the procedure and the associated recovery.  To account for these 
potential physical limitations, dummy variables for overweight, obese, and very obese is 
 196
included as well as a dummy variable to account for the possibility that the individual is 
disabled.  In addition, frequency of MD visits is included as a proxy for chronic 
conditions and a continuous variable for age is included128 to account for limitations that 
might arise from increased age.       
In the detailed probit model (See 7-22, Column 1) household income, new 
information on risk, and having had a heart catheterization procedure are all positively 
related to choosing the procedure.  Education tends to be negative and is significant for 
high school graduates and individuals with a graduate degree.  Higher amounts of stress, 
being disabled, and increased age all decrease the probability of having the procedure.  
These variables suggest that limitations in the individual’s ability to take time off from 
work and physical limitations may be factors that hinder individuals from choosing the 
procedure.   
The sample for Survey 2: Treatment includes two observations for which WTP 
was $100,000 and $300,000. These values are considerably higher than the rest of the 
distribution, and therefore, may be considered outliers.  Both of the respondents who 
indicated these amounts also indicated that were in the top savings category, with savings 
that exceeded $100,000.  Therefore, it is certainly possible that these individuals are 
willing and able to pay these large amounts; however, to consider the effect these two 
observations have on the marginal effects of the explanatory variables, the same probit 
was performed without these potential outliers (See Table 7-22, Column 2).  A 
comparison of the two regressions indicates that there is virtually no change in the factors 
that are significant or in their coefficients.  Additionally, a comparison of the detailed 
probit models (Table 7-22) to the basic probit models (Table 7-21) indicate that income, 
graduate degree, change in perceived risk, and heart catheter are significant across all 
specifications.  The predictive ability of the detailed models is higher, indicating that the 
marginal effects obtained from this model are likely to be more precise.  However, there 
is very little change in the coefficient on Change in Perceived Risk across specifications, 
indicating that this result is very robust, as is the marginal effect for those who have had a 
heart catheterization, which is also very consistent across specifications. 
                                                 
128 Using dummy variables for age (as was done in prior models) indicated that the marginal effect for each 
age category was essentially the same, therefore, a continuous variable for age was used. 
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The results of a likelihood ratio test (χ2 = 37.45 and p-value of 0.039) suggest that 
men and women may be influenced by different factors in terms their decision to have the 
procedure.  Therefore, regression results for these two subgroups are reported in Table 7-
22.  As the probit results in Table 7-22, Column 3 indicate, women with a graduate 
degree are less likely to get the procedure; however, as discussed previously, this result 
may simply indicate the desire to research the procedure further prior to committing to 
have it.  In addition, an increase in perceived risk stemming from the new information 
tends to increase the probability of having the procedure, as does more frequent trips to 
the doctor.  However, women who request additional information about the procedure, 
are already taking a cholesterol-lowering medication, or report that they are currently 
under a great deal of stress, are les likely to select the procedure.  Interestingly enough, 
for men, the decision to have the procedure appears to be influenced by only a few 
factors.  Advanced age, being very obese, and working are all highly significant and 
reduce the probability of men choosing to have the procedure.129    
 The final table presents the results of the OLS regression on WTP for the 
Procedure (See Table 7-23).  The first model (Table 7-23, Column 1) includes all 
observations130, and the second (Table 7-23, Column 2) omits the two potential outliers 
discussed above.  A cursory glance reveals that the two models are very different, 
indicating that the two omitted observations do have a significant effect on the 
coefficients of the independent variables.  Running the model again, indicates that 
excluding only the observation for which WTP=300,000, provides results that closely 
resembles those in Table 7-23, Column 2.  Therefore, the second model (excluding the 
outliers) appears to be more accurate.   
 Looking at the WTP equation in Table 7-23, Column 2, there are several 
significant variables of interest.  As expected, the higher the individual’s wealth (as 
measured by household income and degree of financial security), the more the individual 
is willing to pay for the procedure.  Using the coefficient on income, the income elasticity 
                                                 
129 Work was interacted with years of education to create a variable to measure the opportunity cost of time.  
The models presented in Table 7-22 were also run with this interaction term replacing WORK.  The overall 
results and individual coefficients were nearly identical in the two specifications.  Including the variable 
WORK tended to provide a higher R-squared for the WTP models, therefore this was the variable included 
in the probit models.  
130 All observations for which the individual selected the procedure (Procedure=1). 
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of willingness to pay for the procedure is estimated to be 0.18.131  Again, this value may 
diverge from the income elasticity of demand based on the degree of substitutability 
between the proposed treatment and other available goods, the cross-price elasticities, 
and the share of the budget devoted to each good (Flores and Carson 1997).  The 
coefficients on Change in Perceived Risk and Special Info are negative and significant 
suggesting that when individuals are presented with new information and ask additional 
questions about the procedure, they are less confident in the value of the treatment; and 
are therefore willing to pay less for it.  Finally, frequency of MD visits is negative and 
significant, offering evidence to suggest that those with chronic conditions are willing to 
pay less for the procedure, presumably because it will have less of an expected benefit to 
these individuals. 
 As before, the results of a likelihood ratio test (χ2 = 95.88 and p-value of 0.000) 
strongly suggest that the factors influencing the WTP for the procedure vary across 
gender.  For women, household income has a positive and significant effect on WTP, 
while those who have some college or ask additional questions about the procedure are 
WTP significantly less for the procedure.  For men, new information that changes their 
perceived risk reduces their WTP, which, as discussed earlier, may result from the 
individual feeling less confident about the benefits associated with the procedure and 
therefore lower WTP.  Men who are disabled are WTP more, which may suggest that 
men view the procedure and an alternative way to invest in their health.  Men who live in 
a MSA are willing to pay more for the procedure, which is most likely due to individuals 
in urban areas being accustomed to paying more for services; and finally, the positive and 
highly significant (at the 1% level) coefficient on the variable Secure suggests that for 
men, wealth is a very important determinant in their WTP for treatment.       
  
7.9 Correcting for Starting Point Bias 
 The empirical results on WTP for both screening and treatment suggest that 
starting point bias is present in the data sets.  According to Boyle et al. (1985) starting 
point bias occurs in iterative bidding when the respondent’s final valuation is influenced 
                                                 
131 (.033 * 43,538 )/7,821 = 0.18, where 43,538 is mean household income and 7,821 is the mean WTP for 
the procedure. 
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by the first bid the respondent receives.  The economics literature has shown that iterative 
bidding techniques tend to be prone to starting point bias (Whitehead et al. 1995).  
Brookshire et al. (1981) provide two possible explanations for starting point bias.  One 
possibility is that respondents become bored and terminate the bidding process before 
reaching their true WTP, especially if the respondent recognizes that the initial bid is 
considerably different from his/her true valuation.  A second possible explanation is that 
due to lack of consumer markets for the good/service being valued in the survey, 
respondent’s have little or no experience valuing the good; therefore, the initial bid may 
be viewed as providing market information regarding the value of the good on which the 
respondent anchors his/her own valuation (Boyle et al. 1985).   
Although several iterative bidding studies have identified starting point bias in 
their data, Whitehead et al. (1995) offer two possible methods for adjusting for starting 
point bias such that unbiased estimates of WTP can be obtained.  Whitehead et al. explain 
that the appropriate method to be used depends on the cause of the bias.  If the starting 
point bias stems from boredom, then Whitehead et al. suggest using the corrective 
procedure presented by Farmer and Randall (1994), which includes identifying the 
starting point that has no marginal effect on stated WTP.  However, if the starting point 
bias results from respondents anchoring their valuation on an initial bid that seems 
reasonable, then unbiased estimates of WTP can be obtained by subtracting out the 
marginal effect of the starting point bias (Whitehead et al. 1995).  In fact, Whitehead et 
al. show mathematically that if the marginal effect of the starting point bias can be set 
equal to zero, that unbiased estimates of WTP can be obtained.   
Comments from focus group participants and the completion of the bidding 
process for a large percentage of the sample suggests that respondent boredom was not a 
key issue for this study, rather it is more likely that respondents were unfamiliar with the 
good being valued (since it does not yet exist), and therefore, anchored their valuation on 
the initial bid presented to them.  Since the set of bids from which the initial bid was 
randomly selected was based on the range of valuations provided by focus group 
participants in their open-ended surveys, these initial bids would most certainly provide 
reasonable values to the survey participants.  If this is in fact the source of the starting 
point bias for the data collected in this study, then according to Whitehead et al. (1995), 
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unbiased estimates of WTP can be obtained simply by subtracting out the marginal effect 
of the starting point bias.   
The regression results provide a coefficient for the starting point bias, such that 
the marginal effect of starting point bias for screening and treatment can be calculated 
simply by multiplying the coefficient by the mean initial bid for each good.  For example, 
the coefficient of starting point bias in the regression on WTP for screening in Table 7-
19, Column 2 is + 0.480.  The mean initial bid for Survey 1: Screening was $51.58; 
therefore, it follows that the marginal effect from starting point bias on WTP is an 
upward bias of $24.76.  Therefore, adjusting the mean WTP of $94 down by $25 (in 
effect, setting the starting point bias=0), yields a mean WTP for screening equal to $69.  
The median WTP for screening was $50; therefore, adjusting for starting point bias 
would result in a median WTP of $25.  The same procedure can be applied to the Survey 
2: Treatment data.  The coefficient on the starting bid in Table 7-23, Column 2 is .371.  
Multiplying by the mean starting bid for treatment ($5,404.76) indicates an upward bias 
of $2,005 due to the initial bid. Adjusting for this potential bias results in a mean WTP 
for treatment equal to $5,816 and a median WTP of $495. 
 
7.10 Treatment Effectiveness and Value of Statistical Life 
 The mean reported WTP for the proposed treatment was $7,821.  As part of the 
survey, respondents were told that this new treatment was 85% effective. Therefore, 
having the treatment would not reduce the individual’s risk of heart attack to zero; 
however, it would diminish it considerably.  To find the risk-dollar tradeoff, it is 
necessary to consider the total marginal costs and benefits of having the treatment.  In 
addition to a monetary cost, the treatment also includes a small risk of death equal to 
1/10,000.132   Respondents indicated a mean level of perceived risk for a heart attack for 
this year to be 30/100,000 or 3/10,000.  Since the procedure was stated to be 85% 
effective, having the procedure would presumably lower the mean risk by 2.55/10,000.  
However, it is expected that the procedure would be effective at reducing this risk for 
several years (not just one).   
                                                 
132 This risk stems from the possibility of death from the anesthesia or infection resulting from the 
procedure. 
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The implied number of years the treatment is assumed to be effective can be 
estimated by using the value of a statistical life (VSL).  As discussed in Chapter 2, 
Viscusi and Aldy’s (2003) review article find the most reliable VSL estimates to be in the 
range of 5 million to 9 million dollars.  Using this range of VSL estimates and the mean 
WTP for treatment of $7,821, it can be inferred that respondents expected the treatment 
to be effective for approximately 3.5 to 6 years.133  If the mean WTP adjusted for starting 
point bias is used, then the implied expected duration of treatment is slightly lower at 2.5 
to 4.5 years.134  Therefore, although a VSL can not be calculated directly using the data 
obtained in the survey, the WTP for treatment obtained in the study is consistent with 
published VSL estimates assuming that the treatment is effective for an approximate 
average of 3.5 - 5 years.  Since medically this is a very reasonable estimate given this 
type of procedure, the WTP for treatment obtained in this study appears consistent with 
estimates from VSL studies.    
 
 
 
 
 
 
                                                 
133 2.55/ 10,000 * number of years effective *VSL =  $7,821 + 1/10,000 
  2.55/ 10,000 * number of years effective * 9 million = $7,821 + 1/10,000 = 3.4 years 
  2.55 /10,000 * number of years effective * 5 million = $7,821 + 1/10,000 = 6.1 years 
134 2.55/ 10,000 * number of years effective *VSL =  $5,816 + 1/10,000 
  2.55/ 10,000 * number of years effective * 9 million = $5,816 + 1/10,000 = 2.5 years 
  2.55 /10,000 * number of years effective * 5 million = $5,816 + 1/10,000 = 4.5 years 
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Table 7-1: Key Summary Statistics for Screening and Treatment Data 
Demographics Screening           (n = 268)
Treatment            
(n=295)
Gender Male 53% 51%
Female 47% 49%
Age Range 18-83 18-91
Mean Age 48 64
Education Less than High School 9% 13%
High School Grad 37% 39%
Some College 23% 19%
Associate's Degree 5% 7%
Bachelor's Degree 17% 15%
Graduate Degree 9% 6%
Race White 77% 88%
Black 8% 7%
Hispanic 9% 3%
Other 6% 2%
Household Married 60% 66%
Household Size 2.6 2.3
Head of Household 85% 87%
Work Status Currently Working 65% 34%
Retired 20% 47%
Disabled 6% 10%
Household Income $48,223 $43,538
MSA 83% 87%
Health
Self-Reported Health Status 3.4 2.8
Heart Disease 12% 75%
Heart Attack 5% 37%
Taking Cholesterol Medication 17% 63%
High Cholesterol 35% 59%
High Blood Pressure 32% 40%
Diabetes 8% 22%
Live/Work -Smoking Environment 34% *
Family History of Heart Attack 40% 58%
Weight BMI Range 16-62 16-77
BMI Mean 28.3 29.2
Overweight 30% 38%
Obese 17% 23%
Very Obese 19% 16%
* Data Not Available  
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Table 7-4:  Survey 1: Screening  OLS  Regression on General Health 
Independent Variable
 - 0.265*  - 0.285*   - 0.323**  - 0.312*
(0.164) (0.159) (0.157) (0.161)
  - 0.399**   - 0.329**   - 0.384**    - 0.454***
(0.169) (0.164) (0.162) (0.165)
    - 0.461***    - 0.448***    - 0.495***    - 0.514***
(0.173) (0.168) (0.165) (0.169)
   - 0.469***  - 0.332*  - 0.303*   - 0.417**
(0.173) (0.171) (0.168) (0.169)
0.080 0.064 0.009 0.014
(0.201) (0.195) (0.191) (0.196)
0.213 0.169 0.070 0.092
(0.216) (0.209) (0.207) (0.212)
0.267 0.283 0.187 0.157
(0.298) (0.289) (0.285) (0.292)
  0.448**  0.410* 0.250 0.258
(0.223) (0.216) (0.218) (0.223)
0.173 0.107 - 0.128  - 0.108  
(0.255) (0.248) (0.253) (0.259)
   - 0.553***    - 0.437***    - 0.411***    - 0.507***
(0.134) (0.133) (0.130) (0.131)
   - 0.142***     - 0.117***    - 0.115***    - 0.137***
(0.044) (0.043) (0.042) (0.043)
   0.124***   0.106**   0.104**    0.119***
(0.046) (0.044) (0.043) (0.044)
   - 0.039***    - 0.029***    - 0.029***    - 0.037***
(0.009) (0.009) (0.009) (0.009)
    - 0.136***    - 0.121***
 (0.033) (0.032)
     5.68e-06***    6.60e-06***
  (1.70e-06) (1.72e-06)
     4.03***      4.21***      4.01***      3.82***
(0.243) (0.239) (0.242) (0.243)
F 7.62 8.79 9.28 8.51
Prob > F 0.0000 0.0000 0.0000 0.0000
R2 0.2807 0.3272 0.3558 0.3202
Adjusted R2 0.2439 0.2899 0.3175 0.2826
Root MSE 0.8779 0.8508 0.8341 0.8552
N 268 268 268 268
  *** significant at the 1% level 
** significant at the 5% level 
* significant at the 10% level
Constant
Amount Over Ideal BMI
Freqency of MD Visits
Household Income 
Graduate Degree
Life Threatening Condition
Amount of Stress
Frequency of Exercise
High School Graduate
Some College
Associates Degree
Bachelors Degree
Self-Reported General Health as Dependent Variable
AGE 35-44
AGE 45-54
AGE 65 and above
AGE 55-64
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Table 7-5:  Survey 1: Screening  OLS  Regression on General Health with Overweight 
Variables 
Independent Variable
 -0.299*  -0.309*   -0.345** -0.342**
(0.165) (0.159) (0.156) (0.161)
  -0.437**   -0.351**   -0.400**    -0.483***
(0.170) (0.165) (0.163) (0.166)
   -0.461***    -0.447***    -0.491***    -0.510***
(0.174) (0.169) (0.166) (0.170)
   -0.471*** -0.329*  -0.295*   -0.412**
(0.177) (0.174) (0.171) (0.173)
0.111 0.087 0.029 0.039
(0.203) (0.196) (0.193) (0.198)
0.270 0.218 0.114 0.142
(0.219) (0.212) (0.210) (0.216)
0.406 0.401 0.291 0.277
(0.308) (0.297) (0.293) (0.301)
  0.490**   0.438** 0.273 0.290
(0.225) (0.217) (0.219) (0.225)
0.229 0.153 -0.086 -0.060
(0.257) (0.249) (0.254) (0.262)
   -0.556***    -0.434***    -0.406***    -0.508***
(0.135) (0.133) (0.137) (0.132)
   -0.150***    -0.122***    0.120***    -0.144***
(0.044) (0.043) (0.042) (0.043)
   0.121***   0.102**   0.100**    0.116***
(0.046) (0.045) (0.044) (0.045)
-0.155 -0.133 -0.163 -0.187
(0.138) (0.134) (0.131) (0.135)
   -0.468***   -0.368**   -0.382**    -0.473***
(0.168) (0.164) (0.161) (0.164)
   -0.606***    -0.492***    -0.482***    -0.579***
(0.164) (0.161) (0.158) (0.160)
   -0.140***    -0.125***
(0.032) (0.032)
       5.70e-06***        6.67e-06***
   1.71e-06        (0.1.73e-06)
   4.098***    4.281***    4.091***    3.899***
(0.253) (0.248) (0.249) (0.251)
F 6.56 7.77 8.27 7.41
Prob > F 0.0000 0.0000 0.0000 0.0000
R2 0.2809 0.3313 0.3599 0.321
Adjusted R2 0.2381 0.2886 0.3163 0.2777
Root MSE 0.8813 0.8515 0.8348 0.8581
N 268 268 268 268
  *** significant at the 1% level 
** significant at the 5% level 
* significant at the 10% level
Obese
Overweight
Constant
Very Obese
Freqency of MD Visits
Household Income 
Graduate Degree
Life Threatening Condition
Amount of Stress
Frequency of Exercise
High School Graduate
Some College
Associates Degree
Bachelors Degree
Self-Reported General Health as Dependent Variable
AGE 35-44
AGE 45-54
AGE 65 and above
AGE 55-64
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Table 7-6:  Survey 2: Treatment OLS Regression on General Health 
Independent Variable
-0.144 -0.115 -0.111 -0.138
(0.381) (0.370) (0.368) (0.379)
- 0.465 - 0.431 - 0.405 - 0.433
(0.361) (0.351) (0.350) (0.360)
  - 0.689**  - 0.655*  - 0.629*   - 0.658**
(0.352) (0.342) (0.341) (0.350)
  - 0.780**   - 0.716**  - 0.661*   - 0.714**
(0.348) (0.339) (0.339) (0.348)
   - 0.919***   - 0.788**   - 0.731**   - 0.849**
(0.353) (0.344) (0.344) (0.353)
0.095 0.023 0.018   0.087
(0.167) (0.163) (0.163) (0.166)
0.214 0.150 0.117 0.175
(0.189) (0.184) (0.184) (0.189)
  0.617**   0.575**   0.545**   0.580**
(0.245) (0.238) (0.238) (0.244)
   0.604***     0.557***   0.488**   0.523**
(0.200) (0.195) (0.198) (0.203)
 0.475* 0.388 0.267 0.333
(0.253) (0.247) (0.255) (0.262)
  - 0.232**  - 0.195*   - 0.190**  - 0.224**
(0.118) (0.109) (0.108) (0.111)
   - 0.151***    - 0.126***    - 0.122***    - 0.146***
(0.040) (0.040) (0.040) (0.040)
 0.066* 0.061 0.058 0.063
(0.041) (0.041) (0.040) (0.041)
   - 0.027***    - 0.022***    - 0.021***    - 0.025***
(0.008) (0.008) (0.008) (0.008)
    - 0.131***    - 0.128***
 (0.031) (0.031)
   3.23e-06**   3.73e-06**
  (1.81e-06) (1.86e-06)
    3.77***     4.08***    3.91***     3.58***
(0.410) (0.405) (0.416) (0.420)
F 5.33 6.46 6.3 5.29
Prob > F 0.0000 0.0000 0.0000 0.0000
R2 0.2103 0.2577 0.2661 0.2215
Adjusted R2 0.1708 0.2178 0.2238 0.1796
Root MSE 0.8738 0.8486 0.8453 0.8691
N 295 295 295 295
  *** significant at the 1% level 
** significant at the 5% level 
* significant at the 10% level
Constant
Amount Over Ideal BMI
Freqency of MD visits
Household Income 
Graduate Degree
Life Threatening Condition
Amount of Stress
Frequency of Exercise
High School Grraduate
Some College
Associates Degree
Bachelors Degree
Self-Reported General Health as Dependent Variable
AGE 35-44
AGE 45-54
AGE 75 and above
AGE 55-64
AGE 65-74
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Table 7-7: Survey 1: Screening OLS Regression on Initial Perceived Risk of a Heart 
Attack 
Category Independent Variable Initial Perceived Risk
Initial 
Perceived Risk 
Initial 
Perceived Risk
Initial 
Perceived Risk
1.175 1.529
(1.606) (1.547)
3.267 2.119
(2.361) (2.286)
   5.415**   4.163*
(2.441) (2.365)
     8.064***     7.871***
(2.631) (2.532)
   6.226**   6.484**
(2.634) (2.535)
     7.586***      7.704***
 (1.976) (1.883)
     7.672***     7.671***
 (2.087) (1.989)
2.676 1.484 3.192 1.778
 (2.090) (2.005) (2.114) (2.058)
1.582 0.817 1.546 1.130
 (1.663) (1.591) (1.704) (1.642)
   5.784**   5.422**     6.725***      6.577***
 (2.491) (2.375) (2.466) (2.373
-1.246 -2.108 -2.368 -3.058
 (2.329) (2.225) (2.348) (2.265)
0.246 -1.107 0.186 -1.203
 (1.939) (1.866) (1.949) (1.900)
1.463 0.164 0.956 -0.086
 (1.607) (1.552) (1.634) (1.589)
     5.069***   3.360**     5.194***   3.799**
(1.663) (1.619) (1.707) (2.270)
4.281 2.475 3.372 2.125
(3.299) (3.163) (3.349) (0.660)
      12.833***    9.117**
(4.198) (4.064)
     7.629*** 5.311*
(2.883) (2.821)
   10.818**    9.467**
(4.260) (4.110)
-2.395 -3.170 -3.620 -4.577
(2.932) (2.797) (3.044) (2.937)
    -4.301***      -3.914***
(0.837) (.861)
   -7.169**   -6.398**     -6.334**    -5.765**
(2.888) (2.756) (2.880) (2.774)
  -6.632** -5.433*    -6.491** -5.500*
(3.056) (2.921) (3.054) (2.947)
   -8.499** -7.616*     -10.227**   -9.045**
(4.226) (4.030) (4.218) (4.068)
     -9.394***    -7.136**    -8.565***   -6.567**
(3.236) (3.114) (3.237) (3.146)
  -9.223**   -8.407**    -9.378***   -8.680**
(3.625) (3.457) (3.623) (3.490)
     12.816***      29.270***      10.682***      26.008***
(2.858)  (4.212) (3.180) (4.554)
F 5.88 7.59 5.09 6.19
Prob > F 0.0000 0.0000 0.0000 0.0000
R2 0.2857 0.3543 0.3030 0.3572
Adjusted R2 0.2372 0.3076 0.2435 0.2994
Root MSE 12.369 11.784 12.317 11.853
N 268 268 268 268
       *** significant at the 1% level 
** significant at the 5% level 
Heart Disease
Heart Attack
General Health
Education
Graduate Degree
Taking Cholestrol 
Medication
General Health
High School Graduate
Some College
Associates Degree
Bachelors Degree
r8
r9
r10
r11
r4
r5
r6
r7
r1
r2
r3
Risk Factors male
Age 35-44
Age 45-54
Medication
Age 55-64
Age 65 or higher
Male over Age 45
Female over Age 55
Family History of Heart 
Attack
Smoke or Live / Work 
with Smokers
High Cholesterol
Low HDL             
(Good Cholesterol)
Heart Disease OR Heart 
Attack
constant
Hypertension
Less than 30 Minutes 
Physical Activity / Day
20 Pounds or More 
Overweight
Diabetes
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Table 7-8: Survey 1: Screening OLS Regression on Perceived Risk of a Heart Attack 
After New Information 
Category Independent Variable Perceived Risk after New Info
Perceived Risk 
after New Info
Perceived Risk 
after New Info
Perceived Risk 
after New Info
-.019 0.347
(1.878) (1.826)
  4.555* 3.369
(2.760) (2.697)
  4.922* 3.628
(2.853) (2.790)
       9.314***       9.114***
(3.076) (2.988)
   6.763**     7.029**
(3.079) (2.991)
       7.012***        7.129***
(2.275) (2.197)
      8.945***        8.944***
(2.403) (2.320)
3.339 2.156 3.855 2.394
(2.406) (2.339) (2.472) (2.428)
     3.980**   3.220*   3.839*   3.410*
(1.914) (1.856) (1.992) (1.938)
4.809* 4.450   5.664*     5.511**
(2.868) (2.771) (2.883) (2.800)
1.178 0.322 0.061 -0.653
(2.681) (2.596) (2.746) (2.672)
-0.616 -.1959 -0.608 -2.045
(2.232) (2.177) (2.278) (2.242)
0.490 -0.800 0.168 -0.909
(1.850) (1.811) (1.911) (1.875)
       8.227***        6.531***        8.243***       6.800***
(1.915) (1.889) (1.996) (1.971)
1.346 -0.446 1.052 -0.236
(3.789) (3.691) (3.916) (3.816)
     13.688***      10.000**
(4.833) (4.742)
4.931 2.535
(3.371) (3.328)
    11.320**     9.924**
(4.981) (4.849)
-2.179 -2.948 -2.846 -3.835
(3.375) (3.264) (3.559) (3.465)
     -4.269***      -4.045***
(0.976) (1.016)
     -6.856**  -6.091*  -6.135*   -5.547*
(3.325) (3.215) (3.367) (3.274)
  -6.609* -5.419  -6.502* -5.478
(3.518) (3.408) (3.570) (3.477)
-7.145 -6.269  -9.065* -7.844
(4.865) (4.702) (4.932) (4.799)
 -7.104* -4.862  -6.738* -4.673
(3.725) (3.633) (3.785) (3.712)
    -9.093**    -8.283**    -9.381**    -8.659**
(4.173) (4.034) (4.236) (4.118)
     13.056***       29.387***       11.556***      27.397***
(3.290) (4.903) (3.718) (5.373)
F 5.15 6.28 4.00 4.77
Prob > F 0.0000 0.0000 0.0000 0.0000
R2 0.2594 0.3122 0.2545 0.2998
Adjusted R2 0.2090 0.2625 0.1909 0.2370
Root MSE 14.239 13.749 14.401 13.985
N 268 268 268 268
       *** significant at the 1% level 
** significant at the 5% level 
* significant at the 10% level
Heart Disease
Heart Attack
General Health
Education
Graduate Degree
Taking Cholestrol 
Medication
General Health
High School Graduate
Some College
Associates Degree
Bachelors Degree
r8
r9
r10
r11
r4
r5
r6
r7
r1
r2
r3
Risk Factors male
Age 35-44
Age 45-54
Medication
Age 55-64
Age 65 or higher
Male over Age 45
Female over Age 55
Family History of Heart 
Attack
Smoke or Live / Work 
with Smokers
High Cholesterol
Low HDL             
(Good Cholesterol)
Heart Disease OR Heart 
Attack
constant
Hypertension
Less than 30 Minutes 
Physical Activity / Day
20 Pounds or More 
Overweight
Diabetes
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Table 7-9: Survey 1: Screening OLS Regression on Perceived Risk of a Heart Attack 
Category Independent Variable Initial Perceived Risk
Perceived Risk 
after New Info
Initial 
Perceived Risk
Perceived Risk 
after New Info
-0.494 -1.486 -0.491 -1.434
(1.593) (1.889) (1.599) (1.884)
3.275  5.178* 3.121  4.756*
(2.350) (2.787) (2.363) (2.785)
    5.154**  5.179*    4.995**  4.827*
(2.487) (2.951) (2.504) (2.951)
      7.891***        9.523***       7.860***       9.682***
(2.675) (3.173) (2.709) (3.193)
    6.542**     7.168**     6.264**    6.782**
(2.823) (3.349) (2.904) (3.422)
2.665  3.240 2.639 3.172
(1.680) (1.993) (1.685) (1.986)
1.107 3.093 1.027 2.985
(1.707) (2.024) (1.722) (2.030)
2.680  3.965* 2.621 3.712
(2.001) (2.373) (2.013) (2.373)
1.397 0.907 1.323 0.691
(1.859) (2.206) (1.867) (2.200)
-0.720 -0.829 -0.701 -0.771
(0.654) (0.776) (0.657) (0.774)
   4.885**  4.602*    4.871**  4.549*
(2.003) (2.376) (2.009) (2.368)
    5.693**     5.883**     5.700**    5.890**
(2.409) (2.857) (2.415) (2.846)
       8.509***        8.781***       8.493***       8.785***
(2.440) (2.894) (2.448) (2.885)
1.976 0.406 1.615 -0.639
(3.142) (3.727) (3.182) (3.751)
    6.633** 4.137   6.111** 2.711
(2.906) (3.448) (2.981) (3.513)
    10.687**    10.987**      10.366**    10.103**
(4.312) (5.116) (4.341) (5.116)
-1.449 -0.404 -1.374 -0.309
(1.914) (2.271) (1.928) (2.273)
1.617  3.952*
(2.011) (2.370)
0.064 0.573
(0.634) (0.747)
-0.726 -1.100 -0.690 -0.740
(2.793) (3.314) (2.831) (3.337)
   -6.076**  -6.014*    -6.180**  -6.349*
(2.914) (3.457) (2.926) (3.449)
   -6.642**  -6.130*    -6.913**  -6.976*
(3.095) (3.672) (3.126) (3.685)
   -10.821**    -10.097**    -10.967**   -10.544**
(4.326) (5.132) (4.342) (5.117)
      -8.414***  -7.390*     -8.498***    -7.771**
(3.220) (3.820) (3.239) (3.818)
    -10.651***    -10.945**      -10.771***     -11.513***
(3.631) (4.308) (3.665) (4.319)
    12.167***      13.142***       11.945***      11.535**
(3.731) (4.426) (4.074) (4.801)
F 4.65 3.25 4.28 3.17
Prob > F 0.0000 0.0000 0.0000 0.0000
R2 0.3047 0.2345 0.3068 0.2465
Adjusted R2 0.2392 0.1623 0.2351 0.1687
Root MSE 12.352 14.653 12.385 14.597
N 268 268 268 268
       *** significant at the 1% level 
** significant at the 5% level 
* significant at the 10% level
 incorporates additional health data from Knowledge Networks
 incorporates both the AHA risk questions and other survey
questions on family history of heart attack
High Cholesterol or Low 
HDL
Hypertension   
(Broad)
Heart Disease
constant
Exercise
Overweight
Obese
Very Obese
Diabetes    
(Broad)
Taking Cholestrol 
Medication
male
Age 35-44
Age 45-54
Age 55-64
Age 65 or higher
Family History   
(Broad)
Smoke or Live / Work 
with Smokers
Risk Factors
Medication
Graduate Degree
Life Threat
Stress
High School Graduate
Some College
Associates Degree
Bachelors Degree
Heart Attack
White
Education
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Table 7-10:  Survey 2: Treatment  OLS Regression on Perceived Risk of a Heart Attack 
Category Independent Variable Initial Perceived Risk
Perceived Risk 
after New Info
Initial 
Perceived Risk
Perceived Risk 
after New Info
-1.054 0.076 -1.530 -0.454
(2.043) (2.252) (2.044) (2.253)
3.714 6.512 5.124 8.082
(7.083) (7.810) (7.075) (7.800)
6.696 9.548 7.681 10.644
(6.792) (7.489) (6.769) (7.463)
 11.262*   15.954** 11.878*    16.641**
(6.844) (7.546) (6.811) (7.509)
8.405  12.050* 8.919  12.622*
(6.730) (7.421) (6.696) (7.382)
4.934 7.830 5.745 8.732
(6.777) (7.473) (6.749) (7.441)
 3.362* 2.116 2.719 1.400
(2.018) (2.225) (2.031) (2.239)
 4.210*  4.722* 4.102*  4.601*
(2.464) (2.717) (2.450) (2.702)
0.616 1.479 0.618 1.481
(2.235) (2.465) (2.222) (2.450)
-0.115 0.019 -0.311 -0.199
(0.768) (0.847) (0.769) (0.848)
-0.023 0.153 -0.022 0.154
(0.166) (0.183) (0.165) (0.182)
2.903  4.766* 2.798  4.648*
(2.499) (2.756) (2.485) (2.740)
  5.357**   6.266** 4.559*    5.377**
(2.366) (2.609) (2.384) (2.629)
   3.215***     3.860***      2.961***     3.578***
(0.968) (1.068) (0.971) (1.070)
0.489 0.667 0.450 0.623
(2.541) (2.802) (2.526) (2.785)
 - 4.871***     - 5.620***     -4.750***     -5.485***
(1.167) (1.287) (1.162) (1.281)
   4.383**    4.879**
(2.139) (2.358)
-2.650 -2.745 -2.634 -2.727
(3.141) (3.463) (3.123) (3.443)
-3.771 -5.458 -4.437 -6.200
(3.582) (3.949) (3.576) (3.942)
-0.825 -2.690 -1.191 -3.097
(4.648) (5.125) (4.624) (5.098)
 - 7.031*  - 7.603* -7.027* -7.598*
(3.878) (4.276) (3.855) (4.250)
   - 14.639***     - 14.837***     -15.124***    -15.377***
(4.764) (5.253) (4.742) (5.228)
    22.893***   21.916**    21.026**    19.838**
(8.760) (9.659) (8.757) (9.654)
F 6.35 7.46 6.32 7.4
Prob > F 0.0000 0.0000 0.0000 0.0000
R2 0.328 0.3646 0.3382 0.3744
Adjusted R2 0.2763 0.3157 0.2847 0.3238
Root MSE 16.113 17.766 16.019 17.661
N 295 295 295 295
      *** significant at the 1% level 
** significant at the 5% level 
* significant at the 10% level
Graduate Degree
Taking Cholestrol 
Medication
General Health
High School Graduate
Some College
Associates Degree
Bachelors Degree
General Health
Education
Age 75 and above
Hypertension
Exercise
Risk Factors
constant
Heart Attack
Decrease in Quality of 
Life from Heart Attack
Male
Age 35-44
Age 45-54
Age 55-64
Age 65-74
Family History of Heart 
Attack
High Cholesterol
Life Threating Condition
Amount over BMI
Diabetes
Medication
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Table 7-11: Survey 1: Screening Open Ended Responses 
Treatment 
Effectiveness Serial Please tell us why you chose not to have the test even when it was offered for $0 (FREE).
85% 11 because i think it would be scarry to have someone tell you that you could have a heart attack even 
though it would be helpful in preventing an attack if there is a too stop it.
85% 176 leave well enough alone
85% 334 sometimes i dont beleive in medicine.. i hope i never have to take all kinds of pill to be healthy. also i 
am the type of person that i dont what to know i have something cuz i would just worry about it all the 
time..
85% 456 I don't want to have to worry about this type of condition
85% 547 IF IT WAS POSITIVE I WOULDN'T HAVE THE TREAMENTS.
30% 179 I do not go to the doctors, I do not give blood test. I'll die when I die, I put my faith in GOD, not man.
30% 236  I have already had two heart attacks. My heart is in bad shape I have a pace maker to help my heart 
funtion better. I probably wasn't the one to ask these queations.
30% 238 because I already know that I have a family history of heart problems and would not change my life 
style anyway
30% 283 when its your time its your time why try to prolong the eventual?
none 296 Your information said that there was no treatment available, so why would I want to know that I might 
have this problem. I'm ready to die when God is ready for me.
none 339 If there is no treatment or cure, thn I prefer NOT to know.
none 376 i consider that as the other factors that are analized in a standard blood test, this test must be 
included, after being completely determined that is accuratte, so, it must be completely and 
oabsolutely generalized for all the people having blood testings
none 412 You said earlier that there was nothing they could do for the this blood problem.So why have the test 
done?
none 466 yes I would have the teat done if it were free I hit the wrong botton. 
none 502 In this situation, there is not a treatment for vulnaralbe plaque; therefore, if I have it, I do not want to 
change my life style or worry about something that cannot be fixed anyway. If there were a treatment 
for it, I would be willing to pay $15-$20 for such a test.
none 512 If I can't change the outcome, Id rather not know.
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Table 7-12: Survey 2: Treatment Open Ended Responses 
Treatment Serial Please tell us why you chose not to have the procedure.
Refuse 1015 I would like to consult my Dr's first. Ido not know if I am physically able to go thru the test. I had a Carotid artey surgery last year to prevent a stroke 
While in the hospital I had a bad heart attack.Since thenI have been very ill at times . My lifestyle has changed But I am content with that.Only I 
have a very bitter taste >all food. I think it is the medications..I am S.O.B.at times & have Gas pains & belching.At least I am able to sit here & 
answer surveys.
Refuse 1079 The procedure would be fine but I have a congenital muscle disease that rules out statins or any chloresteral lowering medication. Medication 
creates intolerable pain.
Refuse 1150 i would have to speak to my cardiologist first
Refuse 1186 I would wish to hear what my present Doctor would recommend since I trust his recommendations
Refuse 1247 I have normal cholesterol,low blood pressure,normal pulse.My heart problem is cardiac arythmia,one attack for this type of cardiac arrest has a 
survival rate of 5%.I now have an implanted defibulator.
Refuse 1380 This survey is ridiculous. There are many kinds of heart disease. Mine has nothing to do with plaque or cholesterol or heart damage from an 
attack, so I can't really answer these questions at all.
Refuse 1402 I did't answer the last question because I have other problems, which is complicating matters. I have lung disease also.Plus,I was diagnosed as 
having lymph atenitis,years ago. 
Procedure 1262* because of the risk
Drug 1021 have had all the test - it was only a mild heart attact. and am now on medication
Drug 1036  Because, before I have any medical procedure done, I would check other resourdes (other Drs., computer, other heart patients, etc.) to see if 
there are other options and procedures for me, and then decide what I wanted to do. And, if I found out there were other options, I would not 
appreciate this doctor making it sound like I ONLY had 2 choices in the world. I would feel like he took MY CHOICE away from me when he gave 
me only HIS TWO CHOICES. Then I would not go back to him. I would appreciate a doctor who would explain all the options I had(even bypass 
surgery, etc.), and give me time to check out every resource. Then, I would discuss MY CHOICE with him & TRUST him more - because, then I 
would feel as if he was workimg with me - not for himself, by only giving me his 2 choices. 
Drug 1056 tell me the good it will do.
Drug 1058 I fear any type of operation. Unless I was on the brink of death, I would not choose to have this procedure. So many people come home from a 
hospital in worse shape than when they entered it, due to carelessness on the part of doctors and nurses and non-sterile conditions. 
Drug 1087 THERE IS NO GUARANTEE THAT THIS PROCEDURE IS ABSOLUTELY CORRECT. I DO NOT LIKE TO THINK ABOUT ANY INVASIVE 
SURGERY WITHOUT KNOWING THAT IT IS CLOSE TO 100% ACCURATE. HAVING HAD A HEART CATHERIZATION I WOULD REALLY 
HAVE TO THINK VERY LONG AND HARD ABOUT DOING THIS PROCEDURE.
Drug 1090  I'm soon be 65 years old 
Drug 1097 I am 85 years old right now - if I would be a younger man I would go for the procedure. I already had a heart catherization which told me that I have 
vein and artery blockages. I decided to go with just medication and no operating procedures. That was a year and a half ago and I have been 
doing good with this medication. The medication I am taking is - Zocor, Plavax, topal asperin and a nitro-dur patch every day. 
Drug 1098 I have lymphedema and a history of DVT. I will never have an elective surgical procedure on my legs even a simply cather insertion. I take 
oumadin regularly and will not risk going off unless absoltely necessary. No MD knowing my history would advise it.
Drug 1103 _na_
Drug 1105 I HAVE BEEN TOLD I HAVE HAD AHEART ATTACT. BUT I NEVER FELT ANY THING. I DO HAVE AN ENLARGE HERAT, AND HAVE LOST 
ABOUT 25 PERCENT OF IT FUNTION, FROM PICTURE OF ECHCOGRAM 
Drug 1113 Because I have extenuating circumstances. I went through hyperthyroidism, which caused a thyroid storm & some heart damage which makes me 
very susceptible to atrial fibrillation & I take medication for it, so it is an additional risk when considering surgery of this kind. I would need much 
more consultation with a cardiologist before doing such a procedure. At this time, I am much more apt to go into cardiac arrest than have a heart 
attack, I think.
Drug 1123 I have had test . I have no plaque.
Drug 1135 I fully recovered from my heart attack which was 32 years ago. I have not curtailed my activities, only my choice of foods and have always had my 
own cardiologist who I see 4 times a year and all my tests have been excellent.
Drug 1167 It is something my Doctor would have to order for me and also the answers I had given on this survey is not the best of my knowledge.I'm not very 
good at reading an understandng what I have read.
Drug 1171 unsure at this time need more time to think
Drug 1177 _na_
Drug 1199 _na_
Drug 1206 Do not want surgery as I have a great fear of it
Drug 1223 I have already a five way bypass and at my age and financial situation I do not think anything expencive is justified
Drug 1228 The type of heart problems I have is treated with medication. If it happens more often, then I would consider an invasive procedure to correct the 
problem. I believe the more surgery one subjects themselves to the more apt they are for infections, etc., and possible death unless it is a life and 
death situation.
Drug 1233 I am feeling fine now and I don,t want to go through any more pure Hell than I have already been through in my77 years on earth Thank you
Drug 1258 I would be afraid of this procedure unless I knew for sure that i had a problem I would only try the medication only
Drug 1275 Possibly I did not answer correctly.Although I have never had an attack I did have some problem..that could have caused an attack.Mtral valve 
prolapse..resulting in a valve replacement and replacing of the aortic valve with 5 by passes.I am on socor and have periotic echo cardiograms 
etc.I will discuss this procedure with my physician.it sounds interesting .Knowing the type of practice has surely he may now be aware of this 
Drug 1279 _na_
Drug 1300 I would choose not to have this procdure done because of the following reasons: ...other medical conditions ... breast cancer, bladder removal with 
cancer ... very poor sight, prone to strokes, etc. ...advanced age ...very poor medical health
Drug 1317 i have a negative feeling about it
Drug 1321 I choose not te procedure because of the high risk it have to the patient maybe death
Drug 1334 i resist even taking medication, let alone having a invasive procedure. eating organic, exerciseing and living a stress reduced life makes most 
sence to me. 
Drug 1350 have had five heart attacks. all were when i was still smoking. i quit smoking in 1997. am now overweight, but feel good. my father, 2 brothers, and 
only sister died of heart attacks. 2 siblings also had diabetes. after the last coded heart-attack, i sure am not ready for any other surgery. might be 
a minimal invasion, but i`m not ready yet. due to see heart Dr. soon. will then ask him what he thinks.
Drug 1355 i would not take the meds even. if it my time thats ok
Drug 1399 Because I am scared of any Procedure's that require surgery or being put under ..... 
Drug 1425 ionlyhavemiss in heartbeat 
Drug 1439 I don't know how invasive the 'procedure' is. I am not interested in heart cath--etc. 
Drug 1443 Don't want to be a ginea pig.
Drug 1454 Have no Ins.
Drug 1455 I am alreaedy under the care of physicians for my heart disease. I have had an angiogram with the resultant angioplasty. I have had follow-up 
angiograms showing no advancement of my disease. If my doctor felt that I should undergo this treatment then I would consider it.
* only one to have answered no to zero bid, all others chose medication or refused treatment  
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Table 7-13:  Survey 1: Screening  Censored Regression on WTP 
Independent Variable
       8.12e-04***        8.01e-04***        7.61e-04***        7.62e-04***
(2.91e-04) (2.89e-04) (2.89e-04) (2.88e-04)
34.714 35.918   45.019*   44.250*
(23.132) (23.042) (23.246) (23.219)
17.103 18.313 14.365 12.638
(19.730) (19.660) (19.667) (19.723)
0.193 0.179 0.181 0.190
(0.123) (0.123) (0.123) (0.123)
-13.226 -11.659 -14.261 -14.232
(32.909) (32.782) (32.596) (32.606)
-55.570 -53.529  -60.130*  -59.803*
(34.972) (34.845) (34.630) (34.634)
-56.032 -52.314 -53.909 -55.035
(49.533) (49.375) (49.169) (49.055)
-48.745 -43.698 -50.448 -50.415
(37.873) (37.869) (37.390) (37.309)
       -112.132***     -109.421**       -118.914***      -118.152***
(43.067) (42.909) (42.576) (42.474)
  0.996*
(0.551)
     1.438**
(0.629)
-0.182 0.570 0.516
(0.986) (1.052) (1.052)
    1.790**      1.741**
(0.714) (0.715)
-0.991 -1.007
(1.255) (1.254)
-11.869
(26.443)
-22.069
(26.406)
     0.724**     0.739**      0.725**     0.819**
(0.307) (0.306) (0.305) (0.329)
4.549 4.636 5.116 5.250
(3.403) (3.387) (3.380) (3.375)
-49.184 -56.786 -53.784 -42.723
(45.291) (45.398) (44.796) (48.291)
LR chi2 30.16 32.22 34.17 34.9
Prob > chi2 0.0026 0.0022 0.0019 0.0041
Pseudo R2 0.0092 0.0099 0.0105 0.0107
N 268 268 268 268
  *** significant at the 1% level 
** significant at the 5% level 
* significant at the 10% level
Weak Prior on Perceived Risk
Strong Prior on Perceived Risk
Constant
Treatment Effectiveness 30%
Treatment Effectiveness 85%
Certainty (Broad)
Starting Bid
Graduate Degree
Perceived Risk
Initial Perceived Risk
Change in Perceived Risk
High School Graduate
Some College
Associates Degree
Bachelors Degree
WTP as Dependent Variable
Household Income
MSA
Medical Spending
Life Insurance
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Table 7-14:  Survey 1: Screening  Probit on Choosing the Screening Test 
Independent Variable
4.15e-06 3.97e-06 3.52e-06 3.84e-06
(4.79e-06) (4.81e-06) (4.86e-06) (5.02e-06)
0.0523 0.028 0.137 0.129
(0.357) (0.360) (0.376) (0.378)
     0.693**     0.712**     0.692**     0.696**
(0.310) (0.315) (0.327) (0.328)
0.115 0.097 0.105 0.102
(0.602) (0.610) (0.661) (0.662)
-0.754 -0.826 -1.027 -1.037
(0.570) (0.585) (0.635) (0.637)
-1.075 -1.180 -1.378 -1.398
(0696) (0.710) (0.747) (0.751)
-0.352 -0.425 -0.592 -0.596
(0.640) (0.653) (0.689) (0.690)
-0.981 -1.015 -1.212 -1.231
(0.642) (0.652) (0.697) (0.703)
0.008
((0.010)
0.005
(0.010)
0.030    0.037*   0.037*
(0.022) (0.023) (0.023)
0.008 0.007
(0.013) (0.014)
-0.025* -0.027*
(0.015) (0.016)
        0.946***        1.007***       1.172***       1.200***
(0.372) (0.382) (0.417) (0.433)
       1.066***        1.088***       1.103***       1.118***
(0.353) (0.357) (0.359) (0.364)
  -0.039
  (0.151)
0.503 0.550 0.626 0.758
(0.650) (0.663) (0.659) (0.835)
LR chi2 22.16 23.4 26.72 26.79
Prob > chi2 0.0232 0.0245 0.0136 0.0205
Pseudo R2 0.1828 0.1930 0.2205 0.2210
N 268 268 268 268
  *** significant at the 1% level 
** significant at the 5% level 
* significant at the 10% level
Weak Prior on Perceived Risk
Strong Prior on Perceived Risk
Constant
Treatment Effectiveness 30%
Treatment Effectiveness 85%
General Health
Graduate Degree
Perceived Risk
Initial Perceived Risk
Change in Perceived Risk
High School Graduate
Some College
Associates Degree
Bachelors Degree
 TEST (1=yes, 0=no) as Dependent Variable
Household Income
MSA
Life Insurance
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Table 7-15:  Survey 1: Screening  Probit on Choosing the Screening Test, including 
Medical Spending  
Independent Variable
4.85e-06 4.68e-06 4.47e-06 4.72e-06
(5.11e-06) (5.14e-06) (5.23e-06) (5.48e-06)
0.045 0.019 0.133 0.129
(0.382) (0.386) (0.401) (0.403)
     0.643**      0.658**   0.658* 0.663*
(0.326) (0.332) (0.348) (0.350)
  0.014*     0.015**     0.015** 0.015**
(0.007) (0.007) (0.007) (0.007)
0.146 0.122 0.118 0.115
(0.628) (0.635) (0.697) (0.698)
-0.825 -0.909  -1.200* -1.215*
(0.593) (0.607) (0.679) (0.688)
-1.11  -1.221*  -1.496* -1.515*
(0.739) (0.749) (0.796) (0.807)
-0.453 -0.543 -0.776 -0.785
(0.664) (0.676) (0.727) (0.731)
-1.081  -1.118*  -1.376* -1.395*
(0.671) (0.678) 0.737 (0.749)
0.005
(0.010)
0.002
(0.010)
0.030   0.041* 0.041*
(0.024) (0.024) (0.025)
0.009 0.008
(0.013) (0.014)
-0.028* -0.029*
(0.016) (0.017)
     0.973**        1.035***        1.219*** 1.244***
(0.393) (0.403) (0.443) (0.473)
      1.082***        1.092***       1.140*** 1.158***
(0.365) (0.369) (0.376) (0.394)
  -0.027
  (0.171)
0.188 0.240 0.280 0.368
(0.700) (0.717) (0.718) (0.916)
LR chi2 28.72 30.08 33.95 33.97
Prob > chi2 0.0043 0.0046 0.0021 0.0034
Pseudo R2 0.2369 0.2482 0.2801 0.2803
N 268 268 268 268
  *** significant at the 1% level 
** significant at the 5% level 
* significant at the 10% level
Change in Perceived Risk
Weak Prior on Perceived Risk
Strong Prior on Perceived Risk
Constant
Treatment Effectiveness 30%
Treatment Effectiveness 85%
General Health
Bachelors Degree
Graduate Degree
Perceived Risk
Initial Perceived Risk
 data on medical spending was not available for individuals who did not choose the screening 
(TEST=0).  The mean value of medical spending was assigned to these observations; therefore, this 
table is intended for comparison purposes only.
 Screening TEST (1=yes, 0=no) as Dependent Variable
Household Income
MSA
Medical Spending
Life Insurance
High School Graduate
Some College
Associates Degree
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Table 7-16:  Survey 1: Screening OLS Regression on WTP for TEST=1 
Independent Variable
    7.19e-04**     6.99e-04**     6.62e-04**    6.75e-04**
3.00e-04 2.99e-04 3.00e-04 (2.99e-04)
36.078 37.369 45.699*  42.793*
(23.662) (23.589) (23.904) (23.889)
8.142 9.623 7.246 4.276
(20.348) (20.290) (20.346) (20.349)
0.130 0.113 0.114 0.135
(0.124) (0.124) (0.124) (0.124)
-18.169 -15.733 -19.473 -19.524
(-33.500) (33.403) (33.268) (33.235)
-46.232 -43.522 -49.497 -48.124
(35.839) (35.739) (35.624) (35.587)
-33.48 -28.550 -29.782 -32.683
(52.142) (52.026) (510939) (51.800)
-49.097 -42.680 -49.965 -50.930
(38.693) (38.733) (38.312) (38.204)
  -99.677**   -95.599**   -104.346**  -102.985**
(44.348) (44.245) (44.014) (43.884)
 0.939*
(0.565)
  1.478**
(0.648)
-0.438 0.191 0.029
(0.993) (1.073) (1.073)
  1.805**   1.673**
(0.727) (0.728)
-0.441 -0.417
(1.394) (1.391)
-41.106
(27.953)
 -52.289*
(28.036)
0.574*  0.590*  0.578*   0.737**
(0.311) (0.310) (0.310) (0.335)
     9.030***     9.176***     9.624***     10.108***
(3.500) (3.488) (3.492) (3.491)
-51.889 -61.633 -58.555 -25.182
(46.098) (46.285) (45.721) (48.708)
F 2.34 2.39 2.31 2.25
Prob > F 0.0076 0.0049 0.0055 0.0047
R2 0.1050 0.1155 0.1199 0.1328
Adj R2 0.0601 0.0672 0.0679 0.0138
Root MSE 140.59 140.05 140 139.56
N 252 252 252 252
  *** significant at the 1% level 
** significant at the 5% level 
* significant at the 10% level
Weak Prior on Perceived Risk
Strong Prior on Perceived Risk
Constant
Treatment Effectiveness 30%
Treatment Effectiveness 85%
Certainty (Broad)
Starting Bid
Graduate Degree
Perceived Risk
Initial Perceived Risk
Change in Perceived Risk
High School Graduate
Some College
Associates Degree
Bachelors Degree
WTP as Dependent Variable
Household Income
MSA
Medical Spending
Life Insurance
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Table 7-17:  Survey 1: Screening Heckman Selection Models 
Regression 
Equation
Selection 
Equation
Regression 
Equation
Selection 
Equation
Independent Variable WTP         TEST         (1=yes, 0=no)
WTP TEST         
(1=yes, 0=no)
      7.77e-04*** 3.83e-06      7.09e-04*** 3.88e-06
(2.93e-04) (4.46e-06) (2.90e-04) (2.70e-06)
36.661 0.122  45.206* 0.233
(23.201) (0.414) (23.226) (0.189)
20.067 0.162 16.317 0.276
(19.588) (0.296) (19.631) (0.210)
0.106   0.104
(0.116)  (0.106)
-10.579 -0.125 -14.110 -0.004
(32.705) (0.400) (32.488) (0.242)
-52.209 -0.500  -60.410* -0.382
(34.882) (0.407) (34.579) (0.270)
-43.222  -0.714* -44.313   -0.775**
(49.422) (0.381) (49.191) (0.386)
-44.248 -0.453 -51.515 -0.492
(37.755) (0.300) (37.247) (0.275)
   -108.196***     -0.801***    -117.617***    -0.867***
(42.866) (0.315) (42.532) (0.313)
    1.453** 0.007
(0.630) (0.006)
-0.212 0.004 0.517 0.010
(0.985) (0.013) (1.054) (0.009)
Strong Prior on Perceived Risk     1.820*** 0.002
(0.711) (0.007)
Weak Prior on Perceived Risk -0.885 -0.015
(1.272) (0.011)
 0.096 0.226
 (0.222) (0.183)
  0.324*    0.341**
 (0.171) (0.160)
0.477 0.467
(0.303) (0.298)
  5.730*   7.294**
(3.358) (3.339)
-49.251 0.402 -51.622 0.283
(45.189) (0.818) (44.669) (0.283)
Wald chi2
Prob > chi2
rho (ρ)
lambda (λ)
LR chi2
Prob > chi2
Censored observations
N
  *** significant at the 1% level 
** significant at the 5% level 
* significant at the 10% level
Model 1 Model 2
Household Income
MSA
Medical Spending
Life Insurance
High School Graduate
Some College
Associates Degree
0.0033
Bachelors Degree
Graduate Degree
Initial Perceived Risk
31.10
Change in Perceived Risk
Certainty (Broad)
Starting Bid
Constant
Treatment Effectiveness 30%
Treatment Effectiveness 85%
1
139.66
56.50
0.0000
16
268
34.12
0.0020
1
139.11
54.33
0.0000
16
268
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Table 7-18: Survey 1: Screening Probit on Choosing the Screening TEST (detailed) 
 
Category Independent Variable
      1.27e-05*       1.40e-05*       1.11e-05*       1.13e-05*
    (7.35e-06)      (7.67e-06)      (6.89e-06)      (7.02e-06)
0.406 0.353 0.426 0.412
(0.549) (0.584) (0.500) (0.510)
   1.508**     1.797***       1.391***      1.533***
(0.600) (0.689) (0.512) (0.550)
 0.025*   0.030**
(0.012) (0.014)
0.447 0.217 0.293 0.089
(0.833) (0.884) (0.787) (0.828)
  -1.721**   -2.002**    -1.520**   -1.667**
(0.807) (0.859) (0.728) (0.762)
  -2.407**   -2.964**   -2.139**   -2.500**
(1.109) (1.197) (0.973) (1.022)
-1.203 -1.403 -1.001 -1.165
(0.922) (1.004) (0.836) (0.904)
-1.476 -1.411 -1.385 -1.377
(0.956) (0.987) (0.871) (0.909)
 2.047*      2.334***      1.674***      1.744***
(0.746) (0.801) (0.632) (0.639)
 1.757*     1.923***     1.529***     1.621***
(0.594) (0.617) (0.520) (0.526)
  -0.928**  -0.837*   -0.960**   -0.901**
(0.484) (0.515) (0.445) (0.453)
0.493 0.566 0.272 0.261
(0.706) (0.760) (0.610) (0.630)
-0.636 -0.671 -0.427 -0.473
(0.657) (0.696) (0.571) (0.588)
-1.050  -1.423* -0.929  -1.143*
(0.720) (0.812) (0.659) (0.702)
1.442 1.603 1.404 1.332
(1.176) (1.258) (0.984) (1.013)
-0.035 -0.104 -0.056 -0.106
(0.483) (0.502) (0.427) (0.439)
 -0.786*  -0.911* -0.639 -0.683
(0.488) (0.511) (0.429) (0.436)
-0.970  -1.118* -0.669 -0.686
(0.615) (0.658) (0.493) (0.504)
  2.088**   2.093**    1.784**   1.680**
(0.903) (0.893) (0.759) (0.725)
 -0.338* -0.274   -0.359**  -0.315*
(0.202) (0.201) (0.185) (0.184)
-0.474 -0.529 -0.497 -0.496
(0.575) (0.604) (0.492) (0.503)
1.550  1.906* 1.221 1.365
(1.037) (1.118) (0.896) (0.904)
0.085 0.089 -0.062 -0.019
(0.664) (0.694) (0.578) (0.583)
-0.546 -0.479 -0.719 -0.630
(0.801) (0.855) (0.710) (0.722)
0.882 1.734 0.956 1.359
(1.041) (1.167) (0.844) (0.933)
  -2.977**   -3.267**   -2.769**   -2.745**
(1.401) (1.421) (1.194) (1.179)
0.002 0.173 -0.070 0.056
(0.470) (0.507) (0.420) (0.444)
Cholesterol Medication 0.266 -0.032 0.419 0.288
(0.904) (0.955) (0.732) (0.782)
 0.078* 0.051
(0.044) (0.035)
0.678 0.221 1.473 1.257
(1.178) (1.249) (0.979) (1.011)
LR chi2 55.17 58.65 47.96 50.3
Prob > chi2 0.0024 0.0013 0.0108 0.0084
Pseudo R2 0.4552 0.4838 0.3957 0.4150
N 268 268 268 268
       *** significant at the 1% level 
** significant at the 5% level 
* significant at the 10% level
AGE 65 and above
Family History     
(Broad)
 
Diabetes (Broad)
Smoking Environment
High Cholesterol or Low 
HDL
Exercise
Overweight
Obese
Very obese
 
 
 
Treatment 
Effectiveness
Risk Factors
Risk Aversion
Medical 
Expeditures
Education
Household Income
MSA
Life Insurance
Medical Spending
High School Graduate
Some College
Associates Degree
Income
AGE 55 - 64
constant
Effectiveness 30%
Effectiveness 85%
Male 
AGE 35 - 44
AGE 45 - 54
Hypertension (Broad)
Test (1= yes, 0 = no) as Dependent Variable
Heart disease
Change in Perceived 
Risk
White
Heart attack
Bachelors Degree
Graduate Degree
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Table 7-19: Survey 1: Screening OLS Regression on WTP for TEST=1 (detailed) 
 
Category Independent Variable WTP WTP WTP (Females) WTP (Males)
         9.46e-04***         9.33e-04***         1.20e-02*** 6.72e-04
   (3.07e-04)    (3.08e-04)     (4.21e-04) (4.85e-04)
31.947 32.368 30.606 28.252
(24.263) (24.305) (32.389) (45.900)
11.228 11.353 -6.297 24.824
(20.983) (21.012) (29.456) (31.391)
0.023 0.0219 -0.109 0.147
(0.131) (0.131) (0.180) (0.249)
-19.623 -19.639 -27.392 25.283
(33.870) (33.915) (51.068) (49.912)
 -61.379*  -60.755* -70.246 -15.789
(36.642) (36.705) (53.005) (55.803)
-63.455 -63.302 -107.171 -17.369
(52.633) (52.704) (74.687) (80.731)
-61.156 -60.417  -94.664* -14.061
(38.588) (38.657) (57.712) (59.722)
   -125.781***    -125.353***   -136.029** -78.925
(44.411) (44.476) (66.764) (66.532)
-24.930 -26.153 27.828  -84.749*
(29.872) (29.974) (46.226) (44.606)
-27.798 -28.664 25.634  -88.699*
(29.145) (29.216) (43.142) (45.832)
7.583 7.059
(18.829) (18.873)
2.825 3.801 14.510 -22.542
(27.539) (27.619) (40.958) (39.978)
10.587 10.516 -6.070 14.035
(29.582) (29.623) (43.651) (42.801)
14.687 15.737 -23.528 63.943
(31.296) (31.382) (44.178) (52.742)
61.309* 61.519* 45.620 66.110
(33.273) (33.320) (49.584) (49.980)
21.350 21.918 13.179  47.852*
(19.448) (19.495) (30.171) (28.414)
14.331 15.764 -31.987 43.290
(19.604) (19.759) (30.387) (29.899)
  56.776**   57.743** 33.963     89.128***
(23.067) (23.147) (35.996) (33.758)
-11.007 -11.465 -26.686 -0.343
(21.503) (21.544) (33.320) (34.984)
10.189 10.198  19.317* 8.999
(7.666) (7.676) (11.696) (11.404)
-18.768 -18.727   -81.058** 44.138
(23.383) (23.414) (35.982) (35.235)
-15.308 -15.113 -38.867 1.580
(27.602) (27.641) (43.516) (39.779)
28.565 28.632 -33.878   87.855**
(28.403) (28.441) (38.246) (44.939)
55.395 54.217   128.876** -23.867
(38.611) (38.707) (52.852) (70.339)
48.652 46.798 22.847 50.819
(33.728) (33.899) (50.030) (55.859)
-14.931 -14.678 -57.302 13.990
(50.826) (50.896) (101.640) (63.190)
 -43.511*  -42.269*  -58.499* -17.256
(23.061) (23.174) (33.831) (34.628)
Cholesterol Medication -35.523 -35.770 40.178  -82.775*
(32.960) (33.006) (49.640) (49.729)
-0.634 -1.180 -0.210
(0.993) (1.909) (1.273)
0.483 0.480 0.344 0.615
(0.339) (0.339) (0.464) (0.546)
   8.941**    9.009** 9.047 7.372
(3.586) (3.592) (5.902) (5.087)
-33.906 -33.252 8.098 -87.210
(58.014) (58.102) (98.603) (79.205)
F 2.01 1.95 1.66 1.61
Prob > F 0.0021 0.0028 0.0345 0.0408
R2 0.2205 0.2219 0.3719 0.3303
Adj R2 0.1106 0.1082 0.1481 0.1247
Root MSE 136.75 136.94 131.45 138.3
N 252 252 119 133
       *** significant at the 1% level 
** significant at the 5% level 
* significant at the 10% level
Starting Bid
Certainty (Broad)
AGE 65 and above
Family History         
(Broad)
 
Diabetes (Broad)
Smoking Environment
High Cholesterol or Low 
HDL
Exercise
Overweight
Obese
Very obese
 
 
 
Treatment 
Effectiveness
Risk Factors
Risk Aversion
Medical 
Expeditures
Education
Household Income
MSA
Life Insurance
Medical Spending
High School Graduate
Some College
Associates Degree
Income
Bachelors Degree
Graduate Degree
AGE 55 - 64
constant
Effectiveness 30%
Effectiveness 85%
Male 
AGE 35 - 44
AGE 45 - 54
Hypertension (Broad)
Heart disease
Change in Perceived 
Risk
White
Heart attack
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Table 7-20: Survey 1: Screening Censored Regression on WTP (detailed) 
 
Category Independent Variable WTP          (TEST = 1)
cnreg(cens: 
TEST = 1) tobit (cens = 0) OLS (WTP>0)
      9.33e-04***    1.04e-03***      1.11e-03***    8.86e-04***
  (3.08e-04) (2.87e-04) (3.00e-04) (3.21e-04)
32.368 34.297 35.220 33.514
(24.305) (22.867) (24.014) (25.490)
11.353 23.715   36.745* 5.658
(21.012) (19.769) (21.001) (22.963)
0.0219 0.062 0.065 0.035
(0.131) (0.125) (0.131) (0.134)
-19.639 -19.424 -24.922 -27.443
(33.915) (32.339) (34.084) (36.620)
 -60.755*   -73.475**    -83.033**   -68.540*
(36.705) (34.590) (36.529) (39.439)
-63.302  -89.027*   -96.746* -74.061
(52.704) (48.867) (51.196) (55.140)
-60.417  -62.096*   -70.633*   -70.931*
(38.657) (36.777) (38.776) (41.745)
   -125.353***    -142.559***     -165.628***    -126.571**
(44.476) (41.868) (44.589) (48.879)
-26.153 5.884 19.809 -47.613
(29.974) (27.419) (29.039) (32.676)
-28.664 3.317 15.344 -51.139
(29.216) (26.799) (28.469) (32.216)
7.059 -1.772 -2.178 8.410
(18.873) (17.794) (18.649) (19.715)
3.801 2.319 -3.840 10.979
(27.619) (26.243) (27.470) (28.811)
10.516 8.212 -4.455 13.723
(29.623) (27.680) (29.255) (31.818)
15.737 4.719 -5.718 14.402
(31.382) (29.870) (31.582) (33.720)
61.519*    63.122**   57.036*   61.719*
(33.320) (31.350) (32.873) (34.753)
21.918 21.780 27.09 19.582
(19.495) (18.476) (19.447) (20.579)
15.764 13.274 13.206 14.875
(19.759) (18.660) (19.684) (20.952)
  57.743**    51.171**    58.443**    58.401**
(23.147) (21.849) (22.867) (24.171)
-11.465 5.044 8.770 -16.039
(21.544) (20.393) (21.349) (22.429)
10.198 6.631 7.389 12.145
(7.676) (7.200) (7.643) (8.382)
-18.727 -21.601 -19.517 -24.134
(23.414) (22.128) (23.373) (25.053)
-15.113 -12.078 -2.066 -22.161
(27.641) (26.452) (27.742) (28.958)
28.632 24.005 31.244 20.896
(28.441) (26.912) (28.338) (30.097)
54.217 47.721 52.135 49.895
(38.707) (35.492) (37.278) (40.180)
46.798    64.445**   69.528* 44.224
(33.899) (32.426) (34.114) (35.791)
-14.678 -48.299 -62.377 -15.105
(50.896) (47.430) (50.079) (53.722)
 -42.269*  -41.574*   -38.739*   -42.559*
(23.174) (21.619) (22.720) (24.598)
Cholesterol Medication -35.770 -38.178 -43.503 -37.920
(33.006) (31.117) (32.575) (34.100)
-0.634 -0.255 -0.199 -0.706
(0.993) (0.953) (0.995) (1.027)
0.480 0.527 0.526 0.554
(0.339) (0.323) (0.338) (0.354)
   9.009** 4.088 5.536    10.590***
(3.592) (3.362) (3.597) (3.984)
-33.252 -39.236 -77.872 -10.650
(58.102) (55.159) (58.881) (64.265)
LR chi2 1.95 59.4 64.06
Prob > chi2 0.0028 0.0023 0.0006
Pseudo R2 0.2219 0.0182 0.0205
F 0.1082 1.87
Prob > F 136.94 0.0053
 R2 252 0.2264
Adjusted  R2 0.1075 0.1051
N 252 268 268 237
       *** significant at the 1% level 
** significant at the 5% level 
* significant at the 10% level
Certainty             
(Broad)
AGE 65 plus
Family History
 
Diabetes  (Broad)
Smoking Environment
High Cholesterol or Low 
HDL
Exercise
Overweight
Obese
Very obese
 
 
 
Risk Factors
Risk Aversion
Medical 
Expenditures
Education
Household Income
MSA
Life Insurance
Medical Spending
High School Graduate
Some College
Associates Degree
Income
Bachelors Degree
Graduate Degree
AGE 55 - 64
constant
Effectiveness 30%
Effectiveness 85%
Male 
AGE 35 - 44
AGE 45 - 54
Bhypertension
Change in Perceived 
Risk
Controls
Heart disease
Initial Bid
White
Heart attack
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Table 7-21:  Survey 2: Treatment Probit on Choosing the Procedure 
 
Independent Variable
       1.35e-05***        1.28e-05***
(4.39e-06) (4.59e-06)
-0.176 -0.291
(0.299) (0.315)
0.231 0.234
(0.213) (0.219)
-0.445 -0.427
(0.335) (0.344)
-0.298 -0.337
(0.374) (0.386)
-0.367 -0.259
(0.468) (0.494)
-0.274 -0.180
(0.419) (0.435)
  -1.061**  -0.985*
(0.494) (0.505)
   0.034**    0.035**
(0.015) (0.015)
0.005 0.005
(0.005) (0.006)
0.008 0.010
(0.012) (0.014)
-0.133 -0.240
(0.204) (0.216)
   0.458**
(0.209)
 -0.350*
(0.202)
   0.816**   0.967*
(0.467) (0.499)
LR chi2 23.03 31.75
Prob > chi2 0.0275 0.0043
Pseudo R2 0.094 0.1296
N 295 295
  *** significant at the 1% level 
** significant at the 5% level 
* significant at the 10% level
Constant
Cholesterol Medication
Heart Catherization
Special Information
Graduate Degree
Change in Perceived Risk
Weak Prior on Perceived Risk
Strong Prior on Perceived Risk
High School Graduate
Some College
Associates Degree
Bachelors Degree
Procedure (1=yes, 0=no) as 
Dependent Variable
Household Income
MSA
Life Insurance
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Table 7-22: Survey 2: Treatment Probit on Choosing the Procedure (detailed) 
 
Category Independent Variable Procedure   (1=yes, 0=no)
Procedure   
(w/o outliers)
Procedure  
(females)
Procedure   
(males)
  1.14e-05**   1.12e-05** 9.13e-06 1.80e-05
(5.34e-06) (5.35e-06) (6.96e-06) (1.36e-05)
-0.218 -0.216 -0.394 0.505
(0.341) (0.340) (0.548) (0.748)
-0.217 -0.222 -0.344 -0.332
(0.179) (0.179) (0.252) (0.432)
0.253 0.256 0.214 0.769
(0.263) (0.263) (0.351) (0.698)
0.230 0.230 0.233 0.333
(0.246) (0.245) (0.334) (0.549)
  -0.734*  -0.733*  -0.718 -0.609
(0.402) (0.402) (0.587) (0.878)
-0.622 -0.617 -0.593 0.184
(0.438) (0.438) (0.653) (1.026)
-0.784 -0.784 -0.595 -0.280
(0.557) (0.557) (0.906) (1.097)
-0.381 -0.376 -0.343 0.358
(0.493) (0.493) (0.743) (1.041)
   -1.238**    -1.282**     -2.501*** -1.076
(0.579) (0.582) (1.004) (1.249)
   0.037**   0.037*   0.046* 0.049
(0.016) (0.016) (0.027) (0.035)
0.005 0.005 0.005 0.005
(0.006) (0.006) (0.010) (0.014)
0.017 0.017 0.012  
(0.016) (0.016) (0.019)  
-0.416* -0.400   -0.865** 0.524
(0.258) (0.259) (0.396) (0.581)
  0.413*   0.402*  0.167  0.243
(0.239) (0.240) (0.363) (0.465)
-0.309 -0.301  -0.546* 0.240
(0.223) (0.223) (0.327) (0.519)
-0.214 -0.203 0.349     -1.603***
(0.296) (0.297) (0.453) (0.665)
   -0.224**    -0.228***     -0.421***  -3.29e-04
(0.089) (0.090) (0.142) (0.215)
0.092 0.089 0.453 -0.519
(0.246) (0.246) (0.352) (0.681)
0.169 0.163 0.013  
(0.413) (0.411) (0.560)  
-0.203 -0.214 -0.277 -0.232
(0.287) (0.288) (0.408) (0.713)
0.391 0.374 0.487 -0.284
(0.360) (0.361) (0.494) (0.847)
-0.192 -0.200 0.450  -1.743**
(0.350) (0.351) (0.519) (0.882)
  -0.723*   -0.720* -0.448 -1.294
(0.375) (0.374) (0.507) (1.084)
  -0.022*  -0.022* -0.004      -0.094***
(0.012) (0.012) (0.017) (0.035)
0.067 0.069   0.199* -0.138
(0.071) (0.071) (0.105) (0.145)
0.367 0.360   
(0.240) (0.240)   
    3.396***     3.411***  2.512     8.015***
(1.123) (1.122) (1.614) (2.984)
LR chi2 52.79 52.63 44.98 33.47
Prob > chi2 0.0021 0.0022 0.0118 0.0946
Pseudo R2 0.2154 0.2154 0.3090 0.3838
N 295 293 146 123
       *** significant at the 1% level Variable dropped by Stata
** significant at the 5% level due to insufficient variation
* significant at the 10% level 
Graduate Degree
Household Income
MSA
Life Insurance
Secure
High School Graduate
Weak Prior on 
Perceived Risk
Strong Prior on 
Perceived Risk
Change in Perceived 
Risk
Physical 
Limiations
Disabled
Married
Child Under 18
Overweight
Obese
Very obese
 
 
 
Responsibility
Gender
Medication
Familiarity
Risk Aversion
Education
Risk
Wealth
Bachelors Degree
Own Home
Some College
Associates Degree
constant
Male 
Cholesterol Medication
Heart Catherization
Age
Work
Stress
Frequency of MD Visits
Special Info
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Table 7-23: Survey 2: Treatment OLS Regression on WTP for Procedure = 1 
Category Independent Variable WTP WTP          (w/o outliers)
WTP          
(females)
WTP          
(males)
   0.109**    0.033** 0.077* -0.043
(0.053) (0.029) (0.043) (0.049)
4928.354 2284.069 -2005.946    7209.448**
(4035.789) (2192.194) (3786.757) (3223.649)
 4109.028*     3564.700*** 2674.341      5333.224***
(2184.794) (1188.434) (1903.600) (1766.389)
-1466.485 -513.044 -2811.786 2998.222
(3836.191) (2081.369) (2958.094) (3426.934)
-3198.99 -2794.225 -1851.460 -2858.137
(3534.656) (1917.513) (2784.271) (3120.109)
-1989.560 -337.581 -3968.481 4386.075
(4372.609) (2374.326) (3698.874) (3438.510)
-4689.519 -2497.080 -7984.829* 1669.639
(4969.982) (2697.980) (4106.417) (4020.062)
-72.099 595.552 -9666.696 6987.623
(6488.626) (3520.707) (6916.234) (4717.818)
-4836.537 -2790.105 -5888.573 1714.373
(5262.481) (2857.239) (4520.946) (4094.976)
    19720.280*** -602.035 -3753.547 4467.372
(7112.78) (4009.845) (13,665.87) (4997.631)
    -456.302***  -174.710* -136.912  -237.012*
(175.032) (95.728) (167.009) (125.4868)
-51.282 6.819 22.365 -12.357
(78.378) (42.591) (65.144) (60.668)
213.866 -10.362 -9.784 66.064
(155.183) (84.804) (121.414) (149.354)
-441.288 193.514 -678.573 -135.999
(3299.370) (1805.763) (2781.216) (2609.523)
-2211.117 158.622 2229.917 249.393
(3081.394) (1689.928) (2890.720) (2365.540)
   -5974.020**    -3599.107** -4208.203* -2957.343
(2875.915) (1563.618) (2452.495) (2212.747)
-1832.511 771.701 354.464 363.458
(3811.188) (2075.798) (3072.692) (3175.670)
93.881 936.109 921.855 146.502
(1184.701) (651.036) (1007.738) (993.301)
4128.444 2885.645 2676.920 5089.970
(3382.664) (1836.506) (2494.228) (3281.424)
-7061.518 -3273.953 -693.851 -5202.266
(4437.608) (2413.759) (3929.575) (3546.365)
-2608.203 -1838.732 -4569.191 -1359.294
(3652.386) (1983.329) (3150.075) (2989.931)
5937.888 651.206 1543.381 430.263
(4005.719) (2185.424) (3498.963) (3166.646)
-412.275 -1676.393 -935.609 -7131.897
(4686.081) (2543.341) (3488.426) (4564.376)
1642.73 1345.658 -2494.662     8861.012**
(5209.144) (2825.726) (4144.381) (4459.687)
  -1629.798*  -886.218* -1106.354 -326.008
(868.825) (472.477) (697.425) (744.064)
126.413 71.965 104.172 -86.992
(141.643) (76.87) (107.310) (127.409)
-1117.570 -261.545
(3048.717) (1654.785)
 0.739*  0.371* 0.357    0.650**
(0.407) (0.221) (0.365) (0.322)
706.029 60.368 343.120 -69.350
(466.701) (255.354) (420.831) (362.837)
-9967.795 -4970.592 1021.727 -7926.283
(13,509.030) (7347.943) (11,043.29) (12,080.18)
F 2.53 1.68 1.19 1.33
Prob > F 0.0001 0.0197 0.2626 0.1502
R2 0.2480 0.1817 0.2752 0.2642
Adjusted R2 0.1498 0.0739 0.0446 0.0661
Root MSE 20792 11278 11845 10998
N 252 252 117 133
       *** significant at the 1% level 
** significant at the 5% level 
* significant at the 10% level 
Starting Bid
Certainty (Broad)
Special Info
Weak Prior on 
Perceived Risk
Strong Prior on 
Perceived Risk
constant
Male 
Cholesterol Medication
Heart Catherization
Age
Overweight
Obese
Change in Perceived 
Risk
Risk Aversion
Secure
High School Graduate
Some College
Associates Degree
Bachelors Degree
Graduate Degree
Household Income
MSA
Life Insurance
Wealth
Medication
Risk
Married
Child Under 18
Work
Stress
Physical 
Limiations
Responsibility
Disabled
Very obese
 
Controls
Frequency of MD Visits
Familiarity
 
 
Education
Own Home
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Chapter VIII: Discussion and Conclusion  
 
8.1 Restatement of Motivation and Purpose 
 Despite significant advances in coronary care in the last two decades, national 
fatality rates from heart attacks have remained predominantly unchanged (Muller 1999).  
Recently, it was discovered that treatment was aimed at reducing the amount of plaque in 
the coronary vessels, while the cause of heart attacks was dependent on the composition 
of the plaque.  In particular, cardiologists now believe that 75% of all heart attacks are 
caused by a “vulnerable” plaque which creates a blockage in the vessel when it erupts 
into the bloodstream causing a clot to form.  This new theory explains why traditional 
risk factors for heart disease have failed to identify many people who are risk for heart 
attack and is evidenced by the fact that over half of the individuals who die suddenly 
from coronary heart disease (CHD) had no previous warnings prior to the attack 
(American Heart Association 2003).  Therefore, many individuals at risk for a heart 
attack are not receiving treatment and may not even be aware that they are at risk.  As a 
result, medical researchers are working to develop a screening method that is inexpensive 
and non-invasive enough to administer to the general public to better identify those at risk 
for a heart attack.  Once an individual is identified as being at high risk, treatment can be 
started.  Unfortunately, the only treatment currently available is drug therapy, which is 
only about 30% effective at reducing heart attacks.  Again, the problem being that 
cholesterol lowering drugs were developed to reduce the total amount of plaque, which 
does not necessarily reduce vulnerable plaque.  Therefore now that the cause of heart 
attacks is better understood, medical device companies are researching ways to find the 
hidden plaque and treat it.  Once this is accomplished, it is likely that many individuals 
will be eligible for this procedure; however, choosing who receives it will most likely be 
based on public policy decisions administered by Medicare. 
Because most individuals who are at risk for heart attack are 65 and over, much of 
the expenditures for managing heart disease and treating heart attack patients are covered 
by Medicare.  Therefore, in many heart-related medical cases, public policy determines 
who receives care and the level of care that is given.  In addition, a large portion of 
disability allowances stem from disabilities resulting from CHD and heart attack.  
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Therefore, the screening and treatment of vulnerable plaque is certainly an issue that 
affects the allocation of public funds.  Thus, it is important to understand the underlying 
preferences of individuals who are likely to receive these services, such that efficient 
decisions can be made regarding who is eligible to receive care and the level of care that 
will be provided when these new health options become available.   
To obtain a valuation for these services, and better understand the factors 
affecting demand, two contingent valuation surveys were conducted to elicit the 
underlying preferences of individuals by having them state their WTP for either screening 
or treatment.  The surveys were developed using decision trees that reflected the medical 
options available in both the current and desired states of the world.  After receiving 
valuable information from focus groups, both surveys were converted into web-based 
surveys and administered online.  Because Internet surveys are often prone to coverage 
bias, Knowledge Networks (KN) was selected to administer the web-based surveys using 
their nationally representative panel.  Therefore, Survey 1: Screening was administered to 
adults representing the general population, and resulted in a sample size of 268 
observations.  Using health data obtained from KN panel members, Survey 2: Treatment 
was administered to adults with doctor-diagnosed heart conditions.  This resulted in a 
sample of 295 individuals who had a greater level of familiar with heart issues, and as 
result, are expected to provide more reliable valuations for the WTP for treatment.   
 
8.2  Comparisons to Earlier Work and Theoretical Expectations 
 To help establish the validity of the data sets and better understand the factors 
affecting the WTP for screening and treatment, models of general health and perceived 
risk were developed.  The results of these models are consistent with economic theory 
and therefore, lend credibility to the data sets used to analyze WTP. 
 
8.2.1 General Health 
The general health models for both data sets are consistent with Grossman’s 
(1972) model of health production.  As expected, age has a negative and often significant 
effect on general health, especially for individuals 55 years of age and over.  Consistent 
with Grossman’s theory, education has a positive effect on general health, and is 
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statistically significant for those individuals holding a college degree.  Also as expected, 
individuals who have experienced a life threatening condition or illness report a lower 
level of general health, ceteris paribus, which is consistent with Grossman’s theory of an 
accident or injury reducing the health stock.  In addition, high levels of stress or being 
significantly overweight reduces general health.  Investments in health, such as exercise, 
improve general health; however, frequent visits to the doctor have a negative effect on 
general health, suggesting that this variable is acting as a proxy for chronic conditions 
which negatively affect health.  Finally, as Grossman predicts, individuals with higher 
levels of household income report higher levels of general health, ceteris paribus.  
Therefore, the results of the regression on general health support Grossman’s theory of 
household health production and lend credibility to the data sets used for this study. 
 
8.2.2 Perceived Risk 
Regression models including the American Heart Association (AHA) risk factors, 
and controls for cholesterol lowering medication, and education, indicate that several of 
the risk factors are significant in determining perceived risk.  These include (1) being a 
male over the age of 45, (2) being a female over the age of 55, (3) having high 
cholesterol, (4) being 20 pounds or more overweight, and (5) having coronary heart 
disease or having had a prior heart attack.  Education was highly significant and negative 
at all levels, suggesting that those with more education have lower levels of perceived 
risk.  Separating out risk factors that included more than one variable indicated that age, 
rather than gender, had more of an effect on perceived risk.  In particular, the coefficients 
on the “55 to 64” age group is positive and significant across all specifications.  This is 
not a surprising given that physicians start treating heart disease more aggressively at age 
55.  Not unexpectedly, individuals who had experienced a heart attack had a higher 
perceived risk, and the greater the severity of the attack (as measured by the degree to 
which the heart attack affected the individual’s ability to work, engage in their daily 
activities, provide for their family, and their overall quality of life), the greater the 
individual’s perceived risk.  Finally, individuals who reported a lower general health 
status or who have experienced a life threatening condition or illness also tended to 
indicate higher levels of perceived risk, ceteris paribus.     
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Comparing regressions using the individual’s self-reported perceived risk 
obtained after the new information was presented versus perceived risk prior to the new 
information suggests that individuals understood the new information and responded 
accordingly.  In fact, even though the information presented in the survey was brief and 
to the point, much like the information that would be provided to a patient by a physician, 
the regression results support the fact that respondents were able to process this 
information correctly.  Therefore, as Hoehn and Randall (2002) find in their study, a 
small amount of information is enough for respondents to “fill in” the gaps using prior 
information.  This was evident in this study by the fact that perceived risk (after the new 
information) was not well explained by traditional risk factors.  In fact, it appears the new 
information caused individuals to base their risk perceptions less on traditional risk 
factors and “fill in” using prior information, such that they relied more on factors that are 
commonly known to affect heart disease, including being overweight and smoking.    
Interestingly enough, taking cholesterol lowering medication does not 
significantly reduce perceived risk in any of the specifications, for either the Survey 1: 
Screening data or the Survey 2: Treatment data.  Currently, statin (cholesterol lowering) 
medications are only about 30% effective and take a long time to work; therefore, the 
findings from the perceived risk models suggest that individuals recognize the 
shortcoming of the drug therapy treatment currently available, and lends support to the 
need for a new, more effective treatment method.    
 
8.3 Key Results – WTP for Screening and Treatment 
 The data obtained from Survey 1: Screening indicates that the mean WTP for 
screening is $94, with a median of $50 and standard deviation of $143.  The regression 
results suggest an upward bias of $25 due to the initial bid; therefore, following 
Whitehead et al (1995) this value is subtracted in order to obtain unbiased estimates. 
Thus, after adjusting for starting point bias, the mean WTP for screening is equal to $69 
and the median is $25.  These WTP estimates include some individuals who chose not to 
have the screening and others who would only receive screening if it were offered at no 
out-of-pocket cost.  However, most individuals appear to value the screening and would 
be willing to spend some of their financial resources to receive it.  Even when no 
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treatment is available, many individuals have a positive value for the screening.  This is 
consistent with the finding by Berwick and Weinstein (1985) and suggests that 
information obtained from screening does have value for its own sake; namely, that it is 
likely to increase the individual’s expected utility by allowing for better planning and 
allocation of the individual’s time.    
The results of Survey 2: Treatment data indicate that the mean WTP for a 
treatment that is 85% effective at reducing the risk of heart attack is $7,821 with a 
median of $2,500 and standard deviation of $21,084.  The regression results suggest that 
setting the starting point bias equal to zero requires a downward adjustment of $2,005.  
Therefore, the unbiased mean WTP for treatment is $5,816 and median of $495.  This 
valuation includes some individuals in the general population who preferred drug therapy 
as a treatment option and some individuals who elected to have no treatment at all.  
Again, some individuals would only have the treatment if it were offered at no out-of-
pocket cost to them; however, as the mean and median indicate, most individuals valued 
the procedure and were willing to spend some of their financial resources to receive it.    
 
8.4 Factors that Influence the Demand for Screening and Treatment 
 In analyzing the factors that influence WTP for the screening and treatment of 
vulnerable plaque, the data analysis suggests that some factors appear to influence 
whether the individual will choose to have the screening/procedure, while other factors 
affect how much the individual is willing to pay for it.  A common issue in analyzing 
health data is how to handle the large number of zeros that are typically present in the 
data.  It is often suggested that a two-part model be used, such that a probit/logit equation 
is used to model the decision to have the screening/treatment, and then an OLS regression 
is used to model WTP, but only using those observations for which participation occurs.  
The data analysis for the Survey 1: Screening data and the Survey 2: Treatment data 
support the use of a two-part model in estimating marginal effects for factors influencing 
WTP.     
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8.3.1 The Decision to Have Screening 
The decision to have screening was modeled using two specifications of a probit 
model.  The basic model includes general measures of perceived risk as obtained from 
the respondent assessing his/her risk using a computerized visual analog scale.  The 
detailed model includes specific risk factors as measured by a risk assessment quiz 
published by the American Heart Association (AHA) and from health data obtained from 
KN which included past diagnoses and other health behaviors of the individuals in the 
sample.   
The results of the basic probit regression indicate that the new information 
received by the respondent (as measured by their change in perceived risk) was an 
important factor in the individual choosing to have the screening.  In addition, individuals 
were more likely to have the test if treatment was available (although the level of 
treatment effectiveness was not necessarily important).  And finally, those who are more 
risk averse (as measured by having life insurance) are more likely to choose the 
screening.  The results of the detailed probit model support these broad conclusions.  In 
addition, it appears that males, individuals who exercise, and those who have already 
experienced a heart attack are less likely to get the screening.  However, the base 
likelihood of getting the screening is significantly increased for individuals with high 
blood pressure. 
 Although the lack of a significant difference between WTP for screening when 
treatment is 30% effective versus when treatment is 85% effective may suggest an 
insensitivity to scope, it is important to remember that individuals are being asked to 
value screening; therefore, the effectiveness of the treatment is one step removed from 
the treatment decision.  Although respondents may not distinguish very much between a 
treatment that is 30% effective and one that is 85% effective when determining their 
WTP for screening; it is clear they do differentiate between screening in which treatment 
is available versus screening in which no treatment is available in their decision to get the 
screening test.  Since screening with the possibility of treatment is clearly larger in scope 
(offering a higher level of quality), the results of this study do suggest that individuals 
completing the CV survey did respond to variations in scope.     
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8.3.2 WTP for Screening  
The factors influencing the WTP for screening were determined using an OLS 
regression for those individuals who chose to have the screening (including those who 
would only receive the screening when it involved no out-of-pocket cost).  The data 
indicates construct validity in that, as theory would predict, higher levels of household 
income increases the WTP for screening.  This model also suggests that those with higher 
perceived risk who have strong priors regarding their risk assessment, will have a higher 
WTP for screening.  Race appears to matters in that whites (compared to non-whites) will 
tend to have a lower WTP for screening, all else constant.  And finally, (not surprisingly) 
those who are risk averse and have high cholesterol levels are willing to pay more.    
 
8.3.3 Choosing a More Effective Treatment  
 The results of the probit model indicate that the decision to have treatment is 
largely affected by household income as well as the change in perceived risk brought 
about by the new information.  In addition, familiarity plays an important role in that 
having experience with a heart catheter procedure increases the base probability of 
choosing the procedure by 0.45, indicating that those individuals who have had a heart 
catheterization procedure in the past are significantly more likely to have the procedure.  
However, requesting additional information about the procedure decreases the base 
probability of choosing the procedure by 0.31, indicating that those who are unfamiliar 
with the procedure and ask additional questions are significantly less likely to have the 
procedure, even if their perceived risk of a heart attack is high.  These results suggest that 
providing information about the risks associated with vulnerable plaque is important, but 
perhaps even more important is providing information that makes the patient feel more 
comfortable with the procedure.  Clearly the information provided by the specialist did 
not improve the likelihood that the patient would receive the recommended treatment; 
however, those who had undergone a heart catheterization procedure in the past were far 
more likely to have the procedure.  Therefore, if the objective is to encourage patients to 
receive the recommended treatment, it may be helpful to conduct a focus group of 
patients who have had a heart catheterization in the past to better understand their 
apprehensions prior to the procedure and how those views changed following the 
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procedure.  This information could then be used to create a user-friendly brochure to help 
patients unfamiliar with the procedure feel more at ease.    
 The extended probit model indicates that those individuals with physical 
limitations resulting from disability and advanced age may also be less likely to choose 
the procedure. Certainly the physician would recognize medical conditions that would 
increase the risk associated with the procedure and share those with the patient as part of 
the discussion of treatment options.  However, being aware that this may be a particular 
issue for disabled and elderly patients, care can be taken to ensure the patient is 
accurately assessing these risks, such that he/she can make an informed decision based on 
actual risks, as opposed to perceived risks that may be unfounded.  
  
8.3.4 WTP for Treatment 
  As expected, one of the largest determinants of WTP for treatment is consumer 
wealth.  As theory would predict, individuals with higher levels of household income are 
willing to pay more, as are individuals who have greater financial security.  Individuals 
with chronic conditions (as measured by frequent visits to the doctor) are willing to pay 
less for the procedure.  This is not unexpected since individuals with chronic medical 
problems would be anticipated to have a lower expected utility gain from the procedure.  
Finally, information plays a role.  Those who request additional information about the 
procedure are willing to pay about $3600 less on average compared to those who do not 
request additional information.  In addition, those who feel their risk increases from the 
new information about vulnerable plaque are willing to pay less.  These results suggest 
that those who are uncertain about the procedure and the risk reduction associated with it 
may have significant questions.  As a result, these individuals may feel less confident 
about the value of the procedure, which translates into a lower WTP.          
   
8.5 Contributions to the Literature  
8.5.1 Valuing Heart-Related Health 
In determining the reliability of results from a CV study, comparisons can be 
made to other studies.  Kartman et al. (1996) and Chestnut et al. (1996) estimate WTP to 
reduce the occurrence of angina (chest pain).  Since angina is only one symptom of heart 
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disease, it is expected that the WTP to reduce angina would be significantly less than the 
WTP to reduce the probability of a heart attack.  However, since angina can have a 
significant effect on quality of life, reducing the individual’s ability to work and engage 
in daily activities, the WTP for a reduction in angina is expected to be higher than the 
WTP for screening.  Kartman et al. (1996) find the mean WTP to reduce the number of 
chest pain occurrences by 25%-75% is between $290 and $345 (about $380-$450 in 
today’s dollars).  In order to avoid 8 additional episodes of chest pain, Chestnut et al. 
(1996) find a mean WTP of $218 (approximately $290 in today’s dollars).  Therefore, the 
results from this study seem reasonable in that mean WTP for screening is below reported 
estimates of mean WTP for reducing the occurrence of chest pain, yet the WTP for 
treatment (which would reduce the risk of heart attack) is significantly greater than the 
mean WTP for reducing the occurrence of angina.        
A study by Johannesson, et al. (1993) found that individuals in Sweden with 
elevated cholesterol levels had a mean WTP of SEK 344 (about $61 in current U.S. 
dollars135) per month to achieve a normal cholesterol level.  This equates to $732 per 
year.  Therefore, for the mean WTP for treatment ($7,821), respondents in Sweden could 
receive 10 years of normal cholesterol.  Given that the effectiveness of the treatment was 
estimated to be a maximum of 6.5 years using VSL estimates (See Section 7.9 Treatment 
Effectiveness and Value of a Statistical Life), this suggests that individuals in the 
Swedish study were not willing to pay as much.136  Of course, the goods being valued are 
not exactly the same – the good in the Swedish study reduces one potential cause of heart 
attack completely, but leaves other potential risk factors unchanged.  Therefore, the new 
procedure valued in this study may offer more benefit in that it directly reduces the risk 
of heart attack by 85%.  In addition, it is possible that differences in WTP could arise 
from the different health care systems in the two countries creating cultural differences 
regarding consumer WTP for medical treatment. 
                                                 
135 The exchange rate for August 2, 1993 (the month the study was published) was 1 SEK (Swedish Krona) 
= .123487 USD.  Exchange rate obtained from http://www.x-rates.com/cgi-bin/hlookup.cgi    
Therefore, 344 SEK = $42.48 (1993).  Using the “inflation calculation” on the Bureau of Labor Statistics 
website (http://www.bls.gov/) to adjust by the CPI indicates that $42.48 in 1993 is equivalent to $60.76 in 
current (2007) dollars. 
136 The results are similar if the mean WTP adjusted for starting point bias is used.  A mean WTP of $5,816 
would equate to approximately 8 years of normal cholesterol, compared to the maximum implied 
effectiveness of 4.5 years using VSL estimates. 
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8.5.2 Iterative Bidding with Cheap Talk and Follow-up Certainty Question 
 The iterative bidding technique used for the web-based surveys worked well in 
that a review of individual observations revealed that respondents seemed to take the 
bidding seriously, and in many cases, switched responses several times during the 
bidding process.  Unfortunately, as the empirical results illustrate, starting point bias was 
still an issue.  However, given the greater efficiency of using a multiple-bounded DC 
choice question in eliciting WTP and the power of the Internet to use real-time interface 
to generate questions based on past responses, it is likely that this new format will yield 
other variations of iterative bidding that may not be prone to starting point bias.  In 
addition, the computer capabilities of a web-based survey offer greater opportunities for 
internal checks that may help reduce the possibility of hypothetical bias.   
As mentioned previously, hypothetical bias currently poses one of the greatest 
problems for CV.  As a result, researchers have attempted to eliminate hypothetical bias 
ex ante using a cheap talk script or ex post using calibrations based on a certainty follow-
up question.  Blumenschein et al. (forthcoming 2007) find that the cheap talk script is not 
effective in removing hypothetical bias, but that recalibrating using only individuals who 
are “definitely sure” of their responses can successfully remove hypothetical bias such 
that stated intentions correspond with actual purchase decisions.  The purpose of this 
study was not to test the reliability of these methods; however, because WTP estimates 
were obtained following the cheap talk script, as well as the follow-up certainty question, 
some limited information as to the reliability of these methods can be offered by this 
study.   
For the Survey 1: Screening data, the mean initial WTP for screening (following 
the cheap talk) was $108; however, it was only $94 following the certainty question.  
Likewise, for the Survey 2: Treatment data, the mean initial WTP for treatment 
(following the cheap talk script) was $9,928; however, it dropped to $7,821 following the 
certainty question.  A final certainty question used in the focus groups indicated that most 
respondents were “definitely sure” of their WTP following the cheap talk script and the 
certainty scale question.  Therefore, from these differences, it appears that the cheap talk 
script does not sufficiently reduce hypothetical bias, but the combination of the cheap talk 
script with a certainty follow-up question may eliminate hypothetical bias (with no ex 
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post calibration required).  To test whether the cheap talk script with a follow-up certainty 
scale question can effectively eliminate hypothetical bias, a study could be conducted 
using this method in such a way that stated intentions could be compared to actual 
purchase decisions.  Because the elimination of hypothetical bias is such an important 
issue confronting the ability of CV to provide accurate measures of valuation, this is 
certainty a possible topic for future research. 
 
8.5.3 The Role of Information on Consumer Demand for Health-Related Goods 
The concepts proposed by Hoehn and Randall (2002) are particularly relevant to 
this study.  Presumably “new” information on who is at risk for a heart attack is presented 
and measures of individual risk perception are obtained both before and after respondents 
are made aware of this new information.  As Hoehn and Randall suggest, new 
information may have different effects on respondents’ perception of risk, depending on 
their priors.  The CV surveys used in this study allow for this possible heterogeneity.   In 
particular, data is collected to determine the direction and magnitude that the new 
information has on each respondent’s perception of heart attack risk.  
Although the new information presented in the survey was expected to increase 
perceived risk; as Hoehn and Randall (2002) suggest, new information does not 
necessarily have that effect.  In fact, 65% of the sample who completed Survey 
1:Screening indicate that their risk perception did not change after reading the new 
information, and 5% indicated that the new information lowered their perception of heart 
attack risk.  For the Survey 2: Treatment sample the results were similar.  Sixty percent 
indicated that their perceived risk did not change and almost 5% indicated their risk 
decreased after reading the new information.  Therefore, in both samples, a majority of 
the individuals had strong priors regarding their perceived risk of a heart attack.  As the 
results of this study indicate, this strength of prior risk perception is an important factor in 
the decision to get screening, as well as in determining WTP for the procedure.   
 
8.5.4 Does Information have Value for its own Merit? 
Berwick and Weinstein (1985) find that information that has no bearing on 
medical decisions comprises about 25% of the WTP for ultrasound for women with 
 244
normal pregnancy.  In this study, those who were most certain of their stated WTP 
(certainty=10), indicated a mean WTP of $52 for screening when no treatment is 
available, a mean WTP of $93 for screening when treatment is 30% effective, and a mean 
WTP of $135 for screening when treatment is 85% effective.  These results suggest that 
the value of information (that does not affect medical decision making) from screening is 
approximately 38% of the value of screening when the more effective treatment is 
available.  It should be noted that the number of respondents who received a version of 
Survey 1: Screening in which there was no treatment was fairly small; therefore the 
numerical results should be used cautiously; however, the results do suggest that 
information from screening (in the absence of treatment) clearly has some value for 
individuals.  Due to the fact that it is highly likely medical researchers will develop a 
screening for vulnerable plaque before they develop a treatment, a more in depth study 
focusing on the WTP for screening in the absence of treatment could be a topic for future 
research.  In addition, Berwick and Weinstein point out a potential shortcoming of 
clinical decision analysis in that it does not include the value of information from a non-
clinical standpoint in selecting the best treatment option.  This was evidence by Scenario 
2 in Chapter 4 in which screening is available, but treatment is not.  In this case, 
screening would have no bearing on the medical outcomes (as illustrated by the same 
branches in Figure 2 for both the screening and no screening options); therefore, clinical 
decision analysis would not indicate a preference for screening.  Yet the results of this 
study, and that of Berwick and Weinstein (1985), both suggest that information clearly 
has value for its own merit that should be considered in clinical decision analysis as well 
as in decisions affecting public policy. 
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Appendix A: Survey Instruments 
{Survey 1: Screening} 
{Notes appearing in {brackets} provide information for programming and do not 
appear in the online version of the survey.  Screen breaks are indicated by either 
a page break,  dashed line or solid line, the circles represent radio buttons, and 
navigational buttons appearing in the bottom right-hand corner of each screen 
are indicated by square brackets [ ]} 
{I. Welcome Screen}  
 
{1} How important do you feel it is for your doctor to include you in making 
decisions regarding your health?  
 
 Select one answer only 
 
○   Very important 
○   Somewhat important 
○   Not important  
 
 
 
[Next Question] 
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{II. General Questions} 
 
Medical advances are occurring at a rapid rate; however, this can increase the cost of 
providing health care.  Because of these rising costs, it becomes important to focus on 
how society should allocate its health care resources.  The following questions will assist 
us in determining what is important to you.  Specifically, we would like to ask how you 
would spend your own money for a medical test that could better identify who is at risk 
for a heart attack. 
 
 
 
  
         [Continue] 
 
 
{2} Have you ever been told by a doctor that you have heart disease? 
 
 Select one answer only 
 
○   Yes 
○    No 
○    I don’t know 
 
 
 
         [Next Question] 
 
 
{3} Have you ever taken medicine to reduce your cholesterol (Some examples 
include: Lipitor, Zocor, Mevacor, Pravachol)?   
 
 Select one answer only 
 
○   Yes 
○    No 
○    I don’t know 
 
 
 
         [Next Question] 
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{4} Have you ever experienced a heart attack?  
 
 Select one answer only 
 
○   Yes 
○    No 
 
 
 
         [Next Question] 
 
 
{5} Do you have a relative in your immediate family (spouse, parent, sibling, or child)  
who has experienced a heart attack? 
 
 Select one answer only 
 
○   Yes 
○    No 
 
 
 
         [Next Question] 
 
----------------------------------------------------------------------------------------------------------- 
{If respondent answers “Yes” to question 5, then ask question 5b}  
 
{5b}   Were you involved in making decisions regarding the treatment of this  
family member’s heart condition? 
 
  Select one answer only 
 
○   Yes 
○    No 
 
 
 
         [Next Question] 
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{6} Have you ever undergone a heart catheterization procedure? 
 
 Select one answer only 
 
○   Yes 
○    No 
○    I don’t know 
 
 
 
         [Next Question] 
 
 
{7} Are you a cardiologist or other health care professional who has received specific 
training in the treatment of heart disease?  
 
 Select one answer only 
 
○   Yes 
○    No 
 
 
 
         [Next Question] 
 
 
{8} Have you ever had a life-threatening condition or illness?  
 
 Select one answer only 
 
○   Yes 
○    No 
 
 
 
         [Next Question] 
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{III. Perceived Risk Questions} 
 
According to the American Heart Association, the following are factors that could 
increase your risk for a heart attack. 
 
Please click Yes or No to indicate which risk factors apply to you 
 
  
YES 
 
NO 
 
DON”T 
KNOW
Are you a man over 45 years old.                                                        ○ ○      ○ 
Are you a woman over 55 years old, OR                                    
Are you a woman less than 55, who has passed menopause OR 
Are you a woman less than 55, who has had her ovaries removed, 
but is not taking estrogen. 
   ○    ○      ○ 
Did your father or brother had a heart attack before age 55 OR 
Did your mother or sister have a heart attack before age 65. 
○ ○ ○ 
Do you smoke, or live or work with people who smoke every day. ○ ○ ○ 
 
 
 
 
 
YES 
 
NO 
 
DON”T 
KNOW
Is your total cholesterol level 240 mg/dL or higher OR Have you 
ever been told by your doctor that you have high cholesterol 
○ ○ ○ 
Is your HDL ("good") cholesterol level less than 35 mg/dL. ○ ○ ○ 
Is your blood pressure 140/90 mm Hg or higher, OR have you 
been told that your blood pressure is too high. 
○ ○ ○ 
Do you get less than a total of 30 minutes of physical activity on 
most days. 
○ ○ ○ 
 
 
 
 
 
YES 
 
NO 
 
DON”T 
KNOW
Are you 20 pounds or more overweight for your height and build. ○ ○ ○ 
Do you have diabetes OR a fasting blood sugar of 126 mg/dL or 
higher), OR do you need medicine to control your blood sugar. 
○ ○ ○ 
Do you have coronary heart disease, or have you had a heart 
attack. 
○ ○ ○ 
 
                  [Next Question] 
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   Annual Risk of Fatality (Deaths per 100,000 persons) 
 
No            Auto         High 
Risk         Accident                   Risk 
   |-----------------|-------------------------------|------------------------//------------> 
   0                    19                                      50                                            100,000 
 
 
By identifying your own risk factors on the previous screen, you probably have a better 
awareness of your own risk for having a heart attack.  Suppose you were asked to rate 
your risk of having a heart attack within the next year using the scale above (0 being NO 
risk and 50 being HIGH risk).  If your risk of dying in a car accident within the next year 
is placed at 19, where would you place your risk of having a heart attack?   
 
Although most people will have a risk in the range of 0 to 50, some people (including 
those who have already experienced a heart attack), may have a risk higher than 50 
 
 
Using the above scale as a guide, enter the number that best describes your risk of having 
a heart attack in the next year.   ______  {response will be inserted in follow-up certainty 
question on page 8} 
 
Enter an answer from 0 to 100000  [_______] 
 
{If response is not between 0 and 100,000, an error message is shown} 
 
 
 
           [Next Question] 
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New Information on Who is at Risk for Heart Attacks 
 
Most of us learned that a build up of plaque within our arteries puts us at higher risk for 
heart attack, yet at some point you have probably heard of a very healthy, young man or 
woman who died suddenly of a heart attack.  In fact, over 100,000 Americans die each 
year without ever having experienced any symptoms of heart disease.  A news report that 
aired in January 2001 on the television show 20/20 explained how this can occur.  The 
reporter stated that doctors have discovered that it is not atherosclerosis, or what many of 
us know as “hardening of the arteries,” that causes most heart attacks.  Instead, 
researchers now believe that most heart attacks are caused by something called 
“vulnerable plaque.”   
 
     
           [Continue] 
 
 
What is vulnerable plaque? 
 
Vulnerable plaque is a type of plaque that lies hidden beneath the surface of an artery, 
much like lava within a volcano.  Because this plaque is only covered by a thin cap, 
exercise or stress can “trigger” this plaque to erupt.  When this occurs, it causes a blood 
clot to form instantaneously within the vessel.  This blood clot can block the artery and 
prevent blood from traveling to the heart, which results in a heart attack. 
 
 
 
 
           [Continue] 
 
 
Who is at risk for vulnerable plaque and heart attack? 
 
Although those with high cholesterol and other known risk factors (like those mentioned 
earlier in this survey) are more at risk, apparently healthy individuals with NO prior 
symptoms of heart problems can have vulnerable plaques waiting to erupt.  Unfortunately 
there is currently no way to determine who has vulnerable plaque and who does not.  
Therefore, you may have vulnerable plaque, but be completely unaware that you are at 
increased risk of a heart attack.  
 
 
 
           [Continue] 
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After reading this new information, I feel my own risk of having a heart attack within the 
next year is now 
 
Select one answer only 
  
○   much higher 
○   somewhat higher 
○   the same 
○   somewhat lower 
○   much lower 
 
 
 
           [Next Question] 
 
 
 
   Annual Risk of Fatality (Deaths per 100,000 persons) 
 
No            Auto         High 
Risk         Accident                   Risk 
   |-----------------|-------------------------------|------------------------//------------> 
   0                    19                                      50                                            100,000 
 
 
Earlier you rated your own risk of having a heart attack as ______ on the scale above. 
 
{insert respondent’s answer  from earlier perceived risk question on page 6} 
 
Now that you have learned this new information, where would you place your risk of 
having a heart attack within the next year on this scale? ________ 
   
         
Enter an answer from 0 to 100000  [_______] 
 
{If response is not between 0 and 100,000, an error message is shown} 
 
 
 
           [Next Question] 
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{IV. Willingness to Pay Questions} 
 
Suppose you go to your regular physician for a routine exam.  During the exam, your 
doctor says the following: 
 
As part of your exam I am going to order some routine lab work.  The results from these 
tests will tell us your cholesterol level; however, I would also like to order a new test to 
see if you have vulnerable plaque.  Studies have shown that people who have LOW 
cholesterol levels and NO other risk factors CAN STILL have a heart attack due to 
vulnerable plaque.  In fact, people who have heart attacks due to vulnerable plaque often 
have no warning and show no symptoms of heart problems prior to the attack.     
 
Nearly 50% of all heart attacks result in death.  Therefore, it is very important to identify 
those at risk, so that treatment can be given. 
 
         [Continue] 
 
 
{Option 1: Treatment Version}  
 
If this test indicates you have vulnerable plaque, then we can do further testing to 
determine if treatment is necessary.  If this test indicates you do not have vulnerable 
plaque, then you will have the peace of mind from knowing that you are at significantly 
lower risk of having a heart attack  
 
{Randomize the following such that of those respondents who receive a “treatment” 
version of the survey, half will be told that the treatment is 30% effective, while the other 
half will be told that the treatment is 85% effective} 
  
Currently, the standard treatment for vulnerable plaque is drug therapy, which is 30% 
effective at reducing the occurrence of a heart attack. 
 {OR} 
There is a new treatment available specifically for vulnerable plaque, which is 85% 
effective at reducing the occurrence of a heart attack. 
 
I recommend that you strongly consider having this test.  In fact, I recommend that 
everyone consider having this test as part of their annual exam or every time they have 
their cholesterol checked. 
 
Take a moment to think about what the information from this test would be worth to you.  
Is there a benefit from finding out that you are NOT at high risk for a heart attack?  On 
the other hand, would you benefit from knowing that you ARE at increased risk of a heart 
attack and could receive treatment? 
 
          [Continue] 
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{Option 2: Non-Treatment Version} 
 
Although there is currently NO TREATMENT for vulnerable plaque, the results of this 
test would provide you with INFORMATION regarding your risk of having a heart 
attack. 
 
I recommend that you strongly consider having this test.  In fact, I recommend that 
everyone consider having this test as part of their annual exam or every time they have 
their cholesterol checked. 
 
Take a moment to think about what the information from this test would be worth to you.  
Is there a benefit from finding out that you are NOT at high risk for a heart attack, such as 
peace of mind?  On the other hand, would you benefit from knowing that you ARE at 
increased risk of a heart attack?  Although TREATMENT IS NOT AVAILABLE, it 
would provide information that may lead you to make different life decisions and allow 
you to plan accordingly. 
 
 
         [Continue] 
 
 
 
As you consider how much you would value knowing whether or not you are at increased 
risk for a heart attack, we would like to make you aware of a problem that occurs in 
surveys of this nature called “hypothetical bias.” 
 
Hypothetical bias occurs when people say they will pay more for a particular good or 
service than they actually do when paying for it out of their own pocket.  For example, 
someone may say in a survey that they would buy a pair of sunglasses, but then when 
given the opportunity to buy the sunglasses, decide not to.  That difference is what leads 
to hypothetical bias.  
 
 
          [Continue] 
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Studies have shown that “hypothetical bias” exists and that it can be quite large.  In one 
study, people were asked how much they would pay for therapy to manage a chronic 
condition.  The results of the study revealed that when the decision was hypothetical, 
people said they would pay three times more than they actually chose to pay when the 
decision was real.  That’s quite a difference, isn’t it? 
 
So, in considering what this blood test is worth to you in terms of the information it will 
provide, please also consider that due to hypothetical bias you might be tempted to say 
that it is worth more than you would actually pay if the decision to get this test were real. 
 
Do you understand hypothetical bias? 
 
Select on answer only 
 
○  Yes 
 
○  No, I would like further clarification 
       
 
         [Next Question] 
    
{If respondent selects “No, I would like further clarification, then display the following 
as the next screen, otherwise continue with the survey} 
------------------------------------------------------------------------------------------------------------ 
Suppose as part of a marketing survey you were shown a pair of sunglasses and asked 
whether you would purchase the sunglasses if they were priced at $12.  After thinking 
about it, you indicated on the survey that yes, you would purchase the sunglasses if they 
cost $12.   
 
Later the same day you are in a store and see the exact same sunglasses for sale.  They 
cost $12; however, you decided NOT to buy them.  In this example, what you said you 
would purchase was different from you actually chose to purchase.  This is a very 
common tendency and is called “hypothetical bias.”  It occurs what when people say they 
will purchase under hypothetical conditions differs from what they actually choose to 
purchase under real circumstances. 
 
Do you understand hypothetical bias?    
 
Select one answer only 
 
○  Yes 
 
○  No {Even if they answer no, move on to next question}  
 
 
         [Next Question] 
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Suppose you go to your doctor tomorrow and he/she tells you that a test for vulnerable 
plaque is now available to you.  It is a simple, but accurate blood test that will tell you 
whether you are at increased risk for a heart attack.  If you have to pay for it out of your 
own pocket, how much would you be willing to spend?  What is it worth to you?   
 
Before you answer, please consider the following: 
 
Approximately how many dollars per month do you already spend on medical care (not 
including insurance premiums)? 
 
Select one answer only 
 
  ○   Less than $20.00 per month 
  ○   $20.00 to $49.99 per month 
  ○   $50.00 to $99.99 per month 
  ○   $100.00 to $199.99 per month 
  ○   $200.00 to $500.00 per month 
  ○   More than $500.00 per month 
  ○   Don’t know 
 
 
         [Next Question] 
 
 
So ask yourself these two questions:  
 
Based on what I am already spending for medical care, how much do I have 
available to spend on this test? 
 
If I were really faced with making this decision, would I actually pay out of my 
own pocket to have this test?  Would I really spend my money in this way? 
 
 
 
 
         [Continue] 
 
 
 
      
 257
{***Iterative bidding process  – computer will generate up to 5 bids based on the 
respondent’s answers.  See “Programming Notes on Iterative Bidding” on following 
pages for algorithm and examples ***} 
 
{First bid} 
 
Now that you have considered all of these things,  
 
  If this blood test cost $______, would you choose to have it done? 
 
Select one answer only 
 
○   Yes 
○    No 
 
         [Next Question] 
 
 
{Bids 2-5} 
 
If this blood test cost $______, would you choose to have it done? 
 
Select one answer only 
 
○   Yes 
○    No 
 
         [Next Question] 
 
 
{When presenting a $0 bid, add the word “FREE” so that it appears as “$0 (FREE)”}
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{Programming Notes on Iterative Bidding} 
 
{The bidding question will be asked up to 5 times inserting “bids” according to the 
following algorithm}  
 
{The initial bid should vary randomly between $10, $40, $50, $60, and $100.}  
 
{If the respondent says “Yes” to the initial bid, the second bid should be DOUBLE the 
initial bid (if initial bid is $60, then second bid should be $120).  As long as the 
respondent says “yes”, continue to double the bid.  If the respondent says “No” to the 
initial bid, then HALF the initial bid to generate the next bid.  Continue to reduce the bids 
by HALF as long as the respondent answers “No”. } 
 
{Once the respondent changes their response (from “yes” to “no” OR “no” to “yes”), 
subsequent bids should be generated by splitting the difference between the highest “yes” 
bid and lowest “no” bid..  For example, if the respondent says “Yes” to $50, but “No” to 
$100, then the next bid should be $75 (100+50 divided by 2).}   
 
{If this process does not lead to a number that is an increment of $5, then it should be 
rounded DOWN.  For example, if the respondent’s highest “yes” bid is $50 and their 
lowest “no” bid is $75, then dividing the difference by 2 (50+75 = 125 /2 ) would yield 
$62.50.  This should be rounded down, so that the next bid is $60. (Because this survey is 
asking about the respondent’s willingness to pay for a good, it seemed rounding down the 
bids would be a more conservative approach).  Since the computer program will most 
likely not have a function to round down, this can be accomplished in the following way: 
Divide the bid by 5 (62.5 / 5 = 12.5), truncate the result (to yield 12), and then re-
multiply by 5 (12*5=60).  This method should work for all cases in which the bid does 
not end in 5 or 0 (zero).  
 
{The bidding process should stop once the response is within a $5 interval or a maximum 
of 5 bids have been generated} 
 
 
{Examples} 
 
Example 1: 
 
$50  Y (double bid from $50 to $100)       
$100  Y (double bid from $100 to $200)     
$200  N (split difference between $100 and $200)    
$150  Y (split difference between $150 and $200)   
$175  N           
(go to option 3 on page 16 and report range of $150 to $175)   
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Example 2: 
 
$50  Y (double bid from $50 to $100)   
$100 N (split difference between $50 and $100) 
$75 Y (split difference between $75 and $100 and round down)  
$85 Y (split difference between $85 and $100 and round down)  
$90 N 
(record WTP as $85  and go to page 17) 
 
Example 3: 
 
$40 N  (divide $40 in half)   
$20 Y  (split difference between $20 and $40 
$30 Y  (split difference between $30 and $40)  
$35 N        
(STOP after 4 bids – record WTP as $30 and go to page 17)     
 
{Extreme cases} 
 
Example 4: 
 
$60 N  (divide bid in half)     
$30 N  (divide bid in half)     
$15 N  (divide bid in half and round down)     
$5 N  (divide bid in half and round down)    
$0 Y      
(record WTP as $0 and go to page 17) 
 
Example 5: 
 
$10 N (divide bid in half) 
$5 N (divide bid in half and round down) 
$0 N  
(record as protest and go to page 16, option 1) 
 
Example 6: 
 
$50 Y (double bid) 
$100 Y (double bid) 
$200 Y (double bid ) 
$400 Y (double bid) 
$800 Y    
(For extremes with no upper bound, go to page 16, option 2) 
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{Option 1} 
 
{If a respondent answers “no” to a zero bid, then ask the following open-ended question} 
 
Please tell us why you chose not to have the test even when it was offered for $0 (FREE) 
    
 
         [Continue]  
 
{Direct respondent to Thank You screen and end survey}  
 
 
{Option 2} 
 
{If a respondent answers “yes” to all 5 bids, then ask the following:} 
 
You indicated that you would pay more than $_____ {insert highest “yes” bid} for this 
test.  What is the most you would be willing to spend out of pocket for this test to find out 
if you are at increased risk for a heart attack? 
  
Enter dollar amount here [_________] 
 
 
 
         [Next Question] 
 
{this response will be inserted into certainty question on page 17} 
 
 
{Option 3} 
 
{If the bidding process does not sufficiently converge the respondent’s WTP value to 
within a $5 margin of error, then ask the following:}  
 
You indicated that you would pay at least $______ {insert highest “yes” bid}, but less 
than $_______{insert lowest “no” bid}. 
 
What is the most you would be willing to spend out of pocket for this test to find out if 
you are increased risk for a heart attack? 
 
    Enter dollar amount here [________]  
 
 
         [Next Question] 
 
{this response will be inserted into certainty question on page 17} 
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If you yourself have never experienced a heart problem, then this is probably the first 
time that you have thought about how much you would value this type of test.   
 
Therefore, it is reasonable to assume that you may not be entirely sure how much you 
would really be willing to pay out of your own pocket to have it done.   
 
On a scale of 0 to 10, where 0 is “not sure at all” and 10 is “definitely sure”  
please indicate how sure you are that you would choose to get this potentially life 
saving137 test if it cost $________ {insert respondent’s previously stated WTP} 
 
 
 
      Not Sure    |------------------------------------------------------------------|   Definitely 
         At All             Sure 
              0        1       2       3        4        5       6        7        8       9       10    
 
 
 
    Enter your answer here [________] 
 
 
     
         [Next Question] 
 
         
Earlier you said that you would pay $ _____ for this test. {insert previously stated WTP} 
 
Now that you have had a chance to consider how sure you are about this decision, please 
enter the amount you would definitely (beyond any doubt) pay for this test. $________ 
 
 
 
         [Next Question] 
 
          
How many times would you expect to have this test over the course of your lifetime? 
 
Enter number here [______] 
 
  
   
   
 [Next Question] 
                                                 
137 “potentially life saving” was changed to “informative” in the non-treatment version of this survey 
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{V. Demographic Questions} 
 
To complete the survey, please answer a few questions about your background to help us 
better understand which characteristics are important in making these kinds of health care 
decisions. 
 
In general would you say your health is: 
 
Select one answer only  
         
   ○   Excellent 
  ○   Very Good 
  ○   Good 
  ○   Fair 
  ○   Poor 
 
[Next Question] 
 
 
Is there anyone NOT living with you who is financially or otherwise dependent on you 
(for example: child, elderly parent) 
 
Select one answer only 
 
○   Yes 
○   No 
 
[Next Question] 
 
 
Do you have life insurance? 
 
Select only one answer 
 
  ○   Yes 
○   No 
○   I don’t know 
 
[Next Question] 
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Which of the following best describes how financially secure you feel your family would 
be in the untimely event of your death? 
 
Select one answer only 
 
○   very secure 
○   fairly secure 
○   not very secure 
 
[Next Question] 
 
 
 
Thank you for taking this survey on willingness to pay for a testing method to better 
determine who is at risk for heart attack.  As you may have noticed, the proposed blood 
test you were asked about is hypothetical; however, clinical research is currently being 
done such that this type of test could become available in the near future.  In fact, the 
November 25,  2002  issue of U.S. News and World Report describes a blood test that 
some researchers now believe can provide additional information on who is at risk for a 
heart attack.  Therefore, the results from this study could provide valuable information to 
decision makers regarding the value that society would place on this blood test.   
 
Thanks again for your participation in this important research. 
 
 
[Continue] 
 
 
Thinking about this topic, do you have any comments you would like to 
share? 
 
Any comments welcome! 
 
 
 
 
[Continue] 
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{Survey 2: Treatment} 
 
{Notes appearing in {brackets} provide information for programming and do not 
appear in the online version of the survey.  Screen breaks are indicated by either 
a page break,  dashed line or solid line, the circles represent radio buttons, and 
navigational buttons appearing in the bottom right-hand corner of each screen 
are indicated by square brackets [ ]} 
 
{I. Welcome Screen}  
 
{1} How important do you feel it is for your doctor to include you in making 
decisions regarding your health?  
 
 Select one answer only 
 
○   Very important 
○   Somewhat important 
○   Not important  
 
 
 
[Next Question] 
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{II. General Questions} 
 
Medical advances are occurring at a rapid rate; however, this can increase the cost of 
providing health care.  Because of these rising costs, it becomes important to focus on 
how society should allocate its health care resources.  The following questions will assist 
us in determining what is important to you.  Specifically, we would like to ask how you 
would spend your own money for a medical procedure that could possibly reduce your 
risk of having a heart attack. 
 
 
 
  
         [Continue] 
 
 
{2} Have you ever been told by a doctor that you have heart disease? 
 
 Select one answer only 
 
○   Yes 
○    No 
○    I don’t know 
 
 
 
         [Next Question] 
 
 
{3} Have you ever taken medicine to reduce your cholesterol (Some examples 
include: Lipitor, Zocor, Mevacor, Pravachol)?   
 
 Select one answer only 
 
○   Yes 
○    No 
○    I don’t know 
 
 
 
         [Next Question] 
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{4} Have you ever experienced a heart attack?  
 
 Select one answer only 
 
○   Yes 
○    No 
 
 
 
         [Next Question] 
 
 
{5} Do you have a relative in your immediate family (spouse, parent, sibling, or child)  
who has experienced a heart attack? 
 
 Select one answer only 
 
○   Yes 
○    No 
 
 
 
         [Next Question] 
 
----------------------------------------------------------------------------------------------------------- 
{If respondent answers “Yes” to question 5, then ask question 5b}  
 
{5b}   Were you involved in making decisions regarding the treatment of this  
family member’s heart condition? 
 
  Select one answer only 
 
○   Yes 
○    No 
 
 
 
         [Next Question] 
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{6} Have you ever undergone a heart catheterization procedure? 
 
 Select one answer only 
 
○   Yes 
○    No 
○    I don’t know 
 
 
 
         [Next Question] 
 
 
{7} Are you a cardiologist or other health care professional who has received specific 
training in the treatment of heart disease?  
 
 Select one answer only 
 
○   Yes 
○    No 
 
 
 
         [Next Question] 
 
 
{8} Have you ever had a life-threatening condition or illness?  
 
 Select one answer only 
 
○   Yes 
○    No 
 
 
 
         [Next Question] 
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{III. Quality of Life} 
 
About half of the people who experience a heart attack die as a result.  For those who 
survive, the results can vary substantially – from “no difference” for some, to others who 
are left permanently disabled to the point of being completely dependent on others.  
Because a heart attack permanently damages the heart muscle, a majority of people who 
survive a heart attack experience chronic symptoms such as chest pain, fatigue, and 
shortness of breath.  If you have experienced a heart attack or have a close friend or 
relative who has, then you are probably already aware of how much these symptoms can 
affect your everyday life. 
 
 
                  [Continue] 
 
 
The following table describes how a heart attack may affect your quality of life. 
 
Chronic Symptoms: Symptoms such as chest pain, fatigue, and/or shortness 
of breath can occur anytime for no apparent reason, 
but are especially likely during times of exertion or 
stress.  
Ability to Exercise: Symptoms may become more severe during exercise 
Ability to Lift or engage in any 
type of Physical Exertion: 
Symptoms may become more severe as a result of any 
type of physical exertion (walking up stairs, carrying 
groceries, etc.) 
Ability to Handle Stress: Symptoms may become more severe during times of 
stress  
Potential Hospitalization: Severe symptoms may lead to hospitalization and 
possibly a heart catheterization procedure 
Work Attendance and 
Performance:  
Work attendance may be affected, and symptoms may 
affect your ability to perform your job duties  
Probability of Disability: Two-thirds of the people who experience a heart attack 
do not make a full recovery 
Probability of Recurrent Heart 
Attack 
Individuals who experience a heart attack are at a 
much greater risk of having another heart attack 
Probability of Death: About half of all heart attacks are fatal  
 
As you can see, experiencing a heart attack can greatly affect your everyday life.   
 
Please review this table carefully.  In a moment we are going to ask you how these 
symptoms might affect your life.  
 
                  [Continue] 
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{Option 1} 
 
{If answer to question #4 is “No” then ask following}  
 
Imagine that you experience a heart attack and survive.  Take a moment to think 
about how this could affect your quality of life.  How much physical exertion is required 
by your daily life and work?  How would your condition affect your ability to handle the 
stress you encounter during a typical day?   
 
In the table below, please indicate to what extent each area of your life would be affected 
by these symptoms.  
 
------------------------------------------------------------------------------------------------------------ 
{Option 2} 
 
{If answer to question #4 is “Yes” then ask the following} 
 
Earlier in this survey, you indicated that you had experienced a heart attack. Therefore, 
you know first hand the effect it can have.  Please use the table below to indicate how 
having a heart attack has affected your quality of life 
 
------------------------------------------------------------------------------------------------------------ 
 
{Table below should appear for all respondents} 
  
 Not at all Slightly Moderately Quite a 
bit 
Extremely
Ability to perform 
daily functions 
○ ○ ○ ○ ○ 
      
Ability to effectively 
complete work duties 
○ ○ ○ ○ ○ 
      
Ability to provide for 
family 
○ ○ ○ ○ ○ 
      
Overall quality of life ○ ○ ○ ○ ○ 
      
 
 
 
                  [Next Question] 
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As someone familiar with heart problems, you are probably already aware of several 
factors that place could place you at risk for a heart attack, including high blood pressure, 
high cholesterol, obesity, diabetes, family history, or having had a prior heart attack 
yourself. 
 
                  [Continue] 
    
 
 
   Annual Risk of Fatality (Deaths per 100,000 persons) 
 
No            Auto         High 
Risk         Accident                   Risk 
   |-----------------|-------------------------------|------------------------//------------> 
   0                    19                                      50                                            100,000 
 
 
Suppose you were asked to rate your risk of having a heart attack within the next year 
using the scale above (0 being NO risk and 50 being HIGH risk).  If your risk of dying in 
a car accident within the next year is placed at 19, where would you place your risk of 
having a heart attack?   
 
Everybody’s individual risk is different.  Although most people will have a risk in the 
range of 0 to 50 some people (including those who have already experienced a heart 
attack), may have a risk higher than 50 
 
Using the above scale as a guide, enter the number that you believe best describes your 
risk of having a heart attack in the next year.   ______  {response will be inserted in 
follow-up certainty question on page 28} 
 
Enter an answer from 0 to 100000  [_______] 
 
{If response is not between 0 and 100,000, an error message is shown} 
 
 
 
           [Next Question] 
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New Information on the Primary Cause of Heart Attacks 
 
At some point your doctor probably told you that having high cholesterol and a build up 
of plaque within your arteries put you at higher risk for a heart attack; but what you may 
not know is that recent medical research has revealed that this is not the whole story.  
Researchers have discovered that atherosclerosis or what many of us know as “hardening 
of the arteries” is NOT the primary cause of heart attacks.  Instead, doctors now believe 
that most heart attacks are caused by  a certain type of plaque, called “vulnerable plaque.”  
 
What is vulnerable plaque? 
 
Vulnerable plaque is a “soft” plaque that lies hidden beneath the wall of the artery, much 
like lava within a volcano.  A trigger, such as stress, can cause the plaque to rupture.  
When this happens the plaque enters the blood stream and causes a blood clot to form.  
This clot can block the artery and prevent blood from flowing to the heart, which causes a 
heart attack.  Because this process happens so quickly, a person may not experience chest 
pain or any other warning signs prior to the attack.  Therefore, it is very important to 
identify who has vulnerable plaque in order to prevent these heart attacks from occurring.   
    
           [Continue] 
 
 
Identifying and Treating those with Vulnerable Plaque 
 
It is hard to determine who has vulnerable plaque because it lies hidden within the walls 
of the arteries.  Even laboratory tests, such as those that measure good (HDL) and bad 
(LDL) cholesterol cannot identify who has vulnerable plaque.  The good news is that 
medical research is currently being done to develop a way to detect and treat vulnerable 
plaque.  In the meantime, patients are typically treated using cholesterol lowering 
medication.  However, medication alone is only 30% effective at preventing heart 
attacks.   
 
Doctors now believe that vulnerable plaque causes 75% of all heart attacks.  That is why 
developing a new, more effective treatment is so important.  
 
Who is at risk for a heart attack due to vulnerable plaque? 
 
Anyone can have vulnerable plaque, but those who have coronary artery disease or other 
risk factors like those mentioned earlier in this survey are thought to be at increased risk.  
Because vulnerable plaques tend to be located in several places within the heart vessels, 
those who have already experienced a heart attack are thought to be at even greater risk.  
In fact, research suggests that over half of the people who have already experienced a 
heart attack have at least one other vulnerable plaque that could erupt.  
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         [Continue] 
 
 
After reading this new information, I feel my own risk of having a heart attack within the 
next year is now 
 
Select one answer only 
  
○   much higher 
○   somewhat higher 
○   the same 
○   somewhat lower 
○   much lower 
 
 
 
           [Next Question] 
 
 
 
   Annual Risk of Fatality (Deaths per 100,000 persons) 
 
No            Auto         High 
Risk         Accident                   Risk 
   |-----------------|-------------------------------|------------------------//------------> 
   0                    19                                      50                                            100,000 
 
 
Earlier you rated your own risk of having a heart attack as ______ on the scale above. 
 
{insert respondent’s answer  from earlier perceived risk question on page 26} 
 
Now that you have learned this new information, where would you place your risk of 
having a heart attack within the next year on this scale? ________ 
   
         
Enter an answer from 0 to 100000  [_______] 
 
{If response is not between 0 and 100,000, an error message is shown} 
 
 
 
           [Next Question] 
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{IV. Selecting a Treatment } 
 
Suppose you begin to experience chest pain.  You immediately go see your regular 
doctor.   
 
Now suppose after some preliminary tests, your doctor tells you the following: 
 
“Your tests indicate that you are at high risk for a heart attack.  There 
are two possible treatment options.  The standard treatment for patients 
with your condition has been to prescribe a cholesterol lowering 
medication that you would take daily.  However, medication alone is only 
30% effective at reducing the occurrence of a heart attack.   
 
“Recently, a new treatment has been developed that is more effective.  
This treatment involves taking the medication I just described and having 
a minimally invasive procedure.  Having this procedure in addition to 
taking the medication will reduce your risk of having a heart attack by 
85%.  The procedure does have a very small risk of death associated with 
it – about 10 people out of 100,000 who have this procedure die from 
medical complications.  To put this in perspective, your risk of dying in a 
car accident each year is about twice this high or 19 out of 100,000.       
 
         [Continue] 
 
 
“Even though your tests indicate that you are at high risk for having a 
heart attack, these tests are not perfect.  Performing this procedure would 
give us additional information regarding your actual risk.  If, during the 
procedure, we determine that you are at risk, we can treat you as part of 
the same procedure.  This procedure could require an overnight stay at the 
hospital, but if we determine you are not at risk, you will most likely go 
home the same day.  Beyond this, no additional recovery time is 
necessary.  Therefore, once you return home, you should be able to return 
to work and your regular routine right away. 
 
“About 50% of heart attacks are fatal. For those who do survive, a heart 
attack can greatly reduce an individual’s quality of life.  Chest pain, 
fatigue, and shortness of breath can greatly diminish your ability to 
perform your work duties and can greatly affect your daily routine.  Your 
tests have indicated that you are at high risk for a heart attack.  
Having this procedure would allow us to determine your actual risk with 
much more certainty (my typo) and permit us to treat you if necessary.  
Therefore, performing this procedure could dramatically increase your 
chances of avoiding a fatal or disabling heart attack.” 
 
          [Continue] 
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You seek a second opinion and another trusted physician recommends the 
same procedure.  So, two physicians, including your regular doctor, agree 
that you should strongly consider having BOTH the procedure and 
medication 
 
Medication 
Only 
30% effective 
Procedure 
and 
Medication 
85% effective 
additional risk of death: 10/100,000 
 
 
Based on the risk and effectiveness of each treatment option, which would 
you choose? 
 
Select one answer only 
 
○    Procedure and Medication  {Go to page 33} 
○    Medication Only {Go to demographic questions} 
○    Not sure, I would like more information before deciding {Go to next page}  
 
 
         [Next Question] 
------------------------------------------------------------------------------------------------------------ 
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{If respondent chooses “Not sure, I would like more information before deciding” then 
show the information on the this page and the next as the next two screens} 
 
Because you requested additional information, the doctor who would be performing the 
procedure comes in to provide you with more detailed information. 
 
Suppose the doctor tells you the following: 
   
“This is a minimally invasive procedure that involves making a small 
incision in your upper thigh so that a very thin flexible tube, called a heart 
catheter, can be threaded through the vessel up to the coronary arteries.  
This tube will allow me to “see” into the vessel to determine if you have 
vulnerable plaque.  If vulnerable plaque is found, then I can go ahead and 
treat the area as part of the same procedure using a heart catheter designed 
specifically for treatment.   
   
“This procedure is very similar to the procedure used to place a stent or to 
perform angioplasty.  As with those procedures, you will be given a light 
sedative to relax you, although you will remain awake throughout the 
procedure.  However, you will NOT experience any “chest tightness” that 
is often experienced with angioplasty or placing a stent.  In fact, during 
this procedure you should not experience any pain, although you may feel 
a little discomfort at times.  Following this procedure, you may have to 
stay overnight in the hospital for observation.  However, if there are no 
complications, this will be done on an outpatient basis and you will be 
able to return to work and your normal routine the next day. 
 
        [Continue] 
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{continued from the previous page – screen should only be shown if the 
respondent chooses “Not sure, I would like more information before deciding” to 
the treatment question on page 30} 
 
 “I agree with your regular doctor that given your previous tests which 
indicate you are at high risk for a future heart attack, this is the best course 
of treatment.  Having this procedure in addition to taking medication 
reduces your risk of a future heart attack by 85%, compared to a 30% 
reduction from taking medication alone.  This procedure does have a small 
risk of death.  About 10 people out of 100,000 who have this procedure 
die from medical complications.  However, because your test results 
indicate that you are at high risk for a heart attack, you are probably at a 
greater risk of dying if we do not perform this procedure. 
 
 
Medication 
Only 
30% effective 
Procedure 
and 
Medication 
85% effective 
additional risk of death: 10/100,000 
 
Based on the risk and effectiveness of each treatment option, which would you 
choose? 
 
Select one answer only  
 
○    Procedure and Medication   {Go to next page} 
○    Medication Only   {Go to demographic questions} 
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Again, take a moment to think about how having a disabling or fatal heart attack might 
affect your life and that of your family.  This procedure can greatly reduce your chances 
of having a heart attack.  Think about what that is worth to you and how much you would 
value this procedure.  
 
As you consider how much this procedure would benefit you by reducing your chances of 
having a heart attack, we would like to make you aware of a problem that occurs in 
surveys of this nature called “hypothetical bias.” 
 
Hypothetical bias occurs when people say they will pay more for a particular good or 
service than they actually do when paying for it out of their own pocket.  For example, 
someone may say in a survey that they would buy a pair of sunglasses, but then when 
given the opportunity to buy the sunglasses, decide not to.  That difference is what leads 
to hypothetical bias.  
 
 
          [Continue] 
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Studies have shown that “hypothetical bias” exists and that it can be quite large.  In one 
study, people were asked how much they would pay for therapy to manage a chronic 
condition.  The results of the study revealed that when the decision was hypothetical, 
people said they would pay three times more than they actually chose to pay when the 
decision was real.  That’s quite a difference, isn’t it? 
 
So, in considering what this procedure is worth to you in terms of the reduction in the risk 
of heart attack, please also consider that due to hypothetical bias you might be tempted to 
say that it is worth more than you would actually pay if the decision to have this 
procedure were real. 
 
Do you feel you understand hypothetical bias? 
 
Select on answer only 
 
○  Yes 
 
○  No, I would like further clarification 
          
{If they respond with “No, I would like further clarification, then display the following as 
the next screen, otherwise continue with the survey} 
------------------------------------------------------------------------------------------------------------ 
 
Suppose as part of a marketing survey you were shown a pair of sunglasses and asked 
whether you would purchase the sunglasses if they were priced at $12.  After thinking 
about it, you indicated on the survey that yes, you would purchase the sunglasses if they 
cost $12.   
 
Later the same day you are in a store and see the exact same sunglasses for sale.  They 
cost $12; however, you decided NOT to buy them.  In this example, what you said you 
would purchase was different from you actually chose to purchase.  This is a very 
common tendency and is called “hypothetical bias.”  It occurs what when people say they 
will purchase under hypothetical conditions differs from what they actually choose to 
purchase under real circumstances. 
 
Do you understand hypothetical bias?    
 
Select one answer only 
 
○  Yes 
 
○  No {Even if they answer no, move on to next question}  
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Suppose you experience chest pain tomorrow.  You go to your doctor and he/she tells you 
about your treatment options.  You choose to have the new procedure because it could 
reduce your risk of having a heart attack.  If you have to pay for it out of your own 
pocket, how much would you be willing to spend?  What is it worth to you?   
 
Before you answer, please consider the following: 
 
Approximately how many dollars per month do you already spend on medical care (not 
including insurance premiums)? 
 
Select one answer only 
 
  ○   Less than $20.00 per month 
  ○   $20.00 to $49.99 per month 
  ○   $50.00 to $99.99 per month 
  ○   $100.00 to $199.99 per month 
  ○   $200.00 to $500.00 per month 
  ○   More than $500.00 per month 
  ○   Don’t know 
 
 
         [Next Question] 
 
 
Which category best describes how much you currently have in savings? 
 
Select one answer only 
 
  ○   Less than $2,500 
  ○   $2,500 – $10,000 
  ○   $10,000 - $24,999 
  ○   $25,000 - $50,000 
  ○   $50,000 - $100,000 
  ○   more than $100,000 
 
 
         [Next Question] 
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So ask yourself these two questions:  
 
Based on what I am already spending for medical care, how much do I have 
available to spend on this procedure? 
 
If I were really faced with making this decision, would I actually pay out of my 
own pocket to have this procedure?  Would I really spend my money in this way? 
 
 
 
 
         [Continue] 
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{***Iterative bidding process  – computer will generate up to 5 bids based on the 
respondent’s answers.  Follows same “Programming Notes on Iterative Bidding” as 
used in Survey 1: Screening with the following exceptions: } 
 
{The initial bid should vary randomly between $1,000; $2,000; $5,000; $8,000; and 
$10,000} 
 
{The bidding process should stop once the response is within a $100 interval or a 
maximum of 5 bids have been generated} 
 
 
{First bid} 
 
Now that you have considered all of these things,  
 
  If the procedure costs $______, would you choose to have it done? 
 
Select one answer only 
 
○   Yes 
○    No 
 
         [Next Question] 
 
 
{Bids 2-5} 
 
If the procedure costs $______, would you choose to have it done? 
 
Select one answer only 
 
○   Yes 
○    No 
 
         [Next Question] 
 
 
{When presenting a $0 bid, add the word “FREE” so that it appears as “$0 (FREE) 
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{Examples} 
 
Example 1: 
 
$1,000 – N (divide bid in half) 
$500 – Y (split difference between $500 and $1,000 and round down to nearest $100) 
$700 – N (split difference between $500 and $600) 
$600 – Y 
(STOP after 4 bids – record WTP as $600 and go to page 40) 
 
Example 2: 
 
$2,000 – N (divide bid in half) 
$1,000 – Y (split difference between $1,000 and $2,000) 
$1,500 – Y (split difference between $1,500 and $2,000 and round down) 
$1,700 – N (split difference between $1,500 and $1,700) 
$1,600 – Y 
(record WTP as 1,600 and go to page 40)  
 
Example 3: 
 
$5,000 – Y (double bid) 
$10,000 – Y (double bid) 
$20,000 – N (split difference between $10,000 and $20,000) 
$15,000 – N (split difference between $10,000 and $15,000) 
$12,500 – N 
(go to option 2 on page 39 and report range of $10,000 to $12,500) 
 
 
{Option 1} 
 
{If respondent answers “no” to a zero bid, then ask the following open-ended questions} 
 
Please tell us why you chose not to have the procedure even if it were offered for $0 
(FREE) 
 
{Direct respondent to Thank you screen and end of survey}
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{Option 2} 
 
{If the bidding process does not sufficiently converge the respondent’s WTP value to 
within a $100 margin of error, then ask the following:}  
 
You indicated that you would pay at least $______ {insert highest “yes” bid}, but less 
than $_______{insert lowest “no” bid}. 
 
What is the most you would be willing to spend out of pocket for this new procedure that 
could significantly reduce your risk of a future heart attack? 
 
    Enter dollar amount here [________]  
 
 
         [Next Question] 
 
 
{Option 3} 
 
{If a respondent answers “yes” to all 5 bids, then ask the following:} 
 
You indicated that you would pay more than $_____ {insert highest “yes” bid} for this 
procedure.   
 
What is the most you would be willing to spend out of pocket for this new procedure that 
could significantly reduce your risk of a future heart attack? 
  
Enter dollar amount here [_________] 
 
         [Next Question] 
 
 
{Option 4} 
 
{If a respondent answers “no” to all 5 bids, then ask the following:} 
 
You indicated that you would NOT be willing to pay $_____ {insert lowest “no” bid} for 
this procedure. 
 
How much would you be willing to spend out of pocket for this new procedure that could 
significantly reduce your risk of a future heart attack? 
 
 
Enter dollar amount here [_________] 
 
         [Next Question] 
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If you yourself have never experienced a heart problem, then this is probably the first 
time that you have thought about how much you would value this type of procedure.   
 
Therefore, it is reasonable to assume that you may not be entirely sure how much you 
would really be willing to pay out of your own pocket to have it done.   
 
On a scale of 0 to 10, where 0 is “not sure at all” and 10 is “definitely sure”  
please indicate how sure you are that you would choose to get this potentially life saving 
procedure if it cost $________ {insert respondent’s previously stated WTP} 
 
 
 
      Not Sure    |------------------------------------------------------------------|   Definitely 
         At All             Sure 
              0        1       2       3        4        5       6        7        8       9       10    
 
 
 
    Enter your answer here [________] 
 
 
     
         [Next Question] 
 
         
Earlier you said that you would pay $ _____ for this procedure. {insert respondent’s 
previously stated WTP} 
 
Now that you have had a chance to consider how sure you are about this decision, please 
enter the amount you would definitely (beyond any doubt) pay for this procedure. 
$________ 
 
 
 
         [Next Question] 
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{V. Demographic Questions} 
 
To complete the survey, please answer a few questions about your background to help us 
better understand which characteristics are important in making these kinds of health care 
decisions. 
 
In general would you say your health is: 
 
Select one answer only  
         
   ○   Excellent 
  ○   Very Good 
  ○   Good 
  ○   Fair 
  ○   Poor 
 
[Next Question] 
 
 
Is there anyone NOT living with you who is financially or otherwise dependent on you 
(for example: child, elderly parent) 
 
Select one answer only 
 
○   Yes 
○   No 
 
[Next Question] 
 
 
Do you have life insurance? 
 
Select only one answer 
 
  ○   Yes 
○   No 
○   I don’t know 
 
[Next Question] 
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Which of the following best describes how financially secure you feel your family would 
be in the untimely event of your death? 
 
Select one answer only 
 
○   very secure 
○   fairly secure 
○   not very secure 
 
[Next Question] 
 
 
 
Thank you for taking this survey on willingness to pay for a more effective treatment 
method.  As you may have noticed, the proposed treatment method you were asked about 
is hypothetical; however, clinical research is currently being done such that this type of 
procedure could become available in the near future.  Therefore, the results from this 
study could provide valuable information to decision makers regarding the value that 
society would place on a procedure that would reduce the occurrence of heart attacks.  
 
Thanks again for your participation in this important research. 
 
 
[Continue] 
 
 
Thinking about this topic, do you have any comments you would like to 
share? 
 
Any comments welcome! 
 
 
 
 
[Continue] 
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Appendix B: Key Statistics from Focus Groups 
 
Focus Group #1 Screening / Paper version 
 
This focus group included 6 individuals between the ages of 31-47. 
 
 # Risk 
Factors 
Perceived 
Risk 
(initial) 
Perceived 
Risk (w/ 
new info) 
Initial 
WTP 
Certainty 
(scale 0-10) 
Final 
WTP 
Certainty 
1 2 40 60 500 8 350 Yes, definitely 
2 5 10 10 0 10 0 Yes, probably 
3 3 12 15 100 6 25 Yes, definitely 
4 2 5 15 200 10 200 Yes, definitely 
5 2 5 7 50 3 50 Yes, probably 
6 2 2 18 30 9 30 Yes, probably 
 
Mean Initial WTP = $146.67  Median = $75  Max = $500 Min = $0 
Mean Final  WTP = $109.17  Median = $40  Max = $350 Min = $0 
 
Change in mean WTP (after certainty question) =  - $37.50 (25.6% decrease) 
 
The mean for the Initial WTP for the screening was $146.67.  However, after 
participants had an opportunity to assess the certainty of their initial WTP amount and 
then revise their stated WTP, the mean (Final WTP) for screening fell to $109.17.  
Therefore, the certainty question led to a $37.50 (25.6%) decrease in the mean WTP for 
the screening test.   
The responses given by the focus group to the open-format WTP question in this 
survey helped establish the starting bids that were used in the online version of Survey 1: 
Screening.  Since the mean was more likely to be influenced by a single response, the 
median was used as a guide in establishing the starting bids of $10, $40, $50, $60, $100.   
The computer algorithm used to generate the bids would either double the 
previous bid or half it (depending on the answer given by the respondent); therefore, 
these starting points also allowed the 5 possible bids to cover a range of values from $0-
$1600, which more than covers the range of values ($0-$500) given by the focus group 
participants.   
 
 288
Focus Group #2  Treatment / Paper Version 
 
This focus group included 4 individuals between the ages of 36-49. 
 
 Perceive
d Risk 
(initial) 
Perceived 
Risk (w/ 
new info) 
Initial 
WTP 
Certainty 
(scale 0-10) 
Final 
WTP 
Certainty 
1 40 60 2,000 10 2,000 Yes, definitely 
2 10 10 10,000 10 25,000 Yes, definitely 
3 12 15 1,000 10 1,000 Yes, definitely 
4 5 15 25,000 5 25,000+ Yes, definitely 
 
Mean WTP1 = $9,500 Median = $6,000 Min = $1,000 Max = $25,000  
Mean WTP2 = $13,250 Median = $13,500 Min = $1,000 Max = $25,000 
 
Change in mean WTP (after certainty question) =   $3,750 (28.3% increase) 
 
The mean for the Initial WTP for the procedure was $9,500.  However, after 
participants had an opportunity to assess the certainty of their initial WTP amount and 
then revise their stated WTP, the mean (Final WTP) for the procedure increased to 
$13,250.  Although the certainty question was originally designed to help prevent the 
possibility of hypothetical bias (and therefore was expected to lead to a reduction in the 
mean WTP); the certainty question in this case had the opposite effect.  Although this 
may at first glance seem problematic; when the participant’s reasoning (which was given 
during the focus group) is considered, it actually lends credibility not only to the validity 
of their final stated WTP, but also to the inclusion of the certainty question.    
The participant who increased their maximum WTP from $10,000 to $25,000 
indicated that answering the certainty question gave her an opportunity to reflect and 
compare this purchase decision to other large purchases she has made, such as buying a 
car.  She said “while I was thinking about how certain I was of the value I put down, I 
began to consider how much would I pay for a car, or a mortgage payment?  My life is 
worth more than those things, so I realized I would sell my car or take out a second 
mortgage to pay for this.”  The other participant who stated they would pay $25,000 said 
“I’ve had a life threatening disease and when it comes down to it, your life is worth 
everything.  When it comes down to your life, raising your children, and seeing your 
children grow up, wouldn’t you take out a mortgage?  You’d do almost anything to live.”  
Therefore, these comments suggest that the inclusion of the certainty question gave the 
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individuals an opportunity to compare this decision to other large purchase decisions they 
have made in the past, such as the purchase of a car.  By asking them about their certainty 
level, it also gave them an opportunity to consider additional sources of income that 
could be used to finance the cost of the procedure, such as refinancing their home or 
asking family members for help.   
In addition, the focus group discussion indicated that participants thought about 
quality of life.  Many participants said the warm-up questions made them think about 
how a heart attack would affect their life.  Their comments also clearly indicated that they 
were considering their budget constraint.  One participants made the comparison of  
“What is my life worth? Versus what can I afford?” and all the participants seemed to 
know exactly where they were going to get the money they said they would spend for the 
procedure. As one participant said “your part on hypothetical bias really made me think 
about that more seriously.  Because you put that information in there it made you say 
‘o.k. I’m not just going to throw down a number.’”   
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Appendix C: Informed Consent 
 
{Informed Consent Screen for Survey 1: Screening} 
 
You are invited to participate in an important study concerning a potential new screening 
test to better identify who is at risk for a heart attack.  Researchers at the University of 
Kentucky are conducting it.  It will take about 10-15 minutes to complete. 
 
If you agree to participate in the University of Kentucky study, we think that you will 
find the study interesting. 
 
 Part one contains questions about your perceived risk of having a heart attack and 
what you might be willing to pay for a screening test that would provide more 
information about your risk 
 
 Part two contains background questions about you and your feelings. 
 
You have the right to skip any questions you don’t want to answer.  You also have the 
right to withdraw from the study at any time without penalty.  The potential risk to 
respondents from completing the survey is minimal.  The benefit from completing this 
survey is that you will be contributing to research on how people value a potential new 
screening test that could help identify individuals at risk for a heart attack.  
 
Participation is completely voluntary.  As always, your identity will be unknown to 
anyone looking at the data from the study.  All of the conditions and terms described in 
the “Knowledge Networks, Inc. Privacy & Terms of Use Policy” document that you 
received when you got your WebTV equipment apply to the University of Kentucky 
study.  If you have questions about the study you may contact the investigator, Patricia 
Ryan at 508-740-9941.  She is being guided in this research by Dr. Glenn Blomquist.  If 
you have questions about your rights as a participant in the University of Kentucky study, 
or are dissatisfied with any aspect of it, you may contact the Office of Research Integrity 
at the University of Kentucky at 859-257-9428 or toll free at 1-866-400-9428. 
 
Would you like to participate in the University of Kentucky’s survey? (If you say “No” 
you will be directed to a different survey.) 
 
Select one answer only 
 
○ Yes 
 
○  No 
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{Informed Consent Screen for Survey 2: Treatment} 
 
 
You are invited to participate in an important study concerning a potential new medical 
treatment for patients with heart disease. You have been chosen for this study because 
you indicated in a previous survey that you have a doctor-diagnosed heart problem. 
Researchers at the University of Kentucky are conducting it.  It will take about 10-15 
minutes to complete. 
 
If you agree to participate in the University of Kentucky study, we think that you will 
find the study interesting. 
 
 Part one contains questions about how you feel having a heart attack would affect 
your quality of life and then asks what you would be willing to pay for a potential 
new medical procedure that could reduce your risk of having a heart attack.  
 
 Part two contains background questions about you and your feelings. 
 
You have the right to skip any questions you don’t want to answer.  You also have the 
right to withdraw from the study at any time without penalty.  The potential risk to 
respondents from completing the survey is minimal.  The benefit from completing this 
survey is that you will be contributing to research on the value people place on a potential 
new medical procedure that could reduce the occurrence of heart attacks.   
 
Participation is completely voluntary.  As always, your identity will be unknown to 
anyone looking at the data from the study.  All of the conditions and terms described in 
the “Knowledge Networks, Inc. Privacy & Terms of Use Policy” document that you 
received when you got your WebTV equipment apply to the University of Kentucky 
study.  If you have questions about the study you may contact the investigator, Patricia 
Ryan at 508-740-9941.  She is being guided in this research by Dr. Glenn Blomquist.  If 
you have questions about your rights as a participant in the University of Kentucky study, 
or are dissatisfied with any aspect of it, you may contact the Office of Research Integrity 
at the University of Kentucky at 859-257-9428 or toll free at 1-866-400-9428. 
 
Would you like to participate in the University of Kentucky’s survey? (If you say “No” 
you will be directed to a different survey.) 
 
Select one answer only 
 
○ Yes 
 
○  No 
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Appendix D: Survey Variables and Data Assignment 
 
 
Survey 1: Screening Data 
 
General health assigned for item non-response (data obtained from KN health data): 
serial #88 = 1 (poor) serial #227=2 (fair); designated by genHEALTHassign==1  
 
Stress missing for serial #116, 541, 545, 384, 552, 464, 243, 548, 496, 424, 368. All 
assigned mean =2.700389;  Identified by Stressassign=1 (0 otherwise) 
 
Serial #431 originally had 10 for number of risk factors. Since 2 risk factors are mutually 
exclusive, this would have meant that this individual said “yes” to every possible item 
that applied to them. A check of the data file revealed that this respondent selected yes 
for everything except r6 (low HDL).  The respondent is a 25 year old female; therefore r1 
(male over 55) and r2 (female over55) were changed to =0.  Other information about the 
respondent’s medical history was checked and changes were made accordingly.  Family 
history of heart problem was confirmed, smoking environment could not be confirmed or 
denied, so it was left as r4=1, health data indicated that individual did not have diabetes 
or high cholesterol, so r5, r6, and r7 changed to =0.  Health data on frequency of exercise 
indicates that individual exercises on a regular basis, so r8 (less than 20 minutes physical 
activity per day) changed to =0; individual has not had a heart attack (q4) and does not 
have coronary heart disease (q2), so r10 changed =0.  Amount over BMI = 7.1, so r9 left 
as=1.  In the end, r1, r2, r5, r6, r7, r8, r10, r11=0 and r3, r4, r9 =1 for this observation.  
 
Changes to serial #431 prompted an internal check that revealed others had marked both 
r1 (male over 45) and r2 (female over 55).  All were women, many of whom were 
elderly, so it is likely that they just saw “over 45” and checked the first box even though 
they are not “males over 45”   After confirming their gender with panel data from KN, r1 
was changed to =0 for serial #230 (66 year old female), 342 (50 year old female)*, 237 
(63 year old female), 530 (65 year old female), and 458 (58 year old female). Number of 
risk factors was also adjusted accordingly. 
 
Two additional observations selected “are you a man over 45” when they are actually 
women and answered “no” to “are you a woman over 55.”  Both are females in their 70’s, 
who again, may not have read very carefully.  Since information on their actual gender 
and age was available from KN, these risk factors were adjusted to match, such that for 
serial #249 (71 year old female) and #277 (72 year old female), r1 was changed to =0 and 
r2 was changed to =1. Number of risk factors was also adjusted accordingly.  
 
Serial #234 did not answer either perceived risk question; however, the respondent did 
indicate that the new information did not change their risk of having a heart attack.  
Therefore, initial perceive risk was assigned the sample mean = 15.07491.  Since the 
individual indicated their risk did not change, perceived risk was also set equal to 
15.07490, such that no change occurred between these two measures, as the respondent 
indicated. 
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Survey 2: Treatment Data 
 
General health assigned for item non-response (data obtained from KN health data): 
serial #1245 = 2 (fair); designated by genHEALTHassign==1 (=0 otherwise)  
 
Exercise missing for serial #1038 and 1360.  Both assigned mean =1.924915; designated 
by ExerciseassignMEAN=1 (0 otherwise) 
 
BMI and amount over BMI (AMToverBMI) missing for serial #1244, 1430, 1410, 1036, 
1206.  All assigned mean BMI = 29.21379 and mean AMToverBMI=4.917241; 
Identified by BMIassignMEAN=1 and AMToverBMIassignMEAN=1 (0 otherwise) 
 
Frequency of MD visits (freqMDvisits) missing for serial #1023 and 1022.  Both 
assigned mean = 3.204778; Identified by freqMDvisitsassignMEAN=1 (0 otherwise) 
 
Perceived risk (perRISK) missing for serial #1233 and 1317.  Both assigned mean = 
30.21502; Identified by perRISKassignMEAN=1 (0 otherwise) 
 
Quality of life after MI (QUALpostMI) missing for serial #1219, 1214, 1129, and 1334.  
All assigned mean = 2.116838.  Designated by QUALpostMIassignMEAN=1 (0 
otherwise) 
 
SECURE missing for serial #1364, 1308, 1466, 1299, 1245, and 1439.  All assigned 
mean= 2.062284; Identified by SECUREassignMEAN=1 (0 otherwise)  
 
WTP for serial # 1220 changed from $65,000 to $6,500.  While looking at some 
observations that were potential outliers (top 95%), it was discovered that this individual 
answered “yes” to a bid of $6,000 and “no” to both a bid of both $7,000 and $8,000.  
Therefore, based on the responses to the bidding, it is highly likely that when this 
individual was asked to enter the amount they were WTP, they accidentally hit an extra 
zero and entered $65,000 instead of the intended amount of $6,500.  Given that this 
individual has a household income of $25,000 with savings of $6,250 and is over the age 
of 75 (and may have poor eyesight or not be as familiar using the computer), it seems 
much more reasonable that this respondent was attempting to enter 6500 and not 65000 
as their WTP.  Therefore, the WTP for this observation was changed to correct for this 
likely data entry error.  
   
Assigned mean (78.12351) for medical spending to 28 observations (27 “I don’t know” 
and 1 skipped/refused) 
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